GO.ID,Term,Annotated,Significant,Expected,classicFisher,bonferroni,bh,foldEnrichment,Ontology
GO:0009161,ribonucleoside monophosphate metabolic p...,275,39,4.61,7.9e-25,3.80148e-21,3.80148e-21,8.46,BP
GO:0046034,ATP metabolic process,246,37,4.12,1.6e-24,7.6992e-21,3.8496e-21,8.98,BP
GO:0009123,nucleoside monophosphate metabolic proce...,284,39,4.76,2.7e-24,1.2992400000000001e-20,4.3308e-21,8.19,BP
GO:0009167,purine ribonucleoside monophosphate meta...,271,38,4.54,4.9e-24,2.35788e-20,5.38944e-21,8.37,BP
GO:0009126,purine nucleoside monophosphate metaboli...,272,38,4.56,5.6e-24,2.6947200000000002e-20,5.38944e-21,8.33,BP
GO:0009205,purine ribonucleoside triphosphate metab...,271,37,4.54,5.2e-23,2.50224e-19,4.1704e-20,8.15,BP
GO:0009199,ribonucleoside triphosphate metabolic pr...,275,37,4.61,8.8e-23,4.23456e-19,6.049371428571428e-20,8.03,BP
GO:0009144,purine nucleoside triphosphate metabolic...,279,37,4.67,1.5e-22,7.218e-19,9.0225e-20,7.92,BP
GO:0009141,nucleoside triphosphate metabolic proces...,295,37,4.94,1.0e-21,4.8119999999999995e-18,5.346666666666665e-19,7.49,BP
GO:1901564,organonitrogen compound metabolic proces...,6107,187,102.29,1.8e-21,8.6616e-18,8.661599999999999e-19,1.83,BP
GO:0017144,drug metabolic process,727,53,12.18,1.3e-19,6.255600000000001e-16,5.552307692307692e-17,4.35,BP
GO:0019637,organophosphate metabolic process,957,61,16.03,1.4e-19,6.7368e-16,5.552307692307692e-17,3.81,BP
GO:0044237,cellular metabolic process,9392,241,157.32,1.5e-19,7.218e-16,5.552307692307692e-17,1.53,BP
GO:0009259,ribonucleotide metabolic process,431,41,7.22,2.0e-19,9.624e-16,6.874285714285714e-17,5.68,BP
GO:0009117,nucleotide metabolic process,556,46,9.31,3.0e-19,1.4436e-15,9.624e-17,4.94,BP
GO:0006753,nucleoside phosphate metabolic process,564,46,9.45,5.3e-19,2.55036e-15,1.593975e-16,4.87,BP
GO:0009150,purine ribonucleotide metabolic process,421,40,7.05,6.0e-19,2.8872e-15,1.6983529411764705e-16,5.67,BP
GO:0019693,ribose phosphate metabolic process,448,41,7.5,8.2e-19,3.94584e-15,2.1921333333333332e-16,5.47,BP
GO:0009987,cellular process,15679,327,262.62,1.5e-18,7.218e-15,3.7989473684210527e-16,1.25,BP
GO:0008152,metabolic process,10362,254,173.56,2.0e-18,9.624e-15,4.812e-16,1.46,BP
GO:0006163,purine nucleotide metabolic process,446,40,7.47,4.6e-18,2.21352e-14,1.054057142857143e-15,5.35,BP
GO:0055086,nucleobase-containing small molecule met...,631,47,10.57,8.1e-18,3.89772e-14,1.771690909090909e-15,4.45,BP
GO:0051641,cellular localization,2629,104,44.04,1.1e-17,5.2932e-14,2.301391304347826e-15,2.36,BP
GO:0072521,purine-containing compound metabolic pro...,492,41,8.24,2.4e-17,1.15488e-13,4.812e-15,4.98,BP
GO:0006807,nitrogen compound metabolic process,8802,225,147.43,5.3e-17,2.55036e-13,1.020144e-14,1.53,BP
GO:0006091,generation of precursor metabolites and ...,385,35,6.45,4.2e-16,2.02104e-12,7.77323076923077e-14,5.43,BP
GO:0044238,primary metabolic process,9317,231,156.06,5.7e-16,2.74284e-12,1.0158666666666667e-13,1.48,BP
GO:0008104,protein localization,2633,100,44.1,9.1e-16,4.37892e-12,1.5639e-13,2.27,BP
GO:0006518,peptide metabolic process,749,48,12.55,1.3e-15,6.2556e-12,2.1571034482758624e-13,3.82,BP
GO:0042775,mitochondrial ATP synthesis coupled elec...,59,16,0.99,1.6e-15,7.6992e-12,2.5664e-13,16.16,BP
GO:0033036,macromolecule localization,2958,107,49.55,1.7e-15,8.1804e-12,2.6388387096774195e-13,2.16,BP
GO:0051179,localization,5896,168,98.76,2.7e-15,1.2992400000000001e-11,3.9370909090909093e-13,1.7,BP
GO:0034641,cellular nitrogen compound metabolic pro...,5536,161,92.73,2.7e-15,1.2992400000000001e-11,3.9370909090909093e-13,1.74,BP
GO:0051234,establishment of localization,4469,139,74.86,4.3e-15,2.0691599999999998e-11,6.085764705882352e-13,1.86,BP
GO:0006810,transport,4327,136,72.48,4.5e-15,2.1654e-11,6.11254054054054e-13,1.88,BP
GO:0071704,organic substance metabolic process,9887,238,165.61,4.6e-15,2.21352e-11,6.11254054054054e-13,1.44,BP
GO:0022900,electron transport chain,87,18,1.46,4.7e-15,2.2616399999999998e-11,6.11254054054054e-13,12.33,BP
GO:0042773,ATP synthesis coupled electron transport,63,16,1.06,4.9e-15,2.35788e-11,6.204947368421053e-13,15.09,BP
GO:0006119,oxidative phosphorylation,101,19,1.69,5.2e-15,2.50224e-11,6.416e-13,11.24,BP
GO:0006796,phosphate-containing compound metabolic ...,2963,106,49.63,5.4e-15,2.5984800000000002e-11,6.4962e-13,2.14,BP
GO:0034613,cellular protein localization,1709,75,28.63,7.0e-15,3.3684e-11,8.21560975609756e-13,2.62,BP
GO:0006793,phosphorus metabolic process,2985,106,50,8.8e-15,4.2345599999999994e-11,1.0082285714285714e-12,2.12,BP
GO:0045333,cellular respiration,168,23,2.81,9.3e-15,4.47516e-11,1.0389545454545455e-12,8.19,BP
GO:0070727,cellular macromolecule localization,1719,75,28.79,9.5e-15,4.5714000000000005e-11,1.0389545454545455e-12,2.61,BP
GO:0065008,regulation of biological quality,4092,130,68.54,1.2e-14,5.7743999999999995e-11,1.2832e-12,1.9,BP
GO:0015985,"energy coupled proton transport, down el...",22,11,0.37,1.5e-14,7.217999999999999e-11,1.5357446808510636e-12,29.73,BP
GO:0015986,ATP synthesis coupled proton transport,22,11,0.37,1.5e-14,7.217999999999999e-11,1.5357446808510636e-12,29.73,BP
GO:0044085,cellular component biogenesis,3057,107,51.2,1.7e-14,8.1804e-11,1.70425e-12,2.09,BP
GO:0071840,cellular component organization or bioge...,6181,171,103.53,2.2e-14,1.05864e-10,2.1604897959183674e-12,1.65,BP
GO:0022904,respiratory electron transport chain,83,17,1.39,3.3e-14,1.58796e-10,3.1759199999999997e-12,12.23,BP
GO:0051649,establishment of localization in cell,1933,79,32.38,5.3e-14,2.55036e-10,4.997076923076923e-12,2.44,BP
GO:0015980,energy derivation by oxidation of organi...,262,27,4.39,5.4e-14,2.5984799999999997e-10,4.997076923076923e-12,6.15,BP
GO:1901566,organonitrogen compound biosynthetic pro...,1564,69,26.2,8.3e-14,3.99396e-10,7.53577358490566e-12,2.63,BP
GO:0034622,cellular protein-containing complex asse...,1000,53,16.75,9.2e-14,4.42704e-10,8.198222222222223e-12,3.16,BP
GO:1902600,proton transmembrane transport,90,17,1.51,1.4e-13,6.7368e-10,1.2248727272727272e-11,11.26,BP
GO:0022607,cellular component assembly,2829,99,47.39,2.5e-13,1.2029999999999999e-9,2.1482142857142857e-11,2.09,BP
GO:0043933,protein-containing complex subunit organ...,1969,78,32.98,4.0e-13,1.9248000000000002e-9,3.376842105263158e-11,2.37,BP
GO:0016043,cellular component organization,6004,164,100.57,4.3e-13,2.06916e-9,3.5675172413793106e-11,1.63,BP
GO:0065003,protein-containing complex assembly,1740,72,29.15,5.0e-13,2.4059999999999998e-9,4.0779661016949155e-11,2.47,BP
GO:0055114,oxidation-reduction process,878,48,14.71,5.1e-13,2.4541200000000002e-09,4.0902000000000006e-11,3.26,BP
GO:0046907,intracellular transport,1523,66,25.51,7.3e-13,3.51276e-9,5.758622950819673e-11,2.59,BP
GO:1901135,carbohydrate derivative metabolic proces...,1003,51,16.8,1.4e-12,6.7368e-9,1.052625e-10,3.04,BP
GO:0045184,establishment of protein localization,1896,75,31.76,1.4e-12,6.7368e-9,1.052625e-10,2.36,BP
GO:0043603,cellular amide metabolic process,970,50,16.25,1.4e-12,6.7368e-9,1.052625e-10,3.08,BP
GO:0006412,translation,572,37,9.58,2.3e-12,1.10676e-8,1.7027076923076925e-10,3.86,BP
GO:0044281,small molecule metabolic process,1760,71,29.48,2.5e-12,1.203e-8,1.8227272727272725e-10,2.41,BP
GO:0032880,regulation of protein localization,1057,52,17.7,2.8e-12,1.34736e-8,2.0109850746268658e-10,2.94,BP
GO:0042886,amide transport,1859,73,31.14,4.2e-12,2.02104e-8,2.9721176470588234e-10,2.34,BP
GO:0015031,protein transport,1784,71,29.88,4.8e-12,2.3097599999999998e-8,3.347478260869565e-10,2.38,BP
GO:0060341,regulation of cellular localization,971,49,16.26,5.3e-12,2.55036e-8,3.643371428571429e-10,3.01,BP
GO:0015833,peptide transport,1838,72,30.79,6.9e-12,3.32028e-8,4.676450704225351e-10,2.34,BP
GO:0043043,peptide biosynthetic process,595,37,9.97,7.5e-12,3.609e-8,5.0125e-10,3.71,BP
GO:1903827,regulation of cellular protein localizat...,526,34,8.81,2.0e-11,9.624e-8,1.3005405405405405e-9,3.86,BP
GO:0006996,organelle organization,3599,111,60.28,2.0e-11,9.624e-8,1.3005405405405405e-9,1.84,BP
GO:0019725,cellular homeostasis,940,47,15.75,2.1e-11,1.01052e-7,1.3473599999999998e-9,2.98,BP
GO:0032879,regulation of localization,2869,95,48.06,2.2e-11,1.0586400000000001e-7,1.3929473684210527e-9,1.98,BP
GO:0008219,cell death,2108,77,35.31,3.3e-11,1.5879600000000001e-7,2.0622857142857146e-9,2.18,BP
GO:0071702,organic substance transport,2551,87,42.73,4.6e-11,2.21352e-7,2.837846153846154e-9,2.04,BP
GO:1903829,positive regulation of cellular protein ...,302,25,5.06,6.0e-11,2.8872e-7,3.6546835443037972e-9,4.94,BP
GO:0071705,nitrogen compound transport,2178,78,36.48,6.2e-11,2.98344e-7,3.7293e-9,2.14,BP
GO:0006754,ATP biosynthetic process,133,17,2.23,9.3e-11,4.47516e-7,5.524888888888889e-9,7.62,BP
GO:0006915,apoptotic process,1905,71,31.91,9.7e-11,4.66764e-7,5.681638554216867e-9,2.23,BP
GO:0012501,programmed cell death,1947,72,32.61,9.8e-11,4.71576e-7,5.681638554216867e-9,2.21,BP
GO:0006457,protein folding,153,18,2.56,1.0e-10,4.812e-7,5.728571428571429e-9,7.03,BP
GO:0051050,positive regulation of transport,1096,50,18.36,1.1e-10,5.2932e-7,6.227294117647058e-9,2.72,BP
GO:0009156,ribonucleoside monophosphate biosyntheti...,158,18,2.65,1.8e-10,8.6616e-7,1.0071627906976745e-8,6.79,BP
GO:0043604,amide biosynthetic process,701,38,11.74,2.1e-10,1.01052e-6,1.1615172413793103e-8,3.24,BP
GO:0051128,regulation of cellular component organiz...,2590,86,43.38,2.4e-10,1.15488e-6,1.3123636363636363e-8,1.98,BP
GO:0009206,purine ribonucleoside triphosphate biosy...,143,17,2.4,3.0e-10,1.4436e-6,1.6220224719101125e-8,7.08,BP
GO:0009145,purine nucleoside triphosphate biosynthe...,144,17,2.41,3.3e-10,1.58796e-6,1.745010989010989e-8,7.05,BP
GO:0009124,nucleoside monophosphate biosynthetic pr...,164,18,2.75,3.3e-10,1.58796e-6,1.745010989010989e-8,6.55,BP
GO:0009201,ribonucleoside triphosphate biosynthetic...,146,17,2.45,4.1e-10,1.97292e-6,2.144478260869565e-8,6.94,BP
GO:0006886,intracellular protein transport,901,43,15.09,6.8e-10,3.27216e-6,3.518451612903226e-8,2.85,BP
GO:0009127,purine nucleoside monophosphate biosynth...,154,17,2.58,9.5e-10,4.5714e-6,4.8120000000000003e-8,6.59,BP
GO:0009168,purine ribonucleoside monophosphate bios...,154,17,2.58,9.5e-10,4.5714e-6,4.8120000000000003e-8,6.59,BP
GO:0009142,nucleoside triphosphate biosynthetic pro...,156,17,2.61,1.2e-09,5.7744e-6,5.9529896907216495e-8,6.51,BP
GO:0002181,cytoplasmic translation,83,13,1.39,1.2e-09,5.7744e-6,5.9529896907216495e-8,9.35,BP
GO:0033365,protein localization to organelle,789,39,13.22,1.7e-09,8.180399999999999e-6,8.347346938775509e-8,2.95,BP
GO:0009058,biosynthetic process,5115,135,85.68,3.0e-09,1.4436e-5,1.4581818181818182e-7,1.58,BP
GO:1901576,organic substance biosynthetic process,5019,133,84.07,3.3e-09,1.58796e-5,1.58796e-7,1.58,BP
GO:0044249,cellular biosynthetic process,4923,131,82.46,3.6e-09,1.73232e-5,1.7151683168316832e-7,1.59,BP
GO:0015672,monovalent inorganic cation transport,459,28,7.69,4.6e-09,2.2135199999999998e-5,2.1701176470588235e-7,3.64,BP
GO:0009060,aerobic respiration,76,12,1.27,4.8e-09,2.30976e-5,2.1997714285714287e-7,9.45,BP
GO:0006811,ion transport,1581,59,26.48,4.8e-09,2.30976e-5,2.1997714285714287e-7,2.23,BP
GO:0006812,cation transport,1110,47,18.59,4.8e-09,2.30976e-5,2.1997714285714287e-7,2.53,BP
GO:0051130,positive regulation of cellular componen...,1303,52,21.83,5.0e-09,2.406e-5,2.269811320754717e-7,2.38,BP
GO:0098662,inorganic cation transmembrane transport,621,33,10.4,5.8e-09,2.7909599999999998e-5,2.608373831775701e-7,3.17,BP
GO:0051049,regulation of transport,1973,68,33.05,6.8e-09,3.2721599999999995e-5,3.029777777777778e-7,2.06,BP
GO:0044267,cellular protein metabolic process,4573,123,76.6,7.8e-09,3.75336e-5,3.443449541284404e-7,1.61,BP
GO:0098660,inorganic ion transmembrane transport,664,34,11.12,8.5e-09,4.0902e-5,3.718363636363636e-7,3.06,BP
GO:0098655,cation transmembrane transport,698,35,11.69,8.6e-09,4.1383199999999994e-5,3.7282162162162163e-7,2.99,BP
GO:0009260,ribonucleotide biosynthetic process,228,19,3.82,1.1e-08,5.2931999999999994e-5,4.726071428571428e-7,4.97,BP
GO:0051246,regulation of protein metabolic process,2720,84,45.56,1.3e-08,6.2556e-5,5.535929203539823e-7,1.84,BP
GO:0046390,ribose phosphate biosynthetic process,235,19,3.94,1.8e-08,8.6616e-5,7.597894736842105e-7,4.82,BP
GO:0019538,protein metabolic process,5210,134,87.27,2.0e-08,9.624e-5,8.368695652173913e-7,1.54,BP
GO:0042592,homeostatic process,1899,65,31.81,2.1e-08,1.01052e-4,8.711379310344828e-7,2.04,BP
GO:1904951,positive regulation of establishment of ...,467,27,7.82,2.7e-08,1.29924e-4,1.1104615384615385e-6,3.45,BP
GO:0033043,regulation of organelle organization,1260,49,21.11,3.3e-08,1.58796e-4,1.345728813559322e-6,2.32,BP
GO:0009152,purine ribonucleotide biosynthetic proce...,219,18,3.67,3.4e-08,1.63608e-4,1.3748571428571428e-6,4.9,BP
GO:0048518,positive regulation of biological proces...,6114,150,102.41,3.8e-08,1.82856e-4,1.5238000000000001e-6,1.46,BP
GO:0034220,ion transmembrane transport,887,39,14.86,4.2e-08,2.02104e-4,1.670280991735537e-6,2.62,BP
GO:0051222,positive regulation of protein transport,448,26,7.5,4.5e-08,2.1653999999999998e-4,1.7749180327868853e-6,3.47,BP
GO:0010257,NADH dehydrogenase complex assembly,45,9,0.75,4.9e-08,2.35788e-4,1.901516129032258e-6,12,BP
GO:0032981,mitochondrial respiratory chain complex ...,45,9,0.75,4.9e-08,2.35788e-4,1.901516129032258e-6,12,BP
GO:0055085,transmembrane transport,1281,49,21.46,5.5e-08,2.6466e-4,2.1172800000000003e-6,2.28,BP
GO:0043067,regulation of programmed cell death,1573,56,26.35,6.4e-08,3.0796800000000004e-4,2.4249448818897636e-6,2.13,BP
GO:0070201,regulation of establishment of protein l...,757,35,12.68,6.4e-08,3.0796800000000004e-4,2.4249448818897636e-6,2.76,BP
GO:0042981,regulation of apoptotic process,1552,55,26,9.9e-08,4.76388e-4,3.72178125e-6,2.12,BP
GO:0010941,regulation of cell death,1723,59,28.86,1.0e-07,4.812e-4,3.7302325581395347e-6,2.04,BP
GO:0007399,nervous system development,2347,73,39.31,1.2e-07,5.774399999999999e-4,4.374545454545454e-6,1.86,BP
GO:0006164,purine nucleotide biosynthetic process,238,18,3.99,1.2e-07,5.774399999999999e-4,4.374545454545454e-6,4.51,BP
GO:0006139,nucleobase-containing compound metabolic...,4840,124,81.07,1.2e-07,5.774399999999999e-4,4.374545454545454e-6,1.53,BP
GO:0010638,positive regulation of organelle organiz...,604,30,10.12,1.3e-07,6.2556e-4,4.703458646616542e-6,2.96,BP
GO:0055082,cellular chemical homeostasis,819,36,13.72,1.4e-07,6.736800000000001e-4,4.990222222222223e-6,2.62,BP
GO:0051693,actin filament capping,37,8,0.62,1.4e-07,6.736800000000001e-4,4.990222222222223e-6,12.9,BP
GO:0072522,purine-containing compound biosynthetic ...,243,18,4.07,1.6e-07,7.6992e-4,5.661176470588235e-6,4.42,BP
GO:0060996,dendritic spine development,124,13,2.08,1.7e-07,8.180399999999999e-4,5.971094890510948e-6,6.25,BP
GO:0031175,neuron projection development,1097,43,18.37,2.0e-07,9.624e-4,6.9739130434782605e-6,2.34,BP
GO:0099173,postsynapse organization,196,16,3.28,2.2e-07,0.00105864,7.5080851063829785e-6,4.88,BP
GO:0030182,neuron differentiation,1507,53,25.24,2.2e-07,0.00105864,7.5080851063829785e-6,2.1,BP
GO:0051223,regulation of protein transport,725,33,12.14,2.2e-07,0.00105864,7.5080851063829785e-6,2.72,BP
GO:0006873,cellular ion homeostasis,659,31,11.04,2.6e-07,0.00125112,8.810704225352112e-6,2.81,BP
GO:1901360,organic cyclic compound metabolic proces...,5235,130,87.69,3.2e-07,0.00153984,1.076811188811189e-5,1.48,BP
GO:0009165,nucleotide biosynthetic process,284,19,4.76,3.6e-07,0.0017323199999999999,1.2029999999999998e-5,3.99,BP
GO:0009056,catabolic process,2279,70,38.17,3.7e-07,0.00178044,1.2278896551724139e-5,1.83,BP
GO:0048522,positive regulation of cellular process,5410,133,90.62,3.8e-07,0.0018285600000000001,1.2439183673469389e-5,1.47,BP
GO:0006725,cellular aromatic compound metabolic pro...,5041,126,84.44,3.8e-07,0.0018285600000000001,1.2439183673469389e-5,1.49,BP
GO:0044248,cellular catabolic process,2013,64,33.72,4.0e-07,0.0019248,1.3005405405405406e-5,1.9,BP
GO:0030835,negative regulation of actin filament de...,42,8,0.7,4.1e-07,0.00197292,1.3241073825503356e-5,11.43,BP
GO:0098771,inorganic ion homeostasis,750,33,12.56,4.8e-07,0.0023097599999999997,1.5398399999999998e-5,2.63,BP
GO:1901293,nucleoside phosphate biosynthetic proces...,290,19,4.86,5.0e-07,0.0024059999999999997,1.5933774834437085e-5,3.91,BP
GO:0030003,cellular cation homeostasis,645,30,10.8,5.2e-07,0.00250224,1.6462105263157897e-5,2.78,BP
GO:0046483,heterocycle metabolic process,4969,124,83.23,5.5e-07,0.0026466000000000003,1.7298039215686274e-5,1.49,BP
GO:0048699,generation of neurons,1687,56,28.26,6.3e-07,0.00303156,1.9685454545454545e-5,1.98,BP
GO:0051129,negative regulation of cellular componen...,761,33,12.75,6.7e-07,0.00322404,2.080025806451613e-5,2.59,BP
GO:0033108,mitochondrial respiratory chain complex ...,78,10,1.31,7.0e-07,0.0033683999999999997,2.159230769230769e-5,7.63,BP
GO:0048878,chemical homeostasis,1192,44,19.97,7.5e-07,0.0036090000000000002,2.2987261146496814e-5,2.2,BP
GO:0065009,regulation of molecular function,2513,74,42.09,8.0e-07,0.0038496,2.4364556962025314e-5,1.76,BP
GO:0090087,regulation of peptide transport,769,33,12.88,8.4e-07,0.00404208,2.5263e-5,2.56,BP
GO:0048666,neuron development,1238,45,20.74,8.4e-07,0.00404208,2.5263e-5,2.17,BP
GO:0022008,neurogenesis,1793,58,30.03,8.9e-07,0.00428268,2.6600496894409936e-5,1.93,BP
GO:0051016,barbed-end actin filament capping,21,6,0.35,9.3e-07,0.00447516,2.762444444444444e-5,17.14,BP
GO:0055080,cation homeostasis,736,32,12.33,9.4e-07,0.00452328,2.7750184049079752e-5,2.6,BP
GO:0008380,RNA splicing,366,21,6.13,1.1e-06,0.0052932000000000005,3.2080000000000005e-5,3.43,BP
GO:0050801,ion homeostasis,816,34,13.67,1.1e-06,0.0052932000000000005,3.2080000000000005e-5,2.49,BP
GO:0016192,vesicle-mediated transport,1382,48,23.15,1.3e-06,0.0062556,3.7684337349397596e-5,2.07,BP
GO:0007005,mitochondrion organization,468,24,7.84,1.4e-06,0.006736799999999999,4.01e-5,3.06,BP
GO:0044271,cellular nitrogen compound biosynthetic ...,3970,103,66.5,1.4e-06,0.006736799999999999,4.01e-5,1.55,BP
GO:0016310,phosphorylation,2198,66,36.82,1.9e-06,0.0091428,5.3781176470588236e-5,1.79,BP
GO:0030834,regulation of actin filament depolymeriz...,51,8,0.85,1.9e-06,0.0091428,5.3781176470588236e-5,9.41,BP
GO:0072593,reactive oxygen species metabolic proces...,288,18,4.82,2.0e-06,0.009623999999999999,5.628070175438596e-5,3.73,BP
GO:0044087,regulation of cellular component biogene...,957,37,16.03,2.1e-06,0.010105199999999998,5.875116279069767e-5,2.31,BP
GO:0061024,membrane organization,655,29,10.97,2.2e-06,0.010586400000000001,6.119306358381503e-5,2.64,BP
GO:0006839,mitochondrial transport,182,14,3.05,2.5e-06,0.01203,6.913793103448276e-5,4.59,BP
GO:0090316,positive regulation of intracellular pro...,134,12,2.24,2.7e-06,0.0129924,7.424228571428571e-5,5.36,BP
GO:0016358,dendrite development,296,18,4.96,2.9e-06,0.013954800000000002,7.928863636363636e-5,3.63,BP
GO:0050807,regulation of synapse organization,268,17,4.49,3.1e-06,0.0149172,8.42779661016949e-5,3.79,BP
GO:0043254,regulation of protein complex assembly,458,23,7.67,3.3e-06,0.0158796,8.921123595505619e-5,3,BP
GO:0033554,cellular response to stress,1781,56,29.83,3.4e-06,0.016360800000000002,9.140111731843576e-5,1.88,BP
GO:0030042,actin filament depolymerization,55,8,0.92,3.5e-06,0.016842,9.356666666666667e-5,8.7,BP
GO:0120035,regulation of plasma membrane bounded ce...,784,32,13.13,3.6e-06,0.0173232,9.570828729281768e-5,2.44,BP
GO:1901880,negative regulation of protein depolymer...,74,9,1.24,4.0e-06,0.019247999999999998,1.0518032786885245e-4,7.26,BP
GO:0032268,regulation of cellular protein metabolic...,2529,72,42.36,4.0e-06,0.019247999999999998,1.0518032786885245e-4,1.7,BP
GO:0032271,regulation of protein polymerization,218,15,3.65,4.4e-06,0.021172800000000002,1.150695652173913e-4,4.11,BP
GO:0031344,regulation of cell projection organizati...,793,32,13.28,4.5e-06,0.021654,1.1704864864864865e-4,2.41,BP
GO:0046916,cellular transition metal ion homeostasi...,96,10,1.61,4.8e-06,0.0230976,1.2418064516129032e-4,6.21,BP
GO:0050803,regulation of synapse structure or activ...,278,17,4.66,5.1e-06,0.024541200000000003,1.3123636363636366e-4,3.65,BP
GO:0051186,cofactor metabolic process,506,24,8.48,5.3e-06,0.0255036,1.3565744680851062e-4,2.83,BP
GO:1901698,response to nitrogen compound,997,37,16.7,5.4e-06,0.0259848,1.3748571428571428e-4,2.22,BP
GO:0080090,regulation of primary metabolic process,5295,126,88.69,5.6e-06,0.026947199999999998,1.4182736842105264e-4,1.42,BP
GO:0031333,negative regulation of protein complex a...,144,12,2.41,5.8e-06,0.027909600000000003,1.461235602094241e-4,4.98,BP
GO:1901700,response to oxygen-containing compound,1593,51,26.68,6.0e-06,0.028872000000000002,1.50375e-4,1.91,BP
GO:0042982,amyloid precursor protein metabolic proc...,60,8,1.01,6.9e-06,0.0332028,1.7114845360824744e-4,7.92,BP
GO:0006875,cellular metal ion homeostasis,585,26,9.8,6.9e-06,0.0332028,1.7114845360824744e-4,2.65,BP
GO:1901575,organic substance catabolic process,1874,57,31.39,7.4e-06,0.0356088,1.826092307692308e-4,1.82,BP
GO:0030837,negative regulation of actin filament po...,61,8,1.02,7.8e-06,0.0375336,1.9149795918367346e-4,7.84,BP
GO:0050790,regulation of catalytic activity,1833,56,30.7,7.9e-06,0.0380148,1.9296852791878173e-4,1.82,BP
GO:0043066,negative regulation of apoptotic process,937,35,15.69,8.6e-06,0.0413832,2.0900606060606064e-4,2.23,BP
GO:0010243,response to organonitrogen compound,898,34,15.04,8.8e-06,0.042345600000000004,2.1067462686567164e-4,2.26,BP
GO:0055065,metal ion homeostasis,667,28,11.17,8.8e-06,0.042345600000000004,2.1067462686567164e-4,2.51,BP
GO:0006605,protein targeting,260,16,4.36,8.8e-06,0.042345600000000004,2.1067462686567164e-4,3.67,BP
GO:0055076,transition metal ion homeostasis,126,11,2.11,9.1e-06,0.04378919999999999,2.157103448275862e-4,5.21,BP
GO:0006397,mRNA processing,453,22,7.59,9.1e-06,0.04378919999999999,2.157103448275862e-4,2.9,BP
GO:0031323,regulation of cellular metabolic process,5454,128,91.35,9.4e-06,0.0452328,2.2064780487804876e-4,1.4,BP
GO:0048519,negative regulation of biological proces...,5347,126,89.56,9.4e-06,0.0452328,2.2064780487804876e-4,1.41,BP
GO:1990778,protein localization to cell periphery,355,19,5.95,9.7e-06,0.0466764,2.265844660194175e-4,3.19,BP
GO:0050808,synapse organization,455,22,7.62,9.8e-06,0.047157599999999994,2.2671923076923075e-4,2.89,BP
GO:0099175,regulation of postsynapse organization,127,11,2.13,9.8e-06,0.047157599999999994,2.2671923076923075e-4,5.16,BP
GO:0060548,negative regulation of cell death,1067,38,17.87,1.0e-05,0.04812,2.2914285714285718e-4,2.13,BP
GO:0043242,negative regulation of protein complex d...,83,9,1.39,1.0e-05,0.04812,2.2914285714285718e-4,6.47,BP
GO:0044093,positive regulation of molecular functio...,1450,47,24.29,1.1e-05,0.052932,2.473457943925234e-4,1.93,BP
GO:0019222,regulation of metabolic process,6009,138,100.65,1.1e-05,0.052932,2.473457943925234e-4,1.37,BP
GO:1905477,positive regulation of protein localizat...,105,10,1.76,1.1e-05,0.052932,2.473457943925234e-4,5.68,BP
GO:0051171,regulation of nitrogen compound metaboli...,5150,122,86.26,1.1e-05,0.052932,2.473457943925234e-4,1.41,BP
GO:0022604,regulation of cell morphogenesis,530,24,8.88,1.2e-05,0.057744000000000004,2.6610138248847924e-4,2.7,BP
GO:0120036,plasma membrane bounded cell projection ...,1544,49,25.86,1.2e-05,0.057744000000000004,2.6610138248847924e-4,1.89,BP
GO:0016999,antibiotic metabolic process,130,11,2.18,1.2e-05,0.057744000000000004,2.6610138248847924e-4,5.05,BP
GO:0043069,negative regulation of programmed cell d...,955,35,16,1.3e-05,0.062556,2.86954128440367e-4,2.19,BP
GO:0070887,cellular response to chemical stimulus,3063,81,51.31,1.4e-05,0.067368,3.076164383561644e-4,1.58,BP
GO:1901879,regulation of protein depolymerization,87,9,1.46,1.5e-05,0.07218000000000001,3.251351351351352e-4,6.16,BP
GO:0032535,regulation of cellular component size,400,20,6.7,1.5e-05,0.07218000000000001,3.251351351351352e-4,2.99,BP
GO:0033157,regulation of intracellular protein tran...,213,14,3.57,1.5e-05,0.07218000000000001,3.251351351351352e-4,3.92,BP
GO:0090407,organophosphate biosynthetic process,505,23,8.46,1.6e-05,0.07699199999999999,3.437142857142857e-4,2.72,BP
GO:0006897,endocytosis,615,26,10.3,1.6e-05,0.07699199999999999,3.437142857142857e-4,2.52,BP
GO:0032984,protein-containing complex disassembly,216,14,3.62,1.8e-05,0.086616,3.8496e-4,3.87,BP
GO:0043624,cellular protein complex disassembly,136,11,2.28,1.9e-05,0.09142800000000001,4.0276651982378855e-4,4.82,BP
GO:0030833,regulation of actin filament polymerizat...,162,12,2.71,1.9e-05,0.09142800000000001,4.0276651982378855e-4,4.43,BP
GO:0006120,"mitochondrial electron transport, NADH t...",21,5,0.35,2.1e-05,0.10105199999999999,4.412751091703057e-4,14.29,BP
GO:1905475,regulation of protein localization to me...,191,13,3.2,2.1e-05,0.10105199999999999,4.412751091703057e-4,4.06,BP
GO:0051054,positive regulation of DNA metabolic pro...,249,15,4.17,2.2e-05,0.105864,4.602782608695652e-4,3.6,BP
GO:0050773,regulation of dendrite development,192,13,3.22,2.3e-05,0.110676,4.7911688311688314e-4,4.04,BP
GO:0006396,RNA processing,822,31,13.77,2.4e-05,0.11548800000000001,4.95656652360515e-4,2.25,BP
GO:0010033,response to organic substance,3108,81,52.06,2.4e-05,0.11548800000000001,4.95656652360515e-4,1.56,BP
GO:0030030,cell projection organization,1590,49,26.63,2.5e-05,0.1203,5.141025641025641e-4,1.84,BP
GO:0043170,macromolecule metabolic process,8366,178,140.13,2.6e-05,0.125112,5.278987341772152e-4,1.27,BP
GO:0051261,protein depolymerization,116,10,1.94,2.6e-05,0.125112,5.278987341772152e-4,5.15,BP
GO:0060998,regulation of dendritic spine developmen...,93,9,1.56,2.6e-05,0.125112,5.278987341772152e-4,5.77,BP
GO:1901565,organonitrogen compound catabolic proces...,1158,39,19.4,2.8e-05,0.134736,5.614e-4,2.01,BP
GO:0044260,cellular macromolecule metabolic process,7120,156,119.26,2.8e-05,0.134736,5.614e-4,1.31,BP
GO:0043244,regulation of protein complex disassembl...,117,10,1.96,2.8e-05,0.134736,5.614e-4,5.1,BP
GO:0072350,tricarboxylic acid metabolic process,37,6,0.62,3.2e-05,0.15398399999999998,6.36297520661157e-4,9.68,BP
GO:0010256,endomembrane system organization,387,19,6.48,3.2e-05,0.15398399999999998,6.36297520661157e-4,2.93,BP
GO:0022613,ribonucleoprotein complex biogenesis,427,20,7.15,3.9e-05,0.187668,7.628780487804878e-4,2.8,BP
GO:0043065,positive regulation of apoptotic process,647,26,10.84,3.9e-05,0.187668,7.628780487804878e-4,2.4,BP
GO:0048523,negative regulation of cellular process,4750,112,79.56,3.9e-05,0.187668,7.628780487804878e-4,1.41,BP
GO:0046394,carboxylic acid biosynthetic process,359,18,6.01,3.9e-05,0.187668,7.628780487804878e-4,3,BP
GO:0032272,negative regulation of protein polymeriz...,76,8,1.27,4.0e-05,0.19248,7.792712550607287e-4,6.3,BP
GO:0016053,organic acid biosynthetic process,360,18,6.03,4.1e-05,0.197292,7.955322580645161e-4,2.99,BP
GO:0042221,response to chemical,4182,101,70.05,4.3e-05,0.20691600000000002,8.309879518072289e-4,1.44,BP
GO:1902904,negative regulation of supramolecular fi...,149,11,2.5,4.4e-05,0.211728,8.401904761904761e-4,4.4,BP
GO:0008088,axo-dendritic transport,77,8,1.29,4.4e-05,0.211728,8.401904761904761e-4,6.2,BP
GO:0043068,positive regulation of programmed cell d...,652,26,10.92,4.4e-05,0.211728,8.401904761904761e-4,2.38,BP
GO:0032388,positive regulation of intracellular tra...,205,13,3.43,4.5e-05,0.21654,8.525196850393701e-4,3.79,BP
GO:0007017,microtubule-based process,770,29,12.9,4.5e-05,0.21654,8.525196850393701e-4,2.25,BP
GO:0022411,cellular component disassembly,364,18,6.1,4.7e-05,0.22616399999999998,8.869176470588235e-4,2.95,BP
GO:0030041,actin filament polymerization,178,12,2.98,4.9e-05,0.235788,9.21046875e-4,4.03,BP
GO:0051240,positive regulation of multicellular org...,1957,56,32.78,5.1e-05,0.245412,9.512093023255814e-4,1.71,BP
GO:0008064,regulation of actin polymerization or de...,179,12,3,5.1e-05,0.245412,9.512093023255814e-4,4,BP
GO:0032469,endoplasmic reticulum calcium ion homeos...,25,5,0.42,5.2e-05,0.250224,9.624000000000001e-4,11.9,BP
GO:0060255,regulation of macromolecule metabolic pr...,5534,126,92.69,5.2e-05,0.250224,9.624000000000001e-4,1.36,BP
GO:0106027,neuron projection organization,102,9,1.71,5.5e-05,0.26466,0.0010140229885057471,5.26,BP
GO:0051493,regulation of cytoskeleton organization,548,23,9.18,5.7e-05,0.27428400000000003,0.0010429049429657796,2.51,BP
GO:0030163,protein catabolic process,902,32,15.11,5.7e-05,0.27428400000000003,0.0010429049429657796,2.12,BP
GO:0000902,cell morphogenesis,1114,37,18.66,6.0e-05,0.28872000000000003,0.0010895094339622641,1.98,BP
GO:0030832,regulation of actin filament length,182,12,3.05,6.0e-05,0.28872000000000003,0.0010895094339622641,3.93,BP
GO:0046496,nicotinamide nucleotide metabolic proces...,156,11,2.61,6.7e-05,0.322404,0.0012120451127819551,4.21,BP
GO:0032386,regulation of intracellular transport,445,20,7.45,6.9e-05,0.332028,0.001238910447761194,2.68,BP
GO:0072657,protein localization to membrane,555,23,9.3,6.9e-05,0.332028,0.001238910447761194,2.47,BP
GO:0098657,import into cell,749,28,12.55,7.0e-05,0.33684,0.001242952029520295,2.23,BP
GO:0010659,cardiac muscle cell apoptotic process,61,7,1.02,7.0e-05,0.33684,0.001242952029520295,6.86,BP
GO:0031647,regulation of protein stability,276,15,4.62,7.0e-05,0.33684,0.001242952029520295,3.25,BP
GO:0048667,cell morphogenesis involved in neuron di...,632,25,10.59,7.1e-05,0.341652,0.0012514725274725277,2.36,BP
GO:0010942,positive regulation of cell death,710,27,11.89,7.1e-05,0.341652,0.0012514725274725277,2.27,BP
GO:0019362,pyridine nucleotide metabolic process,158,11,2.65,7.5e-05,0.36089999999999994,0.0013171532846715326,4.15,BP
GO:0051258,protein polymerization,279,15,4.67,8.0e-05,0.38496,0.0013998545454545458,3.21,BP
GO:1901699,cellular response to nitrogen compound,638,25,10.69,8.2e-05,0.394584,0.0014296521739130435,2.34,BP
GO:1901137,carbohydrate derivative biosynthetic pro...,600,24,10.05,8.3e-05,0.399396,0.0014418628158844767,2.39,BP
GO:0010970,transport along microtubule,160,11,2.68,8.4e-05,0.40420799999999996,0.0014487741935483868,4.1,BP
GO:0099111,microtubule-based transport,160,11,2.68,8.4e-05,0.40420799999999996,0.0014487741935483868,4.1,BP
GO:0030029,actin filament-based process,758,28,12.7,8.5e-05,0.40902000000000005,0.0014607857142857144,2.2,BP
GO:0022603,regulation of anatomical structure morph...,1091,36,18.27,8.6e-05,0.41383200000000003,0.0014674893617021277,1.97,BP
GO:0042274,ribosomal small subunit biogenesis,63,7,1.06,8.6e-05,0.41383200000000003,0.0014674893617021277,6.6,BP
GO:0072594,establishment of protein localization to...,383,18,6.42,9.0e-05,0.43308,0.0015303180212014136,2.8,BP
GO:0032989,cellular component morphogenesis,1225,39,20.52,9.2e-05,0.442704,0.0015588169014084505,1.9,BP
GO:0034248,regulation of cellular amide metabolic p...,384,18,6.43,9.3e-05,0.44751599999999997,0.0015702315789473684,2.8,BP
GO:0010658,striated muscle cell apoptotic process,64,7,1.07,9.5e-05,0.45714000000000005,0.0015928222996515681,6.54,BP
GO:0060999,positive regulation of dendritic spine d...,64,7,1.07,9.5e-05,0.45714000000000005,0.0015928222996515681,6.54,BP
GO:0035304,regulation of protein dephosphorylation,86,8,1.44,9.8e-05,0.471576,0.0016314657534246574,5.56,BP
GO:1902903,regulation of supramolecular fiber organ...,351,17,5.88,9.8e-05,0.471576,0.0016314657534246574,2.89,BP
GO:0072524,pyridine-containing compound metabolic p...,163,11,2.73,9.9e-05,0.476388,0.0016314657534246574,4.03,BP
GO:0006414,translational elongation,45,6,0.75,9.9e-05,0.476388,0.0016314657534246574,8,BP
GO:0042987,amyloid precursor protein catabolic proc...,45,6,0.75,9.9e-05,0.476388,0.0016314657534246574,8,BP
GO:0097435,supramolecular fiber organization,687,26,11.51,0.00010,0.4812,0.0016423208191126278,2.26,BP
GO:0043648,dicarboxylic acid metabolic process,87,8,1.46,0.00011,0.52932,0.0017644,5.48,BP
GO:0007010,cytoskeleton organization,1323,41,22.16,0.00011,0.52932,0.0017644,1.85,BP
GO:0072659,protein localization to plasma membrane,287,15,4.81,0.00011,0.52932,0.0017644,3.12,BP
GO:0006734,NADH metabolic process,29,5,0.49,0.00011,0.52932,0.0017644,10.2,BP
GO:0033119,negative regulation of RNA splicing,29,5,0.49,0.00011,0.52932,0.0017644,10.2,BP
GO:0042026,protein refolding,29,5,0.49,0.00011,0.52932,0.0017644,10.2,BP
GO:0098754,detoxification,46,6,0.77,0.00011,0.52932,0.0017644,7.79,BP
GO:0034605,cellular response to heat,66,7,1.11,0.00012,0.5774400000000001,0.0018932459016393441,6.31,BP
GO:0071417,cellular response to organonitrogen comp...,575,23,9.63,0.00012,0.5774400000000001,0.0018932459016393441,2.39,BP
GO:1904375,regulation of protein localization to ce...,139,10,2.33,0.00012,0.5774400000000001,0.0018932459016393441,4.29,BP
GO:1901652,response to peptide,392,18,6.57,0.00012,0.5774400000000001,0.0018932459016393441,2.74,BP
GO:1901653,cellular response to peptide,290,15,4.86,0.00012,0.5774400000000001,0.0018932459016393441,3.09,BP
GO:0019674,NAD metabolic process,47,6,0.79,0.00013,0.6255599999999999,0.0020376547231270355,7.59,BP
GO:0043484,regulation of RNA splicing,140,10,2.35,0.00013,0.6255599999999999,0.0020376547231270355,4.26,BP
GO:0046903,secretion,1250,39,20.94,0.00014,0.67368,0.0021661736334405144,1.86,BP
GO:1901701,cellular response to oxygen-containing c...,1207,38,20.22,0.00014,0.67368,0.0021661736334405144,1.88,BP
GO:0050821,protein stabilization,170,11,2.85,0.00014,0.67368,0.0021661736334405144,3.86,BP
GO:0071826,ribonucleoprotein complex subunit organi...,230,13,3.85,0.00014,0.67368,0.0021661736334405144,3.38,BP
GO:0009893,positive regulation of metabolic process,3528,86,59.09,0.00015,0.7217999999999999,0.002255625,1.46,BP
GO:0032970,regulation of actin filament-based proce...,398,18,6.67,0.00015,0.7217999999999999,0.002255625,2.7,BP
GO:0006913,nucleocytoplasmic transport,295,15,4.94,0.00015,0.7217999999999999,0.002255625,3.04,BP
GO:0051169,nuclear transport,295,15,4.94,0.00015,0.7217999999999999,0.002255625,3.04,BP
GO:0048468,cell development,2424,64,40.6,0.00015,0.7217999999999999,0.002255625,1.58,BP
GO:0045807,positive regulation of endocytosis,171,11,2.86,0.00015,0.7217999999999999,0.002255625,3.85,BP
GO:0006099,tricarboxylic acid cycle,31,5,0.52,0.00015,0.7217999999999999,0.002255625,9.62,BP
GO:0045664,regulation of neuron differentiation,785,28,13.15,0.00015,0.7217999999999999,0.002255625,2.13,BP
GO:1904377,positive regulation of protein localizat...,69,7,1.16,0.00015,0.7217999999999999,0.002255625,6.03,BP
GO:0051960,regulation of nervous system development,1082,35,18.12,0.00016,0.76992,0.0023762962962962965,1.93,BP
GO:0030705,cytoskeleton-dependent intracellular tra...,172,11,2.88,0.00016,0.76992,0.0023762962962962965,3.82,BP
GO:0031346,positive regulation of cell projection o...,474,20,7.94,0.00016,0.76992,0.0023762962962962965,2.52,BP
GO:2000377,regulation of reactive oxygen species me...,202,12,3.38,0.00016,0.76992,0.0023762962962962965,3.55,BP
GO:0006979,response to oxidative stress,402,18,6.73,0.00017,0.8180400000000001,0.0024940243902439024,2.67,BP
GO:0022898,regulation of transmembrane transporter ...,266,14,4.46,0.00017,0.8180400000000001,0.0024940243902439024,3.14,BP
GO:0010720,positive regulation of cell development,669,25,11.21,0.00017,0.8180400000000001,0.0024940243902439024,2.23,BP
GO:0051248,negative regulation of protein metabolic...,1087,35,18.21,0.00017,0.8180400000000001,0.0024940243902439024,1.92,BP
GO:0030036,actin cytoskeleton organization,670,25,11.22,0.00018,0.86616,0.0026089156626506026,2.23,BP
GO:0006101,citrate metabolic process,32,5,0.54,0.00018,0.86616,0.0026089156626506026,9.26,BP
GO:0010591,regulation of lamellipodium assembly,32,5,0.54,0.00018,0.86616,0.0026089156626506026,9.26,BP
GO:0097061,dendritic spine organization,94,8,1.57,0.00018,0.86616,0.0026089156626506026,5.1,BP
GO:0006733,oxidoreduction coenzyme metabolic proces...,175,11,2.93,0.00019,0.9142800000000001,0.00271299703264095,3.75,BP
GO:0008154,actin polymerization or depolymerization,205,12,3.43,0.00019,0.9142800000000001,0.00271299703264095,3.5,BP
GO:0009628,response to abiotic stimulus,1048,34,17.55,0.00019,0.9142800000000001,0.00271299703264095,1.94,BP
GO:0009894,regulation of catabolic process,837,29,14.02,0.00019,0.9142800000000001,0.00271299703264095,2.07,BP
GO:0080135,regulation of cellular response to stres...,674,25,11.29,0.00019,0.9142800000000001,0.00271299703264095,2.21,BP
GO:0032206,positive regulation of telomere maintena...,51,6,0.85,0.00020,0.9624,0.002847337278106509,7.06,BP
GO:0016049,cell growth,521,21,8.73,0.00021,1,0.0029721176470588234,2.41,BP
GO:0031345,negative regulation of cell projection o...,208,12,3.48,0.00021,1,0.0029721176470588234,3.45,BP
GO:0048813,dendrite morphogenesis,178,11,2.98,0.00022,1,0.003086413994169096,3.69,BP
GO:0034976,response to endoplasmic reticulum stress,240,13,4.02,0.00022,1,0.003086413994169096,3.23,BP
GO:0008361,regulation of cell size,209,12,3.5,0.00022,1,0.003086413994169096,3.43,BP
GO:0009057,macromolecule catabolic process,1235,38,20.69,0.00023,1,0.0031895100864553316,1.84,BP
GO:0072507,divalent inorganic cation homeostasis,525,21,8.79,0.00023,1,0.0031895100864553316,2.39,BP
GO:0090066,regulation of anatomical structure size,564,22,9.45,0.00023,1,0.0031895100864553316,2.33,BP
GO:0048812,neuron projection morphogenesis,683,25,11.44,0.00023,1,0.0031895100864553316,2.19,BP
GO:1990748,cellular detoxification,34,5,0.57,0.00024,1,0.00329025641025641,8.77,BP
GO:0006626,protein targeting to mitochondrion,74,7,1.24,0.00024,1,0.00329025641025641,5.65,BP
GO:0060284,regulation of cell development,1106,35,18.53,0.00024,1,0.00329025641025641,1.89,BP
GO:0070585,protein localization to mitochondrion,98,8,1.64,0.00024,1,0.00329025641025641,4.88,BP
GO:0006470,protein dephosphorylation,243,13,4.07,0.00025,1,0.003388732394366197,3.19,BP
GO:0032990,cell part morphogenesis,726,26,12.16,0.00025,1,0.003388732394366197,2.14,BP
GO:0032409,regulation of transporter activity,276,14,4.62,0.00025,1,0.003388732394366197,3.03,BP
GO:0071310,cellular response to organic substance,2470,64,41.37,0.00025,1,0.003388732394366197,1.55,BP
GO:0032273,positive regulation of protein polymeriz...,125,9,2.09,0.00026,1,0.003494748603351955,4.31,BP
GO:0055074,calcium ion homeostasis,492,20,8.24,0.00026,1,0.003494748603351955,2.43,BP
GO:0006950,response to stress,3538,85,59.26,0.00026,1,0.003494748603351955,1.43,BP
GO:0007018,microtubule-based movement,278,14,4.66,0.00027,1,0.003589060773480663,3,BP
GO:0042254,ribosome biogenesis,278,14,4.66,0.00027,1,0.003589060773480663,3,BP
GO:0000904,cell morphogenesis involved in different...,813,28,13.62,0.00027,1,0.003589060773480663,2.06,BP
GO:0007049,cell cycle,1659,47,27.79,0.00027,1,0.003589060773480663,1.69,BP
GO:0006611,protein export from nucleus,126,9,2.11,0.00028,1,0.003701538461538461,4.27,BP
GO:0032956,regulation of actin cytoskeleton organiz...,348,16,5.83,0.00028,1,0.003701538461538461,2.74,BP
GO:0010975,regulation of neuron projection developm...,612,23,10.25,0.00029,1,0.003823232876712329,2.24,BP
GO:0008090,retrograde axonal transport,20,4,0.34,0.00030,1,0.003944262295081967,11.76,BP
GO:0010035,response to inorganic substance,498,20,8.34,0.00031,1,0.00404260162601626,2.4,BP
GO:0034762,regulation of transmembrane transport,576,22,9.65,0.00031,1,0.00404260162601626,2.28,BP
GO:0022618,ribonucleoprotein complex assembly,217,12,3.63,0.00031,1,0.00404260162601626,3.31,BP
GO:0034205,amyloid-beta formation,36,5,0.6,0.00032,1,0.004139354838709678,8.33,BP
GO:1902991,regulation of amyloid precursor protein ...,36,5,0.6,0.00032,1,0.004139354838709678,8.33,BP
GO:0010959,regulation of metal ion transport,425,18,7.12,0.00032,1,0.004139354838709678,2.53,BP
GO:0019220,regulation of phosphate metabolic proces...,1720,48,28.81,0.00033,1,0.004223297872340426,1.67,BP
GO:0072503,cellular divalent inorganic cation homeo...,501,20,8.39,0.00033,1,0.004223297872340426,2.38,BP
GO:0120039,plasma membrane bounded cell projection ...,699,25,11.71,0.00033,1,0.004223297872340426,2.13,BP
GO:0051174,regulation of phosphorus metabolic proce...,1721,48,28.83,0.00033,1,0.004223297872340426,1.66,BP
GO:0051494,negative regulation of cytoskeleton orga...,158,10,2.65,0.00034,1,0.0043397347480106105,3.77,BP
GO:0006458,'de novo' protein folding,37,5,0.62,0.00036,1,0.004582857142857143,8.06,BP
GO:0048858,cell projection morphogenesis,704,25,11.79,0.00037,1,0.004685368421052632,2.12,BP
GO:0010665,regulation of cardiac muscle cell apopto...,57,6,0.95,0.00037,1,0.004685368421052632,6.32,BP
GO:0060249,anatomical structure homeostasis,394,17,6.6,0.00038,1,0.004799370078740158,2.58,BP
GO:0032940,secretion by cell,1091,34,18.27,0.00039,1,0.004912774869109947,1.86,BP
GO:0098930,axonal transport,58,6,0.97,0.00041,1,0.0051378125,6.19,BP
GO:0010608,posttranscriptional regulation of gene e...,510,20,8.54,0.00041,1,0.0051378125,2.34,BP
GO:0009408,response to heat,106,8,1.78,0.00042,1,0.005235854922279793,4.49,BP
GO:0048024,"regulation of mRNA splicing, via spliceo...",106,8,1.78,0.00042,1,0.005235854922279793,4.49,BP
GO:0031329,regulation of cellular catabolic process,711,25,11.91,0.00043,1,0.005346666666666667,2.1,BP
GO:1903311,regulation of mRNA metabolic process,258,13,4.32,0.00044,1,0.005428923076923078,3.01,BP
GO:0050767,regulation of neurogenesis,967,31,16.2,0.00044,1,0.005428923076923078,1.91,BP
GO:0010646,regulation of cell communication,3387,81,56.73,0.00044,1,0.005428923076923078,1.43,BP
GO:0071870,cellular response to catecholamine stimu...,22,4,0.37,0.00045,1,0.005509923664122137,10.81,BP
GO:0051961,negative regulation of nervous system de...,363,16,6.08,0.00045,1,0.005509923664122137,2.63,BP
GO:1903312,negative regulation of mRNA metabolic pr...,82,7,1.37,0.00045,1,0.005509923664122137,5.11,BP
GO:0006874,cellular calcium ion homeostasis,476,19,7.97,0.00046,1,0.005618071065989848,2.38,BP
GO:1902905,positive regulation of supramolecular fi...,195,11,3.27,0.00047,1,0.005711212121212121,3.36,BP
GO:0072330,monocarboxylic acid biosynthetic process,260,13,4.36,0.00047,1,0.005711212121212121,2.98,BP
GO:0006732,coenzyme metabolic process,330,15,5.53,0.00049,1,0.005894699999999999,2.71,BP
GO:0051239,regulation of multicellular organismal p...,3294,79,55.17,0.00049,1,0.005894699999999999,1.43,BP
GO:0051046,regulation of secretion,930,30,15.58,0.00049,1,0.005894699999999999,1.93,BP
GO:0010662,regulation of striated muscle cell apopt...,60,6,1.01,0.00049,1,0.005894699999999999,5.94,BP
GO:1900006,positive regulation of dendrite developm...,109,8,1.83,0.00050,1,0.006,4.37,BP
GO:0032269,negative regulation of cellular protein ...,1020,32,17.09,0.00052,1,0.006224477611940298,1.87,BP
GO:0010592,positive regulation of lamellipodium ass...,23,4,0.39,0.00053,1,0.006297185185185185,10.26,BP
GO:0071868,cellular response to monoamine stimulus,23,4,0.39,0.00053,1,0.006297185185185185,10.26,BP
GO:0071869,response to catecholamine,23,4,0.39,0.00053,1,0.006297185185185185,10.26,BP
GO:0042255,ribosome assembly,61,6,1.02,0.00054,1,0.006368823529411765,5.88,BP
GO:1903078,positive regulation of protein localizat...,61,6,1.02,0.00054,1,0.006368823529411765,5.88,BP
GO:0023051,regulation of signaling,3409,81,57.1,0.00054,1,0.006368823529411765,1.42,BP
GO:0006417,regulation of translation,334,15,5.59,0.00055,1,0.006470904645476773,2.68,BP
GO:0097237,cellular response to toxic substance,169,10,2.83,0.00058,1,0.006807219512195122,3.53,BP
GO:0048193,Golgi vesicle transport,266,13,4.46,0.00059,1,0.0069077372262773724,2.91,BP
GO:0051168,nuclear export,140,9,2.35,0.00060,1,0.006990799031476997,3.83,BP
GO:0051028,mRNA transport,112,8,1.88,0.00060,1,0.006990799031476997,4.26,BP
GO:0016071,mRNA metabolic process,647,23,10.84,0.00062,1,0.007206376811594203,2.12,BP
GO:0071867,response to monoamine,24,4,0.4,0.00063,1,0.007287403846153846,10,BP
GO:0019752,carboxylic acid metabolic process,901,29,15.09,0.00063,1,0.007287403846153846,1.92,BP
GO:1903076,regulation of protein localization to pl...,113,8,1.89,0.00064,1,0.007350071599045347,4.23,BP
GO:0009653,anatomical structure morphogenesis,2759,68,46.21,0.00064,1,0.007350071599045347,1.47,BP
GO:0045454,cell redox homeostasis,63,6,1.06,0.00064,1,0.007350071599045347,5.66,BP
GO:0010765,positive regulation of sodium ion transp...,42,5,0.7,0.00066,1,0.007508085106382979,7.14,BP
GO:0045740,positive regulation of DNA replication,42,5,0.7,0.00066,1,0.007508085106382979,7.14,BP
GO:0051270,regulation of cellular component movemen...,1035,32,17.34,0.00066,1,0.007508085106382979,1.85,BP
GO:0048583,regulation of response to stimulus,3798,88,63.62,0.00066,1,0.007508085106382979,1.38,BP
GO:0060627,regulation of vesicle-mediated transport,570,21,9.55,0.00067,1,0.007603867924528302,2.2,BP
GO:0097190,apoptotic signaling pathway,612,22,10.25,0.00070,1,0.007925647058823529,2.15,BP
GO:0031399,regulation of protein modification proce...,1783,48,29.87,0.00073,1,0.008245915492957745,1.61,BP
GO:0046688,response to copper ion,25,4,0.42,0.00074,1,0.008339297423887587,9.52,BP
GO:0010038,response to metal ion,274,13,4.59,0.00077,1,0.008636923076923077,2.83,BP
GO:0043269,regulation of ion transport,741,25,12.41,0.00077,1,0.008636923076923077,2.01,BP
GO:1903047,mitotic cell cycle process,658,23,11.02,0.00078,1,0.008708491879350348,2.09,BP
GO:0051336,regulation of hydrolase activity,1001,31,16.77,0.00078,1,0.008708491879350348,1.85,BP
GO:0010769,regulation of cell morphogenesis involve...,346,15,5.8,0.00079,1,0.008799722222222223,2.59,BP
GO:0048856,anatomical structure development,5881,126,98.51,0.00080,1,0.008870046082949308,1.28,BP
GO:2001233,regulation of apoptotic signaling pathwa...,421,17,7.05,0.00080,1,0.008870046082949308,2.41,BP
GO:0050684,regulation of mRNA processing,146,9,2.45,0.00081,1,0.008919267734553775,3.67,BP
GO:0070849,response to epidermal growth factor,44,5,0.74,0.00081,1,0.008919267734553775,6.76,BP
GO:1902743,regulation of lamellipodium organization,44,5,0.74,0.00081,1,0.008919267734553775,6.76,BP
GO:0050714,positive regulation of protein secretion,311,14,5.21,0.00082,1,0.008988246013667427,2.69,BP
GO:0034504,protein localization to nucleus,276,13,4.62,0.00082,1,0.008988246013667427,2.81,BP
GO:0043393,regulation of protein binding,243,12,4.07,0.00086,1,0.009405272727272726,2.95,BP
GO:0099537,trans-synaptic signaling,877,28,14.69,0.00089,1,0.009689321266968325,1.91,BP
GO:2000378,negative regulation of reactive oxygen s...,67,6,1.12,0.00089,1,0.009689321266968325,5.36,BP
GO:0050708,regulation of protein secretion,503,19,8.43,0.00090,1,0.009732134831460675,2.25,BP
GO:0002028,regulation of sodium ion transport,92,7,1.54,0.00090,1,0.009732134831460675,4.55,BP
GO:0072655,establishment of protein localization to...,92,7,1.54,0.00090,1,0.009732134831460675,4.55,BP
GO:0006575,cellular modified amino acid metabolic p...,179,10,3,0.00091,1,0.009818206278026907,3.33,BP
GO:0009059,macromolecule biosynthetic process,4105,93,68.76,0.00094,1,0.010119194630872482,1.35,BP
GO:0071426,ribonucleoprotein complex export from nu...,68,6,1.14,0.00097,1,0.010395634743875278,5.26,BP
GO:0050794,regulation of cellular process,10724,209,179.63,0.00097,1,0.010395634743875278,1.16,BP
GO:0050793,regulation of developmental process,2753,67,46.11,0.00098,1,0.010479466666666666,1.45,BP
GO:0007267,cell-cell signaling,1617,44,27.08,0.00099,1,0.010562926829268293,1.62,BP
GO:1904062,regulation of cation transmembrane trans...,354,15,5.93,0.00100,1,0.010599118942731278,2.53,BP
GO:0034645,cellular macromolecule biosynthetic proc...,4006,91,67.1,0.00100,1,0.010599118942731278,1.36,BP
GO:0045010,actin nucleation,46,5,0.77,0.00100,1,0.010599118942731278,6.49,BP
GO:0061640,cytoskeleton-dependent cytokinesis,94,7,1.57,0.00103,1,0.010845426695842453,4.46,BP
GO:0120032,regulation of plasma membrane bounded ce...,182,10,3.05,0.00103,1,0.010845426695842453,3.28,BP
GO:0099536,synaptic signaling,886,28,14.84,0.00103,1,0.010845426695842453,1.89,BP
GO:0060997,dendritic spine morphogenesis,69,6,1.16,0.00104,1,0.010903006535947711,5.17,BP
GO:0071166,ribonucleoprotein complex localization,69,6,1.16,0.00104,1,0.010903006535947711,5.17,BP
GO:0050804,modulation of chemical synaptic transmis...,673,23,11.27,0.00105,1,0.010960086767895878,2.04,BP
GO:0007417,central nervous system development,887,28,14.86,0.00105,1,0.010960086767895878,1.88,BP
GO:0043085,positive regulation of catalytic activit...,1065,32,17.84,0.00106,1,0.011016673866090712,1.79,BP
GO:0070925,organelle assembly,801,26,13.42,0.00106,1,0.011016673866090712,1.94,BP
GO:0099177,regulation of trans-synaptic signaling,674,23,11.29,0.00107,1,0.011096637931034483,2.04,BP
GO:0060491,regulation of cell projection assembly,184,10,3.08,0.00112,1,0.011540556745182012,3.25,BP
GO:2001252,positive regulation of chromosome organi...,184,10,3.08,0.00112,1,0.011540556745182012,3.25,BP
GO:0044265,cellular macromolecule catabolic process,1024,31,17.15,0.00112,1,0.011540556745182012,1.81,BP
GO:0050657,nucleic acid transport,153,9,2.56,0.00113,1,0.011593944562899786,3.52,BP
GO:0050658,RNA transport,153,9,2.56,0.00113,1,0.011593944562899786,3.52,BP
GO:0070198,"protein localization to chromosome, telo...",28,4,0.47,0.00115,1,0.01177404255319149,8.51,BP
GO:1903530,regulation of secretion by cell,849,27,14.22,0.00116,1,0.011851210191082803,1.9,BP
GO:2001235,positive regulation of apoptotic signali...,186,10,3.12,0.00121,1,0.012335847457627119,3.21,BP
GO:0008089,anterograde axonal transport,48,5,0.8,0.00122,1,0.012359242105263159,6.25,BP
GO:0032502,developmental process,6278,132,105.16,0.00122,1,0.012359242105263159,1.26,BP
GO:0043436,oxoacid metabolic process,940,29,15.75,0.00122,1,0.012359242105263159,1.84,BP
GO:0031503,protein-containing complex localization,254,12,4.25,0.00126,1,0.012710943396226417,2.82,BP
GO:0015931,nucleobase-containing compound transport,187,10,3.13,0.00126,1,0.012710943396226417,3.19,BP
GO:0051495,positive regulation of cytoskeleton orga...,220,11,3.69,0.00127,1,0.012785020920502092,2.98,BP
GO:0010604,positive regulation of macromolecule met...,3247,76,54.39,0.00129,1,0.012905363825363824,1.4,BP
GO:0034249,negative regulation of cellular amide me...,156,9,2.61,0.00129,1,0.012905363825363824,3.45,BP
GO:0051236,establishment of RNA localization,156,9,2.61,0.00129,1,0.012905363825363824,3.45,BP
GO:0000723,telomere maintenance,126,8,2.11,0.00130,1,0.012978423236514523,3.79,BP
GO:0000278,mitotic cell cycle,813,26,13.62,0.00131,1,0.013024214876033058,1.91,BP
GO:0051668,localization within membrane,188,10,3.15,0.00131,1,0.013024214876033058,3.17,BP
GO:0071353,cellular response to interleukin-4,29,4,0.49,0.00132,1,0.013069629629629629,8.16,BP
GO:1902235,regulation of endoplasmic reticulum stre...,29,4,0.49,0.00132,1,0.013069629629629629,8.16,BP
GO:0050435,amyloid-beta metabolic process,49,5,0.82,0.00134,1,0.013186257668711657,6.1,BP
GO:0080134,regulation of response to stress,1357,38,22.73,0.00134,1,0.013186257668711657,1.67,BP
GO:2000145,regulation of cell motility,946,29,15.85,0.00134,1,0.013186257668711657,1.83,BP
GO:0043434,response to peptide hormone,328,14,5.49,0.00136,1,0.013328553971486762,2.55,BP
GO:0010467,gene expression,4801,105,80.42,0.00136,1,0.013328553971486762,1.31,BP
GO:0030100,regulation of endocytosis,292,13,4.89,0.00137,1,0.013399268292682927,2.66,BP
GO:0022402,cell cycle process,1128,33,18.89,0.00138,1,0.013458108651911469,1.75,BP
GO:0010647,positive regulation of cell communicatio...,1887,49,31.61,0.00139,1,0.013458108651911469,1.55,BP
GO:0000375,"RNA splicing, via transesterification re...",257,12,4.3,0.00139,1,0.013458108651911469,2.79,BP
GO:0000377,"RNA splicing, via transesterification re...",257,12,4.3,0.00139,1,0.013458108651911469,2.79,BP
GO:0000398,"mRNA splicing, via spliceosome",257,12,4.3,0.00139,1,0.013458108651911469,2.79,BP
GO:0044283,small molecule biosynthetic process,646,22,10.82,0.00140,1,0.013527710843373493,2.03,BP
GO:0051052,regulation of DNA metabolic process,444,17,7.44,0.00143,1,0.013762320000000001,2.28,BP
GO:0032200,telomere organization,128,8,2.14,0.00143,1,0.013762320000000001,3.74,BP
GO:0032412,regulation of ion transmembrane transpor...,258,12,4.32,0.00144,1,0.013803346613545818,2.78,BP
GO:0110053,regulation of actin filament organizatio...,258,12,4.32,0.00144,1,0.013803346613545818,2.78,BP
GO:1903532,positive regulation of secretion by cell,484,18,8.11,0.00145,1,0.013871570576540754,2.22,BP
GO:0006928,movement of cell or subcellular componen...,2039,52,34.15,0.00146,1,0.013939523809523808,1.52,BP
GO:0023056,positive regulation of signaling,1893,49,31.71,0.00148,1,0.01410249504950495,1.55,BP
GO:0010639,negative regulation of organelle organiz...,407,16,6.82,0.00150,1,0.014125244618395304,2.35,BP
GO:0051098,regulation of binding,407,16,6.82,0.00150,1,0.014125244618395304,2.35,BP
GO:0065007,biological regulation,12076,230,202.27,0.00150,1,0.014125244618395304,1.14,BP
GO:0006536,glutamate metabolic process,30,4,0.5,0.00150,1,0.014125244618395304,8,BP
GO:1902003,regulation of amyloid-beta formation,30,4,0.5,0.00150,1,0.014125244618395304,8,BP
GO:0010976,positive regulation of neuron projection...,369,15,6.18,0.00150,1,0.014125244618395304,2.43,BP
GO:2000573,positive regulation of DNA biosynthetic ...,74,6,1.24,0.00151,1,0.014191640625,4.84,BP
GO:0050789,regulation of biological process,11466,220,192.06,0.00152,1,0.014230038910505838,1.15,BP
GO:0035556,intracellular signal transduction,2646,64,44.32,0.00152,1,0.014230038910505838,1.44,BP
GO:0007041,lysosomal transport,101,7,1.69,0.00156,1,0.014576155339805826,4.14,BP
GO:0007268,chemical synaptic transmission,868,27,14.54,0.00159,1,0.014798994197292071,1.86,BP
GO:0098916,anterograde trans-synaptic signaling,868,27,14.54,0.00159,1,0.014798994197292071,1.86,BP
GO:0051402,neuron apoptotic process,298,13,4.99,0.00165,1,0.015298265895953757,2.61,BP
GO:0006892,post-Golgi vesicle-mediated transport,102,7,1.71,0.00165,1,0.015298265895953757,4.09,BP
GO:0044257,cellular protein catabolic process,740,24,12.4,0.00166,1,0.015361384615384617,1.94,BP
GO:0070670,response to interleukin-4,31,4,0.52,0.00170,1,0.01567126436781609,7.69,BP
GO:1902745,positive regulation of lamellipodium org...,31,4,0.52,0.00170,1,0.01567126436781609,7.69,BP
GO:0006406,mRNA export from nucleus,52,5,0.87,0.00175,1,0.0160706106870229,5.75,BP
GO:0071427,mRNA-containing ribonucleoprotein comple...,52,5,0.87,0.00175,1,0.0160706106870229,5.75,BP
GO:0008037,cell recognition,133,8,2.23,0.00183,1,0.016773257142857143,3.59,BP
GO:0050768,negative regulation of neurogenesis,339,14,5.68,0.00185,1,0.016892220113851993,2.46,BP
GO:0040007,growth,1103,32,18.48,0.00185,1,0.016892220113851993,1.73,BP
GO:0043523,regulation of neuron apoptotic process,266,12,4.46,0.00186,1,0.016951363636363636,2.69,BP
GO:0048589,developmental growth,790,25,13.23,0.00187,1,0.01701028355387524,1.89,BP
GO:0006082,organic acid metabolic process,968,29,16.21,0.00189,1,0.01715977358490566,1.79,BP
GO:0042743,hydrogen peroxide metabolic process,53,5,0.89,0.00190,1,0.017185714285714287,5.62,BP
GO:0061077,chaperone-mediated protein folding,53,5,0.89,0.00190,1,0.017185714285714287,5.62,BP
GO:0034599,cellular response to oxidative stress,267,12,4.47,0.00192,1,0.017301573033707864,2.68,BP
GO:0048668,collateral sprouting,32,4,0.54,0.00192,1,0.017301573033707864,7.41,BP
GO:0051783,regulation of nuclear division,198,10,3.32,0.00193,1,0.01735917757009346,3.01,BP
GO:0006413,translational initiation,105,7,1.76,0.00195,1,0.017441263940520445,3.98,BP
GO:0007009,plasma membrane organization,105,7,1.76,0.00195,1,0.017441263940520445,3.98,BP
GO:0010657,muscle cell apoptotic process,105,7,1.76,0.00195,1,0.017441263940520445,3.98,BP
GO:0006405,RNA export from nucleus,78,6,1.31,0.00197,1,0.017587458256029684,4.58,BP
GO:0009306,protein secretion,622,21,10.42,0.00198,1,0.01763513812154696,2.02,BP
GO:0051047,positive regulation of secretion,539,19,9.03,0.00199,1,0.01763513812154696,2.1,BP
GO:0009266,response to temperature stimulus,166,9,2.78,0.00199,1,0.01763513812154696,3.24,BP
GO:1904064,positive regulation of cation transmembr...,166,9,2.78,0.00199,1,0.01763513812154696,3.24,BP
GO:0002793,positive regulation of peptide secretion,342,14,5.73,0.00200,1,0.017691176470588234,2.44,BP
GO:0071453,cellular response to oxygen levels,135,8,2.26,0.00201,1,0.017747009174311927,3.54,BP
GO:0120034,positive regulation of plasma membrane b...,106,7,1.78,0.00206,1,0.018143606557377047,3.93,BP
GO:1900271,regulation of long-term synaptic potenti...,54,5,0.9,0.00207,1,0.018143606557377047,5.56,BP
GO:1903533,regulation of protein targeting,54,5,0.9,0.00207,1,0.018143606557377047,5.56,BP
GO:0035303,regulation of dephosphorylation,167,9,2.8,0.00207,1,0.018143606557377047,3.21,BP
GO:0031324,negative regulation of cellular metaboli...,2476,60,41.47,0.00208,1,0.01819810909090909,1.45,BP
GO:0010833,telomere maintenance via telomere length...,79,6,1.32,0.00211,1,0.018393695652173914,4.55,BP
GO:0051173,positive regulation of nitrogen compound...,3096,72,51.86,0.00211,1,0.018393695652173914,1.39,BP
GO:0035690,cellular response to drug,383,15,6.42,0.00216,1,0.018795515370705243,2.34,BP
GO:0009636,response to toxic substance,345,14,5.78,0.00217,1,0.018848447653429606,2.42,BP
GO:0032446,protein modification by small protein co...,627,21,10.5,0.00218,1,0.01890118918918919,2,BP
GO:0002791,regulation of peptide secretion,544,19,9.11,0.00220,1,0.019040287769784173,2.09,BP
GO:0002790,peptide secretion,671,22,11.24,0.00224,1,0.019351669658886895,1.96,BP
GO:0034764,positive regulation of transmembrane tra...,237,11,3.97,0.00228,1,0.019661935483870966,2.77,BP
GO:0060560,developmental growth involved in morphog...,273,12,4.57,0.00230,1,0.019798926654740607,2.63,BP
GO:0051301,cell division,590,20,9.88,0.00241,1,0.02067187165775401,2.02,BP
GO:0010667,negative regulation of cardiac muscle ce...,34,4,0.57,0.00241,1,0.02067187165775401,7.02,BP
GO:0009896,positive regulation of catabolic process,428,16,7.17,0.00248,1,0.021234448398576515,2.23,BP
GO:0046434,organophosphate catabolic process,205,10,3.43,0.00249,1,0.021282202486678507,2.92,BP
GO:0061564,axon development,509,18,8.53,0.00250,1,0.021329787234042552,2.11,BP
GO:0030334,regulation of cell migration,899,27,15.06,0.00259,1,0.02205854867256637,1.79,BP
GO:0010001,glial cell differentiation,242,11,4.05,0.00268,1,0.022784734982332158,2.72,BP
GO:0035308,negative regulation of protein dephospho...,35,4,0.59,0.00269,1,0.022789225352112676,6.78,BP
GO:2000171,negative regulation of dendrite developm...,35,4,0.59,0.00269,1,0.022789225352112676,6.78,BP
GO:0006464,cellular protein modification process,3496,79,58.56,0.00273,1,0.023006584938704028,1.35,BP
GO:0036211,protein modification process,3496,79,58.56,0.00273,1,0.023006584938704028,1.35,BP
GO:2001242,regulation of intrinsic apoptotic signal...,174,9,2.91,0.00273,1,0.023006584938704028,3.09,BP
GO:1902115,regulation of organelle assembly,208,10,3.48,0.00276,1,0.02321874125874126,2.87,BP
GO:0051094,positive regulation of developmental pro...,1560,41,26.13,0.00279,1,0.02343015706806283,1.57,BP
GO:0032204,regulation of telomere maintenance,84,6,1.41,0.00287,1,0.024060000000000005,4.26,BP
GO:0006986,response to unfolded protein,113,7,1.89,0.00296,1,0.02472833333333333,3.7,BP
GO:0030162,regulation of proteolysis,730,23,12.23,0.00296,1,0.02472833333333333,1.88,BP
GO:0051084,'de novo' posttranslational protein fold...,36,4,0.6,0.00299,1,0.024849533678756475,6.67,BP
GO:0051973,positive regulation of telomerase activi...,36,4,0.6,0.00299,1,0.024849533678756475,6.67,BP
GO:0097106,postsynaptic density organization,36,4,0.6,0.00299,1,0.024849533678756475,6.67,BP
GO:0071375,cellular response to peptide hormone sti...,246,11,4.12,0.00304,1,0.02522151724137931,2.67,BP
GO:0006403,RNA localization,177,9,2.96,0.00306,1,0.025343752151462992,3.04,BP
GO:0006090,pyruvate metabolic process,114,7,1.91,0.00310,1,0.02558696397941681,3.66,BP
GO:0048814,regulation of dendrite morphogenesis,114,7,1.91,0.00310,1,0.02558696397941681,3.66,BP
GO:0001558,regulation of cell growth,439,16,7.35,0.00318,1,0.02620232876712329,2.18,BP
GO:0050680,negative regulation of epithelial cell p...,146,8,2.45,0.00326,1,0.02681558974358974,3.27,BP
GO:0043524,negative regulation of neuron apoptotic ...,179,9,3,0.00330,1,0.02704196943972835,3,BP
GO:0010664,negative regulation of striated muscle c...,37,4,0.62,0.00330,1,0.02704196943972835,6.45,BP
GO:0009719,response to endogenous stimulus,1430,38,23.95,0.00331,1,0.02704196943972835,1.59,BP
GO:0001817,regulation of cytokine production,693,22,11.61,0.00331,1,0.02704196943972835,1.89,BP
GO:0031334,positive regulation of protein complex a...,249,11,4.17,0.00333,1,0.027159254237288138,2.64,BP
GO:2000147,positive regulation of cell motility,565,19,9.46,0.00334,1,0.027194720812182743,2.01,BP
GO:0071824,protein-DNA complex subunit organization,215,10,3.6,0.00350,1,0.02840134907251265,2.78,BP
GO:0007275,multicellular organism development,5380,113,90.12,0.00350,1,0.02840134907251265,1.25,BP
GO:0034765,regulation of ion transmembrane transpor...,485,17,8.12,0.00356,1,0.028839595959595954,2.09,BP
GO:0042063,gliogenesis,326,13,5.46,0.00357,1,0.028872,2.38,BP
GO:0032024,positive regulation of insulin secretion,88,6,1.47,0.00363,1,0.02930798657718121,4.08,BP
GO:0007015,actin filament organization,405,15,6.78,0.00364,1,0.029339497487437187,2.21,BP
GO:0034767,positive regulation of ion transmembrane...,182,9,3.05,0.00368,1,0.02961230769230769,2.95,BP
GO:0051962,positive regulation of nervous system de...,660,21,11.06,0.00396,1,0.0317592,1.9,BP
GO:0048167,regulation of synaptic plasticity,369,14,6.18,0.00396,1,0.0317592,2.27,BP
GO:0016233,telomere capping,39,4,0.65,0.00401,1,0.03210668885191347,6.15,BP
GO:0016567,protein ubiquitination,575,19,9.63,0.00403,1,0.032213222591362126,1.97,BP
GO:0016311,dephosphorylation,370,14,6.2,0.00406,1,0.0323992039800995,2.26,BP
GO:0070059,intrinsic apoptotic signaling pathway in...,63,5,1.06,0.00407,1,0.03242523178807947,4.72,BP
GO:0031400,negative regulation of protein modificat...,578,19,9.68,0.00426,1,0.033882842975206606,1.96,BP
GO:0040012,regulation of locomotion,1025,29,17.17,0.00427,1,0.03390633663366337,1.69,BP
GO:0051481,negative regulation of cytosolic calcium...,20,3,0.34,0.00430,1,0.03403223684210526,8.82,BP
GO:0071157,negative regulation of cell cycle arrest,20,3,0.34,0.00430,1,0.03403223684210526,8.82,BP
GO:0051338,regulation of transferase activity,843,25,14.12,0.00434,1,0.034292413793103445,1.77,BP
GO:1903391,regulation of adherens junction organiza...,64,5,1.07,0.00436,1,0.03439396721311475,4.67,BP
GO:0050796,regulation of insulin secretion,187,9,3.13,0.00440,1,0.03465270049099837,2.88,BP
GO:0044089,positive regulation of cellular componen...,538,18,9.01,0.00446,1,0.0350678431372549,2,BP
GO:0030838,positive regulation of actin filament po...,92,6,1.54,0.00451,1,0.035403132137030995,3.9,BP
GO:0006629,lipid metabolic process,1266,34,21.21,0.00459,1,0.0359139512195122,1.6,BP
GO:0048731,system development,4759,101,79.71,0.00459,1,0.0359139512195122,1.27,BP
GO:0030032,lamellipodium assembly,65,5,1.09,0.00465,1,0.03632435064935065,4.59,BP
GO:0007030,Golgi organization,123,7,2.06,0.00472,1,0.03681141004862237,3.4,BP
GO:0051272,positive regulation of cellular componen...,584,19,9.78,0.00475,1,0.03698543689320388,1.94,BP
GO:0035774,positive regulation of insulin secretion...,41,4,0.69,0.00481,1,0.0373318064516129,5.8,BP
GO:0051247,positive regulation of protein metabolic...,1659,42,27.79,0.00481,1,0.0373318064516129,1.51,BP
GO:0071248,cellular response to metal ion,156,8,2.61,0.00487,1,0.037675948553054665,3.07,BP
GO:0045665,negative regulation of neuron differenti...,262,11,4.39,0.00487,1,0.037675948553054665,2.51,BP
GO:0030335,positive regulation of cell migration,543,18,9.1,0.00490,1,0.03784719101123595,1.98,BP
GO:0032411,positive regulation of transporter activ...,124,7,2.08,0.00493,1,0.03801788461538462,3.37,BP
GO:0046716,muscle cell cellular homeostasis,21,3,0.35,0.00495,1,0.038111040000000006,8.57,BP
GO:0090150,establishment of protein localization to...,226,10,3.79,0.00497,1,0.03820389776357827,2.64,BP
GO:0042493,response to drug,898,26,15.04,0.00499,1,0.038296459330143535,1.73,BP
GO:0048588,developmental cell growth,263,11,4.41,0.00501,1,0.03838872611464968,2.49,BP
GO:0032868,response to insulin,227,10,3.8,0.00512,1,0.039169220985691575,2.63,BP
GO:0050769,positive regulation of neurogenesis,589,19,9.87,0.00519,1,0.03964171428571429,1.93,BP
GO:0099084,postsynaptic specialization organization,42,4,0.7,0.00525,1,0.040036450079239304,5.71,BP
GO:1903578,regulation of ATP metabolic process,95,6,1.59,0.00528,1,0.04020151898734177,3.77,BP
GO:0034332,adherens junction organization,126,7,2.11,0.00538,1,0.040898199052132704,3.32,BP
GO:0042176,regulation of protein catabolic process,383,14,6.42,0.00548,1,0.041592681388012614,2.18,BP
GO:0040008,regulation of growth,724,22,12.13,0.00551,1,0.041754519685039376,1.81,BP
GO:0071456,cellular response to hypoxia,96,6,1.61,0.00555,1,0.041991509433962265,3.73,BP
GO:0032869,cellular response to insulin stimulus,194,9,3.25,0.00557,1,0.042076671899529045,2.77,BP
GO:0006893,Golgi to plasma membrane transport,68,5,1.14,0.00564,1,0.04253868338557994,4.39,BP
GO:0002183,cytoplasmic translational initiation,22,3,0.37,0.00567,1,0.04256480499219969,8.11,BP
GO:0090382,phagosome maturation,22,3,0.37,0.00567,1,0.04256480499219969,8.11,BP
GO:1902307,positive regulation of sodium ion transm...,22,3,0.37,0.00567,1,0.04256480499219969,8.11,BP
GO:0045666,positive regulation of neuron differenti...,468,16,7.84,0.00584,1,0.04377271028037383,2.04,BP
GO:0040017,positive regulation of locomotion,597,19,10,0.00597,1,0.044677511664074646,1.9,BP
GO:0000281,mitotic cytokinesis,69,5,1.16,0.00600,1,0.04483229813664596,4.31,BP
GO:0010721,negative regulation of cell development,388,14,6.5,0.00612,1,0.045587368421052626,2.15,BP
GO:0048584,positive regulation of response to stimu...,2187,52,36.63,0.00612,1,0.045587368421052626,1.42,BP
GO:0033048,negative regulation of mitotic sister ch...,44,4,0.74,0.00620,1,0.04611190108191653,5.41,BP
GO:0046475,glycerophospholipid catabolic process,23,3,0.39,0.00644,1,0.047675815384615385,7.69,BP
GO:0098869,cellular oxidant detoxification,23,3,0.39,0.00644,1,0.047675815384615385,7.69,BP
GO:0007409,axonogenesis,473,16,7.92,0.00644,1,0.047675815384615385,2.02,BP
GO:0031325,positive regulation of cellular metaboli...,3240,72,54.27,0.00653,1,0.04819380368098159,1.33,BP
GO:0051172,negative regulation of nitrogen compound...,2297,54,38.47,0.00653,1,0.04819380368098159,1.4,BP
GO:0006644,phospholipid metabolic process,352,13,5.9,0.00672,1,0.04951371951219512,2.2,BP
GO:0007006,mitochondrial membrane organization,100,6,1.68,0.00675,1,0.04951371951219512,3.57,BP
GO:0010660,regulation of muscle cell apoptotic proc...,100,6,1.68,0.00675,1,0.04951371951219512,3.57,BP
GO:0009892,negative regulation of metabolic process,2874,65,48.14,0.00675,1,0.04951371951219512,1.35,BP
GO:0009166,nucleotide catabolic process,132,7,2.21,0.00690,1,0.050536986301369866,3.17,BP
GO:0007033,vacuole organization,166,8,2.78,0.00702,1,0.05133775075987842,2.88,BP
GO:0006914,autophagy,395,14,6.62,0.00711,1,0.051838363636363634,2.11,BP
GO:0061919,process utilizing autophagic mechanism,395,14,6.62,0.00711,1,0.051838363636363634,2.11,BP
GO:1903725,regulation of phospholipid metabolic pro...,72,5,1.21,0.00717,1,0.052196732223903176,4.13,BP
GO:0000302,response to reactive oxygen species,202,9,3.38,0.00720,1,0.052335951661631415,2.66,BP
GO:0045597,positive regulation of cell differentiat...,1113,30,18.64,0.00722,1,0.0523637668161435,1.61,BP
GO:0033046,negative regulation of sister chromatid ...,46,4,0.77,0.00726,1,0.0523637668161435,5.19,BP
GO:1903727,positive regulation of phospholipid meta...,46,4,0.77,0.00726,1,0.0523637668161435,5.19,BP
GO:0048025,"negative regulation of mRNA splicing, vi...",24,3,0.4,0.00727,1,0.0523637668161435,7.5,BP
GO:0007088,regulation of mitotic nuclear division,167,8,2.8,0.00727,1,0.0523637668161435,2.86,BP
GO:0051017,actin filament bundle assembly,167,8,2.8,0.00727,1,0.0523637668161435,2.86,BP
GO:2000026,regulation of multicellular organismal d...,2207,52,36.97,0.00728,1,0.0523637668161435,1.41,BP
GO:0098876,vesicle-mediated transport to the plasma...,102,6,1.71,0.00742,1,0.05329110447761194,3.51,BP
GO:0006633,fatty acid biosynthetic process,134,7,2.24,0.00747,1,0.05356214285714286,3.12,BP
GO:0051241,negative regulation of multicellular org...,1357,35,22.73,0.00748,1,0.05356214285714286,1.54,BP
GO:0051656,establishment of organelle localization,481,16,8.06,0.00751,1,0.053697057949479945,1.99,BP
GO:1990542,mitochondrial transmembrane transport,73,5,1.22,0.00760,1,0.05425994065281899,4.1,BP
GO:0051726,regulation of cell cycle,976,27,16.35,0.00765,1,0.054535999999999994,1.65,BP
GO:0033044,regulation of chromosome organization,358,13,6,0.00769,1,0.05474005917159763,2.17,BP
GO:0033120,positive regulation of RNA splicing,47,4,0.79,0.00783,1,0.055490368188512516,5.06,BP
GO:0072604,interleukin-6 secretion,47,4,0.79,0.00783,1,0.055490368188512516,5.06,BP
GO:1903018,regulation of glycoprotein metabolic pro...,47,4,0.79,0.00783,1,0.055490368188512516,5.06,BP
GO:0042325,regulation of phosphorylation,1559,39,26.11,0.00790,1,0.055904117647058826,1.49,BP
GO:0070647,protein modification by small protein co...,748,22,12.53,0.00794,1,0.05610466960352422,1.76,BP
GO:0036465,synaptic vesicle recycling,74,5,1.24,0.00804,1,0.05651302325581396,4.03,BP
GO:0050766,positive regulation of phagocytosis,74,5,1.24,0.00804,1,0.05651302325581396,4.03,BP
GO:0061572,actin filament bundle organization,170,8,2.85,0.00806,1,0.05651302325581396,2.81,BP
GO:0061061,muscle structure development,704,21,11.79,0.00807,1,0.05651302325581396,1.78,BP
GO:0007034,vacuolar transport,136,7,2.28,0.00808,1,0.05651302325581396,3.07,BP
GO:0017148,negative regulation of translation,136,7,2.28,0.00808,1,0.05651302325581396,3.07,BP
GO:0035966,response to topologically incorrect prot...,136,7,2.28,0.00808,1,0.05651302325581396,3.07,BP
GO:0050764,regulation of phagocytosis,104,6,1.74,0.00813,1,0.056591341991341984,3.45,BP
GO:0006909,phagocytosis,206,9,3.45,0.00814,1,0.056591341991341984,2.61,BP
GO:0120033,negative regulation of plasma membrane b...,25,3,0.42,0.00815,1,0.056591341991341984,7.14,BP
GO:1903747,regulation of establishment of protein l...,25,3,0.42,0.00815,1,0.056591341991341984,7.14,BP
GO:1905809,negative regulation of synapse organizat...,25,3,0.42,0.00815,1,0.056591341991341984,7.14,BP
GO:0031331,positive regulation of cellular cataboli...,361,13,6.05,0.00822,1,0.05699515850144093,2.15,BP
GO:0034728,nucleosome organization,137,7,2.29,0.00839,1,0.05807586206896551,3.06,BP
GO:0050806,positive regulation of synaptic transmis...,362,13,6.06,0.00840,1,0.05807586206896551,2.15,BP
GO:0070588,calcium ion transmembrane transport,283,11,4.74,0.00851,1,0.0587519655667145,2.32,BP
GO:0051099,positive regulation of binding,208,9,3.48,0.00864,1,0.05956401146131805,2.59,BP
GO:0048675,axon extension,138,7,2.31,0.00872,1,0.060029527896995706,3.03,BP
GO:0048638,regulation of developmental growth,405,14,6.78,0.00876,1,0.06021874285714286,2.06,BP
GO:0022610,biological adhesion,1323,34,22.16,0.00878,1,0.06027012838801712,1.53,BP
GO:0002262,myeloid cell homeostasis,173,8,2.9,0.00890,1,0.0610068376068376,2.76,BP
GO:0030001,metal ion transport,848,24,14.2,0.00894,1,0.06113830028328612,1.69,BP
GO:0007045,cell-substrate adherens junction assembl...,76,5,1.27,0.00897,1,0.06113830028328612,3.94,BP
GO:0030641,regulation of cellular pH,76,5,1.27,0.00897,1,0.06113830028328612,3.94,BP
GO:0048041,focal adhesion assembly,76,5,1.27,0.00897,1,0.06113830028328612,3.94,BP
GO:0034101,erythrocyte homeostasis,139,7,2.33,0.00905,1,0.061403830985915495,3,BP
GO:0099003,vesicle-mediated transport in synapse,247,10,4.14,0.00906,1,0.061403830985915495,2.42,BP
GO:0051985,negative regulation of chromosome segreg...,49,4,0.82,0.00906,1,0.061403830985915495,4.88,BP
GO:0090102,cochlea development,49,4,0.82,0.00906,1,0.061403830985915495,4.88,BP
GO:1902175,regulation of oxidative stress-induced i...,26,3,0.44,0.00911,1,0.061655864978902956,6.82,BP
GO:0043270,positive regulation of ion transport,326,12,5.46,0.00925,1,0.06251544943820225,2.2,BP
GO:0006275,regulation of DNA replication,107,6,1.79,0.00930,1,0.06267731092436975,3.35,BP
GO:0043266,regulation of potassium ion transport,107,6,1.79,0.00930,1,0.06267731092436975,3.35,BP
GO:0050890,cognition,327,12,5.48,0.00947,1,0.06373376223776223,2.19,BP
GO:0051188,cofactor biosynthetic process,249,10,4.17,0.00955,1,0.064182402234636865,2.4,BP
GO:0045732,positive regulation of protein catabolic...,212,9,3.55,0.00972,1,0.06511927677329625,2.54,BP
GO:0030865,cortical cytoskeleton organization,50,4,0.84,0.00973,1,0.06511927677329625,4.76,BP
GO:0001932,regulation of protein phosphorylation,1431,36,23.97,0.00973,1,0.06511927677329625,1.5,BP
GO:0046879,hormone secretion,369,13,6.18,0.00976,1,0.06522933333333333,2.1,BP
GO:0043412,macromolecule modification,3676,79,61.57,0.00988,1,0.06593975034674063,1.28,BP
GO:1905897,regulation of response to endoplasmic re...,78,5,1.31,0.00998,1,0.0665149030470914,3.82,BP
GO:0009889,regulation of biosynthetic process,3570,77,59.8,0.01002,1,0.06668912863070539,1.29,BP
GO:0042744,hydrogen peroxide catabolic process,27,3,0.45,0.01012,1,0.06693234567901234,6.67,BP
GO:0045730,respiratory burst,27,3,0.45,0.01012,1,0.06693234567901234,6.67,BP
GO:0061003,positive regulation of dendritic spine m...,27,3,0.45,0.01012,1,0.06693234567901234,6.67,BP
GO:1904353,regulation of telomere capping,27,3,0.45,0.01012,1,0.06693234567901234,6.67,BP
GO:1900542,regulation of purine nucleotide metaboli...,109,6,1.83,0.01013,1,0.06693234567901234,3.28,BP
GO:0010977,negative regulation of neuron projection...,177,8,2.96,0.01014,1,0.06693234567901234,2.7,BP
GO:0017038,protein import,214,9,3.58,0.01029,1,0.06782942465753425,2.51,BP
GO:0031330,negative regulation of cellular cataboli...,252,10,4.22,0.01034,1,0.0680657729138167,2.37,BP
GO:0071495,cellular response to endogenous stimulus,1241,32,20.79,0.01039,1,0.06812641304347826,1.54,BP
GO:0008038,neuron recognition,51,4,0.85,0.01042,1,0.06812641304347826,4.71,BP
GO:0051972,regulation of telomerase activity,51,4,0.85,0.01042,1,0.06812641304347826,4.71,BP
GO:0061001,regulation of dendritic spine morphogene...,51,4,0.85,0.01042,1,0.06812641304347826,4.71,BP
GO:1902373,negative regulation of mRNA catabolic pr...,51,4,0.85,0.01042,1,0.06812641304347826,4.71,BP
GO:1901292,nucleoside phosphate catabolic process,143,7,2.4,0.01049,1,0.06849101763907733,2.92,BP
GO:0051881,regulation of mitochondrial membrane pot...,79,5,1.32,0.01051,1,0.06852861788617887,3.79,BP
GO:0007611,learning or memory,293,11,4.91,0.01085,1,0.07049385444743934,2.24,BP
GO:0019941,modification-dependent protein catabolic...,589,18,9.87,0.01086,1,0.07049385444743934,1.82,BP
GO:0002687,positive regulation of leukocyte migrati...,144,7,2.41,0.01087,1,0.07049385444743934,2.9,BP
GO:0006333,chromatin assembly or disassembly,144,7,2.41,0.01087,1,0.07049385444743934,2.9,BP
GO:0001816,cytokine production,771,22,12.91,0.01103,1,0.07143520861372812,1.7,BP
GO:2001259,positive regulation of cation channel ac...,80,5,1.34,0.01107,1,0.07150179865771812,3.73,BP
GO:0051051,negative regulation of transport,546,17,9.15,0.01107,1,0.07150179865771812,1.86,BP
GO:0048285,organelle fission,461,15,7.72,0.01142,1,0.07366359249329758,1.94,BP
GO:0032092,positive regulation of protein binding,112,6,1.88,0.01149,1,0.07401590361445784,3.19,BP
GO:0009914,hormone transport,377,13,6.31,0.01152,1,0.07410994652406418,2.06,BP
GO:0097193,intrinsic apoptotic signaling pathway,296,11,4.96,0.01164,1,0.07468224,2.22,BP
GO:0072384,organelle transport along microtubule,81,5,1.36,0.01164,1,0.07468224,3.68,BP
GO:0031113,regulation of microtubule polymerization,53,4,0.89,0.01189,1,0.07618466045272969,4.49,BP
GO:0006140,regulation of nucleotide metabolic proce...,113,6,1.89,0.01197,1,0.0765952659574468,3.17,BP
GO:0016482,cytosolic transport,147,7,2.46,0.01208,1,0.07705573509933775,2.85,BP
GO:0034250,positive regulation of cellular amide me...,147,7,2.46,0.01208,1,0.07705573509933775,2.85,BP
GO:0048869,cellular developmental process,4475,93,74.96,0.01209,1,0.07705573509933775,1.24,BP
GO:0051347,positive regulation of transferase activ...,552,17,9.25,0.01222,1,0.07778126984126983,1.84,BP
GO:0031116,positive regulation of microtubule polym...,29,3,0.49,0.01233,1,0.07817122529644269,6.12,BP
GO:0045292,"mRNA cis splicing, via spliceosome",29,3,0.49,0.01233,1,0.07817122529644269,6.12,BP
GO:0060117,auditory receptor cell development,29,3,0.49,0.01233,1,0.07817122529644269,6.12,BP
GO:0008637,apoptotic mitochondrial changes,114,6,1.91,0.01246,1,0.07885103810775296,3.14,BP
GO:0009895,negative regulation of catabolic process,299,11,5.01,0.01247,1,0.07885103810775296,2.2,BP
GO:0010564,regulation of cell cycle process,598,18,10.02,0.01253,1,0.07912645669291339,1.8,BP
GO:0045839,negative regulation of mitotic nuclear d...,54,4,0.9,0.01268,1,0.07996875491480997,4.44,BP
GO:0043632,modification-dependent macromolecule cat...,599,18,10.03,0.01272,1,0.08011602094240838,1.79,BP
GO:0061178,regulation of insulin secretion involved...,83,5,1.39,0.01284,1,0.08066067885117494,3.6,BP
GO:1901888,regulation of cell junction assembly,83,5,1.39,0.01284,1,0.08066067885117494,3.6,BP
GO:0034614,cellular response to reactive oxygen spe...,149,7,2.5,0.01293,1,0.08112015645371577,2.8,BP
GO:0007155,cell adhesion,1311,33,21.96,0.01297,1,0.08122205461638492,1.5,BP
GO:0009749,response to glucose,185,8,3.1,0.01298,1,0.08122205461638492,2.58,BP
GO:0021953,central nervous system neuron differenti...,223,9,3.74,0.01320,1,0.08249142857142858,2.41,BP
GO:0010770,positive regulation of cell morphogenesi...,186,8,3.12,0.01338,1,0.08339968911917098,2.56,BP
GO:0002831,regulation of response to biotic stimulu...,150,7,2.51,0.01338,1,0.08339968911917098,2.79,BP
GO:0006816,calcium ion transport,427,14,7.15,0.01342,1,0.0835408020698577,1.96,BP
GO:0034620,cellular response to unfolded protein,84,5,1.41,0.01347,1,0.08363566451612903,3.55,BP
GO:0055072,iron ion homeostasis,84,5,1.41,0.01347,1,0.08363566451612903,3.55,BP
GO:0045687,positive regulation of glial cell differ...,55,4,0.92,0.01350,1,0.0837139175257732,4.35,BP
GO:0030900,forebrain development,385,13,6.45,0.01352,1,0.08373003861003861,2.02,BP
GO:0046365,monosaccharide catabolic process,30,3,0.5,0.01354,1,0.08374611825192801,6,BP
GO:0006898,receptor-mediated endocytosis,224,9,3.75,0.01356,1,0.08376215661103979,2.4,BP
GO:0051640,organelle localization,604,18,10.12,0.01374,1,0.08476523076923077,1.78,BP
GO:0030073,insulin secretion,225,9,3.77,0.01392,1,0.0857657362355954,2.39,BP
GO:0051603,proteolysis involved in cellular protein...,696,20,11.66,0.01398,1,0.0860252685421995,1.72,BP
GO:0032414,positive regulation of ion transmembrane...,117,6,1.96,0.01402,1,0.08616122605363985,3.06,BP
GO:0034333,adherens junction assembly,85,5,1.42,0.01412,1,0.08644458015267176,3.52,BP
GO:0048524,positive regulation of viral process,85,5,1.42,0.01412,1,0.08644458015267176,3.52,BP
GO:0097581,lamellipodium organization,85,5,1.42,0.01412,1,0.08644458015267176,3.52,BP
GO:0071241,cellular response to inorganic substance,226,9,3.79,0.01429,1,0.08737418043202035,2.37,BP
GO:0006879,cellular iron ion homeostasis,56,4,0.94,0.01435,1,0.08751863117870723,4.26,BP
GO:0048538,thymus development,56,4,0.94,0.01435,1,0.08751863117870723,4.26,BP
GO:0030155,regulation of cell adhesion,698,20,11.69,0.01438,1,0.08759058227848102,1.71,BP
GO:0009966,regulation of signal transduction,2819,62,47.22,0.01444,1,0.08784485461441213,1.31,BP
GO:0010563,negative regulation of phosphorus metabo...,563,17,9.43,0.01458,1,0.08847283732660781,1.8,BP
GO:0045936,negative regulation of phosphate metabol...,563,17,9.43,0.01458,1,0.08847283732660781,1.8,BP
GO:0009746,response to hexose,189,8,3.17,0.01461,1,0.08854322418136021,2.52,BP
GO:0045595,regulation of cell differentiation,1930,45,32.33,0.01467,1,0.0886389552238806,1.39,BP
GO:0008360,regulation of cell shape,153,7,2.56,0.01478,1,0.0886389552238806,2.73,BP
GO:0007044,cell-substrate junction assembly,86,5,1.44,0.01479,1,0.0886389552238806,3.47,BP
GO:1901379,regulation of potassium ion transmembran...,86,5,1.44,0.01479,1,0.0886389552238806,3.47,BP
GO:0051085,chaperone cofactor-dependent protein ref...,31,3,0.52,0.01481,1,0.0886389552238806,5.77,BP
GO:0060074,synapse maturation,31,3,0.52,0.01481,1,0.0886389552238806,5.77,BP
GO:1903393,positive regulation of adherens junction...,31,3,0.52,0.01481,1,0.0886389552238806,5.77,BP
GO:1903421,regulation of synaptic vesicle recycling,31,3,0.52,0.01481,1,0.0886389552238806,5.77,BP
GO:2000778,positive regulation of interleukin-6 sec...,31,3,0.52,0.01481,1,0.0886389552238806,5.77,BP
GO:0032787,monocarboxylic acid metabolic process,564,17,9.45,0.01481,1,0.0886389552238806,1.8,BP
GO:0016042,lipid catabolic process,307,11,5.14,0.01492,1,0.0891863850931677,2.14,BP
GO:0034284,response to monosaccharide,190,8,3.18,0.01503,1,0.08973245657568238,2.52,BP
GO:0044403,symbiont process,349,12,5.85,0.01518,1,0.09051568773234202,2.05,BP
GO:0051893,regulation of focal adhesion assembly,57,4,0.95,0.01523,1,0.09058932014833128,4.21,BP
GO:0090109,regulation of cell-substrate junction as...,57,4,0.95,0.01523,1,0.09058932014833128,4.21,BP
GO:0071345,cellular response to cytokine stimulus,938,25,15.71,0.01543,1,0.09166562962962962,1.59,BP
GO:0002690,positive regulation of leukocyte chemota...,87,5,1.46,0.01548,1,0.09173615763546798,3.42,BP
GO:0048708,astrocyte differentiation,87,5,1.46,0.01548,1,0.09173615763546798,3.42,BP
GO:0043900,regulation of multi-organism process,393,13,6.58,0.01577,1,0.09333977859778597,1.98,BP
GO:0009108,coenzyme biosynthetic process,192,8,3.22,0.01592,1,0.09411184275184276,2.48,BP
GO:0008608,attachment of spindle microtubules to ki...,32,3,0.54,0.01614,1,0.09506203182374542,5.56,BP
GO:0050686,negative regulation of mRNA processing,32,3,0.54,0.01614,1,0.09506203182374542,5.56,BP
GO:0051642,centrosome localization,32,3,0.54,0.01614,1,0.09506203182374542,5.56,BP
GO:0040014,regulation of multicellular organism gro...,88,5,1.47,0.01620,1,0.09529877750611247,3.4,BP
GO:0031497,chromatin assembly,121,6,2.03,0.01631,1,0.09571185365853659,2.96,BP
GO:0036294,cellular response to decreased oxygen le...,121,6,2.03,0.01631,1,0.09571185365853659,2.96,BP
GO:0032870,cellular response to hormone stimulus,526,16,8.81,0.01644,1,0.09635722289890378,1.82,BP
GO:0009725,response to hormone,708,20,11.86,0.01651,1,0.09664978102189781,1.69,BP
GO:0006468,protein phosphorylation,1842,43,30.85,0.01661,1,0.09705460701330108,1.39,BP
GO:0048872,homeostasis of number of cells,312,11,5.23,0.01662,1,0.09705460701330108,2.1,BP
GO:0010948,negative regulation of cell cycle proces...,232,9,3.89,0.01668,1,0.09705460701330108,2.31,BP
GO:0090276,regulation of peptide hormone secretion,232,9,3.89,0.01668,1,0.09705460701330108,2.31,BP
GO:1903320,regulation of protein modification by sm...,232,9,3.89,0.01668,1,0.09705460701330108,2.31,BP
GO:0045834,positive regulation of lipid metabolic p...,157,7,2.63,0.01681,1,0.09757505428226779,2.66,BP
GO:0050715,positive regulation of cytokine secretio...,157,7,2.63,0.01681,1,0.09757505428226779,2.66,BP
GO:0006888,ER to Golgi vesicle-mediated transport,122,6,2.04,0.01692,1,0.09785942307692308,2.94,BP
GO:0090277,positive regulation of peptide hormone s...,122,6,2.04,0.01692,1,0.09785942307692308,2.94,BP
GO:2000278,regulation of DNA biosynthetic process,122,6,2.04,0.01692,1,0.09785942307692308,2.94,BP
GO:0019219,regulation of nucleobase-containing comp...,3382,72,56.65,0.01708,1,0.09830720763723151,1.27,BP
GO:0010656,negative regulation of muscle cell apopt...,59,4,0.99,0.01710,1,0.09830720763723151,4.04,BP
GO:0043954,cellular component maintenance,59,4,0.99,0.01710,1,0.09830720763723151,4.04,BP
GO:1902369,negative regulation of RNA catabolic pro...,59,4,0.99,0.01710,1,0.09830720763723151,4.04,BP
GO:0034654,nucleobase-containing compound biosynthe...,3328,71,55.74,0.01710,1,0.09830720763723151,1.27,BP
GO:0045787,positive regulation of cell cycle,355,12,5.95,0.01712,1,0.09830720763723151,2.02,BP
GO:0000910,cytokinesis,158,7,2.65,0.01734,1,0.09945182359952326,2.64,BP
GO:0051259,protein complex oligomerization,620,18,10.39,0.01744,1,0.09964873671782763,1.73,BP
GO:0031112,positive regulation of microtubule polym...,33,3,0.55,0.01754,1,0.09964873671782763,5.45,BP
GO:0034314,Arp2/3 complex-mediated actin nucleation,33,3,0.55,0.01754,1,0.09964873671782763,5.45,BP
GO:0061842,microtubule organizing center localizati...,33,3,0.55,0.01754,1,0.09964873671782763,5.45,BP
GO:0090218,positive regulation of lipid kinase acti...,33,3,0.55,0.01754,1,0.09964873671782763,5.45,BP
GO:1903146,regulation of autophagy of mitochondrion,33,3,0.55,0.01754,1,0.09964873671782763,5.45,BP
GO:1904646,cellular response to amyloid-beta,33,3,0.55,0.01754,1,0.09964873671782763,5.45,BP
GO:0045727,positive regulation of translation,123,6,2.06,0.01754,1,0.09964873671782763,2.91,BP
GO:1990138,neuron projection extension,196,8,3.28,0.01779,1,0.10088763250883392,2.44,BP
GO:0023061,signal release,531,16,8.89,0.01780,1,0.10088763250883392,1.8,BP
GO:0071407,cellular response to organic cyclic comp...,487,15,8.16,0.01792,1,0.10144828235294116,1.84,BP
GO:0046847,filopodium assembly,60,4,1.01,0.01809,1,0.10217028169014084,3.96,BP
GO:0060119,inner ear receptor cell development,60,4,1.01,0.01809,1,0.10217028169014084,3.96,BP
GO:0018130,heterocycle biosynthetic process,3392,72,56.82,0.01818,1,0.10255821805392731,1.27,BP
GO:0042552,myelination,160,7,2.68,0.01845,1,0.103586993006993,2.61,BP
GO:1903169,regulation of calcium ion transmembrane ...,160,7,2.68,0.01845,1,0.103586993006993,2.61,BP
GO:0014015,positive regulation of gliogenesis,91,5,1.52,0.01847,1,0.103586993006993,3.29,BP
GO:0021954,central nervous system neuron developmen...,91,5,1.52,0.01847,1,0.103586993006993,3.29,BP
GO:0035773,insulin secretion involved in cellular r...,91,5,1.52,0.01847,1,0.103586993006993,3.29,BP
GO:0032270,positive regulation of cellular protein ...,1551,37,25.98,0.01898,1,0.10618815331010453,1.42,BP
GO:0007617,mating behavior,34,3,0.57,0.01900,1,0.10618815331010453,5.26,BP
GO:2000406,positive regulation of T cell migration,34,3,0.57,0.01900,1,0.10618815331010453,5.26,BP
GO:0006446,regulation of translational initiation,61,4,1.02,0.01911,1,0.10630904046242773,3.92,BP
GO:0006749,glutathione metabolic process,61,4,1.02,0.01911,1,0.10630904046242773,3.92,BP
GO:1901607,alpha-amino acid biosynthetic process,61,4,1.02,0.01911,1,0.10630904046242773,3.92,BP
GO:1902305,regulation of sodium ion transmembrane t...,61,4,1.02,0.01911,1,0.10630904046242773,3.92,BP
GO:0045685,regulation of glial cell differentiation,92,5,1.54,0.01927,1,0.10698255466052935,3.25,BP
GO:0016236,macroautophagy,199,8,3.33,0.01930,1,0.10698255466052935,2.4,BP
GO:0030307,positive regulation of cell growth,199,8,3.33,0.01930,1,0.10698255466052935,2.4,BP
GO:0044770,cell cycle phase transition,404,13,6.77,0.01932,1,0.10698255466052935,1.92,BP
GO:0120031,plasma membrane bounded cell projection ...,492,15,8.24,0.01945,1,0.10757862068965517,1.82,BP
GO:0019438,aromatic compound biosynthetic process,3405,72,57.03,0.01970,1,0.10883628013777266,1.26,BP
GO:0006885,regulation of pH,93,5,1.56,0.02010,1,0.11058293515358361,3.21,BP
GO:0035305,negative regulation of dephosphorylation,93,5,1.56,0.02010,1,0.11058293515358361,3.21,BP
GO:0007040,lysosome organization,62,4,1.04,0.02017,1,0.11058293515358361,3.85,BP
GO:0048488,synaptic vesicle endocytosis,62,4,1.04,0.02017,1,0.11058293515358361,3.85,BP
GO:0080171,lytic vacuole organization,62,4,1.04,0.02017,1,0.11058293515358361,3.85,BP
GO:0140238,presynaptic endocytosis,62,4,1.04,0.02017,1,0.11058293515358361,3.85,BP
GO:0007272,ensheathment of neurons,163,7,2.73,0.02020,1,0.11058293515358361,2.56,BP
GO:0008366,axon ensheathment,163,7,2.73,0.02020,1,0.11058293515358361,2.56,BP
GO:0002685,regulation of leukocyte migration,201,8,3.37,0.02036,1,0.11120581157775256,2.37,BP
GO:0006508,proteolysis,1661,39,27.82,0.02036,1,0.11120581157775256,1.4,BP
GO:0046686,response to cadmium ion,35,3,0.59,0.02053,1,0.111880362400906,5.08,BP
GO:0048679,regulation of axon regeneration,35,3,0.59,0.02053,1,0.111880362400906,5.08,BP
GO:0044772,mitotic cell cycle phase transition,365,12,6.11,0.02076,1,0.11298684745762713,1.96,BP
GO:0032886,regulation of microtubule-based process,241,9,4.04,0.02078,1,0.11298684745762713,2.23,BP
GO:0031396,regulation of protein ubiquitination,202,8,3.38,0.02090,1,0.1134373393461105,2.37,BP
GO:0030218,erythrocyte differentiation,128,6,2.14,0.02091,1,0.1134373393461105,2.8,BP
GO:0046031,ADP metabolic process,94,5,1.57,0.02095,1,0.11352635135135136,3.18,BP
GO:0030072,peptide hormone secretion,282,10,4.72,0.02106,1,0.11379218855218855,2.12,BP
GO:0070482,response to oxygen levels,282,10,4.72,0.02106,1,0.11379218855218855,2.12,BP
GO:0008283,cell proliferation,2027,46,33.95,0.02107,1,0.11379218855218855,1.35,BP
GO:0030154,cell differentiation,4243,87,71.07,0.02137,1,0.11528300448430494,1.22,BP
GO:0009743,response to carbohydrate,203,8,3.4,0.02145,1,0.11558499440089585,2.35,BP
GO:1901362,organic cyclic compound biosynthetic pro...,3529,74,59.11,0.02156,1,0.11604778523489931,1.25,BP
GO:0070997,neuron death,411,13,6.88,0.02187,1,0.11758484916201119,1.89,BP
GO:2000146,negative regulation of cell motility,284,10,4.76,0.02198,1,0.11804437500000001,2.1,BP
GO:0044092,negative regulation of molecular functio...,1018,26,17.05,0.02208,1,0.11826826666666668,1.52,BP
GO:0007094,mitotic spindle assembly checkpoint,36,3,0.6,0.02212,1,0.11826826666666668,5,BP
GO:0071173,spindle assembly checkpoint,36,3,0.6,0.02212,1,0.11826826666666668,5,BP
GO:1904358,positive regulation of telomere maintena...,36,3,0.6,0.02212,1,0.11826826666666668,5,BP
GO:0000280,nuclear division,412,13,6.9,0.02226,1,0.11888470588235295,1.88,BP
GO:0098609,cell-cell adhesion,731,20,12.24,0.02237,1,0.11918216814159291,1.63,BP
GO:0008652,cellular amino acid biosynthetic process,64,4,1.07,0.02239,1,0.11918216814159291,3.74,BP
GO:1904356,regulation of telomere maintenance via t...,64,4,1.07,0.02239,1,0.11918216814159291,3.74,BP
GO:0016032,viral process,285,10,4.77,0.02246,1,0.11942267403314917,2.1,BP
GO:0001666,response to hypoxia,205,8,3.43,0.02259,1,0.1198490407938258,2.33,BP
GO:0070507,regulation of microtubule cytoskeleton o...,205,8,3.43,0.02259,1,0.1198490407938258,2.33,BP
GO:0000045,autophagosome assembly,96,5,1.61,0.02271,1,0.12022059405940594,3.11,BP
GO:0034404,nucleobase-containing small molecule bio...,167,7,2.8,0.02271,1,0.12022059405940594,2.5,BP
GO:1901214,regulation of neuron death,370,12,6.2,0.02278,1,0.12045863736263737,1.94,BP
GO:1901215,negative regulation of neuron death,245,9,4.1,0.02282,1,0.12053769484083425,2.2,BP
GO:0060322,head development,686,19,11.49,0.02293,1,0.12098592105263158,1.65,BP
GO:0006323,DNA packaging,168,7,2.81,0.02337,1,0.12317244249726177,2.49,BP
GO:0009890,negative regulation of biosynthetic proc...,1524,36,25.53,0.02341,1,0.12324827133479213,1.41,BP
GO:0006278,RNA-dependent DNA biosynthetic process,65,4,1.09,0.02355,1,0.12357971646673938,3.67,BP
GO:0007004,telomere maintenance via telomerase,65,4,1.09,0.02355,1,0.12357971646673938,3.67,BP
GO:0051784,negative regulation of nuclear division,65,4,1.09,0.02355,1,0.12357971646673938,3.67,BP
GO:0030004,cellular monovalent inorganic cation hom...,97,5,1.62,0.02363,1,0.12386444444444446,3.09,BP
GO:0001819,positive regulation of cytokine producti...,460,14,7.71,0.02378,1,0.12437973913043478,1.82,BP
GO:0046470,phosphatidylcholine metabolic process,37,3,0.62,0.02378,1,0.12437973913043478,4.84,BP
GO:0007346,regulation of mitotic cell cycle,505,15,8.46,0.02387,1,0.12457965292841647,1.77,BP
GO:0030031,cell projection assembly,505,15,8.46,0.02387,1,0.12457965292841647,1.77,BP
GO:0009967,positive regulation of signal transducti...,1527,36,25.58,0.02403,1,0.12527882990249187,1.41,BP
GO:0043549,regulation of kinase activity,737,20,12.34,0.02413,1,0.12566402597402596,1.62,BP
GO:1902531,regulation of intracellular signal trans...,1733,40,29.03,0.02416,1,0.12568423783783786,1.38,BP
GO:0006334,nucleosome assembly,98,5,1.64,0.02457,1,0.12754135922330098,3.05,BP
GO:0010595,positive regulation of endothelial cell ...,98,5,1.64,0.02457,1,0.12754135922330098,3.05,BP
GO:0009064,glutamine family amino acid metabolic pr...,66,4,1.11,0.02475,1,0.12819913885898818,3.6,BP
GO:0034394,protein localization to cell surface,66,4,1.11,0.02475,1,0.12819913885898818,3.6,BP
GO:0071496,cellular response to external stimulus,290,10,4.86,0.02494,1,0.12904438709677418,2.06,BP
GO:0006952,defense response,1481,35,24.81,0.02509,1,0.12968107411385607,1.41,BP
GO:0006636,unsaturated fatty acid biosynthetic proc...,38,3,0.64,0.02551,1,0.13111030949839916,4.69,BP
GO:0071174,mitotic spindle checkpoint,38,3,0.64,0.02551,1,0.13111030949839916,4.69,BP
GO:2000403,positive regulation of lymphocyte migrat...,38,3,0.64,0.02551,1,0.13111030949839916,4.69,BP
GO:0009135,purine nucleoside diphosphate metabolic ...,99,5,1.66,0.02553,1,0.13111030949839916,3.01,BP
GO:0009179,purine ribonucleoside diphosphate metabo...,99,5,1.66,0.02553,1,0.13111030949839916,3.01,BP
GO:0099072,regulation of postsynaptic membrane neur...,99,5,1.66,0.02553,1,0.13111030949839916,3.01,BP
GO:0035264,multicellular organism growth,210,8,3.52,0.02561,1,0.13124102236421728,2.27,BP
GO:0071103,DNA conformation change,210,8,3.52,0.02561,1,0.13124102236421728,2.27,BP
GO:0014070,response to organic cyclic compound,742,20,12.43,0.02568,1,0.13145974468085106,1.61,BP
GO:0006887,exocytosis,377,12,6.31,0.02585,1,0.1321893730074389,1.9,BP
GO:0001933,negative regulation of protein phosphory...,421,13,7.05,0.02595,1,0.13241930010604455,1.84,BP
GO:0052547,regulation of peptidase activity,421,13,7.05,0.02595,1,0.13241930010604455,1.84,BP
GO:0090559,regulation of membrane permeability,67,4,1.12,0.02598,1,0.1324319491525424,3.57,BP
GO:0044255,cellular lipid metabolic process,936,24,15.68,0.02614,1,0.13287624076029567,1.53,BP
GO:0043271,negative regulation of ion transport,172,7,2.88,0.02615,1,0.13287624076029567,2.43,BP
GO:2001257,regulation of cation channel activity,172,7,2.88,0.02615,1,0.13287624076029567,2.43,BP
GO:0019722,calcium-mediated signaling,211,8,3.53,0.02625,1,0.13324367088607594,2.27,BP
GO:1905037,autophagosome organization,100,5,1.68,0.02652,1,0.13447232876712328,2.98,BP
GO:0010506,regulation of autophagy,252,9,4.22,0.02673,1,0.13539448421052633,2.13,BP
GO:0065004,protein-DNA complex assembly,173,7,2.9,0.02687,1,0.1358097520661157,2.41,BP
GO:0034097,response to cytokine,1037,26,17.37,0.02697,1,0.1358097520661157,1.5,BP
GO:0002708,positive regulation of lymphocyte mediat...,136,6,2.28,0.02716,1,0.1358097520661157,2.63,BP
GO:0002711,positive regulation of T cell mediated i...,68,4,1.14,0.02725,1,0.1358097520661157,3.51,BP
GO:0042273,ribosomal large subunit biogenesis,68,4,1.14,0.02725,1,0.1358097520661157,3.51,BP
GO:0048678,response to axon injury,68,4,1.14,0.02725,1,0.1358097520661157,3.51,BP
GO:0045935,positive regulation of nucleobase-contai...,1852,42,31.02,0.02726,1,0.1358097520661157,1.35,BP
GO:0006998,nuclear envelope organization,39,3,0.65,0.02730,1,0.1358097520661157,4.62,BP
GO:0010613,positive regulation of cardiac muscle hy...,39,3,0.65,0.02730,1,0.1358097520661157,4.62,BP
GO:0014002,astrocyte development,39,3,0.65,0.02730,1,0.1358097520661157,4.62,BP
GO:0061462,protein localization to lysosome,39,3,0.65,0.02730,1,0.1358097520661157,4.62,BP
GO:0070570,regulation of neuron projection regenera...,39,3,0.65,0.02730,1,0.1358097520661157,4.62,BP
GO:0072595,maintenance of protein localization in o...,39,3,0.65,0.02730,1,0.1358097520661157,4.62,BP
GO:1900026,positive regulation of substrate adhesio...,39,3,0.65,0.02730,1,0.1358097520661157,4.62,BP
GO:1901998,toxin transport,39,3,0.65,0.02730,1,0.1358097520661157,4.62,BP
GO:1904645,response to amyloid-beta,39,3,0.65,0.02730,1,0.1358097520661157,4.62,BP
GO:1905710,positive regulation of membrane permeabi...,39,3,0.65,0.02730,1,0.1358097520661157,4.62,BP
GO:0002699,positive regulation of immune effector p...,253,9,4.24,0.02732,1,0.1358097520661157,2.12,BP
GO:0042326,negative regulation of phosphorylation,469,14,7.86,0.02743,1,0.13621585139318884,1.78,BP
GO:0051651,maintenance of location in cell,101,5,1.69,0.02753,1,0.13657150515463917,2.96,BP
GO:0090068,positive regulation of cell cycle proces...,254,9,4.25,0.02793,1,0.1384131410916581,2.12,BP
GO:0010817,regulation of hormone levels,562,16,9.41,0.02823,1,0.13975592592592592,1.7,BP
GO:0033047,regulation of mitotic sister chromatid s...,69,4,1.16,0.02856,1,0.14085946721311476,3.45,BP
GO:0048168,regulation of neuronal synaptic plastici...,69,4,1.16,0.02856,1,0.14085946721311476,3.45,BP
GO:0050885,neuromuscular process controlling balanc...,69,4,1.16,0.02856,1,0.14085946721311476,3.45,BP
GO:0010522,regulation of calcium ion transport into...,102,5,1.71,0.02857,1,0.14085946721311476,2.92,BP
GO:0060047,heart contraction,215,8,3.6,0.02891,1,0.14238988741044012,2.22,BP
GO:0014742,positive regulation of muscle hypertroph...,40,3,0.67,0.02916,1,0.14245474111675127,4.48,BP
GO:0031577,spindle checkpoint,40,3,0.67,0.02916,1,0.14245474111675127,4.48,BP
GO:0032594,protein transport within lipid bilayer,40,3,0.67,0.02916,1,0.14245474111675127,4.48,BP
GO:0035307,positive regulation of protein dephospho...,40,3,0.67,0.02916,1,0.14245474111675127,4.48,BP
GO:0044091,membrane biogenesis,40,3,0.67,0.02916,1,0.14245474111675127,4.48,BP
GO:0045841,negative regulation of mitotic metaphase...,40,3,0.67,0.02916,1,0.14245474111675127,4.48,BP
GO:0045851,pH reduction,40,3,0.67,0.02916,1,0.14245474111675127,4.48,BP
GO:1902108,regulation of mitochondrial membrane per...,40,3,0.67,0.02916,1,0.14245474111675127,4.48,BP
GO:0009185,ribonucleoside diphosphate metabolic pro...,103,5,1.73,0.02963,1,0.1444575075987842,2.89,BP
GO:0045778,positive regulation of ossification,103,5,1.73,0.02963,1,0.1444575075987842,2.89,BP
GO:0034330,cell junction organization,257,9,4.3,0.02979,1,0.14509056680161941,2.09,BP
GO:0043902,positive regulation of multi-organism pr...,177,7,2.96,0.02992,1,0.145576380182002,2.36,BP
GO:0019216,regulation of lipid metabolic process,342,11,5.73,0.03002,1,0.14591539393939393,1.92,BP
GO:0007163,establishment or maintenance of cell pol...,217,8,3.63,0.03031,1,0.14717630676084761,2.2,BP
GO:0034655,nucleobase-containing compound catabolic...,431,13,7.22,0.03055,1,0.1481921370967742,1.8,BP
GO:0010605,negative regulation of macromolecule met...,2612,56,43.75,0.03096,1,0.1489611155378486,1.28,BP
GO:0070838,divalent metal ion transport,477,14,7.99,0.03102,1,0.1489611155378486,1.75,BP
GO:0019932,second-messenger-mediated signaling,432,13,7.24,0.03105,1,0.1489611155378486,1.8,BP
GO:0002832,negative regulation of response to bioti...,41,3,0.69,0.03108,1,0.1489611155378486,4.35,BP
GO:0014037,Schwann cell differentiation,41,3,0.69,0.03108,1,0.1489611155378486,4.35,BP
GO:0021955,central nervous system neuron axonogenes...,41,3,0.69,0.03108,1,0.1489611155378486,4.35,BP
GO:0030501,positive regulation of bone mineralizati...,41,3,0.69,0.03108,1,0.1489611155378486,4.35,BP
GO:0043001,Golgi to plasma membrane protein transpo...,41,3,0.69,0.03108,1,0.1489611155378486,4.35,BP
GO:0048873,homeostasis of number of cells within a ...,41,3,0.69,0.03108,1,0.1489611155378486,4.35,BP
GO:0071364,cellular response to epidermal growth fa...,41,3,0.69,0.03108,1,0.1489611155378486,4.35,BP
GO:2000008,regulation of protein localization to ce...,41,3,0.69,0.03108,1,0.1489611155378486,4.35,BP
GO:2000816,negative regulation of mitotic sister ch...,41,3,0.69,0.03108,1,0.1489611155378486,4.35,BP
GO:0006513,protein monoubiquitination,71,4,1.19,0.03129,1,0.1498183880597015,3.36,BP
GO:0010821,regulation of mitochondrion organization,141,6,2.36,0.03164,1,0.15119332671300895,2.54,BP
GO:0016052,carbohydrate catabolic process,141,6,2.36,0.03164,1,0.15119332671300895,2.54,BP
GO:0140014,mitotic nuclear division,260,9,4.36,0.03175,1,0.15156845238095237,2.06,BP
GO:0035967,cellular response to topologically incor...,105,5,1.76,0.03183,1,0.1517997621407334,2.84,BP
GO:0072511,divalent inorganic cation transport,480,14,8.04,0.03244,1,0.1545557227722772,1.74,BP
GO:0010324,membrane invagination,72,4,1.21,0.03270,1,0.15564035608308605,3.31,BP
GO:0032091,negative regulation of protein binding,106,5,1.78,0.03296,1,0.15656813425468905,2.81,BP
GO:0051983,regulation of chromosome segregation,106,5,1.78,0.03296,1,0.15656813425468905,2.81,BP
GO:0010559,regulation of glycoprotein biosynthetic ...,42,3,0.7,0.03307,1,0.15678112315270937,4.29,BP
GO:1902100,negative regulation of metaphase/anaphas...,42,3,0.7,0.03307,1,0.15678112315270937,4.29,BP
GO:0050707,regulation of cytokine secretion,221,8,3.7,0.03324,1,0.15741911504424777,2.16,BP
GO:0016477,cell migration,1463,34,24.51,0.03327,1,0.15741911504424777,1.39,BP
GO:0031326,regulation of cellular biosynthetic proc...,3496,72,58.56,0.03348,1,0.15825713163064833,1.23,BP
GO:0006338,chromatin remodeling,143,6,2.4,0.03356,1,0.15847960745829243,2.5,BP
GO:0051650,establishment of vesicle localization,263,9,4.41,0.03379,1,0.15939455435847208,2.04,BP
GO:0010556,regulation of macromolecule biosynthetic...,3333,69,55.83,0.03382,1,0.15939455435847208,1.24,BP
GO:0043161,proteasome-mediated ubiquitin-dependent ...,393,12,6.58,0.03399,1,0.1600390215264188,1.82,BP
GO:0016241,regulation of macroautophagy,107,5,1.79,0.03412,1,0.1603687024390244,2.79,BP
GO:0021766,hippocampus development,73,4,1.22,0.03416,1,0.1603687024390244,3.28,BP
GO:0097120,receptor localization to synapse,73,4,1.22,0.03416,1,0.1603687024390244,3.28,BP
GO:0071333,cellular response to glucose stimulus,144,6,2.41,0.03454,1,0.16199461988304095,2.49,BP
GO:0006511,ubiquitin-dependent protein catabolic pr...,577,16,9.66,0.03467,1,0.1624459980525803,1.66,BP
GO:0046883,regulation of hormone secretion,307,10,5.14,0.03486,1,0.16317735408560313,1.95,BP
GO:0001937,negative regulation of endothelial cell ...,43,3,0.72,0.03512,1,0.1635335396518375,4.17,BP
GO:0008631,intrinsic apoptotic signaling pathway in...,43,3,0.72,0.03512,1,0.1635335396518375,4.17,BP
GO:0009395,phospholipid catabolic process,43,3,0.72,0.03512,1,0.1635335396518375,4.17,BP
GO:0048255,mRNA stabilization,43,3,0.72,0.03512,1,0.1635335396518375,4.17,BP
GO:1905819,negative regulation of chromosome separa...,43,3,0.72,0.03512,1,0.1635335396518375,4.17,BP
GO:0000226,microtubule cytoskeleton organization,578,16,9.68,0.03514,1,0.1635335396518375,1.65,BP
GO:1903201,regulation of oxidative stress-induced c...,74,4,1.24,0.03565,1,0.16574666666666668,3.23,BP
GO:0042692,muscle cell differentiation,396,12,6.63,0.03570,1,0.16581891891891892,1.81,BP
GO:0042391,regulation of membrane potential,442,13,7.4,0.03628,1,0.16835039537126326,1.76,BP
GO:0003015,heart process,225,8,3.77,0.03636,1,0.16855907514450869,2.12,BP
GO:0021987,cerebral cortex development,109,5,1.83,0.03652,1,0.1688129106628242,2.73,BP
GO:0045185,maintenance of protein location,109,5,1.83,0.03652,1,0.1688129106628242,2.73,BP
GO:0048259,regulation of receptor-mediated endocyto...,109,5,1.83,0.03652,1,0.1688129106628242,2.73,BP
GO:0007610,behavior,724,19,12.13,0.03674,1,0.16966687140115164,1.57,BP
GO:0045843,negative regulation of striated muscle t...,75,4,1.26,0.03718,1,0.17131824091778203,3.17,BP
GO:0006890,"retrograde vesicle-mediated transport, G...",44,3,0.74,0.03724,1,0.17131824091778203,4.05,BP
GO:0032527,protein exit from endoplasmic reticulum,44,3,0.74,0.03724,1,0.17131824091778203,4.05,BP
GO:0043277,apoptotic cell clearance,44,3,0.74,0.03724,1,0.17131824091778203,4.05,BP
GO:2000112,regulation of cellular macromolecule bio...,3241,67,54.29,0.03736,1,0.17170613180515756,1.23,BP
GO:0044419,interspecies interaction between organis...,399,12,6.68,0.03747,1,0.17204736641221374,1.8,BP
GO:0050896,response to stimulus,9311,173,155.96,0.03753,1,0.17215858913250717,1.11,BP
GO:0071331,cellular response to hexose stimulus,147,6,2.46,0.03762,1,0.1724070857142857,2.44,BP
GO:0030316,osteoclast differentiation,110,5,1.84,0.03776,1,0.1728840342530923,2.72,BP
GO:0003012,muscle system process,400,12,6.7,0.03807,1,0.17413768060836501,1.79,BP
GO:0007420,brain development,632,17,10.59,0.03837,1,0.17534324786324787,1.61,BP
GO:0051716,cellular response to stimulus,7732,146,129.51,0.03849,1,0.1757247438330171,1.13,BP
GO:0071326,cellular response to monosaccharide stim...,148,6,2.48,0.03868,1,0.17591037735849055,2.42,BP
GO:0030099,myeloid cell differentiation,401,12,6.72,0.03868,1,0.17591037735849055,1.79,BP
GO:0010822,positive regulation of mitochondrion org...,76,4,1.27,0.03875,1,0.17591037735849055,3.15,BP
GO:0021879,forebrain neuron differentiation,76,4,1.27,0.03875,1,0.17591037735849055,3.15,BP
GO:0051193,regulation of cofactor metabolic process,76,4,1.27,0.03875,1,0.17591037735849055,3.15,BP
GO:0051865,protein autoubiquitination,76,4,1.27,0.03875,1,0.17591037735849055,3.15,BP
GO:0002688,regulation of leukocyte chemotaxis,111,5,1.86,0.03902,1,0.1768024858757062,2.69,BP
GO:0014074,response to purine-containing compound,111,5,1.86,0.03902,1,0.1768024858757062,2.69,BP
GO:0032965,regulation of collagen biosynthetic proc...,45,3,0.75,0.03942,1,0.17827917293233084,4,BP
GO:0043044,ATP-dependent chromatin remodeling,45,3,0.75,0.03942,1,0.17827917293233084,4,BP
GO:0030336,negative regulation of cell migration,271,9,4.54,0.03967,1,0.17911834896810505,1.98,BP
GO:0006650,glycerophospholipid metabolic process,229,8,3.84,0.03968,1,0.17911834896810505,2.08,BP
GO:0021782,glial cell development,112,5,1.88,0.04030,1,0.1817465791940019,2.66,BP
GO:0048635,negative regulation of muscle organ deve...,77,4,1.29,0.04035,1,0.1818016853932584,3.1,BP
GO:0055067,monovalent inorganic cation homeostasis,150,6,2.51,0.04086,1,0.1839273339569691,2.39,BP
GO:0051924,regulation of calcium ion transport,273,9,4.57,0.04124,1,0.1854643738317757,1.97,BP
GO:0036293,response to decreased oxygen levels,231,8,3.87,0.04140,1,0.18596282003710576,2.07,BP
GO:0014706,striated muscle tissue development,451,13,7.55,0.04151,1,0.18596282003710576,1.72,BP
GO:0030048,actin filament-based movement,113,5,1.89,0.04162,1,0.18596282003710576,2.65,BP
GO:0030516,regulation of axon extension,113,5,1.89,0.04162,1,0.18596282003710576,2.65,BP
GO:1905269,positive regulation of chromatin organiz...,113,5,1.89,0.04162,1,0.18596282003710576,2.65,BP
GO:0017001,antibiotic catabolic process,46,3,0.77,0.04166,1,0.18596282003710576,3.9,BP
GO:1903580,positive regulation of ATP metabolic pro...,46,3,0.77,0.04166,1,0.18596282003710576,3.9,BP
GO:2000404,regulation of T cell migration,46,3,0.77,0.04166,1,0.18596282003710576,3.9,BP
GO:0051093,negative regulation of developmental pro...,1082,26,18.12,0.04185,1,0.18663781278962002,1.43,BP
GO:0046785,microtubule polymerization,78,4,1.31,0.04200,1,0.18696022201665127,3.05,BP
GO:1901862,negative regulation of muscle tissue dev...,78,4,1.31,0.04200,1,0.18696022201665127,3.05,BP
GO:0014013,regulation of gliogenesis,152,6,2.55,0.04311,1,0.1916802216066482,2.35,BP
GO:0050678,regulation of epithelial cell proliferat...,363,11,6.08,0.04314,1,0.1916802216066482,1.81,BP
GO:0043086,negative regulation of catalytic activit...,690,18,11.56,0.04333,1,0.19221389861751148,1.56,BP
GO:0051271,negative regulation of cellular componen...,319,10,5.34,0.04334,1,0.19221389861751148,1.87,BP
GO:0019430,removal of superoxide radicals,20,2,0.34,0.04358,1,0.19221536205316223,5.88,BP
GO:0034377,plasma lipoprotein particle assembly,20,2,0.34,0.04358,1,0.19221536205316223,5.88,BP
GO:0090502,"RNA phosphodiester bond hydrolysis, endo...",20,2,0.34,0.04358,1,0.19221536205316223,5.88,BP
GO:1900451,positive regulation of glutamate recepto...,20,2,0.34,0.04358,1,0.19221536205316223,5.88,BP
GO:1901028,regulation of mitochondrial outer membra...,20,2,0.34,0.04358,1,0.19221536205316223,5.88,BP
GO:1903798,regulation of production of miRNAs invol...,20,2,0.34,0.04358,1,0.19221536205316223,5.88,BP
GO:0003208,cardiac ventricle morphogenesis,79,4,1.32,0.04368,1,0.19248,3.03,BP
GO:0019098,reproductive behavior,47,3,0.79,0.04397,1,0.19305076642335767,3.8,BP
GO:0035196,production of miRNAs involved in gene si...,47,3,0.79,0.04397,1,0.19305076642335767,3.8,BP
GO:0051489,regulation of filopodium assembly,47,3,0.79,0.04397,1,0.19305076642335767,3.8,BP
GO:0061028,establishment of endothelial barrier,47,3,0.79,0.04397,1,0.19305076642335767,3.8,BP
GO:0006606,protein import into nucleus,153,6,2.56,0.04427,1,0.1941907383773929,2.34,BP
GO:0007059,chromosome segregation,321,10,5.38,0.04488,1,0.19668721311475412,1.86,BP
GO:0001912,positive regulation of leukocyte mediate...,80,4,1.34,0.04539,1,0.19838027247956405,2.99,BP
GO:0051781,positive regulation of cell division,80,4,1.34,0.04539,1,0.19838027247956405,2.99,BP
GO:1902117,positive regulation of organelle assembl...,80,4,1.34,0.04539,1,0.19838027247956405,2.99,BP
GO:0062012,regulation of small molecule metabolic p...,367,11,6.15,0.04603,1,0.20099488203266788,1.79,BP
GO:0051704,multi-organism process,2245,48,37.6,0.04615,1,0.20133617407071625,1.28,BP
GO:0047496,vesicle transport along microtubule,48,3,0.8,0.04634,1,0.20179916742081447,3.75,BP
GO:0051653,spindle localization,48,3,0.8,0.04634,1,0.20179916742081447,3.75,BP
GO:0071322,cellular response to carbohydrate stimul...,155,6,2.6,0.04664,1,0.20292195298372512,2.31,BP
GO:0009132,nucleoside diphosphate metabolic process,117,5,1.96,0.04712,1,0.20363392539964476,2.55,BP
GO:0051702,interaction with symbiont,81,4,1.36,0.04715,1,0.20363392539964476,2.94,BP
GO:0060113,inner ear receptor cell differentiation,81,4,1.36,0.04715,1,0.20363392539964476,2.94,BP
GO:0010498,proteasomal protein catabolic process,460,13,7.71,0.04724,1,0.20363392539964476,1.69,BP
GO:0002697,regulation of immune effector process,414,12,6.93,0.04725,1,0.20363392539964476,1.73,BP
GO:0048870,cell motility,1612,36,27,0.04743,1,0.20363392539964476,1.33,BP
GO:0051674,localization of cell,1612,36,27,0.04743,1,0.20363392539964476,1.33,BP
GO:0042180,cellular ketone metabolic process,196,7,3.28,0.04754,1,0.20363392539964476,2.13,BP
GO:0000466,maturation of 5.8S rRNA from tricistroni...,21,2,0.35,0.04765,1,0.20363392539964476,5.71,BP
GO:0000469,cleavage involved in rRNA processing,21,2,0.35,0.04765,1,0.20363392539964476,5.71,BP
GO:0006089,lactate metabolic process,21,2,0.35,0.04765,1,0.20363392539964476,5.71,BP
GO:0006541,glutamine metabolic process,21,2,0.35,0.04765,1,0.20363392539964476,5.71,BP
GO:0031065,positive regulation of histone deacetyla...,21,2,0.35,0.04765,1,0.20363392539964476,5.71,BP
GO:0036336,dendritic cell migration,21,2,0.35,0.04765,1,0.20363392539964476,5.71,BP
GO:0046697,decidualization,21,2,0.35,0.04765,1,0.20363392539964476,5.71,BP
GO:0048143,astrocyte activation,21,2,0.35,0.04765,1,0.20363392539964476,5.71,BP
GO:0051023,regulation of immunoglobulin secretion,21,2,0.35,0.04765,1,0.20363392539964476,5.71,BP
GO:0070920,regulation of production of small RNA in...,21,2,0.35,0.04765,1,0.20363392539964476,5.71,BP
GO:0098780,response to mitochondrial depolarisation,21,2,0.35,0.04765,1,0.20363392539964476,5.71,BP
GO:0098969,neurotransmitter receptor transport to p...,21,2,0.35,0.04765,1,0.20363392539964476,5.71,BP
GO:0045786,negative regulation of cell cycle,462,13,7.74,0.04859,1,0.2071233773087071,1.68,BP
GO:0031050,dsRNA processing,49,3,0.82,0.04877,1,0.2071233773087071,3.66,BP
GO:0043489,RNA stabilization,49,3,0.82,0.04877,1,0.2071233773087071,3.66,BP
GO:0061912,selective autophagy,49,3,0.82,0.04877,1,0.2071233773087071,3.66,BP
GO:0070169,positive regulation of biomineral tissue...,49,3,0.82,0.04877,1,0.2071233773087071,3.66,BP
GO:0070918,production of small RNA involved in gene...,49,3,0.82,0.04877,1,0.2071233773087071,3.66,BP
GO:0099054,presynapse assembly,49,3,0.82,0.04877,1,0.2071233773087071,3.66,BP
GO:0051648,vesicle localization,282,9,4.72,0.04884,1,0.2071233773087071,1.91,BP
GO:0051235,maintenance of location,326,10,5.46,0.04888,1,0.2071233773087071,1.83,BP
GO:0044106,cellular amine metabolic process,82,4,1.37,0.04894,1,0.2071233773087071,2.92,BP
GO:1904029,regulation of cyclin-dependent protein k...,82,4,1.37,0.04894,1,0.2071233773087071,2.92,BP
GO:0021543,pallium development,157,6,2.63,0.04909,1,0.20739339771729587,2.28,BP
GO:0051170,import into nucleus,157,6,2.63,0.04909,1,0.20739339771729587,2.28,BP
GO:0045785,positive regulation of cell adhesion,417,12,6.98,0.04939,1,0.20847778947368423,1.72,BP
GO:0008217,regulation of blood pressure,198,7,3.32,0.04971,1,0.20946105078809107,2.11,BP
GO:1901605,alpha-amino acid metabolic process,198,7,3.32,0.04971,1,0.20946105078809107,2.11,BP
GO:0071346,cellular response to interferon-gamma,119,5,1.99,0.05003,1,0.2106249868766404,2.51,BP
GO:0002252,immune effector process,752,19,12.6,0.05027,1,0.21145038461538465,1.51,BP
GO:0007169,transmembrane receptor protein tyrosine ...,559,15,9.36,0.05054,1,0.2124004192139738,1.6,BP
GO:0033045,regulation of sister chromatid segregati...,83,4,1.39,0.05076,1,0.2129530252833479,2.88,BP
GO:1901019,regulation of calcium ion transmembrane ...,83,4,1.39,0.05076,1,0.2129530252833479,2.88,BP
GO:0044242,cellular lipid catabolic process,199,7,3.33,0.05082,1,0.21301902439024392,2.1,BP
GO:0042491,inner ear auditory receptor cell differe...,50,3,0.84,0.05126,1,0.21467634464751958,3.57,BP
GO:0051276,chromosome organization,1105,26,18.51,0.05148,1,0.21471790017211703,1.4,BP
GO:0031109,microtubule polymerization or depolymeri...,120,5,2.01,0.05152,1,0.21471790017211703,2.49,BP
GO:0010594,regulation of endothelial cell migration,159,6,2.66,0.05161,1,0.21471790017211703,2.26,BP
GO:0000470,maturation of LSU-rRNA,22,2,0.37,0.05185,1,0.21471790017211703,5.41,BP
GO:0009110,vitamin biosynthetic process,22,2,0.37,0.05185,1,0.21471790017211703,5.41,BP
GO:0042178,xenobiotic catabolic process,22,2,0.37,0.05185,1,0.21471790017211703,5.41,BP
GO:0071450,cellular response to oxygen radical,22,2,0.37,0.05185,1,0.21471790017211703,5.41,BP
GO:0071451,cellular response to superoxide,22,2,0.37,0.05185,1,0.21471790017211703,5.41,BP
GO:0071800,podosome assembly,22,2,0.37,0.05185,1,0.21471790017211703,5.41,BP
GO:0097062,dendritic spine maintenance,22,2,0.37,0.05185,1,0.21471790017211703,5.41,BP
GO:0098877,neurotransmitter receptor transport to p...,22,2,0.37,0.05185,1,0.21471790017211703,5.41,BP
GO:1901626,regulation of postsynaptic membrane orga...,22,2,0.37,0.05185,1,0.21471790017211703,5.41,BP
GO:2000010,positive regulation of protein localizat...,22,2,0.37,0.05185,1,0.21471790017211703,5.41,BP
GO:0051480,regulation of cytosolic calcium ion conc...,375,11,6.28,0.05219,1,0.21594005159071367,1.75,BP
GO:0042542,response to hydrogen peroxide,121,5,2.03,0.05304,1,0.2190802403433476,2.46,BP
GO:1903409,reactive oxygen species biosynthetic pro...,121,5,2.03,0.05304,1,0.2190802403433476,2.46,BP
GO:0044270,cellular nitrogen compound catabolic pro...,469,13,7.86,0.05350,1,0.22079073756432246,1.65,BP
GO:0043550,regulation of lipid kinase activity,51,3,0.85,0.05381,1,0.2215001881950385,3.53,BP
GO:1904591,positive regulation of protein import,51,3,0.85,0.05381,1,0.2215001881950385,3.53,BP
GO:2000649,regulation of sodium ion transmembrane t...,51,3,0.85,0.05381,1,0.2215001881950385,3.53,BP
GO:1903362,regulation of cellular protein catabolic...,244,8,4.09,0.05387,1,0.22155764102564102,1.96,BP
GO:0034502,protein localization to chromosome,85,4,1.42,0.05453,1,0.22371291311754682,2.82,BP
GO:1900407,regulation of cellular response to oxida...,85,4,1.42,0.05453,1,0.22371291311754682,2.82,BP
GO:0008286,insulin receptor signaling pathway,122,5,2.04,0.05458,1,0.22371291311754682,2.45,BP
GO:0010508,positive regulation of autophagy,122,5,2.04,0.05458,1,0.22371291311754682,2.45,BP
GO:0006997,nucleus organization,123,5,2.06,0.05615,1,0.2273811055276382,2.43,BP
GO:1900180,regulation of protein localization to nu...,123,5,2.06,0.05615,1,0.2273811055276382,2.43,BP
GO:0002093,auditory receptor cell morphogenesis,23,2,0.39,0.05617,1,0.2273811055276382,5.13,BP
GO:0010666,positive regulation of cardiac muscle ce...,23,2,0.39,0.05617,1,0.2273811055276382,5.13,BP
GO:0010996,response to auditory stimulus,23,2,0.39,0.05617,1,0.2273811055276382,5.13,BP
GO:0022403,cell cycle phase,23,2,0.39,0.05617,1,0.2273811055276382,5.13,BP
GO:0043501,skeletal muscle adaptation,23,2,0.39,0.05617,1,0.2273811055276382,5.13,BP
GO:0048532,anatomical structure arrangement,23,2,0.39,0.05617,1,0.2273811055276382,5.13,BP
GO:0051220,cytoplasmic sequestering of protein,23,2,0.39,0.05617,1,0.2273811055276382,5.13,BP
GO:0071276,cellular response to cadmium ion,23,2,0.39,0.05617,1,0.2273811055276382,5.13,BP
GO:1900242,regulation of synaptic vesicle endocytos...,23,2,0.39,0.05617,1,0.2273811055276382,5.13,BP
GO:1903540,establishment of protein localization to...,23,2,0.39,0.05617,1,0.2273811055276382,5.13,BP
GO:0001662,behavioral fear response,52,3,0.87,0.05642,1,0.2273811055276382,3.45,BP
GO:0010712,regulation of collagen metabolic process,52,3,0.87,0.05642,1,0.2273811055276382,3.45,BP
GO:0030071,regulation of mitotic metaphase/anaphase...,52,3,0.87,0.05642,1,0.2273811055276382,3.45,BP
GO:0030901,midbrain development,52,3,0.87,0.05642,1,0.2273811055276382,3.45,BP
GO:0031103,axon regeneration,52,3,0.87,0.05642,1,0.2273811055276382,3.45,BP
GO:0045981,positive regulation of nucleotide metabo...,52,3,0.87,0.05642,1,0.2273811055276382,3.45,BP
GO:0048713,regulation of oligodendrocyte differenti...,52,3,0.87,0.05642,1,0.2273811055276382,3.45,BP
GO:1900544,positive regulation of purine nucleotide...,52,3,0.87,0.05642,1,0.2273811055276382,3.45,BP
GO:0006096,glycolytic process,86,4,1.44,0.05647,1,0.22739216736401677,2.78,BP
GO:0040013,negative regulation of locomotion,335,10,5.61,0.05668,1,0.22804695652173912,1.78,BP
GO:1901361,organic cyclic compound catabolic proces...,521,14,8.73,0.05700,1,0.22914285714285718,1.6,BP
GO:0017157,regulation of exocytosis,247,8,4.14,0.05705,1,0.2291524207011686,1.93,BP
GO:0044703,multi-organism reproductive process,1015,24,17,0.05711,1,0.22920210175145952,1.41,BP
GO:0060537,muscle tissue development,474,13,7.94,0.05722,1,0.2294522,1.64,BP
GO:0007154,cell communication,6556,124,109.81,0.05762,1,0.23086381348875937,1.13,BP
GO:0008203,cholesterol metabolic process,124,5,2.08,0.05774,1,0.23115214642262896,2.4,BP
GO:0098742,cell-cell adhesion via plasma-membrane a...,205,7,3.43,0.05780,1,0.2312,2.04,BP
GO:0001678,cellular glucose homeostasis,164,6,2.75,0.05827,1,0.23273960199004973,2.18,BP
GO:0006936,muscle contraction,292,9,4.89,0.05831,1,0.23273960199004973,1.84,BP
GO:0009891,positive regulation of biosynthetic proc...,1960,42,32.83,0.05833,1,0.23273960199004973,1.28,BP
GO:0006757,ATP generation from ADP,87,4,1.46,0.05844,1,0.23279245033112583,2.74,BP
GO:0042490,mechanoreceptor differentiation,87,4,1.46,0.05844,1,0.23279245033112583,2.74,BP
GO:0033674,positive regulation of kinase activity,476,13,7.97,0.05875,1,0.23348866995073891,1.63,BP
GO:0046700,heterocycle catabolic process,476,13,7.97,0.05875,1,0.23348866995073891,1.63,BP
GO:0002209,behavioral defense response,53,3,0.89,0.05910,1,0.23348866995073891,3.37,BP
GO:0002720,positive regulation of cytokine producti...,53,3,0.89,0.05910,1,0.23348866995073891,3.37,BP
GO:0031529,ruffle organization,53,3,0.89,0.05910,1,0.23348866995073891,3.37,BP
GO:0043666,regulation of phosphoprotein phosphatase...,53,3,0.89,0.05910,1,0.23348866995073891,3.37,BP
GO:0045777,positive regulation of blood pressure,53,3,0.89,0.05910,1,0.23348866995073891,3.37,BP
GO:0051932,"synaptic transmission, GABAergic",53,3,0.89,0.05910,1,0.23348866995073891,3.37,BP
GO:0055010,ventricular cardiac muscle tissue morpho...,53,3,0.89,0.05910,1,0.23348866995073891,3.37,BP
GO:0099518,vesicle cytoskeletal trafficking,53,3,0.89,0.05910,1,0.23348866995073891,3.37,BP
GO:0031341,regulation of cell killing,125,5,2.09,0.05936,1,0.23432347826086958,2.39,BP
GO:0019953,sexual reproduction,868,21,14.54,0.05955,1,0.23488081967213112,1.44,BP
GO:0023014,signal transduction by protein phosphory...,819,20,13.72,0.06017,1,0.23650551053484606,1.46,BP
GO:0045862,positive regulation of proteolysis,339,10,5.68,0.06040,1,0.23650551053484606,1.76,BP
GO:0031110,regulation of microtubule polymerization...,88,4,1.47,0.06046,1,0.23650551053484606,2.72,BP
GO:0035418,protein localization to synapse,88,4,1.47,0.06046,1,0.23650551053484606,2.72,BP
GO:0009154,purine ribonucleotide catabolic process,24,2,0.4,0.06062,1,0.23650551053484606,5,BP
GO:0009261,ribonucleotide catabolic process,24,2,0.4,0.06062,1,0.23650551053484606,5,BP
GO:0010663,positive regulation of striated muscle c...,24,2,0.4,0.06062,1,0.23650551053484606,5,BP
GO:0048670,regulation of collateral sprouting,24,2,0.4,0.06062,1,0.23650551053484606,5,BP
GO:0051602,response to electrical stimulus,24,2,0.4,0.06062,1,0.23650551053484606,5,BP
GO:0051882,mitochondrial depolarization,24,2,0.4,0.06062,1,0.23650551053484606,5,BP
GO:0065005,protein-lipid complex assembly,24,2,0.4,0.06062,1,0.23650551053484606,5,BP
GO:0070199,establishment of protein localization to...,24,2,0.4,0.06062,1,0.23650551053484606,5,BP
GO:1902683,regulation of receptor localization to s...,24,2,0.4,0.06062,1,0.23650551053484606,5,BP
GO:0051260,protein homooligomerization,385,11,6.45,0.06065,1,0.23650551053484606,1.71,BP
GO:0002064,epithelial cell development,251,8,4.2,0.06148,1,0.2393940824575586,1.9,BP
GO:0034329,cell junction assembly,208,7,3.48,0.06150,1,0.2393940824575586,2.01,BP
GO:0051253,negative regulation of RNA metabolic pro...,1281,29,21.46,0.06154,1,0.2393940824575586,1.35,BP
GO:0007618,mating,54,3,0.9,0.06183,1,0.23955391304347826,3.33,BP
GO:0032964,collagen biosynthetic process,54,3,0.9,0.06183,1,0.23955391304347826,3.33,BP
GO:0043268,positive regulation of potassium ion tra...,54,3,0.9,0.06183,1,0.23955391304347826,3.33,BP
GO:0046503,glycerolipid catabolic process,54,3,0.9,0.06183,1,0.23955391304347826,3.33,BP
GO:0051496,positive regulation of stress fiber asse...,54,3,0.9,0.06183,1,0.23955391304347826,3.33,BP
GO:0046887,positive regulation of hormone secretion,167,6,2.8,0.06250,1,0.24176045016077172,2.14,BP
GO:0021872,forebrain generation of neurons,89,4,1.49,0.06250,1,0.24176045016077172,2.68,BP
GO:0061013,regulation of mRNA catabolic process,127,5,2.13,0.06268,1,0.24226197590361445,2.35,BP
GO:0050900,leukocyte migration,342,10,5.73,0.06329,1,0.2444233386837881,1.75,BP
GO:0060291,long-term synaptic potentiation,253,8,4.24,0.06377,1,0.24607958299919805,1.89,BP
GO:2000113,negative regulation of cellular macromol...,1391,31,23.3,0.06424,1,0.2465911498810468,1.33,BP
GO:0010811,positive regulation of cell-substrate ad...,128,5,2.14,0.06438,1,0.2465911498810468,2.34,BP
GO:0061387,regulation of extent of cell growth,128,5,2.14,0.06438,1,0.2465911498810468,2.34,BP
GO:0042866,pyruvate biosynthetic process,90,4,1.51,0.06459,1,0.2465911498810468,2.65,BP
GO:1903008,organelle disassembly,90,4,1.51,0.06459,1,0.2465911498810468,2.65,BP
GO:0007528,neuromuscular junction development,55,3,0.92,0.06462,1,0.2465911498810468,3.26,BP
GO:0035306,positive regulation of dephosphorylation,55,3,0.92,0.06462,1,0.2465911498810468,3.26,BP
GO:0035315,hair cell differentiation,55,3,0.92,0.06462,1,0.2465911498810468,3.26,BP
GO:0045773,positive regulation of axon extension,55,3,0.92,0.06462,1,0.2465911498810468,3.26,BP
GO:0046902,regulation of mitochondrial membrane per...,55,3,0.92,0.06462,1,0.2465911498810468,3.26,BP
GO:0050775,positive regulation of dendrite morphoge...,55,3,0.92,0.06462,1,0.2465911498810468,3.26,BP
GO:0051187,cofactor catabolic process,55,3,0.92,0.06462,1,0.2465911498810468,3.26,BP
GO:1900024,regulation of substrate adhesion-depende...,55,3,0.92,0.06462,1,0.2465911498810468,3.26,BP
GO:1902099,regulation of metaphase/anaphase transit...,55,3,0.92,0.06462,1,0.2465911498810468,3.26,BP
GO:0050663,cytokine secretion,254,8,4.25,0.06493,1,0.24696548031496066,1.88,BP
GO:0000303,response to superoxide,25,2,0.42,0.06518,1,0.24696548031496066,4.76,BP
GO:0009065,glutamine family amino acid catabolic pr...,25,2,0.42,0.06518,1,0.24696548031496066,4.76,BP
GO:0010640,regulation of platelet-derived growth fa...,25,2,0.42,0.06518,1,0.24696548031496066,4.76,BP
GO:0021895,cerebral cortex neuron differentiation,25,2,0.42,0.06518,1,0.24696548031496066,4.76,BP
GO:0051894,positive regulation of focal adhesion as...,25,2,0.42,0.06518,1,0.24696548031496066,4.76,BP
GO:1901032,negative regulation of response to react...,25,2,0.42,0.06518,1,0.24696548031496066,4.76,BP
GO:1903206,negative regulation of hydrogen peroxide...,25,2,0.42,0.06518,1,0.24696548031496066,4.76,BP
GO:2001039,negative regulation of cellular response...,25,2,0.42,0.06518,1,0.24696548031496066,4.76,BP
GO:0002705,positive regulation of leukocyte mediate...,169,6,2.83,0.06542,1,0.24729068342498037,2.12,BP
GO:0045931,positive regulation of mitotic cell cycl...,169,6,2.83,0.06542,1,0.24729068342498037,2.12,BP
GO:0071897,DNA biosynthetic process,169,6,2.83,0.06542,1,0.24729068342498037,2.12,BP
GO:0051592,response to calcium ion,129,5,2.16,0.06611,1,0.24950691764705882,2.31,BP
GO:1902652,secondary alcohol metabolic process,129,5,2.16,0.06611,1,0.24950691764705882,2.31,BP
GO:0032101,regulation of response to external stimu...,779,19,13.05,0.06638,1,0.250329592476489,1.46,BP
GO:0006814,sodium ion transport,212,7,3.55,0.06666,1,0.25118037558685447,1.97,BP
GO:0002709,regulation of T cell mediated immunity,91,4,1.52,0.06671,1,0.25118037558685447,2.63,BP
GO:0060401,cytosolic calcium ion transport,170,6,2.85,0.06690,1,0.25169882720875686,2.11,BP
GO:0007091,metaphase/anaphase transition of mitotic...,56,3,0.94,0.06746,1,0.25301443491816056,3.19,BP
GO:0031641,regulation of myelination,56,3,0.94,0.06746,1,0.25301443491816056,3.19,BP
GO:0042596,fear response,56,3,0.94,0.06746,1,0.25301443491816056,3.19,BP
GO:0099172,presynapse organization,56,3,0.94,0.06746,1,0.25301443491816056,3.19,BP
GO:0007093,mitotic cell cycle checkpoint,130,5,2.18,0.06785,1,0.2540810894941634,2.29,BP
GO:0044839,cell cycle G2/M phase transition,130,5,2.18,0.06785,1,0.2540810894941634,2.29,BP
GO:0001676,long-chain fatty acid metabolic process,92,4,1.54,0.06886,1,0.25706308766485647,2.6,BP
GO:0009308,amine metabolic process,92,4,1.54,0.06886,1,0.25706308766485647,2.6,BP
GO:0070252,actin-mediated cell contraction,92,4,1.54,0.06886,1,0.25706308766485647,2.6,BP
GO:1903313,positive regulation of mRNA metabolic pr...,92,4,1.54,0.06886,1,0.25706308766485647,2.6,BP
GO:0010810,regulation of cell-substrate adhesion,214,7,3.58,0.06933,1,0.2579571757482732,1.96,BP
GO:0042177,negative regulation of protein catabolic...,131,5,2.19,0.06963,1,0.2579571757482732,2.28,BP
GO:0045055,regulated exocytosis,258,8,4.32,0.06973,1,0.2579571757482732,1.85,BP
GO:0000460,maturation of 5.8S rRNA,26,2,0.44,0.06985,1,0.2579571757482732,4.55,BP
GO:0003299,muscle hypertrophy in response to stress,26,2,0.44,0.06985,1,0.2579571757482732,4.55,BP
GO:0007176,regulation of epidermal growth factor-ac...,26,2,0.44,0.06985,1,0.2579571757482732,4.55,BP
GO:0014898,cardiac muscle hypertrophy in response t...,26,2,0.44,0.06985,1,0.2579571757482732,4.55,BP
GO:0019320,hexose catabolic process,26,2,0.44,0.06985,1,0.2579571757482732,4.55,BP
GO:0048642,negative regulation of skeletal muscle t...,26,2,0.44,0.06985,1,0.2579571757482732,4.55,BP
GO:0070861,regulation of protein exit from endoplas...,26,2,0.44,0.06985,1,0.2579571757482732,4.55,BP
GO:0090140,regulation of mitochondrial fission,26,2,0.44,0.06985,1,0.2579571757482732,4.55,BP
GO:0098901,regulation of cardiac muscle cell action...,26,2,0.44,0.06985,1,0.2579571757482732,4.55,BP
GO:0099010,modification of postsynaptic structure,26,2,0.44,0.06985,1,0.2579571757482732,4.55,BP
GO:2000765,regulation of cytoplasmic translation,26,2,0.44,0.06985,1,0.2579571757482732,4.55,BP
GO:0019439,aromatic compound catabolic process,490,13,8.21,0.07027,1,0.2586495951107716,1.58,BP
GO:0010965,regulation of mitotic sister chromatid s...,57,3,0.95,0.07036,1,0.2586495951107716,3.16,BP
GO:0019080,viral gene expression,57,3,0.95,0.07036,1,0.2586495951107716,3.16,BP
GO:0072678,T cell migration,57,3,0.95,0.07036,1,0.2586495951107716,3.16,BP
GO:1903539,protein localization to postsynaptic mem...,57,3,0.95,0.07036,1,0.2586495951107716,3.16,BP
GO:1905517,macrophage migration,57,3,0.95,0.07036,1,0.2586495951107716,3.16,BP
GO:0036473,cell death in response to oxidative stre...,93,4,1.56,0.07106,1,0.260824347826087,2.56,BP
GO:0046889,positive regulation of lipid biosyntheti...,93,4,1.56,0.07106,1,0.260824347826087,2.56,BP
GO:0043467,regulation of generation of precursor me...,132,5,2.21,0.07143,1,0.26198259146341457,2.26,BP
GO:0046677,response to antibiotic,305,9,5.11,0.07228,1,0.2648982178217822,1.76,BP
GO:0051100,negative regulation of binding,174,6,2.91,0.07305,1,0.266880363086233,2.06,BP
GO:0016125,sterol metabolic process,133,5,2.23,0.07326,1,0.266880363086233,2.24,BP
GO:0030177,positive regulation of Wnt signaling pat...,133,5,2.23,0.07326,1,0.266880363086233,2.24,BP
GO:0007215,glutamate receptor signaling pathway,94,4,1.57,0.07328,1,0.266880363086233,2.55,BP
GO:0031343,positive regulation of cell killing,94,4,1.57,0.07328,1,0.266880363086233,2.55,BP
GO:1902882,regulation of response to oxidative stre...,94,4,1.57,0.07328,1,0.266880363086233,2.55,BP
GO:0015909,long-chain fatty acid transport,58,3,0.97,0.07332,1,0.266880363086233,3.09,BP
GO:0061512,protein localization to cilium,58,3,0.97,0.07332,1,0.266880363086233,3.09,BP
GO:1900449,regulation of glutamate receptor signali...,58,3,0.97,0.07332,1,0.266880363086233,3.09,BP
GO:0016050,vesicle organization,261,8,4.37,0.07346,1,0.2669860422960725,1.83,BP
GO:0048738,cardiac muscle tissue development,261,8,4.37,0.07346,1,0.2669860422960725,1.83,BP
GO:0042127,regulation of cell proliferation,1676,36,28.07,0.07406,1,0.2689635622641509,1.28,BP
GO:0040011,locomotion,1837,39,30.77,0.07420,1,0.269268778280543,1.27,BP
GO:0000305,response to oxygen radical,27,2,0.45,0.07463,1,0.26940702175543885,4.44,BP
GO:0006730,one-carbon metabolic process,27,2,0.45,0.07463,1,0.26940702175543885,4.44,BP
GO:0010460,positive regulation of heart rate,27,2,0.45,0.07463,1,0.26940702175543885,4.44,BP
GO:0014887,cardiac muscle adaptation,27,2,0.45,0.07463,1,0.26940702175543885,4.44,BP
GO:0032069,regulation of nuclease activity,27,2,0.45,0.07463,1,0.26940702175543885,4.44,BP
GO:0048305,immunoglobulin secretion,27,2,0.45,0.07463,1,0.26940702175543885,4.44,BP
GO:1900273,positive regulation of long-term synapti...,27,2,0.45,0.07463,1,0.26940702175543885,4.44,BP
GO:0045926,negative regulation of growth,262,8,4.39,0.07473,1,0.2695657871064468,1.82,BP
GO:0048609,multicellular organismal reproductive pr...,843,20,14.12,0.07559,1,0.27246373033707866,1.42,BP
GO:0044784,metaphase/anaphase transition of cell cy...,59,3,0.99,0.07633,1,0.2743091560866318,3.03,BP
GO:0071806,protein transmembrane transport,59,3,0.99,0.07633,1,0.2743091560866318,3.03,BP
GO:1903902,positive regulation of viral life cycle,59,3,0.99,0.07633,1,0.2743091560866318,3.03,BP
GO:2000401,regulation of lymphocyte migration,59,3,0.99,0.07633,1,0.2743091560866318,3.03,BP
GO:0046683,response to organophosphorus,96,4,1.61,0.07784,1,0.279217913561848,2.48,BP
GO:1901989,positive regulation of cell cycle phase ...,96,4,1.61,0.07784,1,0.279217913561848,2.48,BP
GO:0008016,regulation of heart contraction,177,6,2.96,0.07787,1,0.279217913561848,2.03,BP
GO:0008610,lipid biosynthetic process,548,14,9.18,0.07877,1,0.28219044247787606,1.53,BP
GO:0051306,mitotic sister chromatid separation,60,3,1.01,0.07940,1,0.28219044247787606,2.97,BP
GO:2001238,positive regulation of extrinsic apoptot...,60,3,1.01,0.07940,1,0.28219044247787606,2.97,BP
GO:0006195,purine nucleotide catabolic process,28,2,0.47,0.07951,1,0.28219044247787606,4.26,BP
GO:0010939,regulation of necrotic cell death,28,2,0.47,0.07951,1,0.28219044247787606,4.26,BP
GO:0031063,regulation of histone deacetylation,28,2,0.47,0.07951,1,0.28219044247787606,4.26,BP
GO:0032647,regulation of interferon-alpha productio...,28,2,0.47,0.07951,1,0.28219044247787606,4.26,BP
GO:0044788,modulation by host of viral process,28,2,0.47,0.07951,1,0.28219044247787606,4.26,BP
GO:0090200,positive regulation of release of cytoch...,28,2,0.47,0.07951,1,0.28219044247787606,4.26,BP
GO:0090312,positive regulation of protein deacetyla...,28,2,0.47,0.07951,1,0.28219044247787606,4.26,BP
GO:0090314,positive regulation of protein targeting...,28,2,0.47,0.07951,1,0.28219044247787606,4.26,BP
GO:2000178,negative regulation of neural precursor ...,28,2,0.47,0.07951,1,0.28219044247787606,4.26,BP
GO:2000310,regulation of NMDA receptor activity,28,2,0.47,0.07951,1,0.28219044247787606,4.26,BP
GO:0000075,cell cycle checkpoint,178,6,2.98,0.07952,1,0.28219044247787606,2.01,BP
GO:0007173,epidermal growth factor receptor signali...,97,4,1.62,0.08017,1,0.2840780854197349,2.47,BP
GO:0021761,limbic system development,97,4,1.62,0.08017,1,0.2840780854197349,2.47,BP
GO:0006066,alcohol metabolic process,312,9,5.23,0.08059,1,0.2853562030905077,1.72,BP
GO:0072331,signal transduction by p53 class mediato...,137,5,2.29,0.08081,1,0.2857147097722263,2.18,BP
GO:1903364,positive regulation of cellular protein ...,137,5,2.29,0.08081,1,0.2857147097722263,2.18,BP
GO:0051048,negative regulation of secretion,267,8,4.47,0.08129,1,0.28720079295154183,1.79,BP
GO:0007167,enzyme linked receptor protein signaling...,903,21,15.13,0.08194,1,0.28885998545454544,1.39,BP
GO:0044057,regulation of system process,601,15,10.07,0.08220,1,0.28885998545454544,1.49,BP
GO:0010629,negative regulation of gene expression,1800,38,30.15,0.08236,1,0.28885998545454544,1.26,BP
GO:0001736,establishment of planar polarity,61,3,1.02,0.08251,1,0.28885998545454544,2.94,BP
GO:0021695,cerebellar cortex development,61,3,1.02,0.08251,1,0.28885998545454544,2.94,BP
GO:0031102,neuron projection regeneration,61,3,1.02,0.08251,1,0.28885998545454544,2.94,BP
GO:0042058,regulation of epidermal growth factor re...,61,3,1.02,0.08251,1,0.28885998545454544,2.94,BP
GO:0071156,regulation of cell cycle arrest,61,3,1.02,0.08251,1,0.28885998545454544,2.94,BP
GO:0072665,protein localization to vacuole,61,3,1.02,0.08251,1,0.28885998545454544,2.94,BP
GO:1901016,regulation of potassium ion transmembran...,61,3,1.02,0.08251,1,0.28885998545454544,2.94,BP
GO:0031058,positive regulation of histone modificat...,98,4,1.64,0.08254,1,0.28885998545454544,2.44,BP
GO:0032760,positive regulation of tumor necrosis fa...,98,4,1.64,0.08254,1,0.28885998545454544,2.44,BP
GO:0043502,regulation of muscle adaptation,98,4,1.64,0.08254,1,0.28885998545454544,2.44,BP
GO:0000165,MAPK cascade,802,19,13.43,0.08265,1,0.28903473837209304,1.41,BP
GO:0032504,multicellular organism reproduction,854,20,14.3,0.08348,1,0.29171878260869566,1.4,BP
GO:0031668,cellular response to extracellular stimu...,224,7,3.75,0.08365,1,0.29171878260869566,1.87,BP
GO:0099504,synaptic vesicle cycle,224,7,3.75,0.08365,1,0.29171878260869566,1.87,BP
GO:0010558,negative regulation of macromolecule bio...,1428,31,23.92,0.08366,1,0.29171878260869566,1.3,BP
GO:0000027,ribosomal large subunit assembly,29,2,0.49,0.08449,1,0.2924934388489209,4.08,BP
GO:0030511,positive regulation of transforming grow...,29,2,0.49,0.08449,1,0.2924934388489209,4.08,BP
GO:0043552,positive regulation of phosphatidylinosi...,29,2,0.49,0.08449,1,0.2924934388489209,4.08,BP
GO:0051589,negative regulation of neurotransmitter ...,29,2,0.49,0.08449,1,0.2924934388489209,4.08,BP
GO:0070296,sarcoplasmic reticulum calcium ion trans...,29,2,0.49,0.08449,1,0.2924934388489209,4.08,BP
GO:0090169,regulation of spindle assembly,29,2,0.49,0.08449,1,0.2924934388489209,4.08,BP
GO:0097345,mitochondrial outer membrane permeabiliz...,29,2,0.49,0.08449,1,0.2924934388489209,4.08,BP
GO:1903846,positive regulation of cellular response...,29,2,0.49,0.08449,1,0.2924934388489209,4.08,BP
GO:1904030,negative regulation of cyclin-dependent ...,29,2,0.49,0.08449,1,0.2924934388489209,4.08,BP
GO:1904861,excitatory synapse assembly,29,2,0.49,0.08449,1,0.2924934388489209,4.08,BP
GO:0090304,nucleic acid metabolic process,4304,83,72.09,0.08469,1,0.29278744985673355,1.15,BP
GO:0017158,regulation of calcium ion-dependent exoc...,139,5,2.33,0.08474,1,0.29278744985673355,2.15,BP
GO:0006165,nucleoside diphosphate phosphorylation,99,4,1.66,0.08494,1,0.29278744985673355,2.41,BP
GO:0032755,positive regulation of interleukin-6 pro...,99,4,1.66,0.08494,1,0.29278744985673355,2.41,BP
GO:1903557,positive regulation of tumor necrosis fa...,99,4,1.66,0.08494,1,0.29278744985673355,2.41,BP
GO:2001243,negative regulation of intrinsic apoptot...,99,4,1.66,0.08494,1,0.29278744985673355,2.41,BP
GO:0006820,anion transport,555,14,9.3,0.08519,1,0.2934389978525412,1.51,BP
GO:0042593,glucose homeostasis,270,8,4.52,0.08538,1,0.29388309012875535,1.77,BP
GO:0003229,ventricular cardiac muscle tissue develo...,62,3,1.04,0.08568,1,0.29428419700214137,2.88,BP
GO:0007164,establishment of tissue polarity,62,3,1.04,0.08568,1,0.29428419700214137,2.88,BP
GO:0097006,regulation of plasma lipoprotein particl...,62,3,1.04,0.08568,1,0.29428419700214137,2.88,BP
GO:0023052,signaling,6490,121,108.71,0.08635,1,0.29637389443651924,1.11,BP
GO:0033500,carbohydrate homeostasis,271,8,4.54,0.08677,1,0.2976031646471846,1.76,BP
GO:0010771,negative regulation of cell morphogenesi...,100,4,1.68,0.08737,1,0.29944760683760685,2.38,BP
GO:0009612,response to mechanical stimulus,183,6,3.07,0.08803,1,0.3014949181494662,1.95,BP
GO:0010632,regulation of epithelial cell migration,227,7,3.8,0.08825,1,0.3020334281650071,1.84,BP
GO:0034341,response to interferon-gamma,141,5,2.36,0.08877,1,0.30321397590361443,2.12,BP
GO:0050921,positive regulation of chemotaxis,141,5,2.36,0.08877,1,0.30321397590361443,2.12,BP
GO:0032722,positive regulation of chemokine product...,63,3,1.06,0.08891,1,0.30321397590361443,2.83,BP
GO:0043388,positive regulation of DNA binding,63,3,1.06,0.08891,1,0.30321397590361443,2.83,BP
GO:1905818,regulation of chromosome separation,63,3,1.06,0.08891,1,0.30321397590361443,2.83,BP
GO:0002724,regulation of T cell cytokine production,30,2,0.5,0.08956,1,0.30370875264270614,4,BP
GO:0009303,rRNA transcription,30,2,0.5,0.08956,1,0.30370875264270614,4,BP
GO:0022011,myelination in peripheral nervous system,30,2,0.5,0.08956,1,0.30370875264270614,4,BP
GO:0032292,peripheral nervous system axon ensheathm...,30,2,0.5,0.08956,1,0.30370875264270614,4,BP
GO:0032607,interferon-alpha production,30,2,0.5,0.08956,1,0.30370875264270614,4,BP
GO:0048026,"positive regulation of mRNA splicing, vi...",30,2,0.5,0.08956,1,0.30370875264270614,4,BP
GO:0048714,positive regulation of oligodendrocyte d...,30,2,0.5,0.08956,1,0.30370875264270614,4,BP
GO:1902751,positive regulation of cell cycle G2/M p...,30,2,0.5,0.08956,1,0.30370875264270614,4,BP
GO:0050792,regulation of viral process,184,6,3.08,0.08979,1,0.3038018833450457,1.95,BP
GO:0045921,positive regulation of exocytosis,101,4,1.69,0.08984,1,0.3038018833450457,2.37,BP
GO:0046939,nucleotide phosphorylation,101,4,1.69,0.08984,1,0.3038018833450457,2.37,BP
GO:0090263,positive regulation of canonical Wnt sig...,101,4,1.69,0.08984,1,0.3038018833450457,2.37,BP
GO:0007566,embryo implantation,64,3,1.07,0.09218,1,0.31007681786461966,2.8,BP
GO:0009988,cell-cell recognition,64,3,1.07,0.09218,1,0.31007681786461966,2.8,BP
GO:0032233,positive regulation of actin filament bu...,64,3,1.07,0.09218,1,0.31007681786461966,2.8,BP
GO:0061951,establishment of protein localization to...,64,3,1.07,0.09218,1,0.31007681786461966,2.8,BP
GO:0003300,cardiac muscle hypertrophy,102,4,1.71,0.09234,1,0.31007681786461966,2.34,BP
GO:0021549,cerebellum development,102,4,1.71,0.09234,1,0.31007681786461966,2.34,BP
GO:0033555,multicellular organismal response to str...,102,4,1.71,0.09234,1,0.31007681786461966,2.34,BP
GO:0035601,protein deacylation,102,4,1.71,0.09234,1,0.31007681786461966,2.34,BP
GO:0050848,regulation of calcium-mediated signaling,102,4,1.71,0.09234,1,0.31007681786461966,2.34,BP
GO:0098732,macromolecule deacylation,102,4,1.71,0.09234,1,0.31007681786461966,2.34,BP
GO:0007050,cell cycle arrest,143,5,2.4,0.09289,1,0.31170619246861925,2.08,BP
GO:0006259,DNA metabolic process,920,21,15.41,0.09462,1,0.3142206194081211,1.36,BP
GO:0002026,regulation of the force of heart contrac...,31,2,0.52,0.09471,1,0.3142206194081211,3.85,BP
GO:0006767,water-soluble vitamin metabolic process,31,2,0.52,0.09471,1,0.3142206194081211,3.85,BP
GO:0006884,cell volume homeostasis,31,2,0.52,0.09471,1,0.3142206194081211,3.85,BP
GO:0045920,negative regulation of exocytosis,31,2,0.52,0.09471,1,0.3142206194081211,3.85,BP
GO:0050482,arachidonic acid secretion,31,2,0.52,0.09471,1,0.3142206194081211,3.85,BP
GO:0051491,positive regulation of filopodium assemb...,31,2,0.52,0.09471,1,0.3142206194081211,3.85,BP
GO:0090075,relaxation of muscle,31,2,0.52,0.09471,1,0.3142206194081211,3.85,BP
GO:0099560,synaptic membrane adhesion,31,2,0.52,0.09471,1,0.3142206194081211,3.85,BP
GO:0099632,protein transport within plasma membrane,31,2,0.52,0.09471,1,0.3142206194081211,3.85,BP
GO:0099637,neurotransmitter receptor transport,31,2,0.52,0.09471,1,0.3142206194081211,3.85,BP
GO:1903963,arachidonate transport,31,2,0.52,0.09471,1,0.3142206194081211,3.85,BP
GO:2000781,positive regulation of double-strand bre...,31,2,0.52,0.09471,1,0.3142206194081211,3.85,BP
GO:0001910,regulation of leukocyte mediated cytotox...,103,4,1.73,0.09488,1,0.3142206194081211,2.31,BP
GO:0002702,positive regulation of production of mol...,103,4,1.73,0.09488,1,0.3142206194081211,2.31,BP
GO:0019359,nicotinamide nucleotide biosynthetic pro...,103,4,1.73,0.09488,1,0.3142206194081211,2.31,BP
GO:0043488,regulation of mRNA stability,103,4,1.73,0.09488,1,0.3142206194081211,2.31,BP
GO:0048709,oligodendrocyte differentiation,103,4,1.73,0.09488,1,0.3142206194081211,2.31,BP
GO:1903426,regulation of reactive oxygen species bi...,103,4,1.73,0.09488,1,0.3142206194081211,2.31,BP
GO:0010634,positive regulation of epithelial cell m...,144,5,2.41,0.09499,1,0.3143685557083906,2.07,BP
GO:0001764,neuron migration,187,6,3.13,0.09519,1,0.3145977197802198,1.92,BP
GO:0002706,regulation of lymphocyte mediated immuni...,187,6,3.13,0.09519,1,0.3145977197802198,1.92,BP
GO:0000381,"regulation of alternative mRNA splicing,...",65,3,1.09,0.09550,1,0.31485641095890415,2.75,BP
GO:0099024,plasma membrane invagination,65,3,1.09,0.09550,1,0.31485641095890415,2.75,BP
GO:2001169,regulation of ATP biosynthetic process,65,3,1.09,0.09550,1,0.31485641095890415,2.75,BP
GO:0001775,cell activation,973,22,16.3,0.09553,1,0.31485641095890415,1.35,BP
GO:0001894,tissue homeostasis,232,7,3.89,0.09624,1,0.31697938398357295,1.8,BP
GO:0045859,regulation of protein kinase activity,667,16,11.17,0.09679,1,0.31857283173734613,1.43,BP
GO:0002367,cytokine production involved in immune r...,104,4,1.74,0.09744,1,0.3198371623465211,2.3,BP
GO:0030038,contractile actin filament bundle assemb...,104,4,1.74,0.09744,1,0.3198371623465211,2.3,BP
GO:0032231,regulation of actin filament bundle asse...,104,4,1.74,0.09744,1,0.3198371623465211,2.3,BP
GO:0043149,stress fiber assembly,104,4,1.74,0.09744,1,0.3198371623465211,2.3,BP
GO:0000422,autophagy of mitochondrion,66,3,1.11,0.09887,1,0.32258343050847454,2.7,BP
GO:0030968,endoplasmic reticulum unfolded protein r...,66,3,1.11,0.09887,1,0.32258343050847454,2.7,BP
GO:0046324,regulation of glucose import,66,3,1.11,0.09887,1,0.32258343050847454,2.7,BP
GO:0051591,response to cAMP,66,3,1.11,0.09887,1,0.32258343050847454,2.7,BP
GO:0060425,lung morphogenesis,66,3,1.11,0.09887,1,0.32258343050847454,2.7,BP
GO:0061726,mitochondrion disassembly,66,3,1.11,0.09887,1,0.32258343050847454,2.7,BP
GO:0071260,cellular response to mechanical stimulus,66,3,1.11,0.09887,1,0.32258343050847454,2.7,BP
GO:1901184,regulation of ERBB signaling pathway,66,3,1.11,0.09887,1,0.32258343050847454,2.7,BP
GO:1903305,regulation of regulated secretory pathwa...,189,6,3.17,0.09888,1,0.32258343050847454,1.89,BP
GO:0000070,mitotic sister chromatid segregation,146,5,2.45,0.09926,1,0.323384644549763,2.04,BP
GO:2001251,negative regulation of chromosome organi...,146,5,2.45,0.09926,1,0.323384644549763,2.04,BP
GO:2001234,negative regulation of apoptotic signali...,234,7,3.92,0.09954,1,0.3240774560216509,1.79,BP
GO:0000462,maturation of SSU-rRNA from tricistronic...,32,2,0.54,0.09995,1,0.32431517194875253,3.7,BP
GO:0001893,maternal placenta development,32,2,0.54,0.09995,1,0.32431517194875253,3.7,BP
GO:0021680,cerebellar Purkinje cell layer developme...,32,2,0.54,0.09995,1,0.32431517194875253,3.7,BP
GO:0032212,positive regulation of telomere maintena...,32,2,0.54,0.09995,1,0.32431517194875253,3.7,BP
GO:1902110,positive regulation of mitochondrial mem...,32,2,0.54,0.09995,1,0.32431517194875253,3.7,BP
GO:0046849,bone remodeling,105,4,1.76,0.10004,1,0.32438846361185986,2.27,BP
GO:0008284,positive regulation of cell proliferatio...,979,22,16.4,0.10019,1,0.32465608080808084,1.34,BP
GO:0098693,regulation of synaptic vesicle cycle,147,5,2.46,0.10143,1,0.328453001345895,2.03,BP
GO:0051345,positive regulation of hydrolase activit...,522,13,8.74,0.10184,1,0.3295588971082717,1.49,BP
GO:0045739,positive regulation of DNA repair,67,3,1.12,0.10228,1,0.3301593561368209,2.68,BP
GO:0046824,positive regulation of nucleocytoplasmic...,67,3,1.12,0.10228,1,0.3301593561368209,2.68,BP
GO:0060688,regulation of morphogenesis of a branchi...,67,3,1.12,0.10228,1,0.3301593561368209,2.68,BP
GO:0010628,positive regulation of gene expression,2000,41,33.5,0.10230,1,0.3301593561368209,1.22,BP
GO:0006364,rRNA processing,191,6,3.2,0.10265,1,0.33046691638795983,1.88,BP
GO:0014897,striated muscle hypertrophy,106,4,1.78,0.10267,1,0.33046691638795983,2.25,BP
GO:0019363,pyridine nucleotide biosynthetic process,106,4,1.78,0.10267,1,0.33046691638795983,2.25,BP
GO:0051225,spindle assembly,106,4,1.78,0.10267,1,0.33046691638795983,2.25,BP
GO:0007517,muscle organ development,425,11,7.12,0.10317,1,0.33185430481283423,1.54,BP
GO:0046486,glycerolipid metabolic process,330,9,5.53,0.10452,1,0.33499534699272965,1.63,BP
GO:0044706,multi-multicellular organism process,192,6,3.22,0.10456,1,0.33499534699272965,1.86,BP
GO:0006623,protein targeting to vacuole,33,2,0.55,0.10527,1,0.33499534699272965,3.64,BP
GO:0007097,nuclear migration,33,2,0.55,0.10527,1,0.33499534699272965,3.64,BP
GO:0014044,Schwann cell development,33,2,0.55,0.10527,1,0.33499534699272965,3.64,BP
GO:0021591,ventricular system development,33,2,0.55,0.10527,1,0.33499534699272965,3.64,BP
GO:0043950,positive regulation of cAMP-mediated sig...,33,2,0.55,0.10527,1,0.33499534699272965,3.64,BP
GO:0045672,positive regulation of osteoclast differ...,33,2,0.55,0.10527,1,0.33499534699272965,3.64,BP
GO:0071709,membrane assembly,33,2,0.55,0.10527,1,0.33499534699272965,3.64,BP
GO:0071827,plasma lipoprotein particle organization,33,2,0.55,0.10527,1,0.33499534699272965,3.64,BP
GO:0099563,modification of synaptic structure,33,2,0.55,0.10527,1,0.33499534699272965,3.64,BP
GO:1901890,positive regulation of cell junction ass...,33,2,0.55,0.10527,1,0.33499534699272965,3.64,BP
GO:1903205,regulation of hydrogen peroxide-induced ...,33,2,0.55,0.10527,1,0.33499534699272965,3.64,BP
GO:1903429,regulation of cell maturation,33,2,0.55,0.10527,1,0.33499534699272965,3.64,BP
GO:1905606,regulation of presynapse assembly,33,2,0.55,0.10527,1,0.33499534699272965,3.64,BP
GO:2001171,positive regulation of ATP biosynthetic ...,33,2,0.55,0.10527,1,0.33499534699272965,3.64,BP
GO:0038127,ERBB signaling pathway,107,4,1.79,0.10533,1,0.33499534699272965,2.23,BP
GO:0032387,negative regulation of intracellular tra...,68,3,1.14,0.10575,1,0.3357932234673698,2.63,BP
GO:0043113,receptor clustering,68,3,1.14,0.10575,1,0.3357932234673698,2.63,BP
GO:0003231,cardiac ventricle development,149,5,2.5,0.10584,1,0.3357932234673698,2,BP
GO:0045934,negative regulation of nucleobase-contai...,1410,30,23.62,0.10586,1,0.3357932234673698,1.27,BP
GO:0045930,negative regulation of mitotic cell cycl...,238,7,3.99,0.10632,1,0.3370301976284585,1.75,BP
GO:0006869,lipid transport,332,9,5.56,0.10741,1,0.34026130348913763,1.62,BP
GO:0014896,muscle hypertrophy,108,4,1.81,0.10803,1,0.3412604724409449,2.21,BP
GO:0015844,monoamine transport,108,4,1.81,0.10803,1,0.3412604724409449,2.21,BP
GO:0035725,sodium ion transmembrane transport,108,4,1.81,0.10803,1,0.3412604724409449,2.21,BP
GO:1903522,regulation of blood circulation,239,7,4,0.10806,1,0.3412604724409449,1.75,BP
GO:0002700,regulation of production of molecular me...,150,5,2.51,0.10808,1,0.3412604724409449,1.99,BP
GO:0016239,positive regulation of macroautophagy,69,3,1.16,0.10926,1,0.34408319371727747,2.59,BP
GO:0032482,Rab protein signal transduction,69,3,1.16,0.10926,1,0.34408319371727747,2.59,BP
GO:0043299,leukocyte degranulation,69,3,1.16,0.10926,1,0.34408319371727747,2.59,BP
GO:0051453,regulation of intracellular pH,69,3,1.16,0.10926,1,0.34408319371727747,2.59,BP
GO:0030278,regulation of ossification,240,7,4.02,0.10981,1,0.3448807772020725,1.74,BP
GO:0090257,regulation of muscle system process,240,7,4.02,0.10981,1,0.3448807772020725,1.74,BP
GO:0031669,cellular response to nutrient levels,195,6,3.27,0.11041,1,0.3448807772020725,1.83,BP
GO:0072359,circulatory system development,1150,25,19.26,0.11062,1,0.3448807772020725,1.3,BP
GO:0002717,positive regulation of natural killer ce...,34,2,0.57,0.11066,1,0.3448807772020725,3.51,BP
GO:0006984,ER-nucleus signaling pathway,34,2,0.57,0.11066,1,0.3448807772020725,3.51,BP
GO:0018208,peptidyl-proline modification,34,2,0.57,0.11066,1,0.3448807772020725,3.51,BP
GO:0043243,positive regulation of protein complex d...,34,2,0.57,0.11066,1,0.3448807772020725,3.51,BP
GO:0045070,positive regulation of viral genome repl...,34,2,0.57,0.11066,1,0.3448807772020725,3.51,BP
GO:0045954,positive regulation of natural killer ce...,34,2,0.57,0.11066,1,0.3448807772020725,3.51,BP
GO:0071634,regulation of transforming growth factor...,34,2,0.57,0.11066,1,0.3448807772020725,3.51,BP
GO:0090313,regulation of protein targeting to membr...,34,2,0.57,0.11066,1,0.3448807772020725,3.51,BP
GO:1902686,mitochondrial outer membrane permeabiliz...,34,2,0.57,0.11066,1,0.3448807772020725,3.51,BP
GO:1904467,regulation of tumor necrosis factor secr...,34,2,0.57,0.11066,1,0.3448807772020725,3.51,BP
GO:1905898,positive regulation of response to endop...,34,2,0.57,0.11066,1,0.3448807772020725,3.51,BP
GO:2000785,regulation of autophagosome assembly,34,2,0.57,0.11066,1,0.3448807772020725,3.51,BP
GO:0050673,epithelial cell proliferation,431,11,7.22,0.11076,1,0.34496900970873784,1.52,BP
GO:0043583,ear development,241,7,4.04,0.11158,1,0.3472981630012937,1.73,BP
GO:0003205,cardiac chamber development,196,6,3.28,0.11239,1,0.34959319974143505,1.83,BP
GO:0001885,endothelial cell development,70,3,1.17,0.11281,1,0.35005671179883946,2.56,BP
GO:0006081,cellular aldehyde metabolic process,70,3,1.17,0.11281,1,0.35005671179883946,2.56,BP
GO:2001244,positive regulation of intrinsic apoptot...,70,3,1.17,0.11281,1,0.35005671179883946,2.56,BP
GO:0002684,positive regulation of immune system pro...,942,21,15.78,0.11283,1,0.35005671179883946,1.33,BP
GO:0072525,pyridine-containing compound biosyntheti...,110,4,1.84,0.11350,1,0.3519085051546392,2.17,BP
GO:0030308,negative regulation of cell growth,197,6,3.3,0.11440,1,0.3543353667953668,1.82,BP
GO:0002376,immune system process,2407,48,40.32,0.11443,1,0.3543353667953668,1.19,BP
GO:0002082,regulation of oxidative phosphorylation,35,2,0.59,0.11612,1,0.35767356321839083,3.39,BP
GO:0018345,protein palmitoylation,35,2,0.59,0.11612,1,0.35767356321839083,3.39,BP
GO:0032228,"regulation of synaptic transmission, GAB...",35,2,0.59,0.11612,1,0.35767356321839083,3.39,BP
GO:0036230,granulocyte activation,35,2,0.59,0.11612,1,0.35767356321839083,3.39,BP
GO:0051452,intracellular pH reduction,35,2,0.59,0.11612,1,0.35767356321839083,3.39,BP
GO:2000249,regulation of actin cytoskeleton reorgan...,35,2,0.59,0.11612,1,0.35767356321839083,3.39,BP
GO:2001038,regulation of cellular response to drug,35,2,0.59,0.11612,1,0.35767356321839083,3.39,BP
GO:0007156,homophilic cell adhesion via plasma memb...,111,4,1.86,0.11629,1,0.35767356321839083,2.15,BP
GO:0007632,visual behavior,71,3,1.19,0.11640,1,0.35767356321839083,2.52,BP
GO:0016575,histone deacetylation,71,3,1.19,0.11640,1,0.35767356321839083,2.52,BP
GO:1901796,regulation of signal transduction by p53...,71,3,1.19,0.11640,1,0.35767356321839083,2.52,BP
GO:1904589,regulation of protein import,71,3,1.19,0.11640,1,0.35767356321839083,2.52,BP
GO:0031056,regulation of histone modification,154,5,2.58,0.11728,1,0.36004071428571427,1.94,BP
GO:0007162,negative regulation of cell adhesion,291,8,4.87,0.11732,1,0.36004071428571427,1.64,BP
GO:0043903,"regulation of symbiosis, encompassing mu...",199,6,3.33,0.11846,1,0.36284501591343093,1.8,BP
GO:0071236,cellular response to antibiotic,199,6,3.33,0.11846,1,0.36284501591343093,1.8,BP
GO:1902275,regulation of chromatin organization,199,6,3.33,0.11846,1,0.36284501591343093,1.8,BP
GO:0043487,regulation of RNA stability,112,4,1.88,0.11910,1,0.3645732824427481,2.13,BP
GO:0008015,blood circulation,487,12,8.16,0.11923,1,0.36473919898283536,1.47,BP
GO:0031328,positive regulation of cellular biosynth...,1919,39,32.14,0.11950,1,0.36533290978398986,1.21,BP
GO:0032675,regulation of interleukin-6 production,155,5,2.6,0.11963,1,0.36549813333333336,1.92,BP
GO:0010611,regulation of cardiac muscle hypertrophy,72,3,1.21,0.12004,1,0.36628565630944826,2.48,BP
GO:2000779,regulation of double-strand break repair,72,3,1.21,0.12004,1,0.36628565630944826,2.48,BP
GO:0031327,negative regulation of cellular biosynth...,1485,31,24.87,0.12085,1,0.3685235741444867,1.25,BP
GO:0006471,protein ADP-ribosylation,36,2,0.6,0.12165,1,0.3686076633165829,3.33,BP
GO:0033238,regulation of cellular amine metabolic p...,36,2,0.6,0.12165,1,0.3686076633165829,3.33,BP
GO:0033363,secretory granule organization,36,2,0.6,0.12165,1,0.3686076633165829,3.33,BP
GO:0040020,regulation of meiotic nuclear division,36,2,0.6,0.12165,1,0.3686076633165829,3.33,BP
GO:0060969,negative regulation of gene silencing,36,2,0.6,0.12165,1,0.3686076633165829,3.33,BP
GO:0061384,heart trabecula morphogenesis,36,2,0.6,0.12165,1,0.3686076633165829,3.33,BP
GO:0071604,transforming growth factor beta producti...,36,2,0.6,0.12165,1,0.3686076633165829,3.33,BP
GO:0072583,clathrin-dependent endocytosis,36,2,0.6,0.12165,1,0.3686076633165829,3.33,BP
GO:1903427,negative regulation of reactive oxygen s...,36,2,0.6,0.12165,1,0.3686076633165829,3.33,BP
GO:1990774,tumor necrosis factor secretion,36,2,0.6,0.12165,1,0.3686076633165829,3.33,BP
GO:0007264,small GTPase mediated signal transductio...,489,12,8.19,0.12180,1,0.3686076633165829,1.47,BP
GO:0010557,positive regulation of macromolecule bio...,1813,37,30.37,0.12186,1,0.3686076633165829,1.22,BP
GO:0000086,G2/M transition of mitotic cell cycle,113,4,1.89,0.12195,1,0.3686076633165829,2.12,BP
GO:0001952,regulation of cell-matrix adhesion,113,4,1.89,0.12195,1,0.3686076633165829,2.12,BP
GO:1903037,regulation of leukocyte cell-cell adhesi...,294,8,4.92,0.12235,1,0.3695845574387947,1.63,BP
GO:0031589,cell-substrate adhesion,342,9,5.73,0.12249,1,0.36977533249686323,1.57,BP
GO:0019058,viral life cycle,201,6,3.37,0.12259,1,0.36984519122257054,1.78,BP
GO:0007422,peripheral nervous system development,73,3,1.22,0.12372,1,0.37302045112781956,2.46,BP
GO:0009611,response to wounding,491,12,8.22,0.12439,1,0.3746313642052566,1.46,BP
GO:0060402,calcium ion transport into cytosol,157,5,2.63,0.12441,1,0.3746313642052566,1.9,BP
GO:0043408,regulation of MAPK cascade,746,17,12.5,0.12455,1,0.3748183864915572,1.36,BP
GO:0022037,metencephalon development,114,4,1.91,0.12482,1,0.37516167395377886,2.09,BP
GO:0031398,positive regulation of protein ubiquitin...,114,4,1.91,0.12482,1,0.37516167395377886,2.09,BP
GO:0021537,telencephalon development,249,7,4.17,0.12623,1,0.37913087762669967,1.68,BP
GO:0043542,endothelial cell migration,203,6,3.4,0.12679,1,0.37913087762669967,1.76,BP
GO:0010955,negative regulation of protein processin...,37,2,0.62,0.12724,1,0.37913087762669967,3.23,BP
GO:0021799,cerebral cortex radially oriented cell m...,37,2,0.62,0.12724,1,0.37913087762669967,3.23,BP
GO:0021884,forebrain neuron development,37,2,0.62,0.12724,1,0.37913087762669967,3.23,BP
GO:0033144,negative regulation of intracellular ste...,37,2,0.62,0.12724,1,0.37913087762669967,3.23,BP
GO:0035794,positive regulation of mitochondrial mem...,37,2,0.62,0.12724,1,0.37913087762669967,3.23,BP
GO:0036474,cell death in response to hydrogen perox...,37,2,0.62,0.12724,1,0.37913087762669967,3.23,BP
GO:0048169,regulation of long-term neuronal synapti...,37,2,0.62,0.12724,1,0.37913087762669967,3.23,BP
GO:0071825,protein-lipid complex subunit organizati...,37,2,0.62,0.12724,1,0.37913087762669967,3.23,BP
GO:0098751,bone cell development,37,2,0.62,0.12724,1,0.37913087762669967,3.23,BP
GO:0099174,regulation of presynapse organization,37,2,0.62,0.12724,1,0.37913087762669967,3.23,BP
GO:1903318,negative regulation of protein maturatio...,37,2,0.62,0.12724,1,0.37913087762669967,3.23,BP
GO:0002066,columnar/cuboidal epithelial cell develo...,74,3,1.24,0.12745,1,0.37913087762669967,2.42,BP
GO:1903036,positive regulation of response to wound...,74,3,1.24,0.12745,1,0.37913087762669967,2.42,BP
GO:0030111,regulation of Wnt signaling pathway,297,8,4.97,0.12748,1,0.37913087762669967,1.61,BP
GO:1901987,regulation of cell cycle phase transitio...,297,8,4.97,0.12748,1,0.37913087762669967,1.61,BP
GO:0032368,regulation of lipid transport,115,4,1.93,0.12772,1,0.3796100308832613,2.07,BP
GO:0007626,locomotory behavior,250,7,4.19,0.12813,1,0.3805935555555555,1.67,BP
GO:0052548,regulation of endopeptidase activity,347,9,5.81,0.13045,1,0.38711374616799504,1.55,BP
GO:0008285,negative regulation of cell proliferatio...,700,16,11.73,0.13078,1,0.38711374616799504,1.36,BP
GO:0071214,cellular response to abiotic stimulus,299,8,5.01,0.13097,1,0.38711374616799504,1.6,BP
GO:0104004,cellular response to environmental stimu...,299,8,5.01,0.13097,1,0.38711374616799504,1.6,BP
GO:0014743,regulation of muscle hypertrophy,75,3,1.26,0.13121,1,0.38711374616799504,2.38,BP
GO:0030433,ubiquitin-dependent ERAD pathway,75,3,1.26,0.13121,1,0.38711374616799504,2.38,BP
GO:0045670,regulation of osteoclast differentiation,75,3,1.26,0.13121,1,0.38711374616799504,2.38,BP
GO:0046323,glucose import,75,3,1.26,0.13121,1,0.38711374616799504,2.38,BP
GO:0051851,modification by host of symbiont morphol...,75,3,1.26,0.13121,1,0.38711374616799504,2.38,BP
GO:0060563,neuroepithelial cell differentiation,75,3,1.26,0.13121,1,0.38711374616799504,2.38,BP
GO:0061097,regulation of protein tyrosine kinase ac...,75,3,1.26,0.13121,1,0.38711374616799504,2.38,BP
GO:0007568,aging,252,7,4.22,0.13197,1,0.3891174264705883,1.66,BP
GO:1902533,positive regulation of intracellular sig...,1016,22,17.02,0.13212,1,0.3893211512553582,1.29,BP
GO:0016601,Rac protein signal transduction,38,2,0.64,0.13289,1,0.39015660768761445,3.12,BP
GO:0032506,cytokinetic process,38,2,0.64,0.13289,1,0.39015660768761445,3.12,BP
GO:0040019,positive regulation of embryonic develop...,38,2,0.64,0.13289,1,0.39015660768761445,3.12,BP
GO:0045022,early endosome to late endosome transpor...,38,2,0.64,0.13289,1,0.39015660768761445,3.12,BP
GO:0046329,negative regulation of JNK cascade,38,2,0.64,0.13289,1,0.39015660768761445,3.12,BP
GO:0051647,nucleus localization,38,2,0.64,0.13289,1,0.39015660768761445,3.12,BP
GO:0031032,actomyosin structure organization,206,6,3.45,0.13322,1,0.3908869756097561,1.74,BP
GO:0006282,regulation of DNA repair,117,4,1.96,0.13361,1,0.39179239488117007,2.04,BP
GO:0003013,circulatory system process,498,12,8.34,0.13372,1,0.3918761510353228,1.44,BP
GO:0032418,lysosome localization,76,3,1.27,0.13501,1,0.39445544626593804,2.36,BP
GO:0032507,maintenance of protein location in cell,76,3,1.27,0.13501,1,0.39445544626593804,2.36,BP
GO:0045453,bone resorption,76,3,1.27,0.13501,1,0.39445544626593804,2.36,BP
GO:0055008,cardiac muscle tissue morphogenesis,76,3,1.27,0.13501,1,0.39445544626593804,2.36,BP
GO:0097327,response to antineoplastic agent,76,3,1.27,0.13501,1,0.39445544626593804,2.36,BP
GO:0007276,gamete generation,704,16,11.79,0.13532,1,0.39511510006064277,1.36,BP
GO:0055001,muscle cell development,207,6,3.47,0.13540,1,0.39511510006064277,1.73,BP
GO:0007565,female pregnancy,162,5,2.71,0.13672,1,0.3984837310720775,1.85,BP
GO:0051291,protein heterooligomerization,162,5,2.71,0.13672,1,0.3984837310720775,1.85,BP
GO:0097305,response to alcohol,208,6,3.48,0.13760,1,0.4008058111380145,1.72,BP
GO:0006826,iron ion transport,39,2,0.65,0.13860,1,0.4015311258278146,3.08,BP
GO:0030810,positive regulation of nucleotide biosyn...,39,2,0.65,0.13860,1,0.4015311258278146,3.08,BP
GO:0044088,regulation of vacuole organization,39,2,0.65,0.13860,1,0.4015311258278146,3.08,BP
GO:0046006,regulation of activated T cell prolifera...,39,2,0.65,0.13860,1,0.4015311258278146,3.08,BP
GO:0070528,protein kinase C signaling,39,2,0.65,0.13860,1,0.4015311258278146,3.08,BP
GO:1900087,positive regulation of G1/S transition o...,39,2,0.65,0.13860,1,0.4015311258278146,3.08,BP
GO:1900373,positive regulation of purine nucleotide...,39,2,0.65,0.13860,1,0.4015311258278146,3.08,BP
GO:1901021,positive regulation of calcium ion trans...,39,2,0.65,0.13860,1,0.4015311258278146,3.08,BP
GO:2001024,negative regulation of response to drug,39,2,0.65,0.13860,1,0.4015311258278146,3.08,BP
GO:0000380,"alternative mRNA splicing, via spliceoso...",77,3,1.29,0.13884,1,0.4019844043321299,2.33,BP
GO:0043901,negative regulation of multi-organism pr...,163,5,2.73,0.13925,1,0.40292904389657247,1.83,BP
GO:0051090,regulation of DNA-binding transcription ...,402,10,6.73,0.13970,1,0.4039882211538461,1.49,BP
GO:0045861,negative regulation of proteolysis,353,9,5.91,0.14034,1,0.4055952432432432,1.52,BP
GO:0032635,interleukin-6 production,164,5,2.75,0.14179,1,0.40953990396158463,1.82,BP
GO:0043281,regulation of cysteine-type endopeptidas...,210,6,3.52,0.14204,1,0.4100158848230354,1.7,BP
GO:1901136,carbohydrate derivative catabolic proces...,120,4,2.01,0.14264,1,0.41099260323159786,1.99,BP
GO:0000079,regulation of cyclin-dependent protein s...,78,3,1.31,0.14272,1,0.41099260323159786,2.29,BP
GO:0061515,myeloid cell development,78,3,1.31,0.14272,1,0.41099260323159786,2.29,BP
GO:1900182,positive regulation of protein localizat...,78,3,1.31,0.14272,1,0.41099260323159786,2.29,BP
GO:0051346,negative regulation of hydrolase activit...,404,10,6.77,0.14285,1,0.4111209330143541,1.48,BP
GO:0042098,T cell proliferation,211,6,3.53,0.14428,1,0.41297996434937617,1.7,BP
GO:0048839,inner ear development,211,6,3.53,0.14428,1,0.41297996434937617,1.7,BP
GO:0002369,T cell cytokine production,40,2,0.67,0.14436,1,0.41297996434937617,2.99,BP
GO:0007339,binding of sperm to zona pellucida,40,2,0.67,0.14436,1,0.41297996434937617,2.99,BP
GO:0009069,serine family amino acid metabolic proce...,40,2,0.67,0.14436,1,0.41297996434937617,2.99,BP
GO:0010661,positive regulation of muscle cell apopt...,40,2,0.67,0.14436,1,0.41297996434937617,2.99,BP
GO:0046825,regulation of protein export from nucleu...,40,2,0.67,0.14436,1,0.41297996434937617,2.99,BP
GO:0072523,purine-containing compound catabolic pro...,40,2,0.67,0.14436,1,0.41297996434937617,2.99,BP
GO:0086004,regulation of cardiac muscle cell contra...,40,2,0.67,0.14436,1,0.41297996434937617,2.99,BP
GO:0098927,vesicle-mediated transport between endos...,40,2,0.67,0.14436,1,0.41297996434937617,2.99,BP
GO:0009991,response to extracellular stimulus,405,10,6.78,0.14444,1,0.41297996434937617,1.47,BP
GO:0030595,leukocyte chemotaxis,212,6,3.55,0.14654,1,0.41750506508875745,1.69,BP
GO:2001020,regulation of response to DNA damage sti...,212,6,3.55,0.14654,1,0.41750506508875745,1.69,BP
GO:0030168,platelet activation,79,3,1.32,0.14663,1,0.41750506508875745,2.27,BP
GO:0030808,regulation of nucleotide biosynthetic pr...,79,3,1.32,0.14663,1,0.41750506508875745,2.27,BP
GO:0051279,regulation of release of sequestered cal...,79,3,1.32,0.14663,1,0.41750506508875745,2.27,BP
GO:0071277,cellular response to calcium ion,79,3,1.32,0.14663,1,0.41750506508875745,2.27,BP
GO:1900371,regulation of purine nucleotide biosynth...,79,3,1.32,0.14663,1,0.41750506508875745,2.27,BP
GO:0006643,membrane lipid metabolic process,166,5,2.78,0.14695,1,0.41792163120567377,1.8,BP
GO:0032680,regulation of tumor necrosis factor prod...,166,5,2.78,0.14695,1,0.41792163120567377,1.8,BP
GO:0098813,nuclear chromosome segregation,260,7,4.36,0.14788,1,0.4203181098641465,1.61,BP
GO:0006509,membrane protein ectodomain proteolysis,41,2,0.69,0.15017,1,0.4250694352941176,2.9,BP
GO:0021522,spinal cord motor neuron differentiation,41,2,0.69,0.15017,1,0.4250694352941176,2.9,BP
GO:0034105,positive regulation of tissue remodeling,41,2,0.69,0.15017,1,0.4250694352941176,2.9,BP
GO:0043551,regulation of phosphatidylinositol 3-kin...,41,2,0.69,0.15017,1,0.4250694352941176,2.9,BP
GO:0046326,positive regulation of glucose import,41,2,0.69,0.15017,1,0.4250694352941176,2.9,BP
GO:0050856,regulation of T cell receptor signaling ...,41,2,0.69,0.15017,1,0.4250694352941176,2.9,BP
GO:2000273,positive regulation of signaling recepto...,41,2,0.69,0.15017,1,0.4250694352941176,2.9,BP
GO:0030500,regulation of bone mineralization,80,3,1.34,0.15057,1,0.42545087492660016,2.24,BP
GO:0043525,positive regulation of neuron apoptotic ...,80,3,1.34,0.15057,1,0.42545087492660016,2.24,BP
GO:1904427,positive regulation of calcium ion trans...,80,3,1.34,0.15057,1,0.42545087492660016,2.24,BP
GO:0010921,regulation of phosphatase activity,123,4,2.06,0.15191,1,0.42898528169014083,1.94,BP
GO:1903555,regulation of tumor necrosis factor supe...,168,5,2.81,0.15218,1,0.4294956950146628,1.78,BP
GO:0006402,mRNA catabolic process,215,6,3.6,0.15342,1,0.4327415240328253,1.67,BP
GO:0001818,negative regulation of cytokine producti...,263,7,4.41,0.15408,1,0.4342914519906323,1.59,BP
GO:0001667,ameboidal-type cell migration,411,10,6.88,0.15415,1,0.4342914519906323,1.45,BP
GO:0032103,positive regulation of response to exter...,312,8,5.23,0.15480,1,0.4354424079485681,1.53,BP
GO:0045927,positive regulation of growth,312,8,5.23,0.15480,1,0.4354424079485681,1.53,BP
GO:0032640,tumor necrosis factor production,169,5,2.83,0.15483,1,0.4354424079485681,1.77,BP
GO:0042157,lipoprotein metabolic process,124,4,2.08,0.15504,1,0.43552392294220665,1.92,BP
GO:0043500,muscle adaptation,124,4,2.08,0.15504,1,0.43552392294220665,1.92,BP
GO:0000266,mitochondrial fission,42,2,0.7,0.15603,1,0.43652113953488375,2.86,BP
GO:0009066,aspartate family amino acid metabolic pr...,42,2,0.7,0.15603,1,0.43652113953488375,2.86,BP
GO:0030866,cortical actin cytoskeleton organization,42,2,0.7,0.15603,1,0.43652113953488375,2.86,BP
GO:0050685,positive regulation of mRNA processing,42,2,0.7,0.15603,1,0.43652113953488375,2.86,BP
GO:0060122,inner ear receptor cell stereocilium org...,42,2,0.7,0.15603,1,0.43652113953488375,2.86,BP
GO:0097178,ruffle assembly,42,2,0.7,0.15603,1,0.43652113953488375,2.86,BP
GO:1905521,regulation of macrophage migration,42,2,0.7,0.15603,1,0.43652113953488375,2.86,BP
GO:0010468,regulation of gene expression,3892,73,65.19,0.15615,1,0.43660302149912844,1.12,BP
GO:0007051,spindle organization,170,5,2.85,0.15749,1,0.43958345707656615,1.75,BP
GO:0010952,positive regulation of peptidase activit...,170,5,2.85,0.15749,1,0.43958345707656615,1.75,BP
GO:0097164,ammonium ion metabolic process,170,5,2.85,0.15749,1,0.43958345707656615,1.75,BP
GO:0006665,sphingolipid metabolic process,125,4,2.09,0.15821,1,0.44099319050376373,1.91,BP
GO:0033138,positive regulation of peptidyl-serine p...,125,4,2.09,0.15821,1,0.44099319050376373,1.91,BP
GO:1901990,regulation of mitotic cell cycle phase t...,265,7,4.44,0.15827,1,0.44099319050376373,1.58,BP
GO:0001738,morphogenesis of a polarized epithelium,82,3,1.37,0.15856,1,0.44100270363951477,2.19,BP
GO:0002718,regulation of cytokine production involv...,82,3,1.37,0.15856,1,0.44100270363951477,2.19,BP
GO:0051899,membrane depolarization,82,3,1.37,0.15856,1,0.44100270363951477,2.19,BP
GO:0044282,small molecule catabolic process,314,8,5.26,0.15864,1,0.44100270363951477,1.52,BP
GO:0007612,learning,171,5,2.86,0.16017,1,0.44474208886324296,1.75,BP
GO:0046890,regulation of lipid biosynthetic process,171,5,2.86,0.16017,1,0.44474208886324296,1.75,BP
GO:0006520,cellular amino acid metabolic process,266,7,4.46,0.16039,1,0.4449782593659942,1.57,BP
GO:0002440,production of molecular mediator of immu...,218,6,3.65,0.16044,1,0.4449782593659942,1.64,BP
GO:0030490,maturation of SSU-rRNA,43,2,0.72,0.16192,1,0.44702182444061966,2.78,BP
GO:0031670,cellular response to nutrient,43,2,0.72,0.16192,1,0.44702182444061966,2.78,BP
GO:0045823,positive regulation of heart contraction,43,2,0.72,0.16192,1,0.44702182444061966,2.78,BP
GO:0048246,macrophage chemotaxis,43,2,0.72,0.16192,1,0.44702182444061966,2.78,BP
GO:0051293,establishment of spindle localization,43,2,0.72,0.16192,1,0.44702182444061966,2.78,BP
GO:0090224,regulation of spindle organization,43,2,0.72,0.16192,1,0.44702182444061966,2.78,BP
GO:1901031,regulation of response to reactive oxyge...,43,2,0.72,0.16192,1,0.44702182444061966,2.78,BP
GO:1903573,negative regulation of response to endop...,43,2,0.72,0.16192,1,0.44702182444061966,2.78,BP
GO:1901992,positive regulation of mitotic cell cycl...,83,3,1.39,0.16260,1,0.44861502003434456,2.16,BP
GO:0002573,myeloid leukocyte differentiation,219,6,3.67,0.16281,1,0.44861502003434456,1.63,BP
GO:0001906,cell killing,172,5,2.88,0.16287,1,0.44861502003434456,1.74,BP
GO:0071706,tumor necrosis factor superfamily cytoki...,172,5,2.88,0.16287,1,0.44861502003434456,1.74,BP
GO:0070848,response to growth factor,623,14,10.44,0.16433,1,0.4523775514874142,1.34,BP
GO:0043280,positive regulation of cysteine-type end...,127,4,2.13,0.16460,1,0.4528617495711835,1.88,BP
GO:2001057,reactive nitrogen species metabolic proc...,84,3,1.41,0.16668,1,0.4583223771428571,2.13,BP
GO:0050852,T cell receptor signaling pathway,128,4,2.14,0.16784,1,0.46025203418803423,1.87,BP
GO:0018023,peptidyl-lysine trimethylation,44,2,0.74,0.16786,1,0.46025203418803423,2.7,BP
GO:0042181,ketone biosynthetic process,44,2,0.74,0.16786,1,0.46025203418803423,2.7,BP
GO:0060964,regulation of gene silencing by miRNA,44,2,0.74,0.16786,1,0.46025203418803423,2.7,BP
GO:0098781,ncRNA transcription,44,2,0.74,0.16786,1,0.46025203418803423,2.7,BP
GO:0015748,organophosphate ester transport,85,3,1.42,0.17078,1,0.4679916628701594,2.11,BP
GO:0048640,negative regulation of developmental gro...,129,4,2.16,0.17109,1,0.46857431986340353,1.85,BP
GO:0021700,developmental maturation,321,8,5.38,0.17242,1,0.4719482593856655,1.49,BP
GO:0031401,positive regulation of protein modificat...,1219,25,20.42,0.17272,1,0.47250064809550885,1.22,BP
GO:0006325,chromatin organization,735,16,12.31,0.17346,1,0.4737340430351076,1.3,BP
GO:0014046,dopamine secretion,45,2,0.75,0.17384,1,0.4737340430351076,2.67,BP
GO:0014059,regulation of dopamine secretion,45,2,0.75,0.17384,1,0.4737340430351076,2.67,BP
GO:0070527,platelet aggregation,45,2,0.75,0.17384,1,0.4737340430351076,2.67,BP
GO:0071526,semaphorin-plexin signaling pathway,45,2,0.75,0.17384,1,0.4737340430351076,2.67,BP
GO:1901381,positive regulation of potassium ion tra...,45,2,0.75,0.17384,1,0.4737340430351076,2.67,BP
GO:0016202,regulation of striated muscle tissue dev...,176,5,2.95,0.17386,1,0.4737340430351076,1.69,BP
GO:0002443,leukocyte mediated immunity,372,9,6.23,0.17408,1,0.47406505942275046,1.44,BP
GO:0010827,regulation of glucose transmembrane tran...,86,3,1.44,0.17491,1,0.475249531338227,2.08,BP
GO:0015908,fatty acid transport,86,3,1.44,0.17491,1,0.475249531338227,2.08,BP
GO:0042632,cholesterol homeostasis,86,3,1.44,0.17491,1,0.475249531338227,2.08,BP
GO:0051341,regulation of oxidoreductase activity,86,3,1.44,0.17491,1,0.475249531338227,2.08,BP
GO:0010876,lipid localization,373,9,6.25,0.17595,1,0.47780553047404056,1.44,BP
GO:0043409,negative regulation of MAPK cascade,177,5,2.96,0.17665,1,0.4794358714043993,1.69,BP
GO:0015696,ammonium transport,131,4,2.19,0.17767,1,0.4816608676056338,1.83,BP
GO:0045995,regulation of embryonic development,131,4,2.19,0.17767,1,0.4816608676056338,1.83,BP
GO:1905114,cell surface receptor signaling pathway ...,528,12,8.84,0.17783,1,0.4818231756756757,1.36,BP
GO:0055092,sterol homeostasis,87,3,1.46,0.17907,1,0.4829185714285714,2.05,BP
GO:0017156,calcium ion regulated exocytosis,178,5,2.98,0.17946,1,0.4829185714285714,1.68,BP
GO:0048489,synaptic vesicle transport,178,5,2.98,0.17946,1,0.4829185714285714,1.68,BP
GO:0097480,establishment of synaptic vesicle locali...,178,5,2.98,0.17946,1,0.4829185714285714,1.68,BP
GO:0006631,fatty acid metabolic process,375,9,6.28,0.17973,1,0.4829185714285714,1.43,BP
GO:0031667,response to nutrient levels,375,9,6.28,0.17973,1,0.4829185714285714,1.43,BP
GO:0001916,positive regulation of T cell mediated c...,46,2,0.77,0.17984,1,0.4829185714285714,2.6,BP
GO:0006378,mRNA polyadenylation,46,2,0.77,0.17984,1,0.4829185714285714,2.6,BP
GO:0006576,cellular biogenic amine metabolic proces...,46,2,0.77,0.17984,1,0.4829185714285714,2.6,BP
GO:0010799,regulation of peptidyl-threonine phospho...,46,2,0.77,0.17984,1,0.4829185714285714,2.6,BP
GO:0031111,negative regulation of microtubule polym...,46,2,0.77,0.17984,1,0.4829185714285714,2.6,BP
GO:0032873,negative regulation of stress-activated ...,46,2,0.77,0.17984,1,0.4829185714285714,2.6,BP
GO:0035036,sperm-egg recognition,46,2,0.77,0.17984,1,0.4829185714285714,2.6,BP
GO:0042307,positive regulation of protein import in...,46,2,0.77,0.17984,1,0.4829185714285714,2.6,BP
GO:0070303,negative regulation of stress-activated ...,46,2,0.77,0.17984,1,0.4829185714285714,2.6,BP
GO:0072666,establishment of protein localization to...,46,2,0.77,0.17984,1,0.4829185714285714,2.6,BP
GO:0001936,regulation of endothelial cell prolifera...,132,4,2.21,0.18099,1,0.48573557166759623,1.81,BP
GO:0002263,cell activation involved in immune respo...,276,7,4.62,0.18224,1,0.48838048997772826,1.52,BP
GO:0006790,sulfur compound metabolic process,276,7,4.62,0.18224,1,0.48838048997772826,1.52,BP
GO:1901861,regulation of muscle tissue development,179,5,3,0.18228,1,0.48838048997772826,1.67,BP
GO:0007159,leukocyte cell-cell adhesion,326,8,5.46,0.18259,1,0.48893883138564276,1.47,BP
GO:1900076,regulation of cellular response to insul...,88,3,1.47,0.18326,1,0.49012893333333335,2.04,BP
GO:0010562,positive regulation of phosphorus metabo...,1120,23,18.76,0.18334,1,0.49012893333333335,1.23,BP
GO:0045937,positive regulation of phosphate metabol...,1120,23,18.76,0.18334,1,0.49012893333333335,1.23,BP
GO:0002456,T cell mediated immunity,133,4,2.23,0.18433,1,0.49250192115491387,1.79,BP
GO:0016072,rRNA metabolic process,228,6,3.82,0.18480,1,0.4933560728075013,1.57,BP
GO:0007416,synapse assembly,180,5,3.02,0.18512,1,0.4933560728075013,1.66,BP
GO:0048634,regulation of muscle organ development,180,5,3.02,0.18512,1,0.4933560728075013,1.66,BP
GO:0001941,postsynaptic membrane organization,47,2,0.79,0.18588,1,0.4933560728075013,2.53,BP
GO:0006110,regulation of glycolytic process,47,2,0.79,0.18588,1,0.4933560728075013,2.53,BP
GO:0030811,regulation of nucleotide catabolic proce...,47,2,0.79,0.18588,1,0.4933560728075013,2.53,BP
GO:0032309,icosanoid secretion,47,2,0.79,0.18588,1,0.4933560728075013,2.53,BP
GO:0050798,activated T cell proliferation,47,2,0.79,0.18588,1,0.4933560728075013,2.53,BP
GO:0060135,maternal process involved in female preg...,47,2,0.79,0.18588,1,0.4933560728075013,2.53,BP
GO:0060147,regulation of posttranscriptional gene s...,47,2,0.79,0.18588,1,0.4933560728075013,2.53,BP
GO:0060966,regulation of gene silencing by RNA,47,2,0.79,0.18588,1,0.4933560728075013,2.53,BP
GO:0090659,walking behavior,47,2,0.79,0.18588,1,0.4933560728075013,2.53,BP
GO:0007204,positive regulation of cytosolic calcium...,328,8,5.49,0.18673,1,0.49533889746416765,1.46,BP
GO:0060828,regulation of canonical Wnt signaling pa...,229,6,3.84,0.18731,1,0.4954274712013165,1.56,BP
GO:0051492,regulation of stress fiber assembly,89,3,1.49,0.18747,1,0.4954274712013165,2.01,BP
GO:0051937,catecholamine transport,89,3,1.49,0.18747,1,0.4954274712013165,2.01,BP
GO:0060415,muscle tissue morphogenesis,89,3,1.49,0.18747,1,0.4954274712013165,2.01,BP
GO:0070301,cellular response to hydrogen peroxide,89,3,1.49,0.18747,1,0.4954274712013165,2.01,BP
GO:1901615,organic hydroxy compound metabolic proce...,482,11,8.07,0.18755,1,0.4954274712013165,1.36,BP
GO:0010469,regulation of signaling receptor activit...,134,4,2.24,0.18769,1,0.4954274712013165,1.79,BP
GO:0034763,negative regulation of transmembrane tra...,134,4,2.24,0.18769,1,0.4954274712013165,1.79,BP
GO:0051928,positive regulation of calcium ion trans...,134,4,2.24,0.18769,1,0.4954274712013165,1.79,BP
GO:0000819,sister chromatid segregation,181,5,3.03,0.18798,1,0.4959209210526316,1.65,BP
GO:0008544,epidermis development,329,8,5.51,0.18881,1,0.4978376547945206,1.45,BP
GO:0071900,regulation of protein serine/threonine k...,432,10,7.24,0.19061,1,0.5023084994523549,1.38,BP
GO:1903034,regulation of response to wounding,182,5,3.05,0.19085,1,0.502420131147541,1.64,BP
GO:0001909,leukocyte mediated cytotoxicity,135,4,2.26,0.19107,1,0.502420131147541,1.77,BP
GO:0050905,neuromuscular process,135,4,2.26,0.19107,1,0.502420131147541,1.77,BP
GO:0097306,cellular response to alcohol,135,4,2.26,0.19107,1,0.502420131147541,1.77,BP
GO:0032642,regulation of chemokine production,90,3,1.51,0.19171,1,0.5025372143634386,1.99,BP
GO:0002474,antigen processing and presentation of p...,48,2,0.8,0.19195,1,0.5025372143634386,2.5,BP
GO:0031648,protein destabilization,48,2,0.8,0.19195,1,0.5025372143634386,2.5,BP
GO:0043631,RNA polyadenylation,48,2,0.8,0.19195,1,0.5025372143634386,2.5,BP
GO:0044848,biological phase,48,2,0.8,0.19195,1,0.5025372143634386,2.5,BP
GO:0051438,regulation of ubiquitin-protein transfer...,48,2,0.8,0.19195,1,0.5025372143634386,2.5,BP
GO:0090311,regulation of protein deacetylation,48,2,0.8,0.19195,1,0.5025372143634386,2.5,BP
GO:1902808,positive regulation of cell cycle G1/S p...,48,2,0.8,0.19195,1,0.5025372143634386,2.5,BP
GO:1902532,negative regulation of intracellular sig...,537,12,8.99,0.19230,1,0.5031797716150082,1.33,BP
GO:0016055,Wnt signaling pathway,434,10,7.27,0.19427,1,0.5074781127982646,1.38,BP
GO:0002824,positive regulation of adaptive immune r...,136,4,2.28,0.19447,1,0.5074781127982646,1.75,BP
GO:0097553,calcium ion transmembrane import into cy...,136,4,2.28,0.19447,1,0.5074781127982646,1.75,BP
GO:1903038,negative regulation of leukocyte cell-ce...,136,4,2.28,0.19447,1,0.5074781127982646,1.75,BP
GO:1903322,positive regulation of protein modificat...,136,4,2.28,0.19447,1,0.5074781127982646,1.75,BP
GO:0002682,regulation of immune system process,1351,27,22.63,0.19563,1,0.510228487804878,1.19,BP
GO:0000041,transition metal ion transport,91,3,1.52,0.19597,1,0.5102855194805195,1.97,BP
GO:0006112,energy reserve metabolic process,91,3,1.52,0.19597,1,0.5102855194805195,1.97,BP
GO:0006476,protein deacetylation,91,3,1.52,0.19597,1,0.5102855194805195,1.97,BP
GO:0045596,negative regulation of cell differentiat...,806,17,13.5,0.19687,1,0.5123517793401838,1.26,BP
GO:0016070,RNA metabolic process,3787,70,63.43,0.19712,1,0.5127251027027027,1.1,BP
GO:0198738,cell-cell signaling by wnt,436,10,7.3,0.19796,1,0.5140067313915857,1.37,BP
GO:0014888,striated muscle adaptation,49,2,0.82,0.19804,1,0.5140067313915857,2.44,BP
GO:0090199,regulation of release of cytochrome c fr...,49,2,0.82,0.19804,1,0.5140067313915857,2.44,BP
GO:1903115,regulation of actin filament-based movem...,49,2,0.82,0.19804,1,0.5140067313915857,2.44,BP
GO:0022414,reproductive process,1467,29,24.57,0.20103,1,0.5213086422413793,1.18,BP
GO:0009888,tissue development,1970,38,33,0.20107,1,0.5213086422413793,1.15,BP
GO:0030010,establishment of cell polarity,138,4,2.31,0.20133,1,0.521701647819063,1.73,BP
GO:0045860,positive regulation of protein kinase ac...,438,10,7.34,0.20168,1,0.5223273196986007,1.36,BP
GO:0000003,reproduction,1468,29,24.59,0.20205,1,0.5230040882194729,1.18,BP
GO:2000116,regulation of cysteine-type endopeptidas...,235,6,3.94,0.20266,1,0.5243010322580645,1.52,BP
GO:0010631,epithelial cell migration,285,7,4.77,0.20291,1,0.5246657281031704,1.47,BP
GO:0031347,regulation of defense response,650,14,10.89,0.20374,1,0.5256382664526484,1.29,BP
GO:0010828,positive regulation of glucose transmemb...,50,2,0.84,0.20416,1,0.5256382664526484,2.38,BP
GO:0033173,calcineurin-NFAT signaling cascade,50,2,0.84,0.20416,1,0.5256382664526484,2.38,BP
GO:0035088,establishment or maintenance of apical/b...,50,2,0.84,0.20416,1,0.5256382664526484,2.38,BP
GO:0042269,regulation of natural killer cell mediat...,50,2,0.84,0.20416,1,0.5256382664526484,2.38,BP
GO:0061245,establishment or maintenance of bipolar ...,50,2,0.84,0.20416,1,0.5256382664526484,2.38,BP
GO:0071622,regulation of granulocyte chemotaxis,50,2,0.84,0.20416,1,0.5256382664526484,2.38,BP
GO:0090329,regulation of DNA-dependent DNA replicat...,50,2,0.84,0.20416,1,0.5256382664526484,2.38,BP
GO:0002027,regulation of heart rate,93,3,1.56,0.20456,1,0.526105141635489,1.92,BP
GO:0051304,chromosome separation,93,3,1.56,0.20456,1,0.526105141635489,1.92,BP
GO:0005975,carbohydrate metabolic process,545,12,9.13,0.20560,1,0.5284974358974359,1.31,BP
GO:0090132,epithelium migration,287,7,4.81,0.20763,1,0.5334306246663107,1.46,BP
GO:0006813,potassium ion transport,237,6,3.97,0.20788,1,0.5337879188900747,1.51,BP
GO:0016079,synaptic vesicle exocytosis,140,4,2.35,0.20825,1,0.5344528,1.7,BP
GO:0061351,neural precursor cell proliferation,188,5,3.15,0.20841,1,0.534578315565032,1.59,BP
GO:0032602,chemokine production,94,3,1.57,0.20889,1,0.5352389137380192,1.91,BP
GO:0070555,response to interleukin-1,94,3,1.57,0.20889,1,0.5352389137380192,1.91,BP
GO:0001914,regulation of T cell mediated cytotoxici...,51,2,0.85,0.21030,1,0.5362817170111287,2.35,BP
GO:0002715,regulation of natural killer cell mediat...,51,2,0.85,0.21030,1,0.5362817170111287,2.35,BP
GO:0021587,cerebellum morphogenesis,51,2,0.85,0.21030,1,0.5362817170111287,2.35,BP
GO:0031146,SCF-dependent proteasomal ubiquitin-depe...,51,2,0.85,0.21030,1,0.5362817170111287,2.35,BP
GO:0031663,lipopolysaccharide-mediated signaling pa...,51,2,0.85,0.21030,1,0.5362817170111287,2.35,BP
GO:0033619,membrane protein proteolysis,51,2,0.85,0.21030,1,0.5362817170111287,2.35,BP
GO:0043618,regulation of transcription from RNA pol...,51,2,0.85,0.21030,1,0.5362817170111287,2.35,BP
GO:0051353,positive regulation of oxidoreductase ac...,51,2,0.85,0.21030,1,0.5362817170111287,2.35,BP
GO:2000059,negative regulation of ubiquitin-depende...,51,2,0.85,0.21030,1,0.5362817170111287,2.35,BP
GO:0097479,synaptic vesicle localization,189,5,3.17,0.21138,1,0.5387502966101696,1.58,BP
GO:0042110,T cell activation,496,11,8.31,0.21211,1,0.5403246797247221,1.32,BP
GO:0090130,tissue migration,289,7,4.84,0.21238,1,0.5404911686938128,1.45,BP
GO:0007283,spermatogenesis,549,12,9.2,0.21240,1,0.5404911686938128,1.3,BP
GO:0001704,formation of primary germ layer,95,3,1.59,0.21323,1,0.5411723417721519,1.89,BP
GO:0002444,myeloid leukocyte mediated immunity,95,3,1.59,0.21323,1,0.5411723417721519,1.89,BP
GO:0006906,vesicle fusion,95,3,1.59,0.21323,1,0.5411723417721519,1.89,BP
GO:0051817,modification of morphology or physiology...,95,3,1.59,0.21323,1,0.5411723417721519,1.89,BP
GO:0072676,lymphocyte migration,95,3,1.59,0.21323,1,0.5411723417721519,1.89,BP
GO:0055088,lipid homeostasis,142,4,2.38,0.21524,1,0.5459857037427517,1.68,BP
GO:0001954,positive regulation of cell-matrix adhes...,52,2,0.87,0.21645,1,0.5476116719242902,2.3,BP
GO:0061014,positive regulation of mRNA catabolic pr...,52,2,0.87,0.21645,1,0.5476116719242902,2.3,BP
GO:0070542,response to fatty acid,52,2,0.87,0.21645,1,0.5476116719242902,2.3,BP
GO:1903202,negative regulation of oxidative stress-...,52,2,0.87,0.21645,1,0.5476116719242902,2.3,BP
GO:2001222,regulation of neuron migration,52,2,0.87,0.21645,1,0.5476116719242902,2.3,BP
GO:0002821,positive regulation of adaptive immune r...,143,4,2.4,0.21877,1,0.5531903520756699,1.67,BP
GO:1901342,regulation of vasculature development,343,8,5.75,0.21898,1,0.5534305462184874,1.39,BP
GO:0051252,regulation of RNA metabolic process,3073,57,51.47,0.22020,1,0.5562217322834646,1.11,BP
GO:0036503,ERAD pathway,97,3,1.62,0.22199,1,0.5582321208963001,1.85,BP
GO:0048644,muscle organ morphogenesis,97,3,1.62,0.22199,1,0.5582321208963001,1.85,BP
GO:0070167,regulation of biomineral tissue developm...,97,3,1.62,0.22199,1,0.5582321208963001,1.85,BP
GO:0009416,response to light stimulus,293,7,4.91,0.22201,1,0.5582321208963001,1.43,BP
GO:0009267,cellular response to starvation,144,4,2.41,0.22230,1,0.5582321208963001,1.66,BP
GO:2001056,positive regulation of cysteine-type end...,144,4,2.41,0.22230,1,0.5582321208963001,1.66,BP
GO:0014014,negative regulation of gliogenesis,53,2,0.89,0.22262,1,0.5582321208963001,2.25,BP
GO:0030850,prostate gland development,53,2,0.89,0.22262,1,0.5582321208963001,2.25,BP
GO:0061383,trabecula morphogenesis,53,2,0.89,0.22262,1,0.5582321208963001,2.25,BP
GO:0071242,cellular response to ammonium ion,53,2,0.89,0.22262,1,0.5582321208963001,2.25,BP
GO:0071715,icosanoid transport,53,2,0.89,0.22262,1,0.5582321208963001,2.25,BP
GO:0097720,calcineurin-mediated signaling,53,2,0.89,0.22262,1,0.5582321208963001,2.25,BP
GO:1900408,negative regulation of cellular response...,53,2,0.89,0.22262,1,0.5582321208963001,2.25,BP
GO:1901571,fatty acid derivative transport,53,2,0.89,0.22262,1,0.5582321208963001,2.25,BP
GO:0022408,negative regulation of cell-cell adhesio...,193,5,3.23,0.22342,1,0.559946375,1.55,BP
GO:0002703,regulation of leukocyte mediated immunit...,243,6,4.07,0.22381,1,0.560048736349454,1.47,BP
GO:0006260,DNA replication,243,6,4.07,0.22381,1,0.560048736349454,1.47,BP
GO:0010466,negative regulation of peptidase activit...,243,6,4.07,0.22381,1,0.560048736349454,1.47,BP
GO:0071363,cellular response to growth factor stimu...,610,13,10.22,0.22537,1,0.5636592723492723,1.27,BP
GO:0000209,protein polyubiquitination,194,5,3.25,0.22646,1,0.5652103319502074,1.54,BP
GO:0002429,immune response-activating cell surface ...,194,5,3.25,0.22646,1,0.5652103319502074,1.54,BP
GO:0071804,cellular potassium ion transport,194,5,3.25,0.22646,1,0.5652103319502074,1.54,BP
GO:0071805,potassium ion transmembrane transport,194,5,3.25,0.22646,1,0.5652103319502074,1.54,BP
GO:0007166,cell surface receptor signaling pathway,2396,45,40.13,0.22728,1,0.5669628615863141,1.12,BP
GO:0003044,regulation of systemic arterial blood pr...,54,2,0.9,0.22881,1,0.5693038883143744,2.22,BP
GO:0010517,regulation of phospholipase activity,54,2,0.9,0.22881,1,0.5693038883143744,2.22,BP
GO:0061900,glial cell activation,54,2,0.9,0.22881,1,0.5693038883143744,2.22,BP
GO:0070265,necrotic cell death,54,2,0.9,0.22881,1,0.5693038883143744,2.22,BP
GO:0086001,cardiac muscle cell action potential,54,2,0.9,0.22881,1,0.5693038883143744,2.22,BP
GO:0001935,endothelial cell proliferation,146,4,2.45,0.22942,1,0.56964346749226,1.63,BP
GO:0007613,memory,146,4,2.45,0.22942,1,0.56964346749226,1.63,BP
GO:0031099,regeneration,146,4,2.45,0.22942,1,0.56964346749226,1.63,BP
GO:1905952,regulation of lipid localization,146,4,2.45,0.22942,1,0.56964346749226,1.63,BP
GO:0009314,response to radiation,401,9,6.72,0.23188,1,0.575454646725116,1.34,BP
GO:0048771,tissue remodeling,196,5,3.28,0.23258,1,0.5768943092783505,1.52,BP
GO:1901991,negative regulation of mitotic cell cycl...,147,4,2.46,0.23300,1,0.5776383307573416,1.63,BP
GO:0043087,regulation of GTPase activity,298,7,4.99,0.23425,1,0.5804382080329558,1.4,BP
GO:0006900,vesicle budding from membrane,55,2,0.92,0.23500,1,0.5805030800821355,2.17,BP
GO:0014009,glial cell proliferation,55,2,0.92,0.23500,1,0.5805030800821355,2.17,BP
GO:0019369,arachidonic acid metabolic process,55,2,0.92,0.23500,1,0.5805030800821355,2.17,BP
GO:0021575,hindbrain morphogenesis,55,2,0.92,0.23500,1,0.5805030800821355,2.17,BP
GO:0021795,cerebral cortex cell migration,55,2,0.92,0.23500,1,0.5805030800821355,2.17,BP
GO:0032210,regulation of telomere maintenance via t...,55,2,0.92,0.23500,1,0.5805030800821355,2.17,BP
GO:1903046,meiotic cell cycle process,197,5,3.3,0.23566,1,0.5818347460236019,1.52,BP
GO:0003206,cardiac chamber morphogenesis,148,4,2.48,0.23659,1,0.5838313230769231,1.61,BP
GO:0007411,axon guidance,248,6,4.15,0.23738,1,0.5854805535622757,1.45,BP
GO:0008202,steroid metabolic process,300,7,5.03,0.23921,1,0.5890890704800817,1.39,BP
GO:0007584,response to nutrient,101,3,1.69,0.23970,1,0.5890890704800817,1.78,BP
GO:0033559,unsaturated fatty acid metabolic process,101,3,1.69,0.23970,1,0.5890890704800817,1.78,BP
GO:0060359,response to ammonium ion,101,3,1.69,0.23970,1,0.5890890704800817,1.78,BP
GO:0090174,organelle membrane fusion,101,3,1.69,0.23970,1,0.5890890704800817,1.78,BP
GO:0110020,regulation of actomyosin structure organ...,101,3,1.69,0.23970,1,0.5890890704800817,1.78,BP
GO:0110110,positive regulation of animal organ morp...,101,3,1.69,0.23970,1,0.5890890704800817,1.78,BP
GO:0006401,RNA catabolic process,249,6,4.17,0.24013,1,0.5898445941807045,1.44,BP
GO:0022407,regulation of cell-cell adhesion,405,9,6.78,0.24036,1,0.5901083265306122,1.33,BP
GO:0002833,positive regulation of response to bioti...,56,2,0.94,0.24121,1,0.5912901273560877,2.13,BP
GO:0043620,regulation of DNA-templated transcriptio...,56,2,0.94,0.24121,1,0.5912901273560877,2.13,BP
GO:1902883,negative regulation of response to oxida...,56,2,0.94,0.24121,1,0.5912901273560877,2.13,BP
GO:0097485,neuron projection guidance,250,6,4.19,0.24288,1,0.59508073319755606,1.43,BP
GO:0042737,drug catabolic process,150,4,2.51,0.24382,1,0.5966977755205688,1.59,BP
GO:0021510,spinal cord development,102,3,1.71,0.24416,1,0.5966977755205688,1.75,BP
GO:0031123,RNA 3'-end processing,102,3,1.71,0.24416,1,0.5966977755205688,1.75,BP
GO:0031532,actin cytoskeleton reorganization,102,3,1.71,0.24416,1,0.5966977755205688,1.75,BP
GO:0050772,positive regulation of axonogenesis,102,3,1.71,0.24416,1,0.5966977755205688,1.75,BP
GO:0007588,excretion,57,2,0.95,0.24742,1,0.6013784848484848,2.11,BP
GO:0010823,negative regulation of mitochondrion org...,57,2,0.95,0.24742,1,0.6013784848484848,2.11,BP
GO:0021517,ventral spinal cord development,57,2,0.95,0.24742,1,0.6013784848484848,2.11,BP
GO:0042551,neuron maturation,57,2,0.95,0.24742,1,0.6013784848484848,2.11,BP
GO:0043470,regulation of carbohydrate catabolic pro...,57,2,0.95,0.24742,1,0.6013784848484848,2.11,BP
GO:0043536,positive regulation of blood vessel endo...,57,2,0.95,0.24742,1,0.6013784848484848,2.11,BP
GO:0048260,positive regulation of receptor-mediated...,57,2,0.95,0.24742,1,0.6013784848484848,2.11,BP
GO:0050854,regulation of antigen receptor-mediated ...,57,2,0.95,0.24742,1,0.6013784848484848,2.11,BP
GO:0051196,regulation of coenzyme metabolic process,57,2,0.95,0.24742,1,0.6013784848484848,2.11,BP
GO:0051445,regulation of meiotic cell cycle,57,2,0.95,0.24742,1,0.6013784848484848,2.11,BP
GO:0015718,monocarboxylic acid transport,151,4,2.53,0.24745,1,0.6013784848484848,1.58,BP
GO:0048232,male gamete generation,569,12,9.53,0.24776,1,0.6018279252902575,1.26,BP
GO:0048469,cell maturation,201,5,3.37,0.24808,1,0.602301190716448,1.48,BP
GO:0051348,negative regulation of transferase activ...,252,6,4.22,0.24842,1,0.6028225113464448,1.42,BP
GO:0034446,substrate adhesion-dependent cell spread...,103,3,1.73,0.24864,1,0.6030522580645161,1.73,BP
GO:0048514,blood vessel morphogenesis,625,13,10.47,0.25107,1,0.6086392141057935,1.24,BP
GO:0017015,regulation of transforming growth factor...,104,3,1.74,0.25313,1,0.6123989743589744,1.72,BP
GO:0051289,protein homotetramerization,104,3,1.74,0.25313,1,0.6123989743589744,1.72,BP
GO:1901222,regulation of NIK/NF-kappaB signaling,104,3,1.74,0.25313,1,0.6123989743589744,1.72,BP
GO:2001022,positive regulation of response to DNA d...,104,3,1.74,0.25313,1,0.6123989743589744,1.72,BP
GO:0048016,inositol phosphate-mediated signaling,58,2,0.97,0.25364,1,0.6124012443552433,2.06,BP
GO:0065002,intracellular protein transmembrane tran...,58,2,0.97,0.25364,1,0.6124012443552433,2.06,BP
GO:0070972,protein localization to endoplasmic reti...,58,2,0.97,0.25364,1,0.6124012443552433,2.06,BP
GO:0098900,regulation of action potential,58,2,0.97,0.25364,1,0.6124012443552433,2.06,BP
GO:0005996,monosaccharide metabolic process,254,6,4.25,0.25399,1,0.6129387562688065,1.41,BP
GO:0043410,positive regulation of MAPK cascade,520,11,8.71,0.25710,1,0.620132932330827,1.26,BP
GO:0007160,cell-matrix adhesion,204,5,3.42,0.25751,1,0.6208106813627255,1.46,BP
GO:0055017,cardiac muscle tissue growth,105,3,1.76,0.25764,1,0.620813059589384,1.7,BP
GO:0006937,regulation of muscle contraction,154,4,2.58,0.25842,1,0.6223809009009009,1.55,BP
GO:0015872,dopamine transport,59,2,0.99,0.25986,1,0.6245985614385614,2.02,BP
GO:0032663,regulation of interleukin-2 production,59,2,0.99,0.25986,1,0.6245985614385614,2.02,BP
GO:0070936,protein K48-linked ubiquitination,59,2,0.99,0.25986,1,0.6245985614385614,2.02,BP
GO:0098661,inorganic anion transmembrane transport,59,2,0.99,0.25986,1,0.6245985614385614,2.02,BP
GO:0045765,regulation of angiogenesis,309,7,5.18,0.26194,1,0.6288463609172482,1.35,BP
GO:0050863,regulation of T cell activation,309,7,5.18,0.26194,1,0.6288463609172482,1.35,BP
GO:0030518,intracellular steroid hormone receptor s...,106,3,1.78,0.26215,1,0.6288463609172482,1.69,BP
GO:1903844,regulation of cellular response to trans...,106,3,1.78,0.26215,1,0.6288463609172482,1.69,BP
GO:0035295,tube development,1130,22,18.93,0.26294,1,0.6304271449925262,1.16,BP
GO:0002768,immune response-regulating cell surface ...,206,5,3.45,0.26384,1,0.6319552414136387,1.45,BP
GO:0050770,regulation of axonogenesis,206,5,3.45,0.26384,1,0.6319552414136387,1.45,BP
GO:0008347,glial cell migration,60,2,1.01,0.26608,1,0.6354228089330025,1.98,BP
GO:0021515,cell differentiation in spinal cord,60,2,1.01,0.26608,1,0.6354228089330025,1.98,BP
GO:0031122,cytoplasmic microtubule organization,60,2,1.01,0.26608,1,0.6354228089330025,1.98,BP
GO:0031124,mRNA 3'-end processing,60,2,1.01,0.26608,1,0.6354228089330025,1.98,BP
GO:0090307,mitotic spindle assembly,60,2,1.01,0.26608,1,0.6354228089330025,1.98,BP
GO:1902017,regulation of cilium assembly,60,2,1.01,0.26608,1,0.6354228089330025,1.98,BP
GO:0007265,Ras protein signal transduction,417,9,6.98,0.26645,1,0.6359907738095238,1.29,BP
GO:0045892,"negative regulation of transcription, DN...",1189,23,19.92,0.26686,1,0.6366536043629152,1.15,BP
GO:0001101,response to acid chemical,364,8,6.1,0.26728,1,0.6373396233894946,1.31,BP
GO:0042060,wound healing,365,8,6.11,0.26965,1,0.6426725111441307,1.31,BP
GO:0051403,stress-activated MAPK cascade,260,6,4.36,0.27091,1,0.645355900990099,1.38,BP
GO:0006612,protein targeting to membrane,108,3,1.81,0.27121,1,0.6454315133531157,1.66,BP
GO:1904659,glucose transmembrane transport,108,3,1.81,0.27121,1,0.6454315133531157,1.66,BP
GO:1903507,negative regulation of nucleic acid-temp...,1193,23,19.98,0.27212,1,0.6470654814814815,1.15,BP
GO:0046651,lymphocyte proliferation,313,7,5.24,0.27223,1,0.6470654814814815,1.34,BP
GO:0042267,natural killer cell mediated cytotoxicit...,61,2,1.02,0.27230,1,0.6470654814814815,1.96,BP
GO:0015711,organic anion transport,420,9,7.04,0.27310,1,0.647876865450961,1.28,BP
GO:0007596,blood coagulation,158,4,2.65,0.27318,1,0.647876865450961,1.51,BP
GO:0033135,regulation of peptidyl-serine phosphoryl...,158,4,2.65,0.27318,1,0.647876865450961,1.51,BP
GO:0062013,positive regulation of small molecule me...,158,4,2.65,0.27318,1,0.647876865450961,1.51,BP
GO:1902679,negative regulation of RNA biosynthetic ...,1194,23,20,0.27344,1,0.6481740295566504,1.15,BP
GO:0001942,hair follicle development,109,3,1.83,0.27575,1,0.6520437346437347,1.64,BP
GO:0008344,adult locomotory behavior,109,3,1.83,0.27575,1,0.6520437346437347,1.64,BP
GO:0008645,hexose transmembrane transport,109,3,1.83,0.27575,1,0.6520437346437347,1.64,BP
GO:0032963,collagen metabolic process,109,3,1.83,0.27575,1,0.6520437346437347,1.64,BP
GO:0048145,regulation of fibroblast proliferation,109,3,1.83,0.27575,1,0.6520437346437347,1.64,BP
GO:0007569,cell aging,159,4,2.66,0.27689,1,0.6540965537555229,1.5,BP
GO:0051302,regulation of cell division,159,4,2.66,0.27689,1,0.6540965537555229,1.5,BP
GO:0032943,mononuclear cell proliferation,315,7,5.28,0.27742,1,0.6550270068694799,1.33,BP
GO:0001836,release of cytochrome c from mitochondri...,62,2,1.04,0.27852,1,0.6553732224938874,1.92,BP
GO:0010171,body morphogenesis,62,2,1.04,0.27852,1,0.6553732224938874,1.92,BP
GO:0014911,positive regulation of smooth muscle cel...,62,2,1.04,0.27852,1,0.6553732224938874,1.92,BP
GO:0034308,primary alcohol metabolic process,62,2,1.04,0.27852,1,0.6553732224938874,1.92,BP
GO:0048008,platelet-derived growth factor receptor ...,62,2,1.04,0.27852,1,0.6553732224938874,1.92,BP
GO:0060038,cardiac muscle cell proliferation,62,2,1.04,0.27852,1,0.6553732224938874,1.92,BP
GO:0090501,RNA phosphodiester bond hydrolysis,62,2,1.04,0.27852,1,0.6553732224938874,1.92,BP
GO:0032649,regulation of interferon-gamma productio...,110,3,1.84,0.28030,1,0.6578081982840801,1.63,BP
GO:0038061,NIK/NF-kappaB signaling,110,3,1.84,0.28030,1,0.6578081982840801,1.63,BP
GO:0045446,endothelial cell differentiation,110,3,1.84,0.28030,1,0.6578081982840801,1.63,BP
GO:2000379,positive regulation of reactive oxygen s...,110,3,1.84,0.28030,1,0.6578081982840801,1.63,BP
GO:0007599,hemostasis,160,4,2.68,0.28062,1,0.6578081982840801,1.49,BP
GO:0051146,striated muscle cell differentiation,317,7,5.31,0.28263,1,0.6578081982840801,1.32,BP
GO:2000027,regulation of animal organ morphogenesis,212,5,3.55,0.28304,1,0.6578081982840801,1.41,BP
GO:0006941,striated muscle contraction,161,4,2.7,0.28435,1,0.6578081982840801,1.48,BP
GO:0010950,positive regulation of endopeptidase act...,161,4,2.7,0.28435,1,0.6578081982840801,1.48,BP
GO:0050817,coagulation,161,4,2.7,0.28435,1,0.6578081982840801,1.48,BP
GO:0002228,natural killer cell mediated immunity,63,2,1.06,0.28474,1,0.6578081982840801,1.89,BP
GO:0030858,positive regulation of epithelial cell d...,63,2,1.06,0.28474,1,0.6578081982840801,1.89,BP
GO:0042246,tissue regeneration,63,2,1.06,0.28474,1,0.6578081982840801,1.89,BP
GO:0043331,response to dsRNA,63,2,1.06,0.28474,1,0.6578081982840801,1.89,BP
GO:0043949,regulation of cAMP-mediated signaling,63,2,1.06,0.28474,1,0.6578081982840801,1.89,BP
GO:1903307,positive regulation of regulated secreto...,63,2,1.06,0.28474,1,0.6578081982840801,1.89,BP
GO:2000242,negative regulation of reproductive proc...,63,2,1.06,0.28474,1,0.6578081982840801,1.89,BP
GO:0015749,monosaccharide transmembrane transport,111,3,1.86,0.28485,1,0.6578081982840801,1.61,BP
GO:0022404,molting cycle process,111,3,1.86,0.28485,1,0.6578081982840801,1.61,BP
GO:0022405,hair cycle process,111,3,1.86,0.28485,1,0.6578081982840801,1.61,BP
GO:0048144,fibroblast proliferation,111,3,1.86,0.28485,1,0.6578081982840801,1.61,BP
GO:0098773,skin epidermis development,111,3,1.86,0.28485,1,0.6578081982840801,1.61,BP
GO:1903050,regulation of proteolysis involved in ce...,213,5,3.57,0.28627,1,0.6578081982840801,1.4,BP
GO:0002523,leukocyte migration involved in inflamma...,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0002755,MyD88-dependent toll-like receptor signa...,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0007035,vacuolar acidification,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0010039,response to iron ion,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0010869,regulation of receptor biosynthetic proc...,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0033605,positive regulation of catecholamine sec...,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0035584,calcium-mediated signaling using intrace...,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0045821,positive regulation of glycolytic proces...,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0045838,positive regulation of membrane potentia...,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0045986,negative regulation of smooth muscle con...,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0046514,ceramide catabolic process,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0048199,"vesicle targeting, to, from or within Go...",20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0048261,negative regulation of receptor-mediated...,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0051383,kinetochore organization,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0055064,chloride ion homeostasis,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0070498,interleukin-1-mediated signaling pathway,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0070828,heterochromatin organization,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0071605,monocyte chemotactic protein-1 productio...,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0071637,regulation of monocyte chemotactic prote...,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0072520,seminiferous tubule development,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0090036,regulation of protein kinase C signaling,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0097320,plasma membrane tubulation,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0098840,protein transport along microtubule,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0099118,microtubule-based protein transport,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:1900409,positive regulation of cellular response...,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:1902993,positive regulation of amyloid precursor...,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:1903392,negative regulation of adherens junction...,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:1903975,regulation of glial cell migration,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:1904385,cellular response to angiotensin,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:1990182,exosomal secretion,20,1,0.34,0.28680,1,0.6578081982840801,2.94,BP
GO:0001944,vasculature development,756,15,12.66,0.28736,1,0.6587786183897094,1.18,BP
GO:2001236,regulation of extrinsic apoptotic signal...,162,4,2.71,0.28808,1,0.6601147428571429,1.48,BP
GO:0019079,viral genome replication,112,3,1.88,0.28941,1,0.6625313606089439,1.6,BP
GO:0034219,carbohydrate transmembrane transport,112,3,1.88,0.28941,1,0.6625313606089439,1.6,BP
GO:0043462,regulation of ATPase activity,64,2,1.07,0.29095,1,0.6654236692015209,1.87,BP
GO:0090398,cellular senescence,64,2,1.07,0.29095,1,0.6654236692015209,1.87,BP
GO:0030902,hindbrain development,163,4,2.73,0.29183,1,0.6661877293790548,1.47,BP
GO:0031047,gene silencing by RNA,163,4,2.73,0.29183,1,0.6661877293790548,1.47,BP
GO:0050851,antigen receptor-mediated signaling path...,163,4,2.73,0.29183,1,0.6661877293790548,1.47,BP
GO:0002274,myeloid leukocyte activation,215,5,3.6,0.29274,1,0.6661877293790548,1.39,BP
GO:0050920,regulation of chemotaxis,215,5,3.6,0.29274,1,0.6661877293790548,1.39,BP
GO:0002757,immune response-activating signal transd...,321,7,5.38,0.29313,1,0.6661877293790548,1.3,BP
GO:0043401,steroid hormone mediated signaling pathw...,113,3,1.89,0.29398,1,0.6661877293790548,1.59,BP
GO:2000177,regulation of neural precursor cell prol...,113,3,1.89,0.29398,1,0.6661877293790548,1.59,BP
GO:0043433,negative regulation of DNA-binding trans...,164,4,2.75,0.29558,1,0.6661877293790548,1.45,BP
GO:0048639,positive regulation of developmental gro...,216,5,3.62,0.29599,1,0.6661877293790548,1.38,BP
GO:0001707,mesoderm formation,65,2,1.09,0.29716,1,0.6661877293790548,1.83,BP
GO:0002763,positive regulation of myeloid leukocyte...,65,2,1.09,0.29716,1,0.6661877293790548,1.83,BP
GO:0015914,phospholipid transport,65,2,1.09,0.29716,1,0.6661877293790548,1.83,BP
GO:0030330,"DNA damage response, signal transduction...",65,2,1.09,0.29716,1,0.6661877293790548,1.83,BP
GO:0051926,negative regulation of calcium ion trans...,65,2,1.09,0.29716,1,0.6661877293790548,1.83,BP
GO:0099601,regulation of neurotransmitter receptor ...,65,2,1.09,0.29716,1,0.6661877293790548,1.83,BP
GO:0150076,neuroinflammatory response,65,2,1.09,0.29716,1,0.6661877293790548,1.83,BP
GO:1901264,carbohydrate derivative transport,65,2,1.09,0.29716,1,0.6661877293790548,1.83,BP
GO:2000736,regulation of stem cell differentiation,65,2,1.09,0.29716,1,0.6661877293790548,1.83,BP
GO:0010648,negative regulation of cell communicatio...,1326,25,22.21,0.29838,1,0.6661877293790548,1.13,BP
GO:0000187,activation of MAPK activity,114,3,1.91,0.29855,1,0.6661877293790548,1.57,BP
GO:0016525,negative regulation of angiogenesis,114,3,1.91,0.29855,1,0.6661877293790548,1.57,BP
GO:0046822,regulation of nucleocytoplasmic transpor...,114,3,1.91,0.29855,1,0.6661877293790548,1.57,BP
GO:0060419,heart growth,114,3,1.91,0.29855,1,0.6661877293790548,1.57,BP
GO:0000413,protein peptidyl-prolyl isomerization,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0006516,glycoprotein catabolic process,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0006783,heme biosynthetic process,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0008356,asymmetric cell division,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0010759,positive regulation of macrophage chemot...,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0010866,regulation of triglyceride biosynthetic ...,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0014808,release of sequestered calcium ion into ...,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0015732,prostaglandin transport,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0017000,antibiotic biosynthetic process,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0022010,central nervous system myelination,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0030813,positive regulation of nucleotide catabo...,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0032291,axon ensheathment in central nervous sys...,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0034694,response to prostaglandin,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0042535,positive regulation of tumor necrosis fa...,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0045475,locomotor rhythm,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0046174,polyol catabolic process,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0046325,negative regulation of glucose import,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0051197,positive regulation of coenzyme metaboli...,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0051900,regulation of mitochondrial depolarizati...,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0060457,negative regulation of digestive system ...,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0070633,transepithelial transport,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0097734,extracellular exosome biogenesis,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:0140058,neuron projection arborization,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:1900151,regulation of nuclear-transcribed mRNA c...,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:1901623,regulation of lymphocyte chemotaxis,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:1904666,regulation of ubiquitin protein ligase a...,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:1905153,regulation of membrane invagination,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:1990776,response to angiotensin,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:2001032,regulation of double-strand break repair...,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:2001224,positive regulation of neuron migration,21,1,0.35,0.29876,1,0.6661877293790548,2.86,BP
GO:1901988,negative regulation of cell cycle phase ...,165,4,2.76,0.29934,1,0.6671718758684575,1.45,BP
GO:0001505,regulation of neurotransmitter levels,378,8,6.33,0.30106,1,0.6706947777777778,1.26,BP
GO:0070374,positive regulation of ERK1 and ERK2 cas...,218,5,3.65,0.30250,1,0.6735909301249422,1.37,BP
GO:0051209,release of sequestered calcium ion into ...,115,3,1.93,0.30313,1,0.674257884526559,1.55,BP
GO:0042306,regulation of protein import into nucleu...,66,2,1.11,0.30336,1,0.674257884526559,1.8,BP
GO:0061478,response to platelet aggregation inhibit...,66,2,1.11,0.30336,1,0.674257884526559,1.8,BP
GO:0086003,cardiac muscle cell contraction,66,2,1.11,0.30336,1,0.674257884526559,1.8,BP
GO:0023057,negative regulation of signaling,1330,25,22.28,0.30363,1,0.6744794093216429,1.12,BP
GO:0006955,immune response,1387,26,23.23,0.30374,1,0.6744794093216429,1.12,BP
GO:0033673,negative regulation of kinase activity,219,5,3.67,0.30576,1,0.6766861385242192,1.36,BP
GO:1903828,negative regulation of cellular protein ...,116,3,1.94,0.30771,1,0.6766861385242192,1.55,BP
GO:2001023,regulation of response to drug,116,3,1.94,0.30771,1,0.6766861385242192,1.55,BP
GO:0042327,positive regulation of phosphorylation,1050,20,17.59,0.30874,1,0.6766861385242192,1.14,BP
GO:0006801,superoxide metabolic process,67,2,1.12,0.30954,1,0.6766861385242192,1.79,BP
GO:0006940,regulation of smooth muscle contraction,67,2,1.12,0.30954,1,0.6766861385242192,1.79,BP
GO:0032623,interleukin-2 production,67,2,1.12,0.30954,1,0.6766861385242192,1.79,BP
GO:0072358,cardiovascular system development,769,15,12.88,0.30963,1,0.6766861385242192,1.16,BP
GO:0000423,mitophagy,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0002834,regulation of response to tumor cell,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0002837,regulation of immune response to tumor c...,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0003084,positive regulation of systemic arterial...,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0006837,serotonin transport,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0007063,regulation of sister chromatid cohesion,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0009067,aspartate family amino acid biosynthetic...,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0015874,norepinephrine transport,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0019400,alditol metabolic process,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0021516,dorsal spinal cord development,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0031643,positive regulation of myelination,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0032303,regulation of icosanoid secretion,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0032462,regulation of protein homooligomerizatio...,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0032780,negative regulation of ATPase activity,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0032897,negative regulation of viral transcripti...,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0032930,positive regulation of superoxide anion ...,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0036314,response to sterol,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0042537,benzene-containing compound metabolic pr...,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0046628,positive regulation of insulin receptor ...,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0046823,negative regulation of nucleocytoplasmic...,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0050857,positive regulation of antigen receptor-...,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0051043,regulation of membrane protein ectodomai...,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0051654,establishment of mitochondrion localizat...,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0060009,Sertoli cell development,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0060438,trachea development,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0071359,cellular response to dsRNA,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0090330,regulation of platelet aggregation,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0097107,postsynaptic density assembly,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0099170,postsynaptic modulation of chemical syna...,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:1901223,negative regulation of NIK/NF-kappaB sig...,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:1901673,regulation of mitotic spindle assembly,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:1901889,negative regulation of cell junction ass...,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:1903514,release of sequestered calcium ion into ...,22,1,0.37,0.31051,1,0.6766861385242192,2.7,BP
GO:0042594,response to starvation,168,4,2.81,0.31064,1,0.6766861385242192,1.42,BP
GO:0003073,regulation of systemic arterial blood pr...,117,3,1.96,0.31229,1,0.6793578119349005,1.53,BP
GO:0030282,bone mineralization,117,3,1.96,0.31229,1,0.6793578119349005,1.53,BP
GO:0051283,negative regulation of sequestering of c...,117,3,1.96,0.31229,1,0.6793578119349005,1.53,BP
GO:0001934,positive regulation of protein phosphory...,996,19,16.68,0.31259,1,0.6797031540894714,1.14,BP
GO:0006305,DNA alkylation,68,2,1.14,0.31572,1,0.6840363079693832,1.75,BP
GO:0006306,DNA methylation,68,2,1.14,0.31572,1,0.6840363079693832,1.75,BP
GO:0008542,visual learning,68,2,1.14,0.31572,1,0.6840363079693832,1.75,BP
GO:0032922,circadian regulation of gene expression,68,2,1.14,0.31572,1,0.6840363079693832,1.75,BP
GO:0034109,homotypic cell-cell adhesion,68,2,1.14,0.31572,1,0.6840363079693832,1.75,BP
GO:0045428,regulation of nitric oxide biosynthetic ...,68,2,1.14,0.31572,1,0.6840363079693832,1.75,BP
GO:0048002,antigen processing and presentation of p...,68,2,1.14,0.31572,1,0.6840363079693832,1.75,BP
GO:0055081,anion homeostasis,68,2,1.14,0.31572,1,0.6840363079693832,1.75,BP
GO:0002040,sprouting angiogenesis,118,3,1.98,0.31687,1,0.6856018165467626,1.52,BP
GO:0051701,interaction with host,118,3,1.98,0.31687,1,0.6856018165467626,1.52,BP
GO:2000181,negative regulation of blood vessel morp...,118,3,1.98,0.31687,1,0.6856018165467626,1.52,BP
GO:0007498,mesoderm development,119,3,1.99,0.32146,1,0.6862265604249668,1.51,BP
GO:0051282,regulation of sequestering of calcium io...,119,3,1.99,0.32146,1,0.6862265604249668,1.51,BP
GO:0051963,regulation of synapse assembly,119,3,1.99,0.32146,1,0.6862265604249668,1.51,BP
GO:0001541,ovarian follicle development,69,2,1.16,0.32188,1,0.6862265604249668,1.72,BP
GO:0006766,vitamin metabolic process,69,2,1.16,0.32188,1,0.6862265604249668,1.72,BP
GO:0007405,neuroblast proliferation,69,2,1.16,0.32188,1,0.6862265604249668,1.72,BP
GO:0021536,diencephalon development,69,2,1.16,0.32188,1,0.6862265604249668,1.72,BP
GO:0048146,positive regulation of fibroblast prolif...,69,2,1.16,0.32188,1,0.6862265604249668,1.72,BP
GO:0048332,mesoderm morphogenesis,69,2,1.16,0.32188,1,0.6862265604249668,1.72,BP
GO:0055117,regulation of cardiac muscle contraction,69,2,1.16,0.32188,1,0.6862265604249668,1.72,BP
GO:0008211,glucocorticoid metabolic process,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0010499,proteasomal ubiquitin-independent protei...,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0010874,regulation of cholesterol efflux,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0014912,negative regulation of smooth muscle cel...,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0030252,growth hormone secretion,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0032727,positive regulation of interferon-alpha ...,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0035493,SNARE complex assembly,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0035743,"CD4-positive, alpha-beta T cell cytokine...",23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0036010,protein localization to endosome,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0045056,transcytosis,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0045943,positive regulation of transcription by ...,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0046599,regulation of centriole replication,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0046641,positive regulation of alpha-beta T cell...,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0046931,pore complex assembly,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0050765,negative regulation of phagocytosis,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0060390,regulation of SMAD protein signal transd...,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0090190,positive regulation of branching involve...,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0099149,regulation of postsynaptic neurotransmit...,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0140112,extracellular vesicle biogenesis,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:1902410,mitotic cytokinetic process,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:1902884,positive regulation of response to oxida...,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:1903077,negative regulation of protein localizat...,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:1903306,negative regulation of regulated secreto...,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:1904469,positive regulation of tumor necrosis fa...,23,1,0.39,0.32207,1,0.6862265604249668,2.56,BP
GO:0030324,lung development,224,5,3.75,0.32215,1,0.6862265604249668,1.33,BP
GO:0019318,hexose metabolic process,225,5,3.77,0.32544,1,0.692928,1.33,BP
GO:0007369,gastrulation,172,4,2.88,0.32577,1,0.6929790106007067,1.39,BP
GO:0071902,positive regulation of protein serine/th...,279,6,4.67,0.32603,1,0.6929790106007067,1.28,BP
GO:0051208,sequestering of calcium ion,120,3,2.01,0.32604,1,0.6929790106007067,1.49,BP
GO:2000045,regulation of G1/S transition of mitotic...,120,3,2.01,0.32604,1,0.6929790106007067,1.49,BP
GO:0002764,immune response-regulating signaling pat...,334,7,5.59,0.32778,1,0.6956722609078889,1.25,BP
GO:0002090,regulation of receptor internalization,70,2,1.17,0.32803,1,0.6956722609078889,1.71,BP
GO:0022029,telencephalon cell migration,70,2,1.17,0.32803,1,0.6956722609078889,1.71,BP
GO:0048641,regulation of skeletal muscle tissue dev...,70,2,1.17,0.32803,1,0.6956722609078889,1.71,BP
GO:1903670,regulation of sprouting angiogenesis,70,2,1.17,0.32803,1,0.6956722609078889,1.71,BP
GO:0044070,regulation of anion transport,121,3,2.03,0.33063,1,0.6991343267973856,1.48,BP
GO:1901216,positive regulation of neuron death,121,3,2.03,0.33063,1,0.6991343267973856,1.48,BP
GO:0030323,respiratory tube development,227,5,3.8,0.33204,1,0.6991343267973856,1.32,BP
GO:0034470,ncRNA processing,336,7,5.63,0.33318,1,0.6991343267973856,1.24,BP
GO:0002374,cytokine secretion involved in immune re...,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0002418,immune response to tumor cell,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0006706,steroid catabolic process,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0007064,mitotic sister chromatid cohesion,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0007205,protein kinase C-activating G protein-co...,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0021889,olfactory bulb interneuron differentiati...,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0032352,positive regulation of hormone metabolic...,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0032770,positive regulation of monooxygenase act...,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0032878,regulation of establishment or maintenan...,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0034383,low-density lipoprotein particle clearan...,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0035561,regulation of chromatin binding,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0043921,modulation by host of viral transcriptio...,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0045922,negative regulation of fatty acid metabo...,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0050687,negative regulation of defense response ...,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0050995,negative regulation of lipid catabolic p...,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0051457,maintenance of protein location in nucle...,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0052312,modulation of transcription in other org...,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0052472,modulation by host of symbiont transcrip...,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0060216,definitive hemopoiesis,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0070584,mitochondrion morphogenesis,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:1900120,regulation of receptor binding,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:1903204,negative regulation of oxidative stress-...,24,1,0.4,0.33344,1,0.6991343267973856,2.5,BP
GO:0001913,T cell mediated cytotoxicity,71,2,1.19,0.33416,1,0.6997292950391645,1.68,BP
GO:0045669,positive regulation of osteoblast differ...,71,2,1.19,0.33416,1,0.6997292950391645,1.68,BP
GO:0050433,regulation of catecholamine secretion,71,2,1.19,0.33416,1,0.6997292950391645,1.68,BP
GO:0002377,immunoglobulin production,123,3,2.06,0.33979,1,0.7068676214833759,1.46,BP
GO:0003158,endothelium development,123,3,2.06,0.33979,1,0.7068676214833759,1.46,BP
GO:0006639,acylglycerol metabolic process,123,3,2.06,0.33979,1,0.7068676214833759,1.46,BP
GO:0032609,interferon-gamma production,123,3,2.06,0.33979,1,0.7068676214833759,1.46,BP
GO:0048284,organelle fusion,123,3,2.06,0.33979,1,0.7068676214833759,1.46,BP
GO:0050868,negative regulation of T cell activation,123,3,2.06,0.33979,1,0.7068676214833759,1.46,BP
GO:0050778,positive regulation of immune response,617,12,10.33,0.34000,1,0.7068676214833759,1.16,BP
GO:0060070,canonical Wnt signaling pathway,284,6,4.76,0.34081,1,0.7068676214833759,1.26,BP
GO:0042129,regulation of T cell proliferation,176,4,2.95,0.34095,1,0.7068676214833759,1.36,BP
GO:0070661,leukocyte proliferation,339,7,5.68,0.34129,1,0.7068676214833759,1.23,BP
GO:0001516,prostaglandin biosynthetic process,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0009048,dosage compensation by inactivation of X...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0010742,macrophage derived foam cell differentia...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0010894,negative regulation of steroid biosynthe...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0018126,protein hydroxylation,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0021801,cerebral cortex radial glia guided migra...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0022030,telencephalon glial cell migration,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0031639,plasminogen activation,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0032373,positive regulation of sterol transport,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0032376,positive regulation of cholesterol trans...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0032480,negative regulation of type I interferon...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0032515,negative regulation of phosphoprotein ph...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0032703,negative regulation of interleukin-2 pro...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0032800,receptor biosynthetic process,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0032928,regulation of superoxide anion generatio...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0033522,histone H2A ubiquitination,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0035384,thioester biosynthetic process,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0035455,response to interferon-alpha,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0035813,regulation of renal sodium excretion,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0042059,negative regulation of epidermal growth ...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0045939,negative regulation of steroid metabolic...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0046457,prostanoid biosynthetic process,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0051443,positive regulation of ubiquitin-protein...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0051580,regulation of neurotransmitter uptake,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0055094,response to lipoprotein particle,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0061213,positive regulation of mesonephros devel...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0071616,acyl-CoA biosynthetic process,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0085029,extracellular matrix assembly,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0086019,cell-cell signaling involved in cardiac ...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0090023,positive regulation of neutrophil chemot...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0095500,acetylcholine receptor signaling pathway,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0098810,neurotransmitter reuptake,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:1901798,positive regulation of signal transducti...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:1903649,regulation of cytoplasmic transport,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:1903831,signal transduction involved in cellular...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:1904376,negative regulation of protein localizat...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:1904738,vascular associated smooth muscle cell m...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:1904752,regulation of vascular associated smooth...,25,1,0.42,0.34462,1,0.7068676214833759,2.38,BP
GO:0097191,extrinsic apoptotic signaling pathway,231,5,3.87,0.34526,1,0.7078786195142737,1.29,BP
GO:0021885,forebrain cell migration,73,2,1.22,0.34638,1,0.7095702681992337,1.64,BP
GO:1903051,negative regulation of proteolysis invol...,73,2,1.22,0.34638,1,0.7095702681992337,1.64,BP
GO:0060348,bone development,232,5,3.89,0.34857,1,0.7137526978723404,1.29,BP
GO:0006638,neutral lipid metabolic process,125,3,2.09,0.34895,1,0.7142268821777967,1.44,BP
GO:0007165,signal transduction,5929,103,99.31,0.34922,1,0.714475612244898,1.04,BP
GO:0002449,lymphocyte mediated immunity,287,6,4.81,0.34972,1,0.7151944921376965,1.25,BP
GO:0009968,negative regulation of signal transducti...,1192,22,19.97,0.35004,1,0.7155448088360238,1.1,BP
GO:0048608,reproductive structure development,454,9,7.6,0.35133,1,0.716281004604437,1.18,BP
GO:0140013,meiotic nuclear division,179,4,3,0.35235,1,0.716281004604437,1.33,BP
GO:0002532,production of molecular mediator involve...,74,2,1.24,0.35246,1,0.716281004604437,1.61,BP
GO:0031060,regulation of histone methylation,74,2,1.24,0.35246,1,0.716281004604437,1.61,BP
GO:0042130,negative regulation of T cell proliferat...,74,2,1.24,0.35246,1,0.716281004604437,1.61,BP
GO:0046626,regulation of insulin receptor signaling...,74,2,1.24,0.35246,1,0.716281004604437,1.61,BP
GO:0050432,catecholamine secretion,74,2,1.24,0.35246,1,0.716281004604437,1.61,BP
GO:0060191,regulation of lipase activity,74,2,1.24,0.35246,1,0.716281004604437,1.61,BP
GO:0000289,nuclear-transcribed mRNA poly(A) tail sh...,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0002478,antigen processing and presentation of e...,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0006779,porphyrin-containing compound biosynthet...,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0006817,phosphate ion transport,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0006882,cellular zinc ion homeostasis,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0007289,spermatid nucleus differentiation,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0007620,copulation,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0010155,regulation of proton transport,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0010829,negative regulation of glucose transmemb...,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0030194,positive regulation of blood coagulation,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0034114,regulation of heterotypic cell-cell adhe...,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0042044,fluid transport,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0043171,peptide catabolic process,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0043486,histone exchange,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0045117,azole transport,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0050858,negative regulation of antigen receptor-...,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0051570,regulation of histone H3-K9 methylation,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0072574,hepatocyte proliferation,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0072575,epithelial cell proliferation involved i...,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0090077,foam cell differentiation,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0090189,regulation of branching involved in uret...,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0090208,positive regulation of triglyceride meta...,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:1900048,positive regulation of hemostasis,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:1900078,positive regulation of cellular response...,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:1902473,regulation of protein localization to sy...,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:1904357,negative regulation of telomere maintena...,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:2000738,positive regulation of stem cell differe...,26,1,0.44,0.35561,1,0.716281004604437,2.27,BP
GO:0000082,G1/S transition of mitotic cell cycle,180,4,3.02,0.35615,1,0.7170685355648537,1.32,BP
GO:0002761,regulation of myeloid leukocyte differen...,127,3,2.13,0.35810,1,0.7197523404255319,1.41,BP
GO:0060048,cardiac muscle contraction,127,3,2.13,0.35810,1,0.7197523404255319,1.41,BP
GO:0032872,regulation of stress-activated MAPK casc...,235,5,3.94,0.35851,1,0.7197523404255319,1.27,BP
GO:0090092,regulation of transmembrane receptor pro...,235,5,3.94,0.35851,1,0.7197523404255319,1.27,BP
GO:0002637,regulation of immunoglobulin production,75,2,1.26,0.35853,1,0.7197523404255319,1.59,BP
GO:0010507,negative regulation of autophagy,75,2,1.26,0.35853,1,0.7197523404255319,1.59,BP
GO:0051705,multi-organism behavior,75,2,1.26,0.35853,1,0.7197523404255319,1.59,BP
GO:0061458,reproductive system development,458,9,7.67,0.36078,1,0.7239672060050041,1.17,BP
GO:0010565,regulation of cellular ketone metabolic ...,128,3,2.14,0.36266,1,0.7244096302382909,1.4,BP
GO:0031623,receptor internalization,128,3,2.14,0.36266,1,0.7244096302382909,1.4,BP
GO:0042303,molting cycle,128,3,2.14,0.36266,1,0.7244096302382909,1.4,BP
GO:0042633,hair cycle,128,3,2.14,0.36266,1,0.7244096302382909,1.4,BP
GO:0006809,nitric oxide biosynthetic process,76,2,1.27,0.36457,1,0.7244096302382909,1.57,BP
GO:0071347,cellular response to interleukin-1,76,2,1.27,0.36457,1,0.7244096302382909,1.57,BP
GO:0048534,hematopoietic or lymphoid organ developm...,972,18,16.28,0.36484,1,0.7244096302382909,1.11,BP
GO:0070302,regulation of stress-activated protein k...,237,5,3.97,0.36515,1,0.7244096302382909,1.26,BP
GO:1903531,negative regulation of secretion by cell,237,5,3.97,0.36515,1,0.7244096302382909,1.26,BP
GO:0002520,immune system development,1030,19,17.25,0.36577,1,0.7244096302382909,1.1,BP
GO:0002347,response to tumor cell,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0007263,nitric oxide mediated signal transductio...,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0007549,dosage compensation,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0010971,positive regulation of G2/M transition o...,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0014829,vascular smooth muscle contraction,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0030970,"retrograde protein transport, ER to cyto...",27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0031342,negative regulation of cell killing,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0033014,tetrapyrrole biosynthetic process,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0034067,protein localization to Golgi apparatus,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0035812,renal sodium excretion,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0035987,endodermal cell differentiation,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0039694,viral RNA genome replication,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0045736,negative regulation of cyclin-dependent ...,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0051125,regulation of actin nucleation,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0055069,zinc ion homeostasis,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0060008,Sertoli cell differentiation,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0060343,trabecula formation,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0071402,cellular response to lipoprotein particl...,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0071624,positive regulation of granulocyte chemo...,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:1901185,negative regulation of ERBB signaling pa...,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:1903010,regulation of bone development,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:1903513,endoplasmic reticulum to cytosol transpo...,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:1905144,response to acetylcholine,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:1905145,cellular response to acetylcholine,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:1905523,positive regulation of macrophage migrat...,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:2000727,positive regulation of cardiac muscle ce...,27,1,0.45,0.36642,1,0.7244096302382909,2.22,BP
GO:0001525,angiogenesis,517,10,8.66,0.36689,1,0.7248000984413453,1.15,BP
GO:0014065,phosphatidylinositol 3-kinase signaling,129,3,2.16,0.36722,1,0.7248000984413453,1.39,BP
GO:0035195,gene silencing by miRNA,129,3,2.16,0.36722,1,0.7248000984413453,1.39,BP
GO:0051092,positive regulation of NF-kappaB transcr...,129,3,2.16,0.36722,1,0.7248000984413453,1.39,BP
GO:0031098,stress-activated protein kinase signalin...,293,6,4.91,0.36758,1,0.7252131857318573,1.22,BP
GO:0016485,protein processing,238,5,3.99,0.36846,1,0.7266514426229508,1.25,BP
GO:0014855,striated muscle cell proliferation,77,2,1.29,0.37059,1,0.7296559247135842,1.55,BP
GO:0055021,regulation of cardiac muscle tissue grow...,77,2,1.29,0.37059,1,0.7296559247135842,1.55,BP
GO:0072332,intrinsic apoptotic signaling pathway by...,77,2,1.29,0.37059,1,0.7296559247135842,1.55,BP
GO:1901224,positive regulation of NIK/NF-kappaB sig...,77,2,1.29,0.37059,1,0.7296559247135842,1.55,BP
GO:0051101,regulation of DNA binding,130,3,2.18,0.37178,1,0.7311014957090315,1.38,BP
GO:1901343,negative regulation of vasculature devel...,130,3,2.18,0.37178,1,0.7311014957090315,1.38,BP
GO:0015850,organic hydroxy compound transport,239,5,4,0.37178,1,0.7311014957090315,1.25,BP
GO:0007507,heart development,634,12,10.62,0.37429,1,0.7312843530834341,1.13,BP
GO:0002822,regulation of adaptive immune response b...,185,4,3.1,0.37514,1,0.7312843530834341,1.29,BP
GO:0030193,regulation of blood coagulation,78,2,1.31,0.37658,1,0.7312843530834341,1.53,BP
GO:0032729,positive regulation of interferon-gamma ...,78,2,1.31,0.37658,1,0.7312843530834341,1.53,BP
GO:0034644,cellular response to UV,78,2,1.31,0.37658,1,0.7312843530834341,1.53,BP
GO:0045471,response to ethanol,78,2,1.31,0.37658,1,0.7312843530834341,1.53,BP
GO:0051966,"regulation of synaptic transmission, glu...",78,2,1.31,0.37658,1,0.7312843530834341,1.53,BP
GO:1901606,alpha-amino acid catabolic process,78,2,1.31,0.37658,1,0.7312843530834341,1.53,BP
GO:0006929,substrate-dependent cell migration,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0021952,central nervous system projection neuron...,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0030878,thyroid gland development,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0031440,regulation of mRNA 3'-end processing,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0032369,negative regulation of lipid transport,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0032891,negative regulation of organic acid tran...,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0032925,regulation of activin receptor signaling...,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0033198,response to ATP,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0035335,peptidyl-tyrosine dephosphorylation,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0045332,phospholipid translocation,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0045408,regulation of interleukin-6 biosynthetic...,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0045724,positive regulation of cilium assembly,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0045780,positive regulation of bone resorption,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0045822,negative regulation of heart contraction,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0045956,positive regulation of calcium ion-depen...,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0046852,positive regulation of bone remodeling,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0050849,negative regulation of calcium-mediated ...,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0051194,positive regulation of cofactor metaboli...,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0051354,negative regulation of oxidoreductase ac...,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0051446,positive regulation of meiotic cell cycl...,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0060219,camera-type eye photoreceptor cell diffe...,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0060765,regulation of androgen receptor signalin...,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0061050,regulation of cell growth involved in ca...,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0061217,regulation of mesonephros development,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0072576,liver morphogenesis,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0090103,cochlea morphogenesis,28,1,0.47,0.37704,1,0.7312843530834341,2.13,BP
GO:0045321,leukocyte activation,866,16,14.51,0.37985,1,0.7364376309427881,1.1,BP
GO:0001508,action potential,132,3,2.21,0.38087,1,0.7378206280193236,1.36,BP
GO:1901568,fatty acid derivative metabolic process,132,3,2.21,0.38087,1,0.7378206280193236,1.36,BP
GO:0032088,negative regulation of NF-kappaB transcr...,79,2,1.32,0.38255,1,0.7401811821471653,1.52,BP
GO:0048663,neuron fate commitment,79,2,1.32,0.38255,1,0.7401811821471653,1.52,BP
GO:1900046,regulation of hemostasis,79,2,1.32,0.38255,1,0.7401811821471653,1.52,BP
GO:0000122,negative regulation of transcription by ...,869,16,14.56,0.38511,1,0.7412616970658208,1.1,BP
GO:1902850,microtubule cytoskeleton organization in...,133,3,2.23,0.38541,1,0.7412616970658208,1.35,BP
GO:0006109,regulation of carbohydrate metabolic pro...,188,4,3.15,0.38652,1,0.7412616970658208,1.27,BP
GO:0005979,regulation of glycogen biosynthetic proc...,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0006376,mRNA splice site selection,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0007007,inner mitochondrial membrane organizatio...,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0010800,positive regulation of peptidyl-threonin...,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0010962,regulation of glucan biosynthetic proces...,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0030149,sphingolipid catabolic process,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0033273,response to vitamin,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0034204,lipid translocation,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0034508,centromere complex assembly,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0042119,neutrophil activation,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0042226,interleukin-6 biosynthetic process,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0043032,positive regulation of macrophage activa...,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0050820,positive regulation of coagulation,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0051984,positive regulation of chromosome segreg...,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0060384,innervation,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0071480,cellular response to gamma radiation,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0071880,adenylate cyclase-activating adrenergic ...,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0090181,regulation of cholesterol metabolic proc...,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0098698,postsynaptic specialization assembly,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:1900027,regulation of ruffle assembly,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:1901018,positive regulation of potassium ion tra...,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:1902042,negative regulation of extrinsic apoptot...,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:1903861,positive regulation of dendrite extensio...,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:1904031,positive regulation of cyclin-dependent ...,29,1,0.49,0.38749,1,0.7412616970658208,2.04,BP
GO:0006919,activation of cysteine-type endopeptidas...,80,2,1.34,0.38850,1,0.7412616970658208,1.49,BP
GO:0010923,negative regulation of phosphatase activ...,80,2,1.34,0.38850,1,0.7412616970658208,1.49,BP
GO:0034637,cellular carbohydrate biosynthetic proce...,80,2,1.34,0.38850,1,0.7412616970658208,1.49,BP
GO:0043154,negative regulation of cysteine-type end...,80,2,1.34,0.38850,1,0.7412616970658208,1.49,BP
GO:0044272,sulfur compound biosynthetic process,80,2,1.34,0.38850,1,0.7412616970658208,1.49,BP
GO:0046209,nitric oxide metabolic process,80,2,1.34,0.38850,1,0.7412616970658208,1.49,BP
GO:0050688,regulation of defense response to virus,80,2,1.34,0.38850,1,0.7412616970658208,1.49,BP
GO:0051785,positive regulation of nuclear division,80,2,1.34,0.38850,1,0.7412616970658208,1.49,BP
GO:0061025,membrane fusion,134,3,2.24,0.38994,1,0.7437143400713436,1.34,BP
GO:0007269,neurotransmitter secretion,189,4,3.17,0.39031,1,0.7438303841584157,1.26,BP
GO:0050870,positive regulation of T cell activation,189,4,3.17,0.39031,1,0.7438303841584157,1.26,BP
GO:0060326,cell chemotaxis,301,6,5.04,0.39145,1,0.7446715052508752,1.19,BP
GO:0046777,protein autophosphorylation,245,5,4.1,0.39169,1,0.7446715052508752,1.22,BP
GO:0099643,signal release from synapse,190,4,3.18,0.39409,1,0.7446715052508752,1.26,BP
GO:0006664,glycolipid metabolic process,81,2,1.36,0.39443,1,0.7446715052508752,1.47,BP
GO:0032479,regulation of type I interferon producti...,81,2,1.36,0.39443,1,0.7446715052508752,1.47,BP
GO:0033143,regulation of intracellular steroid horm...,81,2,1.36,0.39443,1,0.7446715052508752,1.47,BP
GO:0038034,signal transduction in absence of ligand,81,2,1.36,0.39443,1,0.7446715052508752,1.47,BP
GO:0043279,response to alkaloid,81,2,1.36,0.39443,1,0.7446715052508752,1.47,BP
GO:0048747,muscle fiber development,81,2,1.36,0.39443,1,0.7446715052508752,1.47,BP
GO:0050805,negative regulation of synaptic transmis...,81,2,1.36,0.39443,1,0.7446715052508752,1.47,BP
GO:0070613,regulation of protein processing,81,2,1.36,0.39443,1,0.7446715052508752,1.47,BP
GO:0097192,extrinsic apoptotic signaling pathway in...,81,2,1.36,0.39443,1,0.7446715052508752,1.47,BP
GO:0035194,posttranscriptional gene silencing by RN...,135,3,2.26,0.39446,1,0.7446715052508752,1.33,BP
GO:1901655,cellular response to ketone,135,3,2.26,0.39446,1,0.7446715052508752,1.33,BP
GO:1902806,regulation of cell cycle G1/S phase tran...,135,3,2.26,0.39446,1,0.7446715052508752,1.33,BP
GO:0051091,positive regulation of DNA-binding trans...,246,5,4.12,0.39500,1,0.7446715052508752,1.21,BP
GO:0006836,neurotransmitter transport,303,6,5.08,0.39742,1,0.7446715052508752,1.18,BP
GO:0046942,carboxylic acid transport,303,6,5.08,0.39742,1,0.7446715052508752,1.18,BP
GO:0000038,very long-chain fatty acid metabolic pro...,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0000132,establishment of mitotic spindle orienta...,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0001556,oocyte maturation,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0001958,endochondral ossification,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0006336,DNA replication-independent nucleosome a...,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0010390,histone monoubiquitination,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0010922,positive regulation of phosphatase activ...,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0016242,negative regulation of macroautophagy,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0031295,T cell costimulation,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0031297,replication fork processing,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0034260,negative regulation of GTPase activity,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0035066,positive regulation of histone acetylati...,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0036075,replacement ossification,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0042168,heme metabolic process,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0042481,regulation of odontogenesis,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0042533,tumor necrosis factor biosynthetic proce...,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0042534,regulation of tumor necrosis factor bios...,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0048384,retinoic acid receptor signaling pathway,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0051569,regulation of histone H3-K4 methylation,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0055022,negative regulation of cardiac muscle ti...,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0060571,morphogenesis of an epithelial fold,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0061117,negative regulation of heart growth,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0070266,necroptotic process,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0070979,protein K11-linked ubiquitination,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0071354,cellular response to interleukin-6,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:1900117,regulation of execution phase of apoptos...,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:1902253,regulation of intrinsic apoptotic signal...,30,1,0.5,0.39776,1,0.7446715052508752,2,BP
GO:0046328,regulation of JNK cascade,191,4,3.2,0.39787,1,0.7446715052508752,1.25,BP
GO:0022406,membrane docking,82,2,1.37,0.40032,1,0.747680605355064,1.46,BP
GO:0046364,monosaccharide biosynthetic process,82,2,1.37,0.40032,1,0.747680605355064,1.46,BP
GO:0046530,photoreceptor cell differentiation,82,2,1.37,0.40032,1,0.747680605355064,1.46,BP
GO:0050818,regulation of coagulation,82,2,1.37,0.40032,1,0.747680605355064,1.46,BP
GO:1903509,liposaccharide metabolic process,82,2,1.37,0.40032,1,0.747680605355064,1.46,BP
GO:0015849,organic acid transport,304,6,5.09,0.40041,1,0.747680605355064,1.18,BP
GO:0031023,microtubule organizing center organizati...,137,3,2.29,0.40347,1,0.7515710260336906,1.31,BP
GO:0042471,ear morphogenesis,137,3,2.29,0.40347,1,0.7515710260336906,1.31,BP
GO:0009605,response to external stimulus,2399,42,40.18,0.40424,1,0.7515710260336906,1.05,BP
GO:0055002,striated muscle cell development,193,4,3.23,0.40542,1,0.7515710260336906,1.24,BP
GO:0006942,regulation of striated muscle contractio...,83,2,1.39,0.40619,1,0.7515710260336906,1.44,BP
GO:1903317,regulation of protein maturation,83,2,1.39,0.40619,1,0.7515710260336906,1.44,BP
GO:0002230,positive regulation of defense response ...,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0002428,antigen processing and presentation of p...,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0007602,phototransduction,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0009584,detection of visible light,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0010043,response to zinc ion,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0010758,regulation of macrophage chemotaxis,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0032232,negative regulation of actin filament bu...,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0032816,positive regulation of natural killer ce...,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0032967,positive regulation of collagen biosynth...,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0034110,regulation of homotypic cell-cell adhesi...,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0034724,DNA replication-independent nucleosome o...,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0043302,positive regulation of leukocyte degranu...,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0044062,regulation of excretion,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0045932,negative regulation of muscle contractio...,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0050999,regulation of nitric-oxide synthase acti...,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0060632,regulation of microtubule-based movement,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0071875,adrenergic receptor signaling pathway,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0086010,membrane depolarization during action po...,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0090022,regulation of neutrophil chemotaxis,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0098884,postsynaptic neurotransmitter receptor i...,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0099633,protein localization to postsynaptic spe...,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0099645,neurotransmitter receptor localization t...,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0140239,postsynaptic endocytosis,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:1901020,negative regulation of calcium ion trans...,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:1901661,quinone metabolic process,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:1905476,negative regulation of protein localizat...,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:2001014,regulation of skeletal muscle cell diffe...,31,1,0.52,0.40787,1,0.7515710260336906,1.92,BP
GO:0009411,response to UV,138,3,2.31,0.40796,1,0.7515710260336906,1.3,BP
GO:0016441,posttranscriptional gene silencing,138,3,2.31,0.40796,1,0.7515710260336906,1.3,BP
GO:0045087,innate immune response,710,13,11.89,0.41138,1,0.7575815384615385,1.09,BP
GO:0044728,DNA methylation or demethylation,84,2,1.41,0.41203,1,0.7576187848681697,1.42,BP
GO:0045913,positive regulation of carbohydrate meta...,84,2,1.41,0.41203,1,0.7576187848681697,1.42,BP
GO:0060420,regulation of heart growth,84,2,1.41,0.41203,1,0.7576187848681697,1.42,BP
GO:1903321,negative regulation of protein modificat...,84,2,1.41,0.41203,1,0.7576187848681697,1.42,BP
GO:0044843,cell cycle G1/S phase transition,195,4,3.27,0.41295,1,0.759020397249809,1.22,BP
GO:2001141,regulation of RNA biosynthetic process,2822,49,47.27,0.41610,1,0.7607620885357549,1.04,BP
GO:0006006,glucose metabolic process,196,4,3.28,0.41671,1,0.7607620885357549,1.22,BP
GO:0016051,carbohydrate biosynthetic process,196,4,3.28,0.41671,1,0.7607620885357549,1.22,BP
GO:0002828,regulation of type 2 immune response,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:0002861,regulation of inflammatory response to a...,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:0003081,regulation of systemic arterial blood pr...,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:0010453,regulation of cell fate commitment,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:0019884,antigen processing and presentation of e...,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:0031294,lymphocyte costimulation,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:0032689,negative regulation of interferon-gamma ...,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:0036475,neuron death in response to oxidative st...,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:0043457,regulation of cellular respiration,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:0045047,protein targeting to ER,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:0046466,membrane lipid catabolic process,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:0060306,regulation of membrane repolarization,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:0060561,apoptotic process involved in morphogene...,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:0070741,response to interleukin-6,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:1900181,negative regulation of protein localizat...,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:1903203,regulation of oxidative stress-induced n...,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:1903859,regulation of dendrite extension,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:2000191,regulation of fatty acid transport,32,1,0.54,0.41780,1,0.7607620885357549,1.85,BP
GO:0014032,neural crest cell development,85,2,1.42,0.41785,1,0.7607620885357549,1.41,BP
GO:0032526,response to retinoic acid,85,2,1.42,0.41785,1,0.7607620885357549,1.41,BP
GO:0032606,type I interferon production,85,2,1.42,0.41785,1,0.7607620885357549,1.41,BP
GO:1903363,negative regulation of cellular protein ...,85,2,1.42,0.41785,1,0.7607620885357549,1.41,BP
GO:0007423,sensory organ development,598,11,10.02,0.41903,1,0.7626219213313162,1.1,BP
GO:0070372,regulation of ERK1 and ERK2 cascade,311,6,5.21,0.42126,1,0.7663009977324263,1.15,BP
GO:0015698,inorganic anion transport,141,3,2.36,0.42137,1,0.7663009977324263,1.27,BP
GO:0009790,embryo development,1241,22,20.79,0.42303,1,0.7690292255383454,1.06,BP
GO:0002275,myeloid cell activation involved in immu...,86,2,1.44,0.42363,1,0.7692481358490566,1.39,BP
GO:0014910,regulation of smooth muscle cell migrati...,86,2,1.44,0.42363,1,0.7692481358490566,1.39,BP
GO:0034103,regulation of tissue remodeling,86,2,1.44,0.42363,1,0.7692481358490566,1.39,BP
GO:0051254,positive regulation of RNA metabolic pro...,1652,29,27.67,0.42392,1,0.7694121372031663,1.05,BP
GO:0006469,negative regulation of protein kinase ac...,198,4,3.32,0.42420,1,0.7694121372031663,1.2,BP
GO:0007519,skeletal muscle tissue development,198,4,3.32,0.42420,1,0.7694121372031663,1.2,BP
GO:0060541,respiratory system development,255,5,4.27,0.42474,1,0.7694341211667913,1.17,BP
GO:0048871,multicellular organismal homeostasis,485,9,8.12,0.42503,1,0.7694341211667913,1.11,BP
GO:0007292,female gamete generation,142,3,2.38,0.42582,1,0.7694341211667913,1.26,BP
GO:0045017,glycerolipid biosynthetic process,142,3,2.38,0.42582,1,0.7694341211667913,1.26,BP
GO:0001706,endoderm formation,33,1,0.55,0.42757,1,0.7694341211667913,1.82,BP
GO:0006084,acetyl-CoA metabolic process,33,1,0.55,0.42757,1,0.7694341211667913,1.82,BP
GO:0007026,negative regulation of microtubule depol...,33,1,0.55,0.42757,1,0.7694341211667913,1.82,BP
GO:0017004,cytochrome complex assembly,33,1,0.55,0.42757,1,0.7694341211667913,1.82,BP
GO:0032660,regulation of interleukin-17 production,33,1,0.55,0.42757,1,0.7694341211667913,1.82,BP
GO:0032743,positive regulation of interleukin-2 pro...,33,1,0.55,0.42757,1,0.7694341211667913,1.82,BP
GO:0035094,response to nicotine,33,1,0.55,0.42757,1,0.7694341211667913,1.82,BP
GO:0040001,establishment of mitotic spindle localiz...,33,1,0.55,0.42757,1,0.7694341211667913,1.82,BP
GO:0045066,regulatory T cell differentiation,33,1,0.55,0.42757,1,0.7694341211667913,1.82,BP
GO:0045879,negative regulation of smoothened signal...,33,1,0.55,0.42757,1,0.7694341211667913,1.82,BP
GO:0046596,regulation of viral entry into host cell,33,1,0.55,0.42757,1,0.7694341211667913,1.82,BP
GO:0061157,mRNA destabilization,33,1,0.55,0.42757,1,0.7694341211667913,1.82,BP
GO:0086091,regulation of heart rate by cardiac cond...,33,1,0.55,0.42757,1,0.7694341211667913,1.82,BP
GO:1901099,negative regulation of signal transducti...,33,1,0.55,0.42757,1,0.7694341211667913,1.82,BP
GO:1901976,regulation of cell cycle checkpoint,33,1,0.55,0.42757,1,0.7694341211667913,1.82,BP
GO:1902624,positive regulation of neutrophil migrat...,33,1,0.55,0.42757,1,0.7694341211667913,1.82,BP
GO:2001240,negative regulation of extrinsic apoptot...,33,1,0.55,0.42757,1,0.7694341211667913,1.82,BP
GO:0060079,excitatory postsynaptic potential,87,2,1.46,0.42939,1,0.7718433619723571,1.37,BP
GO:0070509,calcium ion import,87,2,1.46,0.42939,1,0.7718433619723571,1.37,BP
GO:2000117,negative regulation of cysteine-type end...,87,2,1.46,0.42939,1,0.7718433619723571,1.37,BP
GO:0035637,multicellular organismal signaling,143,3,2.4,0.43026,1,0.7725414626865671,1.25,BP
GO:0106106,cold-induced thermogenesis,143,3,2.4,0.43026,1,0.7725414626865671,1.25,BP
GO:0120161,regulation of cold-induced thermogenesis,143,3,2.4,0.43026,1,0.7725414626865671,1.25,BP
GO:0050679,positive regulation of epithelial cell p...,200,4,3.35,0.43168,1,0.7747445546030564,1.19,BP
GO:0006935,chemotaxis,604,11,10.12,0.43189,1,0.7747445546030564,1.09,BP
GO:0051249,regulation of lymphocyte activation,430,8,7.2,0.43197,1,0.7747445546030564,1.11,BP
GO:0006357,regulation of transcription by RNA polym...,2012,35,33.7,0.43282,1,0.7759798211624441,1.04,BP
GO:0001568,blood vessel development,722,13,12.09,0.43496,1,0.776832363367799,1.08,BP
GO:0019217,regulation of fatty acid metabolic proce...,88,2,1.47,0.43511,1,0.776832363367799,1.36,BP
GO:0032945,negative regulation of mononuclear cell ...,88,2,1.47,0.43511,1,0.776832363367799,1.36,BP
GO:0050672,negative regulation of lymphocyte prolif...,88,2,1.47,0.43511,1,0.776832363367799,1.36,BP
GO:0002819,regulation of adaptive immune response,201,4,3.37,0.43541,1,0.776832363367799,1.19,BP
GO:0002446,neutrophil mediated immunity,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0006356,regulation of transcription by RNA polym...,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0007274,neuromuscular synaptic transmission,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0010543,regulation of platelet activation,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0010714,positive regulation of collagen metaboli...,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0015804,neutral amino acid transport,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0019076,viral release from host cell,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0035116,embryonic hindlimb morphogenesis,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0035890,exit from host,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0035891,exit from host cell,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0042832,defense response to protozoan,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0048194,Golgi vesicle budding,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0048240,sperm capacitation,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0052126,movement in host environment,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0052192,movement in environment of other organis...,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0071539,protein localization to centrosome,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0097242,amyloid-beta clearance,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0099068,postsynapse assembly,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:2000758,positive regulation of peptidyl-lysine a...,34,1,0.57,0.43717,1,0.776832363367799,1.75,BP
GO:0042330,taxis,607,11,10.17,0.43832,1,0.7783010479704796,1.08,BP
GO:0071396,cellular response to lipid,607,11,10.17,0.43832,1,0.7783010479704796,1.08,BP
GO:0007229,integrin-mediated signaling pathway,89,2,1.49,0.44080,1,0.7812022246455834,1.34,BP
GO:0033077,T cell differentiation in thymus,89,2,1.49,0.44080,1,0.7812022246455834,1.34,BP
GO:0051149,positive regulation of muscle cell diffe...,89,2,1.49,0.44080,1,0.7812022246455834,1.34,BP
GO:1903035,negative regulation of response to wound...,89,2,1.49,0.44080,1,0.7812022246455834,1.34,BP
GO:0003006,developmental process involved in reprod...,784,14,13.13,0.44182,1,0.7812022246455834,1.07,BP
GO:0002065,columnar/cuboidal epithelial cell differ...,146,3,2.45,0.44349,1,0.7812022246455834,1.22,BP
GO:1903900,regulation of viral life cycle,146,3,2.45,0.44349,1,0.7812022246455834,1.22,BP
GO:0048513,animal organ development,3502,60,58.66,0.44569,1,0.7812022246455834,1.02,BP
GO:0014031,mesenchymal cell development,90,2,1.51,0.44646,1,0.7812022246455834,1.32,BP
GO:0045833,negative regulation of lipid metabolic p...,90,2,1.51,0.44646,1,0.7812022246455834,1.32,BP
GO:1903524,positive regulation of blood circulation,90,2,1.51,0.44646,1,0.7812022246455834,1.32,BP
GO:1904018,positive regulation of vasculature devel...,204,4,3.42,0.44655,1,0.7812022246455834,1.17,BP
GO:0002475,antigen processing and presentation via ...,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0002701,negative regulation of production of mol...,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0007143,female meiotic nuclear division,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0008045,motor neuron axon guidance,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0009954,proximal/distal pattern formation,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0016572,histone phosphorylation,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0019432,triglyceride biosynthetic process,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0031338,regulation of vesicle fusion,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0032435,negative regulation of proteasomal ubiqu...,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0033866,nucleoside bisphosphate biosynthetic pro...,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0034030,ribonucleoside bisphosphate biosynthetic...,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0034033,purine nucleoside bisphosphate biosynthe...,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0034122,negative regulation of toll-like recepto...,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0035909,aorta morphogenesis,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0038084,vascular endothelial growth factor signa...,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0045686,negative regulation of glial cell differ...,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0046320,regulation of fatty acid oxidation,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0046461,neutral lipid catabolic process,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0046464,acylglycerol catabolic process,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0050779,RNA destabilization,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0051567,histone H3-K9 methylation,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0055083,monovalent inorganic anion homeostasis,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0055090,acylglycerol homeostasis,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0060292,long-term synaptic depression,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0070328,triglyceride homeostasis,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0090322,regulation of superoxide metabolic proce...,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:1902116,negative regulation of organelle assembl...,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:1905508,protein localization to microtubule orga...,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:2000036,regulation of stem cell population maint...,35,1,0.59,0.44661,1,0.7812022246455834,1.69,BP
GO:0035821,modification of morphology or physiology...,147,3,2.46,0.44788,1,0.7828545441336724,1.22,BP
GO:0045667,regulation of osteoblast differentiation,147,3,2.46,0.44788,1,0.7828545441336724,1.22,BP
GO:0007254,JNK cascade,205,4,3.43,0.45025,1,0.7864257713248639,1.17,BP
GO:1903039,positive regulation of leukocyte cell-ce...,205,4,3.43,0.45025,1,0.7864257713248639,1.17,BP
GO:0006497,protein lipidation,91,2,1.52,0.45209,1,0.7879995689655173,1.32,BP
GO:0019226,transmission of nerve impulse,91,2,1.52,0.45209,1,0.7879995689655173,1.32,BP
GO:0048864,stem cell development,91,2,1.52,0.45209,1,0.7879995689655173,1.32,BP
GO:0008643,carbohydrate transport,148,3,2.48,0.45225,1,0.7879995689655173,1.21,BP
GO:0042133,neurotransmitter metabolic process,148,3,2.48,0.45225,1,0.7879995689655173,1.21,BP
GO:0007286,spermatid development,206,4,3.45,0.45394,1,0.7879995689655173,1.16,BP
GO:0071560,cellular response to transforming growth...,206,4,3.45,0.45394,1,0.7879995689655173,1.16,BP
GO:0000184,nuclear-transcribed mRNA catabolic proce...,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:0001963,"synaptic transmission, dopaminergic",36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:0006383,transcription by RNA polymerase III,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:0006739,NADP metabolic process,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:0006972,hyperosmotic response,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:0031114,regulation of microtubule depolymerizati...,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:0032205,negative regulation of telomere maintena...,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:0032735,positive regulation of interleukin-12 pr...,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:0034381,plasma lipoprotein particle clearance,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:0035886,vascular smooth muscle cell differentiat...,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:0042311,vasodilation,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:0043516,"regulation of DNA damage response, signa...",36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:0048710,regulation of astrocyte differentiation,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:0051294,establishment of spindle orientation,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:0070873,regulation of glycogen metabolic process,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:0072599,establishment of protein localization to...,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:1903959,regulation of anion transmembrane transp...,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:1904037,positive regulation of epithelial cell a...,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:1905209,positive regulation of cardiocyte differ...,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:1990089,response to nerve growth factor,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:1990090,cellular response to nerve growth factor...,36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:2000516,"positive regulation of CD4-positive, alp...",36,1,0.6,0.45590,1,0.7879995689655173,1.67,BP
GO:0018105,peptidyl-serine phosphorylation,323,6,5.41,0.45676,1,0.7888267478510028,1.11,BP
GO:0051251,positive regulation of lymphocyte activa...,265,5,4.44,0.45745,1,0.7888267478510028,1.13,BP
GO:0043112,receptor metabolic process,207,4,3.47,0.45762,1,0.7888267478510028,1.15,BP
GO:0060538,skeletal muscle organ development,207,4,3.47,0.45762,1,0.7888267478510028,1.15,BP
GO:0009063,cellular amino acid catabolic process,92,2,1.54,0.45769,1,0.7888267478510028,1.3,BP
GO:0014033,neural crest cell differentiation,92,2,1.54,0.45769,1,0.7888267478510028,1.3,BP
GO:0042770,signal transduction in response to DNA d...,92,2,1.54,0.45769,1,0.7888267478510028,1.3,BP
GO:0043535,regulation of blood vessel endothelial c...,92,2,1.54,0.45769,1,0.7888267478510028,1.3,BP
GO:0035239,tube morphogenesis,911,16,15.26,0.45921,1,0.7911630934479055,1.05,BP
GO:0006355,"regulation of transcription, DNA-templat...",2805,48,46.98,0.46012,1,0.7924471868289191,1.02,BP
GO:0050866,negative regulation of cell activation,208,4,3.48,0.46130,1,0.7939111587982832,1.15,BP
GO:0097529,myeloid leukocyte migration,208,4,3.48,0.46130,1,0.7939111587982832,1.15,BP
GO:0014909,smooth muscle cell migration,93,2,1.56,0.46325,1,0.7954939068610025,1.28,BP
GO:0070664,negative regulation of leukocyte prolife...,93,2,1.56,0.46325,1,0.7954939068610025,1.28,BP
GO:0001562,response to protozoan,37,1,0.62,0.46503,1,0.7954939068610025,1.61,BP
GO:0002483,antigen processing and presentation of e...,37,1,0.62,0.46503,1,0.7954939068610025,1.61,BP
GO:0014003,oligodendrocyte development,37,1,0.62,0.46503,1,0.7954939068610025,1.61,BP
GO:0019885,antigen processing and presentation of e...,37,1,0.62,0.46503,1,0.7954939068610025,1.61,BP
GO:0031279,regulation of cyclase activity,37,1,0.62,0.46503,1,0.7954939068610025,1.61,BP
GO:0032733,positive regulation of interleukin-10 pr...,37,1,0.62,0.46503,1,0.7954939068610025,1.61,BP
GO:0033260,nuclear DNA replication,37,1,0.62,0.46503,1,0.7954939068610025,1.61,BP
GO:0043628,ncRNA 3'-end processing,37,1,0.62,0.46503,1,0.7954939068610025,1.61,BP
GO:0045601,regulation of endothelial cell different...,37,1,0.62,0.46503,1,0.7954939068610025,1.61,BP
GO:0048147,negative regulation of fibroblast prolif...,37,1,0.62,0.46503,1,0.7954939068610025,1.61,BP
GO:0071398,cellular response to fatty acid,37,1,0.62,0.46503,1,0.7954939068610025,1.61,BP
GO:0072348,sulfur compound transport,37,1,0.62,0.46503,1,0.7954939068610025,1.61,BP
GO:0086065,cell communication involved in cardiac c...,37,1,0.62,0.46503,1,0.7954939068610025,1.61,BP
GO:1901385,regulation of voltage-gated calcium chan...,37,1,0.62,0.46503,1,0.7954939068610025,1.61,BP
GO:1903792,negative regulation of anion transport,37,1,0.62,0.46503,1,0.7954939068610025,1.61,BP
GO:2000058,regulation of ubiquitin-dependent protei...,151,3,2.53,0.46528,1,0.7956387206823028,1.19,BP
GO:0007281,germ cell development,326,6,5.46,0.46556,1,0.7958347140319716,1.1,BP
GO:1903506,regulation of nucleic acid-templated tra...,2813,48,47.12,0.46855,1,0.8002019723306136,1.02,BP
GO:0071559,response to transforming growth factor b...,210,4,3.52,0.46862,1,0.8002019723306136,1.14,BP
GO:0042116,macrophage activation,94,2,1.57,0.46878,1,0.8002019723306136,1.27,BP
GO:0048477,oogenesis,94,2,1.57,0.46878,1,0.8002019723306136,1.27,BP
GO:0030217,T cell differentiation,269,5,4.51,0.47040,1,0.8019098243148278,1.11,BP
GO:0070371,ERK1 and ERK2 cascade,328,6,5.49,0.47141,1,0.8019098243148278,1.09,BP
GO:0001503,ossification,387,7,6.48,0.47200,1,0.8019098243148278,1.08,BP
GO:0007623,circadian rhythm,211,4,3.53,0.47227,1,0.8019098243148278,1.13,BP
GO:0000096,sulfur amino acid metabolic process,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0001953,negative regulation of cell-matrix adhes...,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0006284,base-excision repair,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0006778,porphyrin-containing compound metabolic ...,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0006903,vesicle targeting,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0010762,regulation of fibroblast migration,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0032392,DNA geometric change,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0032885,regulation of polysaccharide biosyntheti...,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0042092,type 2 immune response,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0042149,cellular response to glucose starvation,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0042554,superoxide anion generation,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0045005,DNA-dependent DNA replication maintenanc...,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0046460,neutral lipid biosynthetic process,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0046463,acylglycerol biosynthetic process,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0046640,regulation of alpha-beta T cell prolifer...,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0071158,positive regulation of cell cycle arrest,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0071320,cellular response to cAMP,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0071514,genetic imprinting,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:2001025,positive regulation of response to drug,38,1,0.64,0.47400,1,0.8019098243148278,1.56,BP
GO:0001570,vasculogenesis,95,2,1.59,0.47428,1,0.8019098243148278,1.26,BP
GO:0045069,regulation of viral genome replication,95,2,1.59,0.47428,1,0.8019098243148278,1.26,BP
GO:0060968,regulation of gene silencing,95,2,1.59,0.47428,1,0.8019098243148278,1.26,BP
GO:1902749,regulation of cell cycle G2/M phase tran...,95,2,1.59,0.47428,1,0.8019098243148278,1.26,BP
GO:0030097,hemopoiesis,922,16,15.44,0.47859,1,0.80891291886196,1.04,BP
GO:0019935,cyclic-nucleotide-mediated signaling,213,4,3.57,0.47954,1,0.8102340168539327,1.12,BP
GO:0042158,lipoprotein biosynthetic process,96,2,1.61,0.47974,1,0.8102874271674272,1.24,BP
GO:0002366,leukocyte activation involved in immune ...,272,5,4.56,0.48004,1,0.8105096421052632,1.1,BP
GO:0050709,negative regulation of protein secretion,155,3,2.6,0.48243,1,0.811518672720922,1.15,BP
GO:0071478,cellular response to radiation,155,3,2.6,0.48243,1,0.811518672720922,1.15,BP
GO:0002323,natural killer cell activation involved ...,39,1,0.65,0.48283,1,0.811518672720922,1.54,BP
GO:0016339,calcium-dependent cell-cell adhesion via...,39,1,0.65,0.48283,1,0.811518672720922,1.54,BP
GO:0019934,cGMP-mediated signaling,39,1,0.65,0.48283,1,0.811518672720922,1.54,BP
GO:0030521,androgen receptor signaling pathway,39,1,0.65,0.48283,1,0.811518672720922,1.54,BP
GO:0032781,positive regulation of ATPase activity,39,1,0.65,0.48283,1,0.811518672720922,1.54,BP
GO:0046456,icosanoid biosynthetic process,39,1,0.65,0.48283,1,0.811518672720922,1.54,BP
GO:0048741,skeletal muscle fiber development,39,1,0.65,0.48283,1,0.811518672720922,1.54,BP
GO:0060236,regulation of mitotic spindle organizati...,39,1,0.65,0.48283,1,0.811518672720922,1.54,BP
GO:0060251,regulation of glial cell proliferation,39,1,0.65,0.48283,1,0.811518672720922,1.54,BP
GO:1902229,regulation of intrinsic apoptotic signal...,39,1,0.65,0.48283,1,0.811518672720922,1.54,BP
GO:1902692,regulation of neuroblast proliferation,39,1,0.65,0.48283,1,0.811518672720922,1.54,BP
GO:0006304,DNA modification,97,2,1.62,0.48517,1,0.8137462669919833,1.23,BP
GO:0014066,regulation of phosphatidylinositol 3-kin...,97,2,1.62,0.48517,1,0.8137462669919833,1.23,BP
GO:0071482,cellular response to light stimulus,97,2,1.62,0.48517,1,0.8137462669919833,1.23,BP
GO:0099565,"chemical synaptic transmission, postsyna...",97,2,1.62,0.48517,1,0.8137462669919833,1.23,BP
GO:0120162,positive regulation of cold-induced ther...,97,2,1.62,0.48517,1,0.8137462669919833,1.23,BP
GO:0140029,exocytic process,97,2,1.62,0.48517,1,0.8137462669919833,1.23,BP
GO:0006974,cellular response to DNA damage stimulus,748,13,12.53,0.48586,1,0.8141026044568245,1.04,BP
GO:0002521,leukocyte differentiation,570,10,9.55,0.48589,1,0.8141026044568245,1.05,BP
GO:0050865,regulation of cell activation,570,10,9.55,0.48589,1,0.8141026044568245,1.05,BP
GO:0016054,organic acid catabolic process,215,4,3.6,0.48677,1,0.814725996521739,1.11,BP
GO:0046395,carboxylic acid catabolic process,215,4,3.6,0.48677,1,0.814725996521739,1.11,BP
GO:0048515,spermatid differentiation,215,4,3.6,0.48677,1,0.814725996521739,1.11,BP
GO:0009913,epidermal cell differentiation,216,4,3.62,0.49037,1,0.818106579038395,1.1,BP
GO:0045637,regulation of myeloid cell differentiati...,216,4,3.62,0.49037,1,0.818106579038395,1.1,BP
GO:2001237,negative regulation of extrinsic apoptot...,98,2,1.64,0.49056,1,0.818106579038395,1.22,BP
GO:0051250,negative regulation of lymphocyte activa...,157,3,2.63,0.49091,1,0.818106579038395,1.14,BP
GO:0007099,centriole replication,40,1,0.67,0.49151,1,0.818106579038395,1.49,BP
GO:0019883,antigen processing and presentation of e...,40,1,0.67,0.49151,1,0.818106579038395,1.49,BP
GO:0021696,cerebellar cortex morphogenesis,40,1,0.67,0.49151,1,0.818106579038395,1.49,BP
GO:0030225,macrophage differentiation,40,1,0.67,0.49151,1,0.818106579038395,1.49,BP
GO:0032620,interleukin-17 production,40,1,0.67,0.49151,1,0.818106579038395,1.49,BP
GO:0046627,negative regulation of insulin receptor ...,40,1,0.67,0.49151,1,0.818106579038395,1.49,BP
GO:0051968,positive regulation of synaptic transmis...,40,1,0.67,0.49151,1,0.818106579038395,1.49,BP
GO:0060071,"Wnt signaling pathway, planar cell polar...",40,1,0.67,0.49151,1,0.818106579038395,1.49,BP
GO:0071542,dopaminergic neuron differentiation,40,1,0.67,0.49151,1,0.818106579038395,1.49,BP
GO:0099590,neurotransmitter receptor internalizatio...,40,1,0.67,0.49151,1,0.818106579038395,1.49,BP
GO:0110111,negative regulation of animal organ morp...,40,1,0.67,0.49151,1,0.818106579038395,1.49,BP
GO:1905332,positive regulation of morphogenesis of ...,40,1,0.67,0.49151,1,0.818106579038395,1.49,BP
GO:0048646,anatomical structure formation involved ...,1168,20,19.56,0.49249,1,0.8194538264777048,1.02,BP
GO:0033993,response to lipid,811,14,13.58,0.49266,1,0.8194538264777048,1.03,BP
GO:0035265,organ growth,217,4,3.63,0.49396,1,0.8209459160696009,1.1,BP
GO:1990845,adaptive thermogenesis,158,3,2.65,0.49513,1,0.8209459160696009,1.13,BP
GO:0006641,triglyceride metabolic process,99,2,1.66,0.49591,1,0.8209459160696009,1.2,BP
GO:0043473,pigmentation,99,2,1.66,0.49591,1,0.8209459160696009,1.2,BP
GO:0045639,positive regulation of myeloid cell diff...,99,2,1.66,0.49591,1,0.8209459160696009,1.2,BP
GO:0002253,activation of immune response,396,7,6.63,0.49605,1,0.8209459160696009,1.06,BP
GO:0006302,double-strand break repair,218,4,3.65,0.49754,1,0.8209459160696009,1.1,BP
GO:0048015,phosphatidylinositol-mediated signaling,159,3,2.66,0.49932,1,0.8209459160696009,1.13,BP
GO:0006366,transcription by RNA polymerase II,2067,35,34.62,0.49943,1,0.8209459160696009,1.01,BP
GO:0002227,innate immune response in mucosa,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0003298,physiological muscle hypertrophy,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0003301,physiological cardiac muscle hypertrophy,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0006692,prostanoid metabolic process,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0006693,prostaglandin metabolic process,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0009409,response to cold,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0010470,regulation of gastrulation,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0031062,positive regulation of histone methylati...,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0033344,cholesterol efflux,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0033628,regulation of cell adhesion mediated by ...,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0038179,neurotrophin signaling pathway,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0046164,alcohol catabolic process,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0046633,alpha-beta T cell proliferation,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0046782,regulation of viral transcription,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0051154,negative regulation of striated muscle c...,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0051281,positive regulation of release of seques...,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0055026,negative regulation of cardiac muscle ti...,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0061049,cell growth involved in cardiac muscle c...,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0070884,regulation of calcineurin-NFAT signaling...,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0086009,membrane repolarization,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0097300,programmed necrotic cell death,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0098534,centriole assembly,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0098801,regulation of renal system process,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0106056,regulation of calcineurin-mediated signa...,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:1902622,regulation of neutrophil migration,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:1903170,negative regulation of calcium ion trans...,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:1903672,positive regulation of sprouting angioge...,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:1905953,negative regulation of lipid localizatio...,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:2000772,regulation of cellular senescence,41,1,0.69,0.50004,1,0.8209459160696009,1.45,BP
GO:0042445,hormone metabolic process,219,4,3.67,0.50110,1,0.8214982152588555,1.09,BP
GO:0043406,positive regulation of MAP kinase activi...,219,4,3.67,0.50110,1,0.8214982152588555,1.09,BP
GO:0006821,chloride transport,100,2,1.68,0.50123,1,0.8214982152588555,1.19,BP
GO:0035710,"CD4-positive, alpha-beta T cell activati...",100,2,1.68,0.50123,1,0.8214982152588555,1.19,BP
GO:0042102,positive regulation of T cell proliferat...,100,2,1.68,0.50123,1,0.8214982152588555,1.19,BP
GO:0008654,phospholipid biosynthetic process,160,3,2.68,0.50350,1,0.8246569094622191,1.12,BP
GO:0071383,cellular response to steroid hormone sti...,160,3,2.68,0.50350,1,0.8246569094622191,1.12,BP
GO:0055024,regulation of cardiac muscle tissue deve...,101,2,1.69,0.50652,1,0.8282211103588355,1.18,BP
GO:0006954,inflammatory response,699,12,11.71,0.50673,1,0.8282211103588355,1.02,BP
GO:0009755,hormone-mediated signaling pathway,161,3,2.7,0.50766,1,0.8282211103588355,1.11,BP
GO:0031214,biomineral tissue development,161,3,2.7,0.50766,1,0.8282211103588355,1.11,BP
GO:0001709,cell fate determination,42,1,0.7,0.50843,1,0.8282211103588355,1.43,BP
GO:0006687,glycosphingolipid metabolic process,42,1,0.7,0.50843,1,0.8282211103588355,1.43,BP
GO:0032459,regulation of protein oligomerization,42,1,0.7,0.50843,1,0.8282211103588355,1.43,BP
GO:0032768,regulation of monooxygenase activity,42,1,0.7,0.50843,1,0.8282211103588355,1.43,BP
GO:0034198,cellular response to amino acid starvati...,42,1,0.7,0.50843,1,0.8282211103588355,1.43,BP
GO:0038083,peptidyl-tyrosine autophosphorylation,42,1,0.7,0.50843,1,0.8282211103588355,1.43,BP
GO:0042398,cellular modified amino acid biosyntheti...,42,1,0.7,0.50843,1,0.8282211103588355,1.43,BP
GO:0045197,establishment or maintenance of epitheli...,42,1,0.7,0.50843,1,0.8282211103588355,1.43,BP
GO:0055023,positive regulation of cardiac muscle ti...,42,1,0.7,0.50843,1,0.8282211103588355,1.43,BP
GO:0090175,regulation of establishment of planar po...,42,1,0.7,0.50843,1,0.8282211103588355,1.43,BP
GO:1902742,apoptotic process involved in developmen...,42,1,0.7,0.50843,1,0.8282211103588355,1.43,BP
GO:1903523,negative regulation of blood circulation,42,1,0.7,0.50843,1,0.8282211103588355,1.43,BP
GO:0032102,negative regulation of response to exter...,341,6,5.71,0.50895,1,0.828787614213198,1.05,BP
GO:0008306,associative learning,102,2,1.71,0.51176,1,0.8320370675675676,1.17,BP
GO:0050886,endocrine process,102,2,1.71,0.51176,1,0.8320370675675676,1.17,BP
GO:0062014,negative regulation of small molecule me...,102,2,1.71,0.51176,1,0.8320370675675676,1.17,BP
GO:0048017,inositol lipid-mediated signaling,162,3,2.71,0.51181,1,0.8320370675675676,1.11,BP
GO:0051147,regulation of muscle cell differentiatio...,162,3,2.71,0.51181,1,0.8320370675675676,1.11,BP
GO:0032774,RNA biosynthetic process,2918,49,48.88,0.51609,1,0.8353457488247147,1,BP
GO:0007212,dopamine receptor signaling pathway,43,1,0.72,0.51668,1,0.8353457488247147,1.39,BP
GO:0010518,positive regulation of phospholipase act...,43,1,0.72,0.51668,1,0.8353457488247147,1.39,BP
GO:0010569,regulation of double-strand break repair...,43,1,0.72,0.51668,1,0.8353457488247147,1.39,BP
GO:0010907,positive regulation of glucose metabolic...,43,1,0.72,0.51668,1,0.8353457488247147,1.39,BP
GO:0014904,myotube cell development,43,1,0.72,0.51668,1,0.8353457488247147,1.39,BP
GO:0032371,regulation of sterol transport,43,1,0.72,0.51668,1,0.8353457488247147,1.39,BP
GO:0032374,regulation of cholesterol transport,43,1,0.72,0.51668,1,0.8353457488247147,1.39,BP
GO:0042771,intrinsic apoptotic signaling pathway in...,43,1,0.72,0.51668,1,0.8353457488247147,1.39,BP
GO:0043403,skeletal muscle tissue regeneration,43,1,0.72,0.51668,1,0.8353457488247147,1.39,BP
GO:0044743,protein transmembrane import into intrac...,43,1,0.72,0.51668,1,0.8353457488247147,1.39,BP
GO:0045911,positive regulation of DNA recombination,43,1,0.72,0.51668,1,0.8353457488247147,1.39,BP
GO:0046621,negative regulation of organ growth,43,1,0.72,0.51668,1,0.8353457488247147,1.39,BP
GO:0086002,cardiac muscle cell action potential inv...,43,1,0.72,0.51668,1,0.8353457488247147,1.39,BP
GO:0097484,dendrite extension,43,1,0.72,0.51668,1,0.8353457488247147,1.39,BP
GO:1901985,positive regulation of protein acetylati...,43,1,0.72,0.51668,1,0.8353457488247147,1.39,BP
GO:0001708,cell fate specification,103,2,1.73,0.51697,1,0.8353457488247147,1.16,BP
GO:0051897,positive regulation of protein kinase B ...,103,2,1.73,0.51697,1,0.8353457488247147,1.16,BP
GO:0006281,DNA repair,465,8,7.79,0.51937,1,0.8389420745216515,1.03,BP
GO:0050878,regulation of body fluid levels,345,6,5.78,0.52030,1,0.8401622818791946,1.04,BP
GO:0042136,neurotransmitter biosynthetic process,104,2,1.74,0.52215,1,0.8425841046277666,1.15,BP
GO:2000300,regulation of synaptic vesicle exocytosi...,104,2,1.74,0.52215,1,0.8425841046277666,1.15,BP
GO:0002792,negative regulation of peptide secretion,165,3,2.76,0.52413,1,0.8428870093457943,1.09,BP
GO:0060041,retina development in camera-type eye,165,3,2.76,0.52413,1,0.8428870093457943,1.09,BP
GO:0048732,gland development,467,8,7.82,0.52425,1,0.8428870093457943,1.02,BP
GO:0002455,humoral immune response mediated by circ...,44,1,0.74,0.52479,1,0.8428870093457943,1.35,BP
GO:0010824,regulation of centrosome duplication,44,1,0.74,0.52479,1,0.8428870093457943,1.35,BP
GO:0019083,viral transcription,44,1,0.74,0.52479,1,0.8428870093457943,1.35,BP
GO:0030890,positive regulation of B cell proliferat...,44,1,0.74,0.52479,1,0.8428870093457943,1.35,BP
GO:0032814,regulation of natural killer cell activa...,44,1,0.74,0.52479,1,0.8428870093457943,1.35,BP
GO:0032924,activin receptor signaling pathway,44,1,0.74,0.52479,1,0.8428870093457943,1.35,BP
GO:0048854,brain morphogenesis,44,1,0.74,0.52479,1,0.8428870093457943,1.35,BP
GO:0050691,regulation of defense response to virus ...,44,1,0.74,0.52479,1,0.8428870093457943,1.35,BP
GO:0050918,positive chemotaxis,44,1,0.74,0.52479,1,0.8428870093457943,1.35,BP
GO:0061098,positive regulation of protein tyrosine ...,44,1,0.74,0.52479,1,0.8428870093457943,1.35,BP
GO:1900077,negative regulation of cellular response...,44,1,0.74,0.52479,1,0.8428870093457943,1.35,BP
GO:0002224,toll-like receptor signaling pathway,105,2,1.76,0.52728,1,0.8466037237237237,1.14,BP
GO:0007179,transforming growth factor beta receptor...,166,3,2.78,0.52819,1,0.8476436678892963,1.08,BP
GO:0098542,defense response to other organism,529,9,8.86,0.52828,1,0.8476436678892963,1.02,BP
GO:0018209,peptidyl-serine modification,348,6,5.83,0.52875,1,0.8481150000000002,1.03,BP
GO:0034766,negative regulation of ion transmembrane...,106,2,1.78,0.53238,1,0.8497478422273781,1.12,BP
GO:0035249,"synaptic transmission, glutamatergic",106,2,1.78,0.53238,1,0.8497478422273781,1.12,BP
GO:1903706,regulation of hemopoiesis,410,7,6.87,0.53275,1,0.8497478422273781,1.02,BP
GO:0003254,regulation of membrane depolarization,45,1,0.75,0.53277,1,0.8497478422273781,1.33,BP
GO:0005978,glycogen biosynthetic process,45,1,0.75,0.53277,1,0.8497478422273781,1.33,BP
GO:0006695,cholesterol biosynthetic process,45,1,0.75,0.53277,1,0.8497478422273781,1.33,BP
GO:0007628,adult walking behavior,45,1,0.75,0.53277,1,0.8497478422273781,1.33,BP
GO:0009250,glucan biosynthetic process,45,1,0.75,0.53277,1,0.8497478422273781,1.33,BP
GO:0010464,regulation of mesenchymal cell prolifera...,45,1,0.75,0.53277,1,0.8497478422273781,1.33,BP
GO:0032881,regulation of polysaccharide metabolic p...,45,1,0.75,0.53277,1,0.8497478422273781,1.33,BP
GO:0035136,forelimb morphogenesis,45,1,0.75,0.53277,1,0.8497478422273781,1.33,BP
GO:0050974,detection of mechanical stimulus involve...,45,1,0.75,0.53277,1,0.8497478422273781,1.33,BP
GO:0051646,mitochondrion localization,45,1,0.75,0.53277,1,0.8497478422273781,1.33,BP
GO:0060421,positive regulation of heart growth,45,1,0.75,0.53277,1,0.8497478422273781,1.33,BP
GO:0061647,histone H3-K9 modification,45,1,0.75,0.53277,1,0.8497478422273781,1.33,BP
GO:0090184,positive regulation of kidney developmen...,45,1,0.75,0.53277,1,0.8497478422273781,1.33,BP
GO:0090207,regulation of triglyceride metabolic pro...,45,1,0.75,0.53277,1,0.8497478422273781,1.33,BP
GO:0045165,cell fate commitment,289,5,4.84,0.53345,1,0.8505504970178925,1.03,BP
GO:0046649,lymphocyte activation,714,12,11.96,0.53657,1,0.8552417489234846,1,BP
GO:0000956,nuclear-transcribed mRNA catabolic proce...,107,2,1.79,0.53744,1,0.8557780542686962,1.12,BP
GO:0014812,muscle cell migration,107,2,1.79,0.53744,1,0.8557780542686962,1.12,BP
GO:0046474,glycerophospholipid biosynthetic process,107,2,1.79,0.53744,1,0.8557780542686962,1.12,BP
GO:0048863,stem cell differentiation,230,4,3.85,0.53959,1,0.8568561660079052,1.04,BP
GO:0050670,regulation of lymphocyte proliferation,230,4,3.85,0.53959,1,0.8568561660079052,1.04,BP
GO:1901617,organic hydroxy compound biosynthetic pr...,230,4,3.85,0.53959,1,0.8568561660079052,1.04,BP
GO:0001774,microglial cell activation,46,1,0.77,0.54061,1,0.8568561660079052,1.3,BP
GO:0001990,regulation of systemic arterial blood pr...,46,1,0.77,0.54061,1,0.8568561660079052,1.3,BP
GO:0002269,leukocyte activation involved in inflamm...,46,1,0.77,0.54061,1,0.8568561660079052,1.3,BP
GO:0006904,vesicle docking involved in exocytosis,46,1,0.77,0.54061,1,0.8568561660079052,1.3,BP
GO:0016574,histone ubiquitination,46,1,0.77,0.54061,1,0.8568561660079052,1.3,BP
GO:0021772,olfactory bulb development,46,1,0.77,0.54061,1,0.8568561660079052,1.3,BP
GO:0033013,tetrapyrrole metabolic process,46,1,0.77,0.54061,1,0.8568561660079052,1.3,BP
GO:0042073,intraciliary transport,46,1,0.77,0.54061,1,0.8568561660079052,1.3,BP
GO:0060323,head morphogenesis,46,1,0.77,0.54061,1,0.8568561660079052,1.3,BP
GO:1902653,secondary alcohol biosynthetic process,46,1,0.77,0.54061,1,0.8568561660079052,1.3,BP
GO:1990928,response to amino acid starvation,46,1,0.77,0.54061,1,0.8568561660079052,1.3,BP
GO:0050776,regulation of immune response,777,13,13.01,0.54153,1,0.858031728679618,1,BP
GO:0003014,renal system process,108,2,1.81,0.54247,1,0.8589554590325765,1.1,BP
GO:0007052,mitotic spindle organization,108,2,1.81,0.54247,1,0.8589554590325765,1.1,BP
GO:1902107,positive regulation of leukocyte differe...,170,3,2.85,0.54427,1,0.8612388161788886,1.05,BP
GO:2000241,regulation of reproductive process,170,3,2.85,0.54427,1,0.8612388161788886,1.05,BP
GO:0032944,regulation of mononuclear cell prolifera...,232,4,3.89,0.54642,1,0.8639541060903734,1.03,BP
GO:0006690,icosanoid metabolic process,109,2,1.83,0.54745,1,0.8639541060903734,1.09,BP
GO:0019882,antigen processing and presentation,109,2,1.83,0.54745,1,0.8639541060903734,1.09,BP
GO:0034968,histone lysine methylation,109,2,1.83,0.54745,1,0.8639541060903734,1.09,BP
GO:1902803,regulation of synaptic vesicle transport,109,2,1.83,0.54745,1,0.8639541060903734,1.09,BP
GO:0021532,neural tube patterning,47,1,0.79,0.54832,1,0.8639541060903734,1.27,BP
GO:0030517,negative regulation of axon extension,47,1,0.79,0.54832,1,0.8639541060903734,1.27,BP
GO:0035137,hindlimb morphogenesis,47,1,0.79,0.54832,1,0.8639541060903734,1.27,BP
GO:0045429,positive regulation of nitric oxide bios...,47,1,0.79,0.54832,1,0.8639541060903734,1.27,BP
GO:0071300,cellular response to retinoic acid,47,1,0.79,0.54832,1,0.8639541060903734,1.27,BP
GO:0090279,regulation of calcium ion import,47,1,0.79,0.54832,1,0.8639541060903734,1.27,BP
GO:0120163,negative regulation of cold-induced ther...,47,1,0.79,0.54832,1,0.8639541060903734,1.27,BP
GO:1902041,regulation of extrinsic apoptotic signal...,47,1,0.79,0.54832,1,0.8639541060903734,1.27,BP
GO:0043543,protein acylation,233,4,3.9,0.54982,1,0.8660339901800327,1.03,BP
GO:0050727,regulation of inflammatory response,356,6,5.96,0.55098,1,0.8675771465968587,1.01,BP
GO:0042035,regulation of cytokine biosynthetic proc...,110,2,1.84,0.55240,1,0.8688012081844755,1.09,BP
GO:0048511,rhythmic process,296,5,4.96,0.55472,1,0.8688012081844755,1.01,BP
GO:0000245,spliceosomal complex assembly,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0001504,neurotransmitter uptake,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0003382,epithelial cell morphogenesis,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0006368,transcription elongation from RNA polyme...,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0007157,heterophilic cell-cell adhesion via plas...,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0010107,potassium ion import,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0021988,olfactory lobe development,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0031952,regulation of protein autophosphorylatio...,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0032456,endocytic recycling,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0043303,mast cell degranulation,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0044786,cell cycle DNA replication,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0045104,intermediate filament cytoskeleton organ...,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0045581,negative regulation of T cell differenti...,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0045646,regulation of erythrocyte differentiatio...,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0048599,oocyte development,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0048701,embryonic cranial skeleton morphogenesis,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0050850,positive regulation of calcium-mediated ...,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0050853,B cell receptor signaling pathway,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:1904407,positive regulation of nitric oxide meta...,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:2000725,regulation of cardiac muscle cell differ...,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:2001239,regulation of extrinsic apoptotic signal...,48,1,0.8,0.55591,1,0.8688012081844755,1.25,BP
GO:0001890,placenta development,173,3,2.9,0.55612,1,0.8688472207792207,1.03,BP
GO:0006351,"transcription, DNA-templated",2897,48,48.52,0.55637,1,0.8689556767283351,0.99,BP
GO:0045089,positive regulation of innate immune res...,235,4,3.94,0.55657,1,0.8689859961064245,1.02,BP
GO:0009410,response to xenobiotic stimulus,236,4,3.95,0.55993,1,0.8738055252918288,1.01,BP
GO:1901654,response to ketone,174,3,2.91,0.56002,1,0.8738055252918288,1.03,BP
GO:1902105,regulation of leukocyte differentiation,298,5,4.99,0.56071,1,0.8745985478119936,1,BP
GO:0006939,smooth muscle contraction,112,2,1.88,0.56218,1,0.874762284607938,1.06,BP
GO:0042100,B cell proliferation,112,2,1.88,0.56218,1,0.874762284607938,1.06,BP
GO:0072329,monocarboxylic acid catabolic process,112,2,1.88,0.56218,1,0.874762284607938,1.06,BP
GO:0090100,positive regulation of transmembrane rec...,112,2,1.88,0.56218,1,0.874762284607938,1.06,BP
GO:1901657,glycosyl compound metabolic process,112,2,1.88,0.56218,1,0.874762284607938,1.06,BP
GO:0001961,positive regulation of cytokine-mediated...,49,1,0.82,0.56336,1,0.874762284607938,1.22,BP
GO:0002279,mast cell activation involved in immune ...,49,1,0.82,0.56336,1,0.874762284607938,1.22,BP
GO:0002448,mast cell mediated immunity,49,1,0.82,0.56336,1,0.874762284607938,1.22,BP
GO:0007520,myoblast fusion,49,1,0.82,0.56336,1,0.874762284607938,1.22,BP
GO:0030195,negative regulation of blood coagulation,49,1,0.82,0.56336,1,0.874762284607938,1.22,BP
GO:0042088,T-helper 1 type immune response,49,1,0.82,0.56336,1,0.874762284607938,1.22,BP
GO:0043300,regulation of leukocyte degranulation,49,1,0.82,0.56336,1,0.874762284607938,1.22,BP
GO:0045103,intermediate filament-based process,49,1,0.82,0.56336,1,0.874762284607938,1.22,BP
GO:0090342,regulation of cell aging,49,1,0.82,0.56336,1,0.874762284607938,1.22,BP
GO:0097659,nucleic acid-templated transcription,2905,48,48.66,0.56458,1,0.8763738580645161,0.99,BP
GO:0022412,cellular process involved in reproductio...,423,7,7.09,0.56586,1,0.8780774975814255,0.99,BP
GO:0051604,protein maturation,300,5,5.03,0.56666,1,0.8784456278171281,0.99,BP
GO:0006805,xenobiotic metabolic process,113,2,1.89,0.56701,1,0.8784456278171281,1.06,BP
GO:0007589,body fluid secretion,113,2,1.89,0.56701,1,0.8784456278171281,1.06,BP
GO:0008585,female gonad development,113,2,1.89,0.56701,1,0.8784456278171281,1.06,BP
GO:0060078,regulation of postsynaptic membrane pote...,113,2,1.89,0.56701,1,0.8784456278171281,1.06,BP
GO:0002639,positive regulation of immunoglobulin pr...,50,1,0.84,0.57069,1,0.8810267179980751,1.19,BP
GO:0006303,double-strand break repair via nonhomolo...,50,1,0.84,0.57069,1,0.8810267179980751,1.19,BP
GO:0006360,transcription by RNA polymerase I,50,1,0.84,0.57069,1,0.8810267179980751,1.19,BP
GO:0010761,fibroblast migration,50,1,0.84,0.57069,1,0.8810267179980751,1.19,BP
GO:0032941,secretion by tissue,50,1,0.84,0.57069,1,0.8810267179980751,1.19,BP
GO:0051055,negative regulation of lipid biosyntheti...,50,1,0.84,0.57069,1,0.8810267179980751,1.19,BP
GO:0060043,regulation of cardiac muscle cell prolif...,50,1,0.84,0.57069,1,0.8810267179980751,1.19,BP
GO:0071675,regulation of mononuclear cell migration,50,1,0.84,0.57069,1,0.8810267179980751,1.19,BP
GO:0098586,cellular response to virus,50,1,0.84,0.57069,1,0.8810267179980751,1.19,BP
GO:1900047,negative regulation of hemostasis,50,1,0.84,0.57069,1,0.8810267179980751,1.19,BP
GO:1902930,regulation of alcohol biosynthetic proce...,50,1,0.84,0.57069,1,0.8810267179980751,1.19,BP
GO:0043123,positive regulation of I-kappaB kinase/N...,114,2,1.91,0.57181,1,0.8824726491340603,1.05,BP
GO:0007178,transmembrane receptor protein serine/th...,364,6,6.1,0.57273,1,0.8836090926579031,0.98,BP
GO:0051321,meiotic cell cycle,303,5,5.08,0.57551,1,0.8873290996475488,0.98,BP
GO:0060271,cilium assembly,303,5,5.08,0.57551,1,0.8873290996475488,0.98,BP
GO:0016570,histone modification,427,7,7.15,0.57584,1,0.8875535169762973,0.98,BP
GO:0042472,inner ear morphogenesis,115,2,1.93,0.57656,1,0.8876012767315672,1.04,BP
GO:0071901,negative regulation of protein serine/th...,115,2,1.93,0.57656,1,0.8876012767315672,1.04,BP
GO:1905330,regulation of morphogenesis of an epithe...,115,2,1.93,0.57656,1,0.8876012767315672,1.04,BP
GO:0010332,response to gamma radiation,51,1,0.85,0.57790,1,0.8876012767315672,1.18,BP
GO:0016126,sterol biosynthetic process,51,1,0.85,0.57790,1,0.8876012767315672,1.18,BP
GO:0032648,regulation of interferon-beta production,51,1,0.85,0.57790,1,0.8876012767315672,1.18,BP
GO:0032715,negative regulation of interleukin-6 pro...,51,1,0.85,0.57790,1,0.8876012767315672,1.18,BP
GO:0048247,lymphocyte chemotaxis,51,1,0.85,0.57790,1,0.8876012767315672,1.18,BP
GO:0050819,negative regulation of coagulation,51,1,0.85,0.57790,1,0.8876012767315672,1.18,BP
GO:0051954,positive regulation of amine transport,51,1,0.85,0.57790,1,0.8876012767315672,1.18,BP
GO:1901570,fatty acid derivative biosynthetic proce...,51,1,0.85,0.57790,1,0.8876012767315672,1.18,BP
GO:0071216,cellular response to biotic stimulus,304,5,5.09,0.57844,1,0.888147185705169,0.98,BP
GO:0001659,temperature homeostasis,179,3,3,0.57925,1,0.8885403251514186,1,BP
GO:0007219,Notch signaling pathway,179,3,3,0.57925,1,0.8885403251514186,1,BP
GO:0010951,negative regulation of endopeptidase act...,179,3,3,0.57925,1,0.8885403251514186,1,BP
GO:0002237,response to molecule of bacterial origin,367,6,6.15,0.58075,1,0.890557361376673,0.98,BP
GO:0010927,cellular component assembly involved in ...,116,2,1.94,0.58128,1,0.8906412989493792,1.03,BP
GO:0046545,development of primary female sexual cha...,116,2,1.94,0.58128,1,0.8906412989493792,1.03,BP
GO:0002460,adaptive immune response based on somati...,305,5,5.11,0.58136,1,0.8906412989493792,0.98,BP
GO:0000288,nuclear-transcribed mRNA catabolic proce...,52,1,0.87,0.58499,1,0.8930748350253808,1.15,BP
GO:0001895,retina homeostasis,52,1,0.87,0.58499,1,0.8930748350253808,1.15,BP
GO:0007019,microtubule depolymerization,52,1,0.87,0.58499,1,0.8930748350253808,1.15,BP
GO:0009994,oocyte differentiation,52,1,0.87,0.58499,1,0.8930748350253808,1.15,BP
GO:0017145,stem cell division,52,1,0.87,0.58499,1,0.8930748350253808,1.15,BP
GO:0032481,positive regulation of type I interferon...,52,1,0.87,0.58499,1,0.8930748350253808,1.15,BP
GO:0035924,cellular response to vascular endothelia...,52,1,0.87,0.58499,1,0.8930748350253808,1.15,BP
GO:0044058,regulation of digestive system process,52,1,0.87,0.58499,1,0.8930748350253808,1.15,BP
GO:0045124,regulation of bone resorption,52,1,0.87,0.58499,1,0.8930748350253808,1.15,BP
GO:0048066,developmental pigmentation,52,1,0.87,0.58499,1,0.8930748350253808,1.15,BP
GO:0060428,lung epithelium development,52,1,0.87,0.58499,1,0.8930748350253808,1.15,BP
GO:0043534,blood vessel endothelial cell migration,117,2,1.96,0.58596,1,0.8939884337349397,1.02,BP
GO:0090305,nucleic acid phosphodiester bond hydroly...,117,2,1.96,0.58596,1,0.8939884337349397,1.02,BP
GO:0019933,cAMP-mediated signaling,181,3,3.03,0.58679,1,0.8949709920760697,0.99,BP
GO:0048729,tissue morphogenesis,679,11,11.37,0.58774,1,0.8961358935361218,0.97,BP
GO:0070663,regulation of leukocyte proliferation,245,4,4.1,0.58952,1,0.8985651694646817,0.98,BP
GO:0061136,regulation of proteasomal protein catabo...,182,3,3.05,0.59053,1,0.8987878557874762,0.98,BP
GO:0098656,anion transmembrane transport,182,3,3.05,0.59053,1,0.8987878557874762,0.98,BP
GO:0014020,primary neural tube formation,118,2,1.98,0.59060,1,0.8987878557874762,1.01,BP
GO:0019751,polyol metabolic process,118,2,1.98,0.59060,1,0.8987878557874762,1.01,BP
GO:1903052,positive regulation of proteolysis invol...,118,2,1.98,0.59060,1,0.8987878557874762,1.01,BP
GO:0009583,detection of light stimulus,53,1,0.89,0.59196,1,0.8994352762867067,1.12,BP
GO:0032608,interferon-beta production,53,1,0.89,0.59196,1,0.8994352762867067,1.12,BP
GO:0045214,sarcomere organization,53,1,0.89,0.59196,1,0.8994352762867067,1.12,BP
GO:0046148,pigment biosynthetic process,53,1,0.89,0.59196,1,0.8994352762867067,1.12,BP
GO:0097035,regulation of membrane lipid distributio...,53,1,0.89,0.59196,1,0.8994352762867067,1.12,BP
GO:0048585,negative regulation of response to stimu...,1599,26,26.78,0.59245,1,0.899895643939394,0.97,BP
GO:0022409,positive regulation of cell-cell adhesio...,246,4,4.12,0.59273,1,0.9000368444304196,0.97,BP
GO:0031349,positive regulation of defense response,372,6,6.23,0.59395,1,0.901604858044164,0.96,BP
GO:0035051,cardiocyte differentiation,183,3,3.07,0.59425,1,0.9017757805108797,0.98,BP
GO:0051952,regulation of amine transport,119,2,1.99,0.59520,1,0.902932660781841,1.01,BP
GO:0032147,activation of protein kinase activity,247,4,4.14,0.59593,1,0.9037551717617396,0.97,BP
GO:0051262,protein tetramerization,184,3,3.08,0.59794,1,0.9049854648241206,0.97,BP
GO:0002385,mucosal immune response,54,1,0.9,0.59881,1,0.9049854648241206,1.11,BP
GO:0032350,regulation of hormone metabolic process,54,1,0.9,0.59881,1,0.9049854648241206,1.11,BP
GO:0032731,positive regulation of interleukin-1 bet...,54,1,0.9,0.59881,1,0.9049854648241206,1.11,BP
GO:0034113,heterotypic cell-cell adhesion,54,1,0.9,0.59881,1,0.9049854648241206,1.11,BP
GO:0035065,regulation of histone acetylation,54,1,0.9,0.59881,1,0.9049854648241206,1.11,BP
GO:0051568,histone H3-K4 methylation,54,1,0.9,0.59881,1,0.9049854648241206,1.11,BP
GO:0055025,positive regulation of cardiac muscle ti...,54,1,0.9,0.59881,1,0.9049854648241206,1.11,BP
GO:0055078,sodium ion homeostasis,54,1,0.9,0.59881,1,0.9049854648241206,1.11,BP
GO:0072698,protein localization to microtubule cyto...,54,1,0.9,0.59881,1,0.9049854648241206,1.11,BP
GO:0098815,modulation of excitatory postsynaptic po...,54,1,0.9,0.59881,1,0.9049854648241206,1.11,BP
GO:0045944,positive regulation of transcription by ...,1238,20,20.74,0.59940,1,0.9055927158555731,0.96,BP
GO:0045766,positive regulation of angiogenesis,185,3,3.1,0.60161,1,0.908361255098839,0.97,BP
GO:0051588,regulation of neurotransmitter transport,185,3,3.1,0.60161,1,0.908361255098839,0.97,BP
GO:0032501,multicellular organismal process,8233,136,137.9,0.60262,1,0.9096008281053953,0.99,BP
GO:0018022,peptidyl-lysine methylation,121,2,2.03,0.60428,1,0.9114352455426963,0.99,BP
GO:0046620,regulation of organ growth,121,2,2.03,0.60428,1,0.9114352455426963,0.99,BP
GO:0032655,regulation of interleukin-12 production,55,1,0.92,0.60554,1,0.9114352455426963,1.09,BP
GO:0043030,regulation of macrophage activation,55,1,0.92,0.60554,1,0.9114352455426963,1.09,BP
GO:0044060,regulation of endocrine process,55,1,0.92,0.60554,1,0.9114352455426963,1.09,BP
GO:0045599,negative regulation of fat cell differen...,55,1,0.92,0.60554,1,0.9114352455426963,1.09,BP
GO:0046718,viral entry into host cell,55,1,0.92,0.60554,1,0.9114352455426963,1.09,BP
GO:0060193,positive regulation of lipase activity,55,1,0.92,0.60554,1,0.9114352455426963,1.09,BP
GO:1901799,negative regulation of proteasomal prote...,55,1,0.92,0.60554,1,0.9114352455426963,1.09,BP
GO:0060429,epithelium development,1182,19,19.8,0.60718,1,0.9136179362101314,0.96,BP
GO:0001889,liver development,122,2,2.04,0.60877,1,0.9147607492975337,0.98,BP
GO:0010906,regulation of glucose metabolic process,122,2,2.04,0.60877,1,0.9147607492975337,0.98,BP
GO:0042089,cytokine biosynthetic process,122,2,2.04,0.60877,1,0.9147607492975337,0.98,BP
GO:0046717,acid secretion,122,2,2.04,0.60877,1,0.9147607492975337,0.98,BP
GO:0002695,negative regulation of leukocyte activat...,187,3,3.13,0.60889,1,0.9147607492975337,0.96,BP
GO:0002204,somatic recombination of immunoglobulin ...,56,1,0.94,0.61217,1,0.9167496111975117,1.06,BP
GO:0002208,somatic diversification of immunoglobuli...,56,1,0.94,0.61217,1,0.9167496111975117,1.06,BP
GO:0002251,organ or tissue specific immune response,56,1,0.94,0.61217,1,0.9167496111975117,1.06,BP
GO:0006911,"phagocytosis, engulfment",56,1,0.94,0.61217,1,0.9167496111975117,1.06,BP
GO:0007062,sister chromatid cohesion,56,1,0.94,0.61217,1,0.9167496111975117,1.06,BP
GO:0019731,antibacterial humoral response,56,1,0.94,0.61217,1,0.9167496111975117,1.06,BP
GO:0035019,somatic stem cell population maintenance,56,1,0.94,0.61217,1,0.9167496111975117,1.06,BP
GO:0043330,response to exogenous dsRNA,56,1,0.94,0.61217,1,0.9167496111975117,1.06,BP
GO:0045190,isotype switching,56,1,0.94,0.61217,1,0.9167496111975117,1.06,BP
GO:0060760,positive regulation of response to cytok...,56,1,0.94,0.61217,1,0.9167496111975117,1.06,BP
GO:0030534,adult behavior,188,3,3.15,0.61250,1,0.9167496111975117,0.95,BP
GO:0043200,response to amino acid,188,3,3.15,0.61250,1,0.9167496111975117,0.95,BP
GO:0043062,extracellular structure organization,316,5,5.29,0.61272,1,0.9167937313432836,0.95,BP
GO:0015837,amine transport,123,2,2.06,0.61321,1,0.9172416910164751,0.97,BP
GO:0016569,covalent chromatin modification,444,7,7.44,0.61696,1,0.9205591094619666,0.94,BP
GO:0014902,myotube differentiation,124,2,2.08,0.61762,1,0.9205591094619666,0.96,BP
GO:0032434,regulation of proteasomal ubiquitin-depe...,124,2,2.08,0.61762,1,0.9205591094619666,0.96,BP
GO:0042752,regulation of circadian rhythm,124,2,2.08,0.61762,1,0.9205591094619666,0.96,BP
GO:0051153,regulation of striated muscle cell diffe...,124,2,2.08,0.61762,1,0.9205591094619666,0.96,BP
GO:0071621,granulocyte chemotaxis,124,2,2.08,0.61762,1,0.9205591094619666,0.96,BP
GO:0002696,positive regulation of leukocyte activat...,318,5,5.33,0.61827,1,0.9205591094619666,0.94,BP
GO:0000726,non-recombinational repair,57,1,0.95,0.61868,1,0.9205591094619666,1.05,BP
GO:0009247,glycolipid biosynthetic process,57,1,0.95,0.61868,1,0.9205591094619666,1.05,BP
GO:0010463,mesenchymal cell proliferation,57,1,0.95,0.61868,1,0.9205591094619666,1.05,BP
GO:0032653,regulation of interleukin-10 production,57,1,0.95,0.61868,1,0.9205591094619666,1.05,BP
GO:0045620,negative regulation of lymphocyte differ...,57,1,0.95,0.61868,1,0.9205591094619666,1.05,BP
GO:0046622,positive regulation of organ growth,57,1,0.95,0.61868,1,0.9205591094619666,1.05,BP
GO:0046676,negative regulation of insulin secretion,57,1,0.95,0.61868,1,0.9205591094619666,1.05,BP
GO:0050994,regulation of lipid catabolic process,57,1,0.95,0.61868,1,0.9205591094619666,1.05,BP
GO:0072347,response to anesthetic,57,1,0.95,0.61868,1,0.9205591094619666,1.05,BP
GO:0090303,positive regulation of wound healing,57,1,0.95,0.61868,1,0.9205591094619666,1.05,BP
GO:0043491,protein kinase B signaling,190,3,3.18,0.61964,1,0.9217025285935085,0.94,BP
GO:0061008,hepaticobiliary system development,125,2,2.09,0.62199,1,0.9249122002472189,0.96,BP
GO:0001754,eye photoreceptor cell differentiation,58,1,0.97,0.62509,1,0.9280879605060166,1.03,BP
GO:0002437,inflammatory response to antigenic stimu...,58,1,0.97,0.62509,1,0.9280879605060166,1.03,BP
GO:0008333,endosome to lysosome transport,58,1,0.97,0.62509,1,0.9280879605060166,1.03,BP
GO:0032615,interleukin-12 production,58,1,0.97,0.62509,1,0.9280879605060166,1.03,BP
GO:0061337,cardiac conduction,58,1,0.97,0.62509,1,0.9280879605060166,1.03,BP
GO:0000724,double-strand break repair via homologou...,126,2,2.11,0.62632,1,0.9284817744916821,0.95,BP
GO:0000725,recombinational repair,126,2,2.11,0.62632,1,0.9284817744916821,0.95,BP
GO:0007631,feeding behavior,126,2,2.11,0.62632,1,0.9284817744916821,0.95,BP
GO:0016064,immunoglobulin mediated immune response,126,2,2.11,0.62632,1,0.9284817744916821,0.95,BP
GO:0018107,peptidyl-threonine phosphorylation,126,2,2.11,0.62632,1,0.9284817744916821,0.95,BP
GO:0071695,anatomical structure maturation,192,3,3.22,0.62670,1,0.9287589775177088,0.93,BP
GO:0018108,peptidyl-tyrosine phosphorylation,322,5,5.39,0.62924,1,0.9311065154765553,0.93,BP
GO:0021915,neural tube development,193,3,3.23,0.63019,1,0.9311065154765553,0.93,BP
GO:0010212,response to ionizing radiation,127,2,2.13,0.63061,1,0.9311065154765553,0.94,BP
GO:0001755,neural crest cell migration,59,1,0.99,0.63138,1,0.9311065154765553,1.01,BP
GO:0007029,endoplasmic reticulum organization,59,1,0.99,0.63138,1,0.9311065154765553,1.01,BP
GO:0010524,positive regulation of calcium ion trans...,59,1,0.99,0.63138,1,0.9311065154765553,1.01,BP
GO:0030260,entry into host cell,59,1,0.99,0.63138,1,0.9311065154765553,1.01,BP
GO:0035567,non-canonical Wnt signaling pathway,59,1,0.99,0.63138,1,0.9311065154765553,1.01,BP
GO:0044409,entry into host,59,1,0.99,0.63138,1,0.9311065154765553,1.01,BP
GO:0045744,negative regulation of G protein-coupled...,59,1,0.99,0.63138,1,0.9311065154765553,1.01,BP
GO:0045806,negative regulation of endocytosis,59,1,0.99,0.63138,1,0.9311065154765553,1.01,BP
GO:0046128,purine ribonucleoside metabolic process,59,1,0.99,0.63138,1,0.9311065154765553,1.01,BP
GO:0051148,negative regulation of muscle cell diffe...,59,1,0.99,0.63138,1,0.9311065154765553,1.01,BP
GO:0051806,entry into cell of other organism involv...,59,1,0.99,0.63138,1,0.9311065154765553,1.01,BP
GO:0051828,entry into other organism involved in sy...,59,1,0.99,0.63138,1,0.9311065154765553,1.01,BP
GO:1901616,organic hydroxy compound catabolic proce...,59,1,0.99,0.63138,1,0.9311065154765553,1.01,BP
GO:0009607,response to biotic stimulus,1076,17,18.02,0.63316,1,0.9334454411764705,0.94,BP
GO:0009582,detection of abiotic stimulus,128,2,2.14,0.63486,1,0.9353785425597061,0.93,BP
GO:0042107,cytokine metabolic process,128,2,2.14,0.63486,1,0.9353785425597061,0.93,BP
GO:0048598,embryonic morphogenesis,642,10,10.75,0.63689,1,0.9365186080586082,0.93,BP
GO:0002285,lymphocyte activation involved in immune...,195,3,3.27,0.63711,1,0.9365186080586082,0.92,BP
GO:0018212,peptidyl-tyrosine modification,325,5,5.44,0.63734,1,0.9365186080586082,0.92,BP
GO:0044380,protein localization to cytoskeleton,60,1,1.01,0.63758,1,0.9365186080586082,0.99,BP
GO:0045776,negative regulation of blood pressure,60,1,1.01,0.63758,1,0.9365186080586082,0.99,BP
GO:0050982,detection of mechanical stimulus,60,1,1.01,0.63758,1,0.9365186080586082,0.99,BP
GO:0060324,face development,60,1,1.01,0.63758,1,0.9365186080586082,0.99,BP
GO:0060986,endocrine hormone secretion,60,1,1.01,0.63758,1,0.9365186080586082,0.99,BP
GO:0070098,chemokine-mediated signaling pathway,60,1,1.01,0.63758,1,0.9365186080586082,0.99,BP
GO:0090183,regulation of kidney development,60,1,1.01,0.63758,1,0.9365186080586082,0.99,BP
GO:0003279,cardiac septum development,129,2,2.16,0.63908,1,0.9379364318389753,0.93,BP
GO:0009581,detection of external stimulus,129,2,2.16,0.63908,1,0.9379364318389753,0.93,BP
GO:0016458,gene silencing,261,4,4.37,0.63913,1,0.9379364318389753,0.92,BP
GO:0019724,B cell mediated immunity,130,2,2.18,0.64325,1,0.9425720998174073,0.92,BP
GO:0016447,somatic recombination of immunoglobulin ...,61,1,1.02,0.64366,1,0.9425720998174073,0.98,BP
GO:0032613,interleukin-10 production,61,1,1.02,0.64366,1,0.9425720998174073,0.98,BP
GO:0042698,ovulation cycle,61,1,1.02,0.64366,1,0.9425720998174073,0.98,BP
GO:0048512,circadian behavior,61,1,1.02,0.64366,1,0.9425720998174073,0.98,BP
GO:1903428,positive regulation of reactive oxygen s...,61,1,1.02,0.64366,1,0.9425720998174073,0.98,BP
GO:1905207,regulation of cardiocyte differentiation,61,1,1.02,0.64366,1,0.9425720998174073,0.98,BP
GO:0007266,Rho protein signal transduction,197,3,3.3,0.64394,1,0.94269524794645565,0.91,BP
GO:1990823,response to leukemia inhibitory factor,328,5,5.49,0.64533,1,0.9441556582547886,0.91,BP
GO:1990830,cellular response to leukemia inhibitory...,328,5,5.49,0.64533,1,0.9441556582547886,0.91,BP
GO:0006367,transcription initiation from RNA polyme...,62,1,1.04,0.64965,1,0.9484574635922329,0.96,BP
GO:0010812,negative regulation of cell-substrate ad...,62,1,1.04,0.64965,1,0.9484574635922329,0.96,BP
GO:0032732,positive regulation of interleukin-1 pro...,62,1,1.04,0.64965,1,0.9484574635922329,0.96,BP
GO:0042461,photoreceptor cell development,62,1,1.04,0.64965,1,0.9484574635922329,0.96,BP
GO:0046605,regulation of centrosome cycle,62,1,1.04,0.64965,1,0.9484574635922329,0.96,BP
GO:0046850,regulation of bone remodeling,62,1,1.04,0.64965,1,0.9484574635922329,0.96,BP
GO:0070206,protein trimerization,62,1,1.04,0.64965,1,0.9484574635922329,0.96,BP
GO:0050730,regulation of peptidyl-tyrosine phosphor...,265,4,4.44,0.65091,1,0.950008771610555,0.9,BP
GO:0044782,cilium organization,331,5,5.54,0.65321,1,0.9530765676167373,0.9,BP
GO:2000756,regulation of peptidyl-lysine acetylatio...,63,1,1.06,0.65553,1,0.9559110909090909,0.94,BP
GO:0001841,neural tube formation,133,2,2.23,0.65555,1,0.9559110909090909,0.9,BP
GO:0002698,negative regulation of immune effector p...,134,2,2.24,0.65958,1,0.9599613393665158,0.89,BP
GO:0018210,peptidyl-threonine modification,134,2,2.24,0.65958,1,0.9599613393665158,0.89,BP
GO:0030522,intracellular receptor signaling pathway,202,3,3.38,0.66062,1,0.9599613393665158,0.89,BP
GO:0050867,positive regulation of cell activation,334,5,5.59,0.66098,1,0.9599613393665158,0.89,BP
GO:0001658,branching involved in ureteric bud morph...,64,1,1.07,0.66132,1,0.9599613393665158,0.93,BP
GO:0007622,rhythmic behavior,64,1,1.07,0.66132,1,0.9599613393665158,0.93,BP
GO:0010676,positive regulation of cellular carbohyd...,64,1,1.07,0.66132,1,0.9599613393665158,0.93,BP
GO:0030512,negative regulation of transforming grow...,64,1,1.07,0.66132,1,0.9599613393665158,0.93,BP
GO:0031638,zymogen activation,64,1,1.07,0.66132,1,0.9599613393665158,0.93,BP
GO:0032720,negative regulation of tumor necrosis fa...,64,1,1.07,0.66132,1,0.9599613393665158,0.93,BP
GO:0034121,regulation of toll-like receptor signali...,64,1,1.07,0.66132,1,0.9599613393665158,0.93,BP
GO:0035904,aorta development,64,1,1.07,0.66132,1,0.9599613393665158,0.93,BP
GO:0042278,purine nucleoside metabolic process,64,1,1.07,0.66132,1,0.9599613393665158,0.93,BP
GO:0045840,positive regulation of mitotic nuclear d...,64,1,1.07,0.66132,1,0.9599613393665158,0.93,BP
GO:2000514,"regulation of CD4-positive, alpha-beta T...",64,1,1.07,0.66132,1,0.9599613393665158,0.93,BP
GO:0002694,regulation of leukocyte activation,528,8,8.84,0.66222,1,0.9609778769601931,0.9,BP
GO:0006261,DNA-dependent DNA replication,135,2,2.26,0.66357,1,0.9626466204401568,0.88,BP
GO:0034660,ncRNA metabolic process,465,7,7.79,0.66464,1,0.9639082820976492,0.9,BP
GO:0006354,"DNA-templated transcription, elongation",65,1,1.09,0.66701,1,0.9646122475961538,0.92,BP
GO:0033627,cell adhesion mediated by integrin,65,1,1.09,0.66701,1,0.9646122475961538,0.92,BP
GO:0048278,vesicle docking,65,1,1.09,0.66701,1,0.9646122475961538,0.92,BP
GO:0060042,retina morphogenesis in camera-type eye,65,1,1.09,0.66701,1,0.9646122475961538,0.92,BP
GO:0071479,cellular response to ionizing radiation,65,1,1.09,0.66701,1,0.9646122475961538,0.92,BP
GO:1903556,negative regulation of tumor necrosis fa...,65,1,1.09,0.66701,1,0.9646122475961538,0.92,BP
GO:1904321,response to forskolin,65,1,1.09,0.66701,1,0.9646122475961538,0.92,BP
GO:1904322,cellular response to forskolin,65,1,1.09,0.66701,1,0.9646122475961538,0.92,BP
GO:2000134,negative regulation of G1/S transition o...,65,1,1.09,0.66701,1,0.9646122475961538,0.92,BP
GO:0001649,osteoblast differentiation,204,3,3.42,0.66713,1,0.9646122475961538,0.88,BP
GO:0009791,post-embryonic development,137,2,2.29,0.67143,1,0.9699128918189992,0.87,BP
GO:0046928,regulation of neurotransmitter secretion,137,2,2.29,0.67143,1,0.9699128918189992,0.87,BP
GO:0050671,positive regulation of lymphocyte prolif...,137,2,2.29,0.67143,1,0.9699128918189992,0.87,BP
GO:0003407,neural retina development,66,1,1.11,0.67261,1,0.9699128918189992,0.9,BP
GO:0019748,secondary metabolic process,66,1,1.11,0.67261,1,0.9699128918189992,0.9,BP
GO:0042440,pigment metabolic process,66,1,1.11,0.67261,1,0.9699128918189992,0.9,BP
GO:0043647,inositol phosphate metabolic process,66,1,1.11,0.67261,1,0.9699128918189992,0.9,BP
GO:1903845,negative regulation of cellular response...,66,1,1.11,0.67261,1,0.9699128918189992,0.9,BP
GO:1904888,cranial skeletal system development,66,1,1.11,0.67261,1,0.9699128918189992,0.9,BP
GO:0016571,histone methylation,138,2,2.31,0.67530,1,0.9735001797483522,0.87,BP
GO:0090287,regulation of cellular response to growt...,274,4,4.59,0.67646,1,0.9748803593890386,0.87,BP
GO:0051224,negative regulation of protein transport,207,3,3.47,0.67672,1,0.9749630658682635,0.86,BP
GO:0002381,immunoglobulin production involved in im...,67,1,1.12,0.67811,1,0.9752137836222354,0.89,BP
GO:0006487,protein N-linked glycosylation,67,1,1.12,0.67811,1,0.9752137836222354,0.89,BP
GO:0006635,fatty acid beta-oxidation,67,1,1.12,0.67811,1,0.9752137836222354,0.89,BP
GO:0016445,somatic diversification of immunoglobuli...,67,1,1.12,0.67811,1,0.9752137836222354,0.89,BP
GO:0097194,execution phase of apoptosis,67,1,1.12,0.67811,1,0.9752137836222354,0.89,BP
GO:2000179,positive regulation of neural precursor ...,67,1,1.12,0.67811,1,0.9752137836222354,0.89,BP
GO:0009100,glycoprotein metabolic process,341,5,5.71,0.67866,1,0.9757131520764866,0.88,BP
GO:0032946,positive regulation of mononuclear cell ...,139,2,2.33,0.67914,1,0.9761116129032257,0.86,BP
GO:0016197,endosomal transport,208,3,3.48,0.67987,1,0.9768690474768587,0.86,BP
GO:0045893,"positive regulation of transcription, DN...",1547,24,25.91,0.68247,1,0.9797730831099195,0.93,BP
GO:0002221,pattern recognition receptor signaling p...,140,2,2.35,0.68294,1,0.9797730831099195,0.85,BP
GO:0015893,drug transport,209,3,3.5,0.68300,1,0.9797730831099195,0.86,BP
GO:1903708,positive regulation of hemopoiesis,209,3,3.5,0.68300,1,0.9797730831099195,0.86,BP
GO:0050710,negative regulation of cytokine secretio...,68,1,1.14,0.68352,1,0.9797730831099195,0.88,BP
GO:0050771,negative regulation of axonogenesis,68,1,1.14,0.68352,1,0.9797730831099195,0.88,BP
GO:0090278,negative regulation of peptide hormone s...,68,1,1.14,0.68352,1,0.9797730831099195,0.88,BP
GO:1905515,non-motile cilium assembly,68,1,1.14,0.68352,1,0.9797730831099195,0.88,BP
GO:0007338,single fertilization,141,2,2.36,0.68670,1,0.9832838801542569,0.85,BP
GO:0046165,alcohol biosynthetic process,141,2,2.36,0.68670,1,0.9832838801542569,0.85,BP
GO:0050729,positive regulation of inflammatory resp...,141,2,2.36,0.68670,1,0.9832838801542569,0.85,BP
GO:1903508,positive regulation of nucleic acid-temp...,1551,24,25.98,0.68730,1,0.9832838801542569,0.92,BP
GO:0009615,response to virus,278,4,4.66,0.68740,1,0.9832838801542569,0.86,BP
GO:0018205,peptidyl-lysine modification,345,5,5.78,0.68849,1,0.9832838801542569,0.87,BP
GO:1902680,positive regulation of RNA biosynthetic ...,1552,24,26,0.68850,1,0.9832838801542569,0.92,BP
GO:0000768,syncytium formation by plasma membrane f...,69,1,1.16,0.68883,1,0.9832838801542569,0.86,BP
GO:0030888,regulation of B cell proliferation,69,1,1.16,0.68883,1,0.9832838801542569,0.86,BP
GO:0032370,positive regulation of lipid transport,69,1,1.16,0.68883,1,0.9832838801542569,0.86,BP
GO:0033692,cellular polysaccharide biosynthetic pro...,69,1,1.16,0.68883,1,0.9832838801542569,0.86,BP
GO:0045576,mast cell activation,69,1,1.16,0.68883,1,0.9832838801542569,0.86,BP
GO:0051298,centrosome duplication,69,1,1.16,0.68883,1,0.9832838801542569,0.86,BP
GO:0140253,cell-cell fusion,69,1,1.16,0.68883,1,0.9832838801542569,0.86,BP
GO:0002758,innate immune response-activating signal...,142,2,2.38,0.69043,1,0.9852755516014234,0.84,BP
GO:1904950,negative regulation of establishment of ...,212,3,3.55,0.69226,1,0.9867372053175775,0.85,BP
GO:0003007,heart morphogenesis,280,4,4.69,0.69276,1,0.9867372053175775,0.85,BP
GO:0002562,somatic diversification of immune recept...,70,1,1.17,0.69406,1,0.9867372053175775,0.85,BP
GO:0006855,drug transmembrane transport,70,1,1.17,0.69406,1,0.9867372053175775,0.85,BP
GO:0010633,negative regulation of epithelial cell m...,70,1,1.17,0.69406,1,0.9867372053175775,0.85,BP
GO:0016444,somatic cell DNA recombination,70,1,1.17,0.69406,1,0.9867372053175775,0.85,BP
GO:0046635,positive regulation of alpha-beta T cell...,70,1,1.17,0.69406,1,0.9867372053175775,0.85,BP
GO:0050909,sensory perception of taste,70,1,1.17,0.69406,1,0.9867372053175775,0.85,BP
GO:1902807,negative regulation of cell cycle G1/S p...,70,1,1.17,0.69406,1,0.9867372053175775,0.85,BP
GO:1990868,response to chemokine,70,1,1.17,0.69406,1,0.9867372053175775,0.85,BP
GO:1990869,cellular response to chemokine,70,1,1.17,0.69406,1,0.9867372053175775,0.85,BP
GO:0061041,regulation of wound healing,143,2,2.4,0.69412,1,0.9867372053175775,0.83,BP
GO:0072089,stem cell proliferation,143,2,2.4,0.69412,1,0.9867372053175775,0.83,BP
GO:0009101,glycoprotein biosynthetic process,281,4,4.71,0.69542,1,0.9877098701298702,0.85,BP
GO:0042742,defense response to bacterium,281,4,4.71,0.69542,1,0.9877098701298702,0.85,BP
GO:0071219,cellular response to molecule of bacteri...,281,4,4.71,0.69542,1,0.9877098701298702,0.85,BP
GO:0046330,positive regulation of JNK cascade,144,2,2.41,0.69777,1,0.9898647837599295,0.83,BP
GO:0055007,cardiac muscle cell differentiation,144,2,2.41,0.69777,1,0.9898647837599295,0.83,BP
GO:0071229,cellular response to acid chemical,282,4,4.72,0.69807,1,0.9898647837599295,0.85,BP
GO:0006949,syncytium formation,71,1,1.19,0.69920,1,0.9898647837599295,0.84,BP
GO:0007492,endoderm development,71,1,1.19,0.69920,1,0.9898647837599295,0.84,BP
GO:0009119,ribonucleoside metabolic process,71,1,1.19,0.69920,1,0.9898647837599295,0.84,BP
GO:0032413,negative regulation of ion transmembrane...,71,1,1.19,0.69920,1,0.9898647837599295,0.84,BP
GO:0046173,polyol biosynthetic process,71,1,1.19,0.69920,1,0.9898647837599295,0.84,BP
GO:0060675,ureteric bud morphogenesis,71,1,1.19,0.69920,1,0.9898647837599295,0.84,BP
GO:0061045,negative regulation of wound healing,71,1,1.19,0.69920,1,0.9898647837599295,0.84,BP
GO:0070192,chromosome organization involved in meio...,71,1,1.19,0.69920,1,0.9898647837599295,0.84,BP
GO:0030239,myofibril assembly,72,1,1.21,0.70426,1,0.9958846194534235,0.83,BP
GO:0072171,mesonephric tubule morphogenesis,72,1,1.21,0.70426,1,0.9958846194534235,0.83,BP
GO:0097755,positive regulation of blood vessel diam...,72,1,1.21,0.70426,1,0.9958846194534235,0.83,BP
GO:0008406,gonad development,216,3,3.62,0.70428,1,0.9958846194534235,0.83,BP
GO:0007224,smoothened signaling pathway,146,2,2.45,0.70497,1,0.9959822783323546,0.82,BP
GO:0070665,positive regulation of leukocyte prolife...,146,2,2.45,0.70497,1,0.9959822783323546,0.82,BP
GO:0097530,granulocyte migration,146,2,2.45,0.70497,1,0.9959822783323546,0.82,BP
GO:0046660,female sex differentiation,147,2,2.46,0.70852,1,1,0.81,BP
GO:0006094,gluconeogenesis,73,1,1.22,0.70923,1,1,0.82,BP
GO:0051145,smooth muscle cell differentiation,73,1,1.22,0.70923,1,1,0.82,BP
GO:0006475,internal protein amino acid acetylation,148,2,2.48,0.71203,1,1,0.81,BP
GO:0030856,regulation of epithelial cell differenti...,148,2,2.48,0.71203,1,1,0.81,BP
GO:0043547,positive regulation of GTPase activity,219,3,3.67,0.71305,1,1,0.82,BP
GO:0040029,"regulation of gene expression, epigeneti...",288,4,4.82,0.71358,1,1,0.83,BP
GO:0007193,adenylate cyclase-inhibiting G protein-c...,74,1,1.24,0.71412,1,1,0.81,BP
GO:0008543,fibroblast growth factor receptor signal...,74,1,1.24,0.71412,1,1,0.81,BP
GO:0031397,negative regulation of protein ubiquitin...,74,1,1.24,0.71412,1,1,0.81,BP
GO:0042108,positive regulation of cytokine biosynth...,74,1,1.24,0.71412,1,1,0.81,BP
GO:0050810,regulation of steroid biosynthetic proce...,74,1,1.24,0.71412,1,1,0.81,BP
GO:0051155,positive regulation of striated muscle c...,74,1,1.24,0.71412,1,1,0.81,BP
GO:1901983,regulation of protein acetylation,74,1,1.24,0.71412,1,1,0.81,BP
GO:0045137,development of primary sexual characteri...,220,3,3.69,0.71594,1,1,0.81,BP
GO:0048545,response to steroid hormone,220,3,3.69,0.71594,1,1,0.81,BP
GO:0008625,extrinsic apoptotic signaling pathway vi...,75,1,1.26,0.71892,1,1,0.79,BP
GO:0048645,animal organ formation,75,1,1.26,0.71892,1,1,0.79,BP
GO:0060350,endochondral bone morphogenesis,75,1,1.26,0.71892,1,1,0.79,BP
GO:0045580,regulation of T cell differentiation,151,2,2.53,0.72235,1,1,0.79,BP
GO:0019229,regulation of vasoconstriction,76,1,1.27,0.72365,1,1,0.79,BP
GO:0019319,hexose biosynthetic process,76,1,1.27,0.72365,1,1,0.79,BP
GO:0048844,artery morphogenesis,76,1,1.27,0.72365,1,1,0.79,BP
GO:0031348,negative regulation of defense response,223,3,3.74,0.72444,1,1,0.8,BP
GO:0043588,skin development,293,4,4.91,0.72606,1,1,0.81,BP
GO:0000271,polysaccharide biosynthetic process,77,1,1.29,0.72829,1,1,0.78,BP
GO:0002200,somatic diversification of immune recept...,77,1,1.29,0.72829,1,1,0.78,BP
GO:0015918,sterol transport,77,1,1.29,0.72829,1,1,0.78,BP
GO:0030301,cholesterol transport,77,1,1.29,0.72829,1,1,0.78,BP
GO:0051303,establishment of chromosome localization,77,1,1.29,0.72829,1,1,0.78,BP
GO:0051965,positive regulation of synapse assembly,77,1,1.29,0.72829,1,1,0.78,BP
GO:0140056,organelle localization by membrane tethe...,77,1,1.29,0.72829,1,1,0.78,BP
GO:0043405,regulation of MAP kinase activity,294,4,4.92,0.72850,1,1,0.81,BP
GO:0010675,regulation of cellular carbohydrate meta...,154,2,2.58,0.73236,1,1,0.78,BP
GO:0050000,chromosome localization,78,1,1.31,0.73286,1,1,0.76,BP
GO:0001838,embryonic epithelial tube formation,155,2,2.6,0.73562,1,1,0.77,BP
GO:0045088,regulation of innate immune response,297,4,4.97,0.73574,1,1,0.8,BP
GO:0010389,regulation of G2/M transition of mitotic...,79,1,1.32,0.73735,1,1,0.76,BP
GO:0060976,coronary vasculature development,79,1,1.32,0.73735,1,1,0.76,BP
GO:0061844,antimicrobial humoral immune response me...,79,1,1.32,0.73735,1,1,0.76,BP
GO:0070373,negative regulation of ERK1 and ERK2 cas...,79,1,1.32,0.73735,1,1,0.76,BP
GO:0072078,nephron tubule morphogenesis,79,1,1.32,0.73735,1,1,0.76,BP
GO:0006694,steroid biosynthetic process,156,2,2.61,0.73886,1,1,0.77,BP
GO:0030178,negative regulation of Wnt signaling pat...,156,2,2.61,0.73886,1,1,0.77,BP
GO:0050954,sensory perception of mechanical stimulu...,299,4,5.01,0.74049,1,1,0.8,BP
GO:0009887,animal organ morphogenesis,1090,16,18.26,0.74169,1,1,0.88,BP
GO:0032410,negative regulation of transporter activ...,80,1,1.34,0.74177,1,1,0.75,BP
GO:0032890,regulation of organic acid transport,80,1,1.34,0.74177,1,1,0.75,BP
GO:0046631,alpha-beta T cell activation,157,2,2.63,0.74206,1,1,0.76,BP
GO:0051896,regulation of protein kinase B signaling,157,2,2.63,0.74206,1,1,0.76,BP
GO:0030855,epithelial cell differentiation,638,9,10.69,0.74513,1,1,0.84,BP
GO:0002088,lens development in camera-type eye,81,1,1.36,0.74611,1,1,0.74,BP
GO:0005977,glycogen metabolic process,81,1,1.36,0.74611,1,1,0.74,BP
GO:0006073,cellular glucan metabolic process,81,1,1.36,0.74611,1,1,0.74,BP
GO:0042147,"retrograde transport, endosome to Golgi",81,1,1.36,0.74611,1,1,0.74,BP
GO:0043367,"CD4-positive, alpha-beta T cell differen...",81,1,1.36,0.74611,1,1,0.74,BP
GO:0044042,glucan metabolic process,81,1,1.36,0.74611,1,1,0.74,BP
GO:0072088,nephron epithelium morphogenesis,81,1,1.36,0.74611,1,1,0.74,BP
GO:2000243,positive regulation of reproductive proc...,81,1,1.36,0.74611,1,1,0.74,BP
GO:0051606,detection of stimulus,231,3,3.87,0.74616,1,1,0.78,BP
GO:0090596,sensory organ morphogenesis,302,4,5.06,0.74749,1,1,0.79,BP
GO:0006637,acyl-CoA metabolic process,82,1,1.37,0.75038,1,1,0.73,BP
GO:0021675,nerve development,82,1,1.37,0.75038,1,1,0.73,BP
GO:0031646,positive regulation of neurological syst...,82,1,1.37,0.75038,1,1,0.73,BP
GO:0032651,regulation of interleukin-1 beta product...,82,1,1.37,0.75038,1,1,0.73,BP
GO:0035383,thioester metabolic process,82,1,1.37,0.75038,1,1,0.73,BP
GO:0071674,mononuclear cell migration,82,1,1.37,0.75038,1,1,0.73,BP
GO:0072028,nephron morphogenesis,82,1,1.37,0.75038,1,1,0.73,BP
GO:0071356,cellular response to tumor necrosis fact...,161,2,2.7,0.75452,1,1,0.74,BP
GO:0071466,cellular response to xenobiotic stimulus,161,2,2.7,0.75452,1,1,0.74,BP
GO:0072175,epithelial tube formation,161,2,2.7,0.75452,1,1,0.74,BP
GO:0002312,B cell activation involved in immune res...,83,1,1.39,0.75458,1,1,0.72,BP
GO:0032436,positive regulation of proteasomal ubiqu...,83,1,1.39,0.75458,1,1,0.72,BP
GO:0006672,ceramide metabolic process,84,1,1.41,0.75870,1,1,0.71,BP
GO:0045844,positive regulation of striated muscle t...,84,1,1.41,0.75870,1,1,0.71,BP
GO:0048636,positive regulation of muscle organ deve...,84,1,1.41,0.75870,1,1,0.71,BP
GO:0051607,defense response to virus,236,3,3.95,0.75903,1,1,0.76,BP
GO:0051707,response to other organism,1040,15,17.42,0.76000,1,1,0.86,BP
GO:0043207,response to external biotic stimulus,1042,15,17.45,0.76250,1,1,0.86,BP
GO:0008589,regulation of smoothened signaling pathw...,85,1,1.42,0.76276,1,1,0.7,BP
GO:0050871,positive regulation of B cell activation,85,1,1.42,0.76276,1,1,0.7,BP
GO:0061333,renal tubule morphogenesis,85,1,1.42,0.76276,1,1,0.7,BP
GO:1901863,positive regulation of muscle tissue dev...,85,1,1.42,0.76276,1,1,0.7,BP
GO:0006970,response to osmotic stress,86,1,1.44,0.76675,1,1,0.69,BP
GO:0098659,inorganic cation import across plasma me...,86,1,1.44,0.76675,1,1,0.69,BP
GO:0099587,inorganic ion import across plasma membr...,86,1,1.44,0.76675,1,1,0.69,BP
GO:0003281,ventricular septum development,87,1,1.46,0.77067,1,1,0.68,BP
GO:0002218,activation of innate immune response,167,2,2.8,0.77224,1,1,0.71,BP
GO:0001763,morphogenesis of a branching structure,242,3,4.05,0.77377,1,1,0.74,BP
GO:0044344,cellular response to fibroblast growth f...,88,1,1.47,0.77453,1,1,0.68,BP
GO:0019827,stem cell population maintenance,169,2,2.83,0.77790,1,1,0.71,BP
GO:0043122,regulation of I-kappaB kinase/NF-kappaB ...,169,2,2.83,0.77790,1,1,0.71,BP
GO:0035914,skeletal muscle cell differentiation,89,1,1.49,0.77832,1,1,0.67,BP
GO:1904035,regulation of epithelial cell apoptotic ...,89,1,1.49,0.77832,1,1,0.67,BP
GO:0009116,nucleoside metabolic process,90,1,1.51,0.78205,1,1,0.66,BP
GO:0071774,response to fibroblast growth factor,90,1,1.51,0.78205,1,1,0.66,BP
GO:0072091,regulation of stem cell proliferation,90,1,1.51,0.78205,1,1,0.66,BP
GO:1904063,negative regulation of cation transmembr...,90,1,1.51,0.78205,1,1,0.66,BP
GO:1905954,positive regulation of lipid localizatio...,90,1,1.51,0.78205,1,1,0.66,BP
GO:0048562,embryonic organ morphogenesis,318,4,5.33,0.78240,1,1,0.75,BP
GO:0032874,positive regulation of stress-activated ...,172,2,2.88,0.78615,1,1,0.69,BP
GO:0035296,regulation of tube diameter,173,2,2.9,0.78884,1,1,0.69,BP
GO:0050880,regulation of blood vessel size,173,2,2.9,0.78884,1,1,0.69,BP
GO:0070304,positive regulation of stress-activated ...,173,2,2.9,0.78884,1,1,0.69,BP
GO:0097746,regulation of blood vessel diameter,173,2,2.9,0.78884,1,1,0.69,BP
GO:0098727,maintenance of cell number,173,2,2.9,0.78884,1,1,0.69,BP
GO:0001938,positive regulation of endothelial cell ...,92,1,1.54,0.78932,1,1,0.65,BP
GO:0009798,axis specification,92,1,1.54,0.78932,1,1,0.65,BP
GO:0035107,appendage morphogenesis,174,2,2.91,0.79150,1,1,0.69,BP
GO:0035108,limb morphogenesis,174,2,2.91,0.79150,1,1,0.69,BP
GO:0035150,regulation of tube size,174,2,2.91,0.79150,1,1,0.69,BP
GO:0009062,fatty acid catabolic process,93,1,1.56,0.79287,1,1,0.64,BP
GO:0060395,SMAD protein signal transduction,93,1,1.56,0.79287,1,1,0.64,BP
GO:0031644,regulation of neurological system proces...,175,2,2.93,0.79413,1,1,0.68,BP
GO:0030098,lymphocyte differentiation,396,5,6.63,0.79580,1,1,0.75,BP
GO:0032611,interleukin-1 beta production,94,1,1.57,0.79635,1,1,0.64,BP
GO:2000060,positive regulation of ubiquitin-depende...,94,1,1.57,0.79635,1,1,0.64,BP
GO:0035148,tube formation,176,2,2.95,0.79673,1,1,0.68,BP
GO:0006479,protein methylation,177,2,2.96,0.79931,1,1,0.68,BP
GO:0008213,protein alkylation,177,2,2.96,0.79931,1,1,0.68,BP
GO:0045582,positive regulation of T cell differenti...,95,1,1.59,0.79978,1,1,0.63,BP
GO:0060021,roof of mouth development,95,1,1.59,0.79978,1,1,0.63,BP
GO:0034612,response to tumor necrosis factor,178,2,2.98,0.80185,1,1,0.67,BP
GO:0006352,"DNA-templated transcription, initiation",96,1,1.61,0.80315,1,1,0.62,BP
GO:0061053,somite development,96,1,1.61,0.80315,1,1,0.62,BP
GO:0007200,phospholipase C-activating G protein-cou...,97,1,1.62,0.80646,1,1,0.62,BP
GO:0019395,fatty acid oxidation,97,1,1.62,0.80646,1,1,0.62,BP
GO:0046888,negative regulation of hormone secretion,97,1,1.62,0.80646,1,1,0.62,BP
GO:0048525,negative regulation of viral process,97,1,1.62,0.80646,1,1,0.62,BP
GO:0072080,nephron tubule development,97,1,1.62,0.80646,1,1,0.62,BP
GO:0019730,antimicrobial humoral response,98,1,1.64,0.80972,1,1,0.61,BP
GO:0045132,meiotic chromosome segregation,98,1,1.64,0.80972,1,1,0.61,BP
GO:0060993,kidney morphogenesis,98,1,1.64,0.80972,1,1,0.61,BP
GO:0033865,nucleoside bisphosphate metabolic proces...,99,1,1.66,0.81292,1,1,0.6,BP
GO:0033875,ribonucleoside bisphosphate metabolic pr...,99,1,1.66,0.81292,1,1,0.6,BP
GO:0034032,purine nucleoside bisphosphate metabolic...,99,1,1.66,0.81292,1,1,0.6,BP
GO:0034440,lipid oxidation,99,1,1.66,0.81292,1,1,0.6,BP
GO:0002683,negative regulation of immune system pro...,478,6,8.01,0.81479,1,1,0.75,BP
GO:0030101,natural killer cell activation,100,1,1.68,0.81607,1,1,0.6,BP
GO:0032652,regulation of interleukin-1 production,100,1,1.68,0.81607,1,1,0.6,BP
GO:0016331,morphogenesis of embryonic epithelium,184,2,3.08,0.81652,1,1,0.65,BP
GO:0045619,regulation of lymphocyte differentiation,184,2,3.08,0.81652,1,1,0.65,BP
GO:0001578,microtubule bundle formation,101,1,1.69,0.81916,1,1,0.59,BP
GO:0030593,neutrophil chemotaxis,101,1,1.69,0.81916,1,1,0.59,BP
GO:0042310,vasoconstriction,101,1,1.69,0.81916,1,1,0.59,BP
GO:0055013,cardiac muscle cell development,101,1,1.69,0.81916,1,1,0.59,BP
GO:0009566,fertilization,186,2,3.12,0.82119,1,1,0.64,BP
GO:0000077,DNA damage checkpoint,102,1,1.71,0.82221,1,1,0.58,BP
GO:0019218,regulation of steroid metabolic process,103,1,1.73,0.82520,1,1,0.58,BP
GO:0061326,renal tubule development,103,1,1.73,0.82520,1,1,0.58,BP
GO:1902106,negative regulation of leukocyte differe...,103,1,1.73,0.82520,1,1,0.58,BP
GO:0043010,camera-type eye development,341,4,5.71,0.82575,1,1,0.7,BP
GO:0006473,protein acetylation,188,2,3.15,0.82576,1,1,0.63,BP
GO:0019221,cytokine-mediated signaling pathway,342,4,5.73,0.82746,1,1,0.7,BP
GO:0001657,ureteric bud development,104,1,1.74,0.82814,1,1,0.57,BP
GO:0009953,dorsal/ventral pattern formation,104,1,1.74,0.82814,1,1,0.57,BP
GO:0043255,regulation of carbohydrate biosynthetic ...,104,1,1.74,0.82814,1,1,0.57,BP
GO:0046634,regulation of alpha-beta T cell activati...,104,1,1.74,0.82814,1,1,0.57,BP
GO:0048704,embryonic skeletal system morphogenesis,104,1,1.74,0.82814,1,1,0.57,BP
GO:0072163,mesonephric epithelium development,104,1,1.74,0.82814,1,1,0.57,BP
GO:0072164,mesonephric tubule development,104,1,1.74,0.82814,1,1,0.57,BP
GO:0007605,sensory perception of sound,268,3,4.49,0.82933,1,1,0.67,BP
GO:0000018,regulation of DNA recombination,105,1,1.76,0.83103,1,1,0.57,BP
GO:1901800,positive regulation of proteasomal prote...,105,1,1.76,0.83103,1,1,0.57,BP
GO:1903825,organic acid transmembrane transport,105,1,1.76,0.83103,1,1,0.57,BP
GO:1905039,carboxylic acid transmembrane transport,105,1,1.76,0.83103,1,1,0.57,BP
GO:0001655,urogenital system development,345,4,5.78,0.83251,1,1,0.69,BP
GO:0009617,response to bacterium,769,10,12.88,0.83329,1,1,0.78,BP
GO:0001823,mesonephros development,107,1,1.79,0.83667,1,1,0.56,BP
GO:0044264,cellular polysaccharide metabolic proces...,107,1,1.79,0.83667,1,1,0.56,BP
GO:0055006,cardiac cell development,107,1,1.79,0.83667,1,1,0.56,BP
GO:0060840,artery development,107,1,1.79,0.83667,1,1,0.56,BP
GO:0097756,negative regulation of blood vessel diam...,107,1,1.79,0.83667,1,1,0.56,BP
GO:0030198,extracellular matrix organization,272,3,4.56,0.83676,1,1,0.66,BP
GO:0071222,cellular response to lipopolysaccharide,273,3,4.57,0.83857,1,1,0.66,BP
GO:0032496,response to lipopolysaccharide,349,4,5.85,0.83906,1,1,0.68,BP
GO:0022600,digestive system process,108,1,1.81,0.83942,1,1,0.55,BP
GO:0072009,nephron epithelium development,108,1,1.81,0.83942,1,1,0.55,BP
GO:0045621,positive regulation of lymphocyte differ...,109,1,1.83,0.84213,1,1,0.55,BP
GO:0050731,positive regulation of peptidyl-tyrosine...,196,2,3.28,0.84298,1,1,0.61,BP
GO:0009792,embryo development ending in birth or eg...,848,11,14.2,0.84498,1,1,0.77,BP
GO:0007249,I-kappaB kinase/NF-kappaB signaling,197,2,3.3,0.84502,1,1,0.61,BP
GO:0001843,neural tube closure,111,1,1.86,0.84740,1,1,0.54,BP
GO:0046632,alpha-beta T cell differentiation,111,1,1.86,0.84740,1,1,0.54,BP
GO:0006486,protein glycosylation,199,2,3.33,0.84903,1,1,0.6,BP
GO:0043413,macromolecule glycosylation,199,2,3.33,0.84903,1,1,0.6,BP
GO:0048736,appendage development,199,2,3.33,0.84903,1,1,0.6,BP
GO:0060173,limb development,199,2,3.33,0.84903,1,1,0.6,BP
GO:0001959,regulation of cytokine-mediated signalin...,112,1,1.88,0.84997,1,1,0.53,BP
GO:0031570,DNA integrity checkpoint,112,1,1.88,0.84997,1,1,0.53,BP
GO:0060606,tube closure,112,1,1.88,0.84997,1,1,0.53,BP
GO:0001822,kidney development,280,3,4.69,0.85077,1,1,0.64,BP
GO:0002286,T cell activation involved in immune res...,113,1,1.89,0.85249,1,1,0.53,BP
GO:0032612,interleukin-1 production,113,1,1.89,0.85249,1,1,0.53,BP
GO:0050830,defense response to Gram-positive bacter...,113,1,1.89,0.85249,1,1,0.53,BP
GO:0090101,negative regulation of transmembrane rec...,113,1,1.89,0.85249,1,1,0.53,BP
GO:0006310,DNA recombination,282,3,4.72,0.85411,1,1,0.64,BP
GO:0008630,intrinsic apoptotic signaling pathway in...,114,1,1.91,0.85498,1,1,0.52,BP
GO:1904019,epithelial cell apoptotic process,114,1,1.91,0.85498,1,1,0.52,BP
GO:0046467,membrane lipid biosynthetic process,115,1,1.93,0.85742,1,1,0.52,BP
GO:0003018,vascular process in circulatory system,204,2,3.42,0.85865,1,1,0.58,BP
GO:0006959,humoral immune response,204,2,3.42,0.85865,1,1,0.58,BP
GO:0043414,macromolecule methylation,285,3,4.77,0.85899,1,1,0.63,BP
GO:0007188,adenylate cyclase-modulating G protein-c...,205,2,3.43,0.86051,1,1,0.58,BP
GO:0002250,adaptive immune response,439,5,7.35,0.86178,1,1,0.68,BP
GO:0060349,bone morphogenesis,117,1,1.96,0.86218,1,1,0.51,BP
GO:0044262,cellular carbohydrate metabolic process,288,3,4.82,0.86373,1,1,0.62,BP
GO:0005976,polysaccharide metabolic process,118,1,1.98,0.86450,1,1,0.51,BP
GO:0042476,odontogenesis,118,1,1.98,0.86450,1,1,0.51,BP
GO:0098739,import across plasma membrane,119,1,1.99,0.86679,1,1,0.5,BP
GO:1990266,neutrophil migration,119,1,1.99,0.86679,1,1,0.5,BP
GO:0007548,sex differentiation,290,3,4.86,0.86681,1,1,0.62,BP
GO:0051216,cartilage development,210,2,3.52,0.86945,1,1,0.57,BP
GO:0018193,peptidyl-amino acid modification,1147,15,19.21,0.86992,1,1,0.78,BP
GO:0008584,male gonad development,122,1,2.04,0.87341,1,1,0.49,BP
GO:0070085,glycosylation,213,2,3.57,0.87457,1,1,0.56,BP
GO:0046546,development of primary male sexual chara...,123,1,2.06,0.87554,1,1,0.49,BP
GO:0060759,regulation of response to cytokine stimu...,123,1,2.06,0.87554,1,1,0.49,BP
GO:0007586,digestion,124,1,2.08,0.87764,1,1,0.48,BP
GO:0090090,negative regulation of canonical Wnt sig...,124,1,2.08,0.87764,1,1,0.48,BP
GO:0001501,skeletal system development,528,6,8.84,0.87972,1,1,0.68,BP
GO:0072001,renal system development,301,3,5.04,0.88269,1,1,0.6,BP
GO:0048762,mesenchymal cell differentiation,219,2,3.67,0.88424,1,1,0.54,BP
GO:0007098,centrosome cycle,128,1,2.14,0.88568,1,1,0.47,BP
GO:0008277,regulation of G protein-coupled receptor...,129,1,2.16,0.88760,1,1,0.46,BP
GO:0007189,adenylate cyclase-activating G protein-c...,131,1,2.19,0.89136,1,1,0.46,BP
GO:0001654,eye development,389,4,6.52,0.89344,1,1,0.61,BP
GO:0043009,chordate embryonic development,831,10,13.92,0.89345,1,1,0.72,BP
GO:0001701,in utero embryonic development,542,6,9.08,0.89406,1,1,0.66,BP
GO:0050906,detection of stimulus involved in sensor...,133,1,2.23,0.89499,1,1,0.45,BP
GO:0150063,visual system development,392,4,6.57,0.89678,1,1,0.61,BP
GO:0070646,protein modification by small protein re...,135,1,2.26,0.89850,1,1,0.44,BP
GO:0048880,sensory system development,395,4,6.62,0.90003,1,1,0.6,BP
GO:0035023,regulation of Rho protein signal transdu...,136,1,2.28,0.90021,1,1,0.44,BP
GO:0050864,regulation of B cell activation,136,1,2.28,0.90021,1,1,0.44,BP
GO:0035270,endocrine system development,137,1,2.29,0.90189,1,1,0.44,BP
GO:0045598,regulation of fat cell differentiation,137,1,2.29,0.90189,1,1,0.44,BP
GO:0048593,camera-type eye morphogenesis,137,1,2.29,0.90189,1,1,0.44,BP
GO:0009952,anterior/posterior pattern specification,232,2,3.89,0.90289,1,1,0.51,BP
GO:0048706,embryonic skeletal system development,139,1,2.33,0.90517,1,1,0.43,BP
GO:0007187,G protein-coupled receptor signaling pat...,234,2,3.92,0.90549,1,1,0.51,BP
GO:0002009,morphogenesis of an epithelium,555,6,9.3,0.90604,1,1,0.65,BP
GO:0016573,histone acetylation,140,1,2.35,0.90677,1,1,0.43,BP
GO:0033002,muscle cell proliferation,237,2,3.97,0.90928,1,1,0.5,BP
GO:0030216,keratinocyte differentiation,142,1,2.38,0.90989,1,1,0.42,BP
GO:0072073,kidney epithelium development,142,1,2.38,0.90989,1,1,0.42,BP
GO:0019233,sensory perception of pain,144,1,2.41,0.91290,1,1,0.41,BP
GO:0090288,negative regulation of cellular response...,144,1,2.41,0.91290,1,1,0.41,BP
GO:0018393,internal peptidyl-lysine acetylation,145,1,2.43,0.91437,1,1,0.41,BP
GO:0030326,embryonic limb morphogenesis,145,1,2.43,0.91437,1,1,0.41,BP
GO:0035113,embryonic appendage morphogenesis,145,1,2.43,0.91437,1,1,0.41,BP
GO:0072006,nephron development,146,1,2.45,0.91582,1,1,0.41,BP
GO:0045216,cell-cell junction organization,147,1,2.46,0.91724,1,1,0.41,BP
GO:0048568,embryonic organ development,495,5,8.29,0.92011,1,1,0.6,BP
GO:0006865,amino acid transport,151,1,2.53,0.92268,1,1,0.4,BP
GO:0022612,gland morphogenesis,151,1,2.53,0.92268,1,1,0.4,BP
GO:0050728,negative regulation of inflammatory resp...,152,1,2.55,0.92399,1,1,0.39,BP
GO:0001824,blastocyst development,153,1,2.56,0.92527,1,1,0.39,BP
GO:0032259,methylation,339,3,5.68,0.92534,1,1,0.53,BP
GO:0046661,male sex differentiation,154,1,2.58,0.92653,1,1,0.39,BP
GO:0051053,negative regulation of DNA metabolic pro...,155,1,2.6,0.92777,1,1,0.38,BP
GO:0018394,peptidyl-lysine acetylation,156,1,2.61,0.92899,1,1,0.38,BP
GO:0002244,hematopoietic progenitor cell differenti...,158,1,2.65,0.93136,1,1,0.38,BP
GO:1903707,negative regulation of hemopoiesis,159,1,2.66,0.93252,1,1,0.38,BP
GO:0030509,BMP signaling pathway,170,1,2.85,0.94405,1,1,0.35,BP
GO:0060485,mesenchyme development,275,2,4.61,0.94645,1,1,0.43,BP
GO:0071230,cellular response to amino acid stimulus,175,1,2.93,0.94861,1,1,0.34,BP
GO:0042113,B cell activation,278,2,4.66,0.94866,1,1,0.43,BP
GO:0048592,eye morphogenesis,176,1,2.95,0.94948,1,1,0.34,BP
GO:0061448,connective tissue development,284,2,4.76,0.95284,1,1,0.42,BP
GO:0071772,response to BMP,181,1,3.03,0.95361,1,1,0.33,BP
GO:0071773,cellular response to BMP stimulus,181,1,3.03,0.95361,1,1,0.33,BP
GO:0060562,epithelial tube morphogenesis,381,3,6.38,0.95565,1,1,0.47,BP
GO:0048754,branching morphogenesis of an epithelial...,186,1,3.12,0.95740,1,1,0.32,BP
GO:0030258,lipid modification,221,1,3.7,0.97655,1,1,0.27,BP
GO:0061138,morphogenesis of a branching epithelium,223,1,3.74,0.97733,1,1,0.27,BP
GO:0046578,regulation of Ras protein signal transdu...,229,1,3.84,0.97954,1,1,0.26,BP
GO:0045444,fat cell differentiation,241,1,4.04,0.98333,1,1,0.25,BP
GO:0003008,system process,2937,36,49.19,0.98593,1,1,0.73,BP
GO:0003002,regionalization,376,2,6.3,0.98761,1,1,0.32,BP
GO:0048705,skeletal system morphogenesis,259,1,4.34,0.98775,1,1,0.23,BP
GO:0051056,regulation of small GTPase mediated sign...,260,1,4.36,0.98796,1,1,0.23,BP
GO:0007389,pattern specification process,470,2,7.87,0.99701,1,1,0.25,BP
GO:0050877,nervous system process,2290,20,38.36,0.99979,1,1,0.52,BP
GO:0007186,G protein-coupled receptor signaling pat...,1902,8,31.86,1.00000,1,1,0.25,BP
GO:0007600,sensory perception,1781,6,29.83,1.00000,1,1,0.2,BP
GO:0007606,sensory perception of chemical stimulus,1218,1,20.4,1.00000,1,1,0.05,BP
GO:0008150,biological_process,21194,355,355,1.00000,1,1,1,BP
GO:0000002,mitochondrial genome maintenance,34,0,0.57,1.00000,1,1,0,BP
GO:0000154,rRNA modification,25,0,0.42,1.00000,1,1,0,BP
GO:0000186,activation of MAPKK activity,34,0,0.57,1.00000,1,1,0,BP
GO:0000272,polysaccharide catabolic process,25,0,0.42,1.00000,1,1,0,BP
GO:0000387,spliceosomal snRNP assembly,31,0,0.52,1.00000,1,1,0,BP
GO:0000578,embryonic axis specification,38,0,0.64,1.00000,1,1,0,BP
GO:0000731,DNA synthesis involved in DNA repair,28,0,0.47,1.00000,1,1,0,BP
GO:0000737,"DNA catabolic process, endonucleolytic",26,0,0.44,1.00000,1,1,0,BP
GO:0000959,mitochondrial RNA metabolic process,42,0,0.7,1.00000,1,1,0,BP
GO:0001510,RNA methylation,64,0,1.07,1.00000,1,1,0,BP
GO:0001523,retinoid metabolic process,55,0,0.92,1.00000,1,1,0,BP
GO:0001539,cilium or flagellum-dependent cell motil...,35,0,0.59,1.00000,1,1,0,BP
GO:0001569,branching involved in blood vessel morph...,44,0,0.74,1.00000,1,1,0,BP
GO:0001573,ganglioside metabolic process,20,0,0.34,1.00000,1,1,0,BP
GO:0001580,detection of chemical stimulus involved ...,48,0,0.8,1.00000,1,1,0,BP
GO:0001656,metanephros development,89,0,1.49,1.00000,1,1,0,BP
GO:0001696,gastric acid secretion,20,0,0.34,1.00000,1,1,0,BP
GO:0001702,gastrulation with mouth forming second,37,0,0.62,1.00000,1,1,0,BP
GO:0001756,somitogenesis,77,0,1.29,1.00000,1,1,0,BP
GO:0001759,organ induction,28,0,0.47,1.00000,1,1,0,BP
GO:0001773,myeloid dendritic cell activation,33,0,0.55,1.00000,1,1,0,BP
GO:0001776,leukocyte homeostasis,110,0,1.84,1.00000,1,1,0,BP
GO:0001779,natural killer cell differentiation,31,0,0.52,1.00000,1,1,0,BP
GO:0001780,neutrophil homeostasis,22,0,0.37,1.00000,1,1,0,BP
GO:0001782,B cell homeostasis,37,0,0.62,1.00000,1,1,0,BP
GO:0001783,B cell apoptotic process,41,0,0.69,1.00000,1,1,0,BP
GO:0001825,blastocyst formation,60,0,1.01,1.00000,1,1,0,BP
GO:0001829,trophectodermal cell differentiation,25,0,0.42,1.00000,1,1,0,BP
GO:0001832,blastocyst growth,31,0,0.52,1.00000,1,1,0,BP
GO:0001835,blastocyst hatching,40,0,0.67,1.00000,1,1,0,BP
GO:0001837,epithelial to mesenchymal transition,135,0,2.26,1.00000,1,1,0,BP
GO:0001881,receptor recycling,40,0,0.67,1.00000,1,1,0,BP
GO:0001892,embryonic placenta development,114,0,1.91,1.00000,1,1,0,BP
GO:0001911,negative regulation of leukocyte mediate...,23,0,0.39,1.00000,1,1,0,BP
GO:0001919,regulation of receptor recycling,29,0,0.49,1.00000,1,1,0,BP
GO:0001945,lymph vessel development,29,0,0.49,1.00000,1,1,0,BP
GO:0001946,lymphangiogenesis,21,0,0.35,1.00000,1,1,0,BP
GO:0001947,heart looping,60,0,1.01,1.00000,1,1,0,BP
GO:0001956,positive regulation of neurotransmitter ...,26,0,0.44,1.00000,1,1,0,BP
GO:0001960,negative regulation of cytokine-mediated...,52,0,0.87,1.00000,1,1,0,BP
GO:0001964,startle response,32,0,0.54,1.00000,1,1,0,BP
GO:0001974,blood vessel remodeling,51,0,0.85,1.00000,1,1,0,BP
GO:0001976,neurological system process involved in ...,21,0,0.35,1.00000,1,1,0,BP
GO:0002011,morphogenesis of an epithelial sheet,59,0,0.99,1.00000,1,1,0,BP
GO:0002021,response to dietary excess,34,0,0.57,1.00000,1,1,0,BP
GO:0002029,desensitization of G protein-coupled rec...,28,0,0.47,1.00000,1,1,0,BP
GO:0002042,cell migration involved in sprouting ang...,57,0,0.95,1.00000,1,1,0,BP
GO:0002052,positive regulation of neuroblast prolif...,27,0,0.45,1.00000,1,1,0,BP
GO:0002053,positive regulation of mesenchymal cell ...,37,0,0.62,1.00000,1,1,0,BP
GO:0002062,chondrocyte differentiation,119,0,1.99,1.00000,1,1,0,BP
GO:0002063,chondrocyte development,45,0,0.75,1.00000,1,1,0,BP
GO:0002067,glandular epithelial cell differentiatio...,59,0,0.99,1.00000,1,1,0,BP
GO:0002068,glandular epithelial cell development,28,0,0.47,1.00000,1,1,0,BP
GO:0002076,osteoblast development,20,0,0.34,1.00000,1,1,0,BP
GO:0002089,lens morphogenesis in camera-type eye,28,0,0.47,1.00000,1,1,0,BP
GO:0002092,positive regulation of receptor internal...,29,0,0.49,1.00000,1,1,0,BP
GO:0002097,tRNA wobble base modification,21,0,0.35,1.00000,1,1,0,BP
GO:0002115,store-operated calcium entry,22,0,0.37,1.00000,1,1,0,BP
GO:0002260,lymphocyte homeostasis,78,0,1.31,1.00000,1,1,0,BP
GO:0002287,alpha-beta T cell activation involved in...,66,0,1.11,1.00000,1,1,0,BP
GO:0002292,T cell differentiation involved in immun...,71,0,1.19,1.00000,1,1,0,BP
GO:0002293,alpha-beta T cell differentiation involv...,65,0,1.09,1.00000,1,1,0,BP
GO:0002294,"CD4-positive, alpha-beta T cell differen...",64,0,1.07,1.00000,1,1,0,BP
GO:0002313,mature B cell differentiation involved i...,20,0,0.34,1.00000,1,1,0,BP
GO:0002320,lymphoid progenitor cell differentiation,23,0,0.39,1.00000,1,1,0,BP
GO:0002335,mature B cell differentiation,27,0,0.45,1.00000,1,1,0,BP
GO:0002360,T cell lineage commitment,28,0,0.47,1.00000,1,1,0,BP
GO:0002438,acute inflammatory response to antigenic...,25,0,0.42,1.00000,1,1,0,BP
GO:0002476,antigen processing and presentation of e...,30,0,0.5,1.00000,1,1,0,BP
GO:0002484,antigen processing and presentation of e...,30,0,0.5,1.00000,1,1,0,BP
GO:0002486,antigen processing and presentation of e...,29,0,0.49,1.00000,1,1,0,BP
GO:0002495,antigen processing and presentation of p...,21,0,0.35,1.00000,1,1,0,BP
GO:0002504,antigen processing and presentation of p...,22,0,0.37,1.00000,1,1,0,BP
GO:0002507,tolerance induction,28,0,0.47,1.00000,1,1,0,BP
GO:0002526,acute inflammatory response,119,0,1.99,1.00000,1,1,0,BP
GO:0002534,cytokine production involved in inflamma...,45,0,0.75,1.00000,1,1,0,BP
GO:0002548,monocyte chemotaxis,54,0,0.9,1.00000,1,1,0,BP
GO:0002577,regulation of antigen processing and pre...,21,0,0.35,1.00000,1,1,0,BP
GO:0002673,regulation of acute inflammatory respons...,63,0,1.06,1.00000,1,1,0,BP
GO:0002675,positive regulation of acute inflammator...,32,0,0.54,1.00000,1,1,0,BP
GO:0002686,negative regulation of leukocyte migrati...,40,0,0.67,1.00000,1,1,0,BP
GO:0002691,regulation of cellular extravasation,32,0,0.54,1.00000,1,1,0,BP
GO:0002693,positive regulation of cellular extravas...,23,0,0.39,1.00000,1,1,0,BP
GO:0002704,negative regulation of leukocyte mediate...,56,0,0.94,1.00000,1,1,0,BP
GO:0002707,negative regulation of lymphocyte mediat...,46,0,0.77,1.00000,1,1,0,BP
GO:0002712,regulation of B cell mediated immunity,61,0,1.02,1.00000,1,1,0,BP
GO:0002714,positive regulation of B cell mediated i...,46,0,0.77,1.00000,1,1,0,BP
GO:0002716,negative regulation of natural killer ce...,20,0,0.34,1.00000,1,1,0,BP
GO:0002719,negative regulation of cytokine producti...,23,0,0.39,1.00000,1,1,0,BP
GO:0002753,cytoplasmic pattern recognition receptor...,38,0,0.64,1.00000,1,1,0,BP
GO:0002762,negative regulation of myeloid leukocyte...,48,0,0.8,1.00000,1,1,0,BP
GO:0002820,negative regulation of adaptive immune r...,47,0,0.79,1.00000,1,1,0,BP
GO:0002823,negative regulation of adaptive immune r...,42,0,0.7,1.00000,1,1,0,BP
GO:0002825,regulation of T-helper 1 type immune res...,31,0,0.52,1.00000,1,1,0,BP
GO:0002827,positive regulation of T-helper 1 type i...,24,0,0.4,1.00000,1,1,0,BP
GO:0002886,regulation of myeloid leukocyte mediated...,61,0,1.02,1.00000,1,1,0,BP
GO:0002888,positive regulation of myeloid leukocyte...,41,0,0.69,1.00000,1,1,0,BP
GO:0002889,regulation of immunoglobulin mediated im...,61,0,1.02,1.00000,1,1,0,BP
GO:0002891,positive regulation of immunoglobulin me...,46,0,0.77,1.00000,1,1,0,BP
GO:0002902,regulation of B cell apoptotic process,30,0,0.5,1.00000,1,1,0,BP
GO:0002903,negative regulation of B cell apoptotic ...,23,0,0.39,1.00000,1,1,0,BP
GO:0002920,regulation of humoral immune response,36,0,0.6,1.00000,1,1,0,BP
GO:0002931,response to ischemia,35,0,0.59,1.00000,1,1,0,BP
GO:0003009,skeletal muscle contraction,40,0,0.67,1.00000,1,1,0,BP
GO:0003016,respiratory system process,33,0,0.55,1.00000,1,1,0,BP
GO:0003071,renal system process involved in regulat...,27,0,0.45,1.00000,1,1,0,BP
GO:0003085,negative regulation of systemic arterial...,27,0,0.45,1.00000,1,1,0,BP
GO:0003094,glomerular filtration,22,0,0.37,1.00000,1,1,0,BP
GO:0003143,embryonic heart tube morphogenesis,67,0,1.12,1.00000,1,1,0,BP
GO:0003148,outflow tract septum morphogenesis,29,0,0.49,1.00000,1,1,0,BP
GO:0003151,outflow tract morphogenesis,84,0,1.41,1.00000,1,1,0,BP
GO:0003156,regulation of animal organ formation,44,0,0.74,1.00000,1,1,0,BP
GO:0003170,heart valve development,58,0,0.97,1.00000,1,1,0,BP
GO:0003171,atrioventricular valve development,27,0,0.45,1.00000,1,1,0,BP
GO:0003176,aortic valve development,23,0,0.39,1.00000,1,1,0,BP
GO:0003177,pulmonary valve development,21,0,0.35,1.00000,1,1,0,BP
GO:0003179,heart valve morphogenesis,47,0,0.79,1.00000,1,1,0,BP
GO:0003181,atrioventricular valve morphogenesis,24,0,0.4,1.00000,1,1,0,BP
GO:0003197,endocardial cushion development,47,0,0.79,1.00000,1,1,0,BP
GO:0003203,endocardial cushion morphogenesis,34,0,0.57,1.00000,1,1,0,BP
GO:0003209,cardiac atrium morphogenesis,34,0,0.57,1.00000,1,1,0,BP
GO:0003230,cardiac atrium development,38,0,0.64,1.00000,1,1,0,BP
GO:0003272,endocardial cushion formation,24,0,0.4,1.00000,1,1,0,BP
GO:0003283,atrial septum development,21,0,0.35,1.00000,1,1,0,BP
GO:0003309,type B pancreatic cell differentiation,31,0,0.52,1.00000,1,1,0,BP
GO:0003323,type B pancreatic cell development,22,0,0.37,1.00000,1,1,0,BP
GO:0003333,amino acid transmembrane transport,75,0,1.26,1.00000,1,1,0,BP
GO:0003338,metanephros morphogenesis,27,0,0.45,1.00000,1,1,0,BP
GO:0003341,cilium movement,70,0,1.17,1.00000,1,1,0,BP
GO:0003351,epithelial cilium movement,25,0,0.42,1.00000,1,1,0,BP
GO:0003401,axis elongation,36,0,0.6,1.00000,1,1,0,BP
GO:0003413,chondrocyte differentiation involved in ...,29,0,0.49,1.00000,1,1,0,BP
GO:0003416,endochondral bone growth,43,0,0.72,1.00000,1,1,0,BP
GO:0003417,growth plate cartilage development,36,0,0.6,1.00000,1,1,0,BP
GO:0003418,growth plate cartilage chondrocyte diffe...,22,0,0.37,1.00000,1,1,0,BP
GO:0003433,chondrocyte development involved in endo...,22,0,0.37,1.00000,1,1,0,BP
GO:0005980,glycogen catabolic process,20,0,0.34,1.00000,1,1,0,BP
GO:0006022,aminoglycan metabolic process,101,0,1.69,1.00000,1,1,0,BP
GO:0006023,aminoglycan biosynthetic process,53,0,0.89,1.00000,1,1,0,BP
GO:0006024,glycosaminoglycan biosynthetic process,43,0,0.72,1.00000,1,1,0,BP
GO:0006026,aminoglycan catabolic process,26,0,0.44,1.00000,1,1,0,BP
GO:0006029,proteoglycan metabolic process,79,0,1.32,1.00000,1,1,0,BP
GO:0006040,amino sugar metabolic process,43,0,0.72,1.00000,1,1,0,BP
GO:0006111,regulation of gluconeogenesis,51,0,0.85,1.00000,1,1,0,BP
GO:0006144,purine nucleobase metabolic process,23,0,0.39,1.00000,1,1,0,BP
GO:0006213,pyrimidine nucleoside metabolic process,26,0,0.44,1.00000,1,1,0,BP
GO:0006220,pyrimidine nucleotide metabolic process,32,0,0.54,1.00000,1,1,0,BP
GO:0006221,pyrimidine nucleotide biosynthetic proce...,24,0,0.4,1.00000,1,1,0,BP
GO:0006270,DNA replication initiation,29,0,0.49,1.00000,1,1,0,BP
GO:0006289,nucleotide-excision repair,54,0,0.9,1.00000,1,1,0,BP
GO:0006298,mismatch repair,26,0,0.44,1.00000,1,1,0,BP
GO:0006301,postreplication repair,23,0,0.39,1.00000,1,1,0,BP
GO:0006308,DNA catabolic process,33,0,0.55,1.00000,1,1,0,BP
GO:0006312,mitotic recombination,24,0,0.4,1.00000,1,1,0,BP
GO:0006335,DNA replication-dependent nucleosome ass...,31,0,0.52,1.00000,1,1,0,BP
GO:0006342,chromatin silencing,84,0,1.41,1.00000,1,1,0,BP
GO:0006346,methylation-dependent chromatin silencin...,23,0,0.39,1.00000,1,1,0,BP
GO:0006349,regulation of gene expression by genetic...,21,0,0.35,1.00000,1,1,0,BP
GO:0006353,"DNA-templated transcription, termination",22,0,0.37,1.00000,1,1,0,BP
GO:0006379,mRNA cleavage,20,0,0.34,1.00000,1,1,0,BP
GO:0006399,tRNA metabolic process,169,0,2.83,1.00000,1,1,0,BP
GO:0006400,tRNA modification,72,0,1.21,1.00000,1,1,0,BP
GO:0006418,tRNA aminoacylation for protein translat...,41,0,0.69,1.00000,1,1,0,BP
GO:0006482,protein demethylation,31,0,0.52,1.00000,1,1,0,BP
GO:0006493,protein O-linked glycosylation,61,0,1.02,1.00000,1,1,0,BP
GO:0006505,GPI anchor metabolic process,32,0,0.54,1.00000,1,1,0,BP
GO:0006506,GPI anchor biosynthetic process,31,0,0.52,1.00000,1,1,0,BP
GO:0006515,protein quality control for misfolded or...,27,0,0.45,1.00000,1,1,0,BP
GO:0006525,arginine metabolic process,20,0,0.34,1.00000,1,1,0,BP
GO:0006582,melanin metabolic process,24,0,0.4,1.00000,1,1,0,BP
GO:0006584,catecholamine metabolic process,57,0,0.95,1.00000,1,1,0,BP
GO:0006625,protein targeting to peroxisome,20,0,0.34,1.00000,1,1,0,BP
GO:0006661,phosphatidylinositol biosynthetic proces...,59,0,0.99,1.00000,1,1,0,BP
GO:0006688,glycosphingolipid biosynthetic process,20,0,0.34,1.00000,1,1,0,BP
GO:0006699,bile acid biosynthetic process,20,0,0.34,1.00000,1,1,0,BP
GO:0006720,isoprenoid metabolic process,81,0,1.36,1.00000,1,1,0,BP
GO:0006721,terpenoid metabolic process,62,0,1.04,1.00000,1,1,0,BP
GO:0006760,folic acid-containing compound metabolic...,25,0,0.42,1.00000,1,1,0,BP
GO:0006775,fat-soluble vitamin metabolic process,33,0,0.55,1.00000,1,1,0,BP
GO:0006829,zinc ion transport,32,0,0.54,1.00000,1,1,0,BP
GO:0006835,dicarboxylic acid transport,79,0,1.32,1.00000,1,1,0,BP
GO:0006891,intra-Golgi vesicle-mediated transport,26,0,0.44,1.00000,1,1,0,BP
GO:0006907,pinocytosis,21,0,0.35,1.00000,1,1,0,BP
GO:0006921,cellular component disassembly involved ...,30,0,0.5,1.00000,1,1,0,BP
GO:0006925,inflammatory cell apoptotic process,25,0,0.42,1.00000,1,1,0,BP
GO:0006953,acute-phase response,41,0,0.69,1.00000,1,1,0,BP
GO:0006956,complement activation,52,0,0.87,1.00000,1,1,0,BP
GO:0006958,"complement activation, classical pathway",30,0,0.5,1.00000,1,1,0,BP
GO:0007020,microtubule nucleation,23,0,0.39,1.00000,1,1,0,BP
GO:0007031,peroxisome organization,35,0,0.59,1.00000,1,1,0,BP
GO:0007032,endosome organization,51,0,0.85,1.00000,1,1,0,BP
GO:0007043,cell-cell junction assembly,109,0,1.83,1.00000,1,1,0,BP
GO:0007080,mitotic metaphase plate congression,43,0,0.72,1.00000,1,1,0,BP
GO:0007095,mitotic G2 DNA damage checkpoint,21,0,0.35,1.00000,1,1,0,BP
GO:0007127,meiosis I,112,0,1.88,1.00000,1,1,0,BP
GO:0007129,synapsis,51,0,0.85,1.00000,1,1,0,BP
GO:0007130,synaptonemal complex assembly,22,0,0.37,1.00000,1,1,0,BP
GO:0007131,reciprocal meiotic recombination,48,0,0.8,1.00000,1,1,0,BP
GO:0007140,male meiotic nuclear division,51,0,0.85,1.00000,1,1,0,BP
GO:0007141,male meiosis I,22,0,0.37,1.00000,1,1,0,BP
GO:0007190,activation of adenylate cyclase activity,21,0,0.35,1.00000,1,1,0,BP
GO:0007214,gamma-aminobutyric acid signaling pathwa...,27,0,0.45,1.00000,1,1,0,BP
GO:0007218,neuropeptide signaling pathway,81,0,1.36,1.00000,1,1,0,BP
GO:0007257,activation of JUN kinase activity,39,0,0.65,1.00000,1,1,0,BP
GO:0007259,JAK-STAT cascade,190,0,3.18,1.00000,1,1,0,BP
GO:0007260,tyrosine phosphorylation of STAT protein,76,0,1.27,1.00000,1,1,0,BP
GO:0007271,"synaptic transmission, cholinergic",34,0,0.57,1.00000,1,1,0,BP
GO:0007340,acrosome reaction,39,0,0.65,1.00000,1,1,0,BP
GO:0007368,determination of left/right symmetry,123,0,2.06,1.00000,1,1,0,BP
GO:0007413,axonal fasciculation,26,0,0.44,1.00000,1,1,0,BP
GO:0007431,salivary gland development,42,0,0.7,1.00000,1,1,0,BP
GO:0007435,salivary gland morphogenesis,38,0,0.64,1.00000,1,1,0,BP
GO:0007530,sex determination,29,0,0.49,1.00000,1,1,0,BP
GO:0007585,respiratory gaseous exchange,56,0,0.94,1.00000,1,1,0,BP
GO:0007595,lactation,60,0,1.01,1.00000,1,1,0,BP
GO:0007601,visual perception,162,0,2.71,1.00000,1,1,0,BP
GO:0007608,sensory perception of smell,1120,0,18.76,1.00000,1,1,0,BP
GO:0007616,long-term memory,39,0,0.65,1.00000,1,1,0,BP
GO:0007625,grooming behavior,21,0,0.35,1.00000,1,1,0,BP
GO:0007635,chemosensory behavior,22,0,0.37,1.00000,1,1,0,BP
GO:0008033,tRNA processing,115,0,1.93,1.00000,1,1,0,BP
GO:0008053,mitochondrial fusion,21,0,0.35,1.00000,1,1,0,BP
GO:0008156,negative regulation of DNA replication,35,0,0.59,1.00000,1,1,0,BP
GO:0008206,bile acid metabolic process,29,0,0.49,1.00000,1,1,0,BP
GO:0008207,C21-steroid hormone metabolic process,39,0,0.65,1.00000,1,1,0,BP
GO:0008210,estrogen metabolic process,21,0,0.35,1.00000,1,1,0,BP
GO:0008214,protein dealkylation,31,0,0.52,1.00000,1,1,0,BP
GO:0008299,isoprenoid biosynthetic process,30,0,0.5,1.00000,1,1,0,BP
GO:0008340,determination of adult lifespan,28,0,0.47,1.00000,1,1,0,BP
GO:0008535,respiratory chain complex IV assembly,23,0,0.39,1.00000,1,1,0,BP
GO:0008593,regulation of Notch signaling pathway,87,0,1.46,1.00000,1,1,0,BP
GO:0009072,aromatic amino acid family metabolic pro...,34,0,0.57,1.00000,1,1,0,BP
GO:0009112,nucleobase metabolic process,36,0,0.6,1.00000,1,1,0,BP
GO:0009163,nucleoside biosynthetic process,27,0,0.45,1.00000,1,1,0,BP
GO:0009187,cyclic nucleotide metabolic process,35,0,0.59,1.00000,1,1,0,BP
GO:0009190,cyclic nucleotide biosynthetic process,24,0,0.4,1.00000,1,1,0,BP
GO:0009225,nucleotide-sugar metabolic process,31,0,0.52,1.00000,1,1,0,BP
GO:0009251,glucan catabolic process,20,0,0.34,1.00000,1,1,0,BP
GO:0009262,deoxyribonucleotide metabolic process,31,0,0.52,1.00000,1,1,0,BP
GO:0009268,response to pH,40,0,0.67,1.00000,1,1,0,BP
GO:0009299,mRNA transcription,26,0,0.44,1.00000,1,1,0,BP
GO:0009311,oligosaccharide metabolic process,35,0,0.59,1.00000,1,1,0,BP
GO:0009394,2'-deoxyribonucleotide metabolic process,26,0,0.44,1.00000,1,1,0,BP
GO:0009404,toxin metabolic process,22,0,0.37,1.00000,1,1,0,BP
GO:0009451,RNA modification,138,0,2.31,1.00000,1,1,0,BP
GO:0009593,detection of chemical stimulus,87,0,1.46,1.00000,1,1,0,BP
GO:0009595,detection of biotic stimulus,26,0,0.44,1.00000,1,1,0,BP
GO:0009620,response to fungus,39,0,0.65,1.00000,1,1,0,BP
GO:0009648,photoperiodism,24,0,0.4,1.00000,1,1,0,BP
GO:0009649,entrainment of circadian clock,26,0,0.44,1.00000,1,1,0,BP
GO:0009651,response to salt stress,41,0,0.69,1.00000,1,1,0,BP
GO:0009712,catechol-containing compound metabolic p...,57,0,0.95,1.00000,1,1,0,BP
GO:0009713,catechol-containing compound biosyntheti...,26,0,0.44,1.00000,1,1,0,BP
GO:0009799,specification of symmetry,133,0,2.23,1.00000,1,1,0,BP
GO:0009855,determination of bilateral symmetry,132,0,2.21,1.00000,1,1,0,BP
GO:0009880,embryonic pattern specification,64,0,1.07,1.00000,1,1,0,BP
GO:0009948,anterior/posterior axis specification,54,0,0.9,1.00000,1,1,0,BP
GO:0010092,specification of animal organ identity,40,0,0.67,1.00000,1,1,0,BP
GO:0010165,response to X-ray,25,0,0.42,1.00000,1,1,0,BP
GO:0010259,multicellular organism aging,46,0,0.77,1.00000,1,1,0,BP
GO:0010458,exit from mitosis,28,0,0.47,1.00000,1,1,0,BP
GO:0010560,positive regulation of glycoprotein bios...,21,0,0.35,1.00000,1,1,0,BP
GO:0010573,vascular endothelial growth factor produ...,34,0,0.57,1.00000,1,1,0,BP
GO:0010574,regulation of vascular endothelial growt...,32,0,0.54,1.00000,1,1,0,BP
GO:0010575,positive regulation of vascular endothel...,25,0,0.42,1.00000,1,1,0,BP
GO:0010586,miRNA metabolic process,29,0,0.49,1.00000,1,1,0,BP
GO:0010596,negative regulation of endothelial cell ...,51,0,0.85,1.00000,1,1,0,BP
GO:0010614,negative regulation of cardiac muscle hy...,32,0,0.54,1.00000,1,1,0,BP
GO:0010623,programmed cell death involved in cell d...,20,0,0.34,1.00000,1,1,0,BP
GO:0010669,epithelial structure maintenance,25,0,0.42,1.00000,1,1,0,BP
GO:0010677,negative regulation of cellular carbohyd...,47,0,0.79,1.00000,1,1,0,BP
GO:0010717,regulation of epithelial to mesenchymal ...,88,0,1.47,1.00000,1,1,0,BP
GO:0010718,positive regulation of epithelial to mes...,48,0,0.8,1.00000,1,1,0,BP
GO:0010719,negative regulation of epithelial to mes...,28,0,0.47,1.00000,1,1,0,BP
GO:0010737,protein kinase A signaling,35,0,0.59,1.00000,1,1,0,BP
GO:0010738,regulation of protein kinase A signaling,24,0,0.4,1.00000,1,1,0,BP
GO:0010743,regulation of macrophage derived foam ce...,21,0,0.35,1.00000,1,1,0,BP
GO:0010803,regulation of tumor necrosis factor-medi...,30,0,0.5,1.00000,1,1,0,BP
GO:0010830,regulation of myotube differentiation,64,0,1.07,1.00000,1,1,0,BP
GO:0010831,positive regulation of myotube different...,39,0,0.65,1.00000,1,1,0,BP
GO:0010837,regulation of keratinocyte proliferation,34,0,0.57,1.00000,1,1,0,BP
GO:0010842,retina layer formation,20,0,0.34,1.00000,1,1,0,BP
GO:0010862,positive regulation of pathway-restricte...,49,0,0.82,1.00000,1,1,0,BP
GO:0010863,positive regulation of phospholipase C a...,26,0,0.44,1.00000,1,1,0,BP
GO:0010883,regulation of lipid storage,43,0,0.72,1.00000,1,1,0,BP
GO:0010884,positive regulation of lipid storage,23,0,0.39,1.00000,1,1,0,BP
GO:0010893,positive regulation of steroid biosynthe...,27,0,0.45,1.00000,1,1,0,BP
GO:0010954,positive regulation of protein processin...,28,0,0.47,1.00000,1,1,0,BP
GO:0010972,negative regulation of G2/M transition o...,41,0,0.69,1.00000,1,1,0,BP
GO:0014047,glutamate secretion,34,0,0.57,1.00000,1,1,0,BP
GO:0014048,regulation of glutamate secretion,25,0,0.42,1.00000,1,1,0,BP
GO:0014068,positive regulation of phosphatidylinosi...,72,0,1.21,1.00000,1,1,0,BP
GO:0014075,response to amine,20,0,0.34,1.00000,1,1,0,BP
GO:0014741,negative regulation of muscle hypertroph...,34,0,0.57,1.00000,1,1,0,BP
GO:0014821,phasic smooth muscle contraction,25,0,0.42,1.00000,1,1,0,BP
GO:0014823,response to activity,34,0,0.57,1.00000,1,1,0,BP
GO:0014850,response to muscle activity,21,0,0.35,1.00000,1,1,0,BP
GO:0015012,heparan sulfate proteoglycan biosyntheti...,30,0,0.5,1.00000,1,1,0,BP
GO:0015695,organic cation transport,37,0,0.62,1.00000,1,1,0,BP
GO:0015721,bile acid and bile salt transport,23,0,0.39,1.00000,1,1,0,BP
GO:0015800,acidic amino acid transport,63,0,1.06,1.00000,1,1,0,BP
GO:0015807,L-amino acid transport,60,0,1.01,1.00000,1,1,0,BP
GO:0015813,L-glutamate transmembrane transport,22,0,0.37,1.00000,1,1,0,BP
GO:0016048,detection of temperature stimulus,22,0,0.37,1.00000,1,1,0,BP
GO:0016073,snRNA metabolic process,42,0,0.7,1.00000,1,1,0,BP
GO:0016075,rRNA catabolic process,24,0,0.4,1.00000,1,1,0,BP
GO:0016082,synaptic vesicle priming,28,0,0.47,1.00000,1,1,0,BP
GO:0016101,diterpenoid metabolic process,57,0,0.95,1.00000,1,1,0,BP
GO:0016180,snRNA processing,25,0,0.42,1.00000,1,1,0,BP
GO:0016556,mRNA modification,27,0,0.45,1.00000,1,1,0,BP
GO:0016577,histone demethylation,28,0,0.47,1.00000,1,1,0,BP
GO:0016578,histone deubiquitination,24,0,0.4,1.00000,1,1,0,BP
GO:0016579,protein deubiquitination,117,0,1.96,1.00000,1,1,0,BP
GO:0016925,protein sumoylation,44,0,0.74,1.00000,1,1,0,BP
GO:0016973,poly(A)+ mRNA export from nucleus,20,0,0.34,1.00000,1,1,0,BP
GO:0018149,peptide cross-linking,62,0,1.04,1.00000,1,1,0,BP
GO:0018195,peptidyl-arginine modification,27,0,0.45,1.00000,1,1,0,BP
GO:0018196,peptidyl-asparagine modification,21,0,0.35,1.00000,1,1,0,BP
GO:0018198,peptidyl-cysteine modification,46,0,0.77,1.00000,1,1,0,BP
GO:0018200,peptidyl-glutamic acid modification,26,0,0.44,1.00000,1,1,0,BP
GO:0018230,peptidyl-L-cysteine S-palmitoylation,22,0,0.37,1.00000,1,1,0,BP
GO:0018231,peptidyl-S-diacylglycerol-L-cysteine bio...,22,0,0.37,1.00000,1,1,0,BP
GO:0018279,protein N-linked glycosylation via aspar...,20,0,0.34,1.00000,1,1,0,BP
GO:0018958,phenol-containing compound metabolic pro...,111,0,1.86,1.00000,1,1,0,BP
GO:0019048,modulation by virus of host morphology o...,24,0,0.4,1.00000,1,1,0,BP
GO:0019068,virion assembly,24,0,0.4,1.00000,1,1,0,BP
GO:0019228,neuronal action potential,45,0,0.75,1.00000,1,1,0,BP
GO:0019236,response to pheromone,105,0,1.76,1.00000,1,1,0,BP
GO:0019373,epoxygenase P450 pathway,31,0,0.52,1.00000,1,1,0,BP
GO:0019433,triglyceride catabolic process,26,0,0.44,1.00000,1,1,0,BP
GO:0019692,deoxyribose phosphate metabolic process,26,0,0.44,1.00000,1,1,0,BP
GO:0019835,cytolysis,35,0,0.59,1.00000,1,1,0,BP
GO:0019915,lipid storage,71,0,1.19,1.00000,1,1,0,BP
GO:0021511,spinal cord patterning,28,0,0.47,1.00000,1,1,0,BP
GO:0021513,spinal cord dorsal/ventral patterning,26,0,0.44,1.00000,1,1,0,BP
GO:0021533,cell differentiation in hindbrain,26,0,0.44,1.00000,1,1,0,BP
GO:0021544,subpallium development,24,0,0.4,1.00000,1,1,0,BP
GO:0021545,cranial nerve development,50,0,0.84,1.00000,1,1,0,BP
GO:0021602,cranial nerve morphogenesis,31,0,0.52,1.00000,1,1,0,BP
GO:0021697,cerebellar cortex formation,27,0,0.45,1.00000,1,1,0,BP
GO:0021846,cell proliferation in forebrain,36,0,0.6,1.00000,1,1,0,BP
GO:0021871,forebrain regionalization,27,0,0.45,1.00000,1,1,0,BP
GO:0021904,dorsal/ventral neural tube patterning,30,0,0.5,1.00000,1,1,0,BP
GO:0021983,pituitary gland development,39,0,0.65,1.00000,1,1,0,BP
GO:0022401,negative adaptation of signaling pathway,28,0,0.47,1.00000,1,1,0,BP
GO:0022410,circadian sleep/wake cycle process,32,0,0.54,1.00000,1,1,0,BP
GO:0022602,ovulation cycle process,48,0,0.8,1.00000,1,1,0,BP
GO:0022616,DNA strand elongation,22,0,0.37,1.00000,1,1,0,BP
GO:0022617,extracellular matrix disassembly,31,0,0.52,1.00000,1,1,0,BP
GO:0023019,signal transduction involved in regulati...,23,0,0.39,1.00000,1,1,0,BP
GO:0023058,adaptation of signaling pathway,30,0,0.5,1.00000,1,1,0,BP
GO:0030104,water homeostasis,56,0,0.94,1.00000,1,1,0,BP
GO:0030148,sphingolipid biosynthetic process,78,0,1.31,1.00000,1,1,0,BP
GO:0030166,proteoglycan biosynthetic process,55,0,0.92,1.00000,1,1,0,BP
GO:0030183,B cell differentiation,150,0,2.51,1.00000,1,1,0,BP
GO:0030199,collagen fibril organization,54,0,0.9,1.00000,1,1,0,BP
GO:0030201,heparan sulfate proteoglycan metabolic p...,35,0,0.59,1.00000,1,1,0,BP
GO:0030203,glycosaminoglycan metabolic process,83,0,1.39,1.00000,1,1,0,BP
GO:0030204,chondroitin sulfate metabolic process,22,0,0.37,1.00000,1,1,0,BP
GO:0030212,hyaluronan metabolic process,27,0,0.45,1.00000,1,1,0,BP
GO:0030219,megakaryocyte differentiation,53,0,0.89,1.00000,1,1,0,BP
GO:0030224,monocyte differentiation,29,0,0.49,1.00000,1,1,0,BP
GO:0030261,chromosome condensation,45,0,0.75,1.00000,1,1,0,BP
GO:0030262,apoptotic nuclear changes,29,0,0.49,1.00000,1,1,0,BP
GO:0030279,negative regulation of ossification,99,0,1.66,1.00000,1,1,0,BP
GO:0030317,flagellated sperm motility,104,0,1.74,1.00000,1,1,0,BP
GO:0030318,melanocyte differentiation,29,0,0.49,1.00000,1,1,0,BP
GO:0030325,adrenal gland development,24,0,0.4,1.00000,1,1,0,BP
GO:0030431,sleep,39,0,0.65,1.00000,1,1,0,BP
GO:0030488,tRNA methylation,29,0,0.49,1.00000,1,1,0,BP
GO:0030510,regulation of BMP signaling pathway,97,0,1.62,1.00000,1,1,0,BP
GO:0030513,positive regulation of BMP signaling pat...,38,0,0.64,1.00000,1,1,0,BP
GO:0030514,negative regulation of BMP signaling pat...,53,0,0.89,1.00000,1,1,0,BP
GO:0030520,intracellular estrogen receptor signalin...,49,0,0.82,1.00000,1,1,0,BP
GO:0030539,male genitalia development,23,0,0.39,1.00000,1,1,0,BP
GO:0030574,collagen catabolic process,36,0,0.6,1.00000,1,1,0,BP
GO:0030728,ovulation,23,0,0.39,1.00000,1,1,0,BP
GO:0030851,granulocyte differentiation,38,0,0.64,1.00000,1,1,0,BP
GO:0030857,negative regulation of epithelial cell d...,48,0,0.8,1.00000,1,1,0,BP
GO:0030879,mammary gland development,163,0,2.73,1.00000,1,1,0,BP
GO:0030889,negative regulation of B cell proliferat...,20,0,0.34,1.00000,1,1,0,BP
GO:0030903,notochord development,24,0,0.4,1.00000,1,1,0,BP
GO:0030947,regulation of vascular endothelial growt...,33,0,0.55,1.00000,1,1,0,BP
GO:0031016,pancreas development,90,0,1.51,1.00000,1,1,0,BP
GO:0031018,endocrine pancreas development,52,0,0.87,1.00000,1,1,0,BP
GO:0031057,negative regulation of histone modificat...,43,0,0.72,1.00000,1,1,0,BP
GO:0031061,negative regulation of histone methylati...,24,0,0.4,1.00000,1,1,0,BP
GO:0031069,hair follicle morphogenesis,32,0,0.54,1.00000,1,1,0,BP
GO:0031076,embryonic camera-type eye development,39,0,0.65,1.00000,1,1,0,BP
GO:0031100,animal organ regeneration,25,0,0.42,1.00000,1,1,0,BP
GO:0031128,developmental induction,43,0,0.72,1.00000,1,1,0,BP
GO:0031290,retinal ganglion cell axon guidance,21,0,0.35,1.00000,1,1,0,BP
GO:0031365,N-terminal protein amino acid modificati...,27,0,0.45,1.00000,1,1,0,BP
GO:0031424,keratinization,35,0,0.59,1.00000,1,1,0,BP
GO:0031572,G2 DNA damage checkpoint,32,0,0.54,1.00000,1,1,0,BP
GO:0031579,membrane raft organization,22,0,0.37,1.00000,1,1,0,BP
GO:0031629,synaptic vesicle fusion to presynaptic a...,25,0,0.42,1.00000,1,1,0,BP
GO:0031640,killing of cells of other organism,40,0,0.67,1.00000,1,1,0,BP
GO:0031645,negative regulation of neurological syst...,30,0,0.5,1.00000,1,1,0,BP
GO:0031649,heat generation,22,0,0.37,1.00000,1,1,0,BP
GO:0031929,TOR signaling,121,0,2.03,1.00000,1,1,0,BP
GO:0031935,regulation of chromatin silencing,38,0,0.64,1.00000,1,1,0,BP
GO:0031954,positive regulation of protein autophosp...,24,0,0.4,1.00000,1,1,0,BP
GO:0031960,response to corticosteroid,91,0,1.52,1.00000,1,1,0,BP
GO:0032006,regulation of TOR signaling,101,0,1.69,1.00000,1,1,0,BP
GO:0032007,negative regulation of TOR signaling,46,0,0.77,1.00000,1,1,0,BP
GO:0032008,positive regulation of TOR signaling,40,0,0.67,1.00000,1,1,0,BP
GO:0032042,mitochondrial DNA metabolic process,22,0,0.37,1.00000,1,1,0,BP
GO:0032094,response to food,35,0,0.59,1.00000,1,1,0,BP
GO:0032095,regulation of response to food,20,0,0.34,1.00000,1,1,0,BP
GO:0032098,regulation of appetite,22,0,0.37,1.00000,1,1,0,BP
GO:0032104,regulation of response to extracellular ...,26,0,0.44,1.00000,1,1,0,BP
GO:0032107,regulation of response to nutrient level...,26,0,0.44,1.00000,1,1,0,BP
GO:0032148,activation of protein kinase B activity,20,0,0.34,1.00000,1,1,0,BP
GO:0032196,transposition,22,0,0.37,1.00000,1,1,0,BP
GO:0032211,negative regulation of telomere maintena...,20,0,0.34,1.00000,1,1,0,BP
GO:0032288,myelin assembly,20,0,0.34,1.00000,1,1,0,BP
GO:0032330,regulation of chondrocyte differentiatio...,50,0,0.84,1.00000,1,1,0,BP
GO:0032331,negative regulation of chondrocyte diffe...,22,0,0.37,1.00000,1,1,0,BP
GO:0032332,positive regulation of chondrocyte diffe...,21,0,0.35,1.00000,1,1,0,BP
GO:0032355,response to estradiol,51,0,0.85,1.00000,1,1,0,BP
GO:0032365,intracellular lipid transport,27,0,0.45,1.00000,1,1,0,BP
GO:0032366,intracellular sterol transport,22,0,0.37,1.00000,1,1,0,BP
GO:0032367,intracellular cholesterol transport,22,0,0.37,1.00000,1,1,0,BP
GO:0032400,melanosome localization,22,0,0.37,1.00000,1,1,0,BP
GO:0032461,positive regulation of protein oligomeri...,24,0,0.4,1.00000,1,1,0,BP
GO:0032465,regulation of cytokinesis,79,0,1.32,1.00000,1,1,0,BP
GO:0032467,positive regulation of cytokinesis,33,0,0.55,1.00000,1,1,0,BP
GO:0032495,response to muramyl dipeptide,23,0,0.39,1.00000,1,1,0,BP
GO:0032508,DNA duplex unwinding,32,0,0.54,1.00000,1,1,0,BP
GO:0032509,endosome transport via multivesicular bo...,27,0,0.45,1.00000,1,1,0,BP
GO:0032528,microvillus organization,26,0,0.44,1.00000,1,1,0,BP
GO:0032543,mitochondrial translation,76,0,1.27,1.00000,1,1,0,BP
GO:0032616,interleukin-13 production,22,0,0.37,1.00000,1,1,0,BP
GO:0032633,interleukin-4 production,38,0,0.64,1.00000,1,1,0,BP
GO:0032637,interleukin-8 production,69,0,1.16,1.00000,1,1,0,BP
GO:0032673,regulation of interleukin-4 production,31,0,0.52,1.00000,1,1,0,BP
GO:0032677,regulation of interleukin-8 production,63,0,1.06,1.00000,1,1,0,BP
GO:0032682,negative regulation of chemokine product...,22,0,0.37,1.00000,1,1,0,BP
GO:0032691,negative regulation of interleukin-1 bet...,24,0,0.4,1.00000,1,1,0,BP
GO:0032692,negative regulation of interleukin-1 pro...,33,0,0.55,1.00000,1,1,0,BP
GO:0032693,negative regulation of interleukin-10 pr...,21,0,0.35,1.00000,1,1,0,BP
GO:0032728,positive regulation of interferon-beta p...,32,0,0.54,1.00000,1,1,0,BP
GO:0032753,positive regulation of interleukin-4 pro...,25,0,0.42,1.00000,1,1,0,BP
GO:0032757,positive regulation of interleukin-8 pro...,46,0,0.77,1.00000,1,1,0,BP
GO:0032784,regulation of DNA-templated transcriptio...,51,0,0.85,1.00000,1,1,0,BP
GO:0032786,positive regulation of DNA-templated tra...,34,0,0.57,1.00000,1,1,0,BP
GO:0032801,receptor catabolic process,27,0,0.45,1.00000,1,1,0,BP
GO:0032835,glomerulus development,59,0,0.99,1.00000,1,1,0,BP
GO:0032892,positive regulation of organic acid tran...,48,0,0.8,1.00000,1,1,0,BP
GO:0032957,inositol trisphosphate metabolic process,27,0,0.45,1.00000,1,1,0,BP
GO:0032958,inositol phosphate biosynthetic process,43,0,0.72,1.00000,1,1,0,BP
GO:0032959,inositol trisphosphate biosynthetic proc...,23,0,0.39,1.00000,1,1,0,BP
GO:0032968,positive regulation of transcription elo...,23,0,0.39,1.00000,1,1,0,BP
GO:0033003,regulation of mast cell activation,50,0,0.84,1.00000,1,1,0,BP
GO:0033005,positive regulation of mast cell activat...,30,0,0.5,1.00000,1,1,0,BP
GO:0033006,regulation of mast cell activation invol...,36,0,0.6,1.00000,1,1,0,BP
GO:0033008,positive regulation of mast cell activat...,22,0,0.37,1.00000,1,1,0,BP
GO:0033028,myeloid cell apoptotic process,37,0,0.62,1.00000,1,1,0,BP
GO:0033032,regulation of myeloid cell apoptotic pro...,34,0,0.57,1.00000,1,1,0,BP
GO:0033033,negative regulation of myeloid cell apop...,20,0,0.34,1.00000,1,1,0,BP
GO:0033059,cellular pigmentation,42,0,0.7,1.00000,1,1,0,BP
GO:0033081,regulation of T cell differentiation in ...,31,0,0.52,1.00000,1,1,0,BP
GO:0033137,negative regulation of peptidyl-serine p...,29,0,0.49,1.00000,1,1,0,BP
GO:0033139,regulation of peptidyl-serine phosphoryl...,31,0,0.52,1.00000,1,1,0,BP
GO:0033141,positive regulation of peptidyl-serine p...,29,0,0.49,1.00000,1,1,0,BP
GO:0033145,positive regulation of intracellular ste...,23,0,0.39,1.00000,1,1,0,BP
GO:0033146,regulation of intracellular estrogen rec...,37,0,0.62,1.00000,1,1,0,BP
GO:0033209,tumor necrosis factor-mediated signaling...,60,0,1.01,1.00000,1,1,0,BP
GO:0033233,regulation of protein sumoylation,24,0,0.4,1.00000,1,1,0,BP
GO:0033561,regulation of water loss via skin,31,0,0.52,1.00000,1,1,0,BP
GO:0033598,mammary gland epithelial cell proliferat...,33,0,0.55,1.00000,1,1,0,BP
GO:0033599,regulation of mammary gland epithelial c...,20,0,0.34,1.00000,1,1,0,BP
GO:0033617,mitochondrial respiratory chain complex ...,20,0,0.34,1.00000,1,1,0,BP
GO:0033622,integrin activation,24,0,0.4,1.00000,1,1,0,BP
GO:0033630,positive regulation of cell adhesion med...,20,0,0.34,1.00000,1,1,0,BP
GO:0033687,osteoblast proliferation,30,0,0.5,1.00000,1,1,0,BP
GO:0033688,regulation of osteoblast proliferation,27,0,0.45,1.00000,1,1,0,BP
GO:0033962,cytoplasmic mRNA processing body assembl...,20,0,0.34,1.00000,1,1,0,BP
GO:0034104,negative regulation of tissue remodeling,24,0,0.4,1.00000,1,1,0,BP
GO:0034123,positive regulation of toll-like recepto...,26,0,0.44,1.00000,1,1,0,BP
GO:0034142,toll-like receptor 4 signaling pathway,33,0,0.55,1.00000,1,1,0,BP
GO:0034143,regulation of toll-like receptor 4 signa...,20,0,0.34,1.00000,1,1,0,BP
GO:0034243,regulation of transcription elongation f...,37,0,0.62,1.00000,1,1,0,BP
GO:0034311,diol metabolic process,23,0,0.39,1.00000,1,1,0,BP
GO:0034340,response to type I interferon,44,0,0.74,1.00000,1,1,0,BP
GO:0034367,protein-containing complex remodeling,21,0,0.35,1.00000,1,1,0,BP
GO:0034368,protein-lipid complex remodeling,20,0,0.34,1.00000,1,1,0,BP
GO:0034369,plasma lipoprotein particle remodeling,20,0,0.34,1.00000,1,1,0,BP
GO:0034390,smooth muscle cell apoptotic process,29,0,0.49,1.00000,1,1,0,BP
GO:0034391,regulation of smooth muscle cell apoptot...,29,0,0.49,1.00000,1,1,0,BP
GO:0034405,response to fluid shear stress,22,0,0.37,1.00000,1,1,0,BP
GO:0034453,microtubule anchoring,27,0,0.45,1.00000,1,1,0,BP
GO:0034505,tooth mineralization,24,0,0.4,1.00000,1,1,0,BP
GO:0034629,cellular protein-containing complex loca...,29,0,0.49,1.00000,1,1,0,BP
GO:0034661,ncRNA catabolic process,37,0,0.62,1.00000,1,1,0,BP
GO:0034723,DNA replication-dependent nucleosome org...,31,0,0.52,1.00000,1,1,0,BP
GO:0034754,cellular hormone metabolic process,106,0,1.78,1.00000,1,1,0,BP
GO:0035024,negative regulation of Rho protein signa...,25,0,0.42,1.00000,1,1,0,BP
GO:0035025,positive regulation of Rho protein signa...,33,0,0.55,1.00000,1,1,0,BP
GO:0035050,embryonic heart tube development,83,0,1.39,1.00000,1,1,0,BP
GO:0035082,axoneme assembly,68,0,1.14,1.00000,1,1,0,BP
GO:0035115,embryonic forelimb morphogenesis,36,0,0.6,1.00000,1,1,0,BP
GO:0035162,embryonic hemopoiesis,28,0,0.47,1.00000,1,1,0,BP
GO:0035176,social behavior,53,0,0.89,1.00000,1,1,0,BP
GO:0035188,hatching,40,0,0.67,1.00000,1,1,0,BP
GO:0035268,protein mannosylation,22,0,0.37,1.00000,1,1,0,BP
GO:0035272,exocrine system development,55,0,0.92,1.00000,1,1,0,BP
GO:0035282,segmentation,106,0,1.78,1.00000,1,1,0,BP
GO:0035329,hippo signaling,32,0,0.54,1.00000,1,1,0,BP
GO:0035357,peroxisome proliferator activated recept...,21,0,0.35,1.00000,1,1,0,BP
GO:0035456,response to interferon-beta,66,0,1.11,1.00000,1,1,0,BP
GO:0035458,cellular response to interferon-beta,56,0,0.94,1.00000,1,1,0,BP
GO:0035510,DNA dealkylation,23,0,0.39,1.00000,1,1,0,BP
GO:0035634,response to stilbenoid,22,0,0.37,1.00000,1,1,0,BP
GO:0035640,exploration behavior,30,0,0.5,1.00000,1,1,0,BP
GO:0035767,endothelial cell chemotaxis,31,0,0.52,1.00000,1,1,0,BP
GO:0035809,regulation of urine volume,26,0,0.44,1.00000,1,1,0,BP
GO:0035825,homologous recombination,49,0,0.82,1.00000,1,1,0,BP
GO:0035850,epithelial cell differentiation involved...,37,0,0.62,1.00000,1,1,0,BP
GO:0035855,megakaryocyte development,20,0,0.34,1.00000,1,1,0,BP
GO:0035883,enteroendocrine cell differentiation,34,0,0.57,1.00000,1,1,0,BP
GO:0035929,steroid hormone secretion,26,0,0.44,1.00000,1,1,0,BP
GO:0036003,positive regulation of transcription fro...,27,0,0.45,1.00000,1,1,0,BP
GO:0036037,"CD8-positive, alpha-beta T cell activati...",27,0,0.45,1.00000,1,1,0,BP
GO:0036297,interstrand cross-link repair,28,0,0.47,1.00000,1,1,0,BP
GO:0036303,lymph vessel morphogenesis,22,0,0.37,1.00000,1,1,0,BP
GO:0036342,post-anal tail morphogenesis,26,0,0.44,1.00000,1,1,0,BP
GO:0036344,platelet morphogenesis,20,0,0.34,1.00000,1,1,0,BP
GO:0038066,p38MAPK cascade,48,0,0.8,1.00000,1,1,0,BP
GO:0038202,TORC1 signaling,43,0,0.72,1.00000,1,1,0,BP
GO:0039528,cytoplasmic pattern recognition receptor...,24,0,0.4,1.00000,1,1,0,BP
GO:0040018,positive regulation of multicellular org...,43,0,0.72,1.00000,1,1,0,BP
GO:0040036,regulation of fibroblast growth factor r...,32,0,0.54,1.00000,1,1,0,BP
GO:0042036,negative regulation of cytokine biosynth...,32,0,0.54,1.00000,1,1,0,BP
GO:0042053,regulation of dopamine metabolic process,21,0,0.35,1.00000,1,1,0,BP
GO:0042069,regulation of catecholamine metabolic pr...,22,0,0.37,1.00000,1,1,0,BP
GO:0042093,T-helper cell differentiation,63,0,1.06,1.00000,1,1,0,BP
GO:0042094,interleukin-2 biosynthetic process,22,0,0.37,1.00000,1,1,0,BP
GO:0042104,positive regulation of activated T cell ...,27,0,0.45,1.00000,1,1,0,BP
GO:0042220,response to cocaine,42,0,0.7,1.00000,1,1,0,BP
GO:0042304,regulation of fatty acid biosynthetic pr...,41,0,0.69,1.00000,1,1,0,BP
GO:0042403,thyroid hormone metabolic process,25,0,0.42,1.00000,1,1,0,BP
GO:0042417,dopamine metabolic process,42,0,0.7,1.00000,1,1,0,BP
GO:0042423,catecholamine biosynthetic process,26,0,0.44,1.00000,1,1,0,BP
GO:0042430,indole-containing compound metabolic pro...,25,0,0.42,1.00000,1,1,0,BP
GO:0042438,melanin biosynthetic process,22,0,0.37,1.00000,1,1,0,BP
GO:0042446,hormone biosynthetic process,75,0,1.26,1.00000,1,1,0,BP
GO:0042451,purine nucleoside biosynthetic process,20,0,0.34,1.00000,1,1,0,BP
GO:0042455,ribonucleoside biosynthetic process,27,0,0.45,1.00000,1,1,0,BP
GO:0042462,eye photoreceptor cell development,44,0,0.74,1.00000,1,1,0,BP
GO:0042474,middle ear morphogenesis,24,0,0.4,1.00000,1,1,0,BP
GO:0042475,odontogenesis of dentin-containing tooth,87,0,1.46,1.00000,1,1,0,BP
GO:0042501,serine phosphorylation of STAT protein,36,0,0.6,1.00000,1,1,0,BP
GO:0042509,regulation of tyrosine phosphorylation o...,72,0,1.21,1.00000,1,1,0,BP
GO:0042531,positive regulation of tyrosine phosphor...,56,0,0.94,1.00000,1,1,0,BP
GO:0042538,hyperosmotic salinity response,28,0,0.47,1.00000,1,1,0,BP
GO:0042558,pteridine-containing compound metabolic ...,31,0,0.52,1.00000,1,1,0,BP
GO:0042572,retinol metabolic process,24,0,0.4,1.00000,1,1,0,BP
GO:0042573,retinoic acid metabolic process,25,0,0.42,1.00000,1,1,0,BP
GO:0042634,regulation of hair cycle,31,0,0.52,1.00000,1,1,0,BP
GO:0042730,fibrinolysis,20,0,0.34,1.00000,1,1,0,BP
GO:0042733,embryonic digit morphogenesis,73,0,1.22,1.00000,1,1,0,BP
GO:0042738,exogenous drug catabolic process,53,0,0.89,1.00000,1,1,0,BP
GO:0042745,circadian sleep/wake cycle,35,0,0.59,1.00000,1,1,0,BP
GO:0042749,regulation of circadian sleep/wake cycle,31,0,0.52,1.00000,1,1,0,BP
GO:0042753,positive regulation of circadian rhythm,27,0,0.45,1.00000,1,1,0,BP
GO:0042755,eating behavior,48,0,0.8,1.00000,1,1,0,BP
GO:0043011,myeloid dendritic cell differentiation,20,0,0.34,1.00000,1,1,0,BP
GO:0043029,T cell homeostasis,46,0,0.77,1.00000,1,1,0,BP
GO:0043038,amino acid activation,45,0,0.75,1.00000,1,1,0,BP
GO:0043039,tRNA aminoacylation,44,0,0.74,1.00000,1,1,0,BP
GO:0043090,amino acid import,31,0,0.52,1.00000,1,1,0,BP
GO:0043114,regulation of vascular permeability,36,0,0.6,1.00000,1,1,0,BP
GO:0043124,negative regulation of I-kappaB kinase/N...,46,0,0.77,1.00000,1,1,0,BP
GO:0043153,entrainment of circadian clock by photop...,23,0,0.39,1.00000,1,1,0,BP
GO:0043267,negative regulation of potassium ion tra...,38,0,0.64,1.00000,1,1,0,BP
GO:0043276,anoikis,31,0,0.52,1.00000,1,1,0,BP
GO:0043297,apical junction assembly,54,0,0.9,1.00000,1,1,0,BP
GO:0043304,regulation of mast cell degranulation,35,0,0.59,1.00000,1,1,0,BP
GO:0043306,positive regulation of mast cell degranu...,22,0,0.37,1.00000,1,1,0,BP
GO:0043368,positive T cell selection,38,0,0.64,1.00000,1,1,0,BP
GO:0043369,"CD4-positive or CD8-positive, alpha-beta...",21,0,0.35,1.00000,1,1,0,BP
GO:0043370,"regulation of CD4-positive, alpha-beta T...",50,0,0.84,1.00000,1,1,0,BP
GO:0043371,"negative regulation of CD4-positive, alp...",23,0,0.39,1.00000,1,1,0,BP
GO:0043372,"positive regulation of CD4-positive, alp...",30,0,0.5,1.00000,1,1,0,BP
GO:0043392,negative regulation of DNA binding,54,0,0.9,1.00000,1,1,0,BP
GO:0043407,negative regulation of MAP kinase activi...,69,0,1.16,1.00000,1,1,0,BP
GO:0043496,regulation of protein homodimerization a...,24,0,0.4,1.00000,1,1,0,BP
GO:0043506,regulation of JUN kinase activity,94,0,1.57,1.00000,1,1,0,BP
GO:0043507,positive regulation of JUN kinase activi...,78,0,1.31,1.00000,1,1,0,BP
GO:0043537,negative regulation of blood vessel endo...,32,0,0.54,1.00000,1,1,0,BP
GO:0043567,regulation of insulin-like growth factor...,25,0,0.42,1.00000,1,1,0,BP
GO:0043574,peroxisomal transport,20,0,0.34,1.00000,1,1,0,BP
GO:0043576,regulation of respiratory gaseous exchan...,23,0,0.39,1.00000,1,1,0,BP
GO:0043586,tongue development,21,0,0.35,1.00000,1,1,0,BP
GO:0043616,keratinocyte proliferation,45,0,0.75,1.00000,1,1,0,BP
GO:0043627,response to estrogen,73,0,1.22,1.00000,1,1,0,BP
GO:0043687,post-translational protein modification,23,0,0.39,1.00000,1,1,0,BP
GO:0043931,ossification involved in bone maturation,20,0,0.34,1.00000,1,1,0,BP
GO:0043951,negative regulation of cAMP-mediated sig...,30,0,0.5,1.00000,1,1,0,BP
GO:0043966,histone H3 acetylation,63,0,1.06,1.00000,1,1,0,BP
GO:0043967,histone H4 acetylation,63,0,1.06,1.00000,1,1,0,BP
GO:0043984,histone H4-K16 acetylation,21,0,0.35,1.00000,1,1,0,BP
GO:0044003,modification by symbiont of host morphol...,28,0,0.47,1.00000,1,1,0,BP
GO:0044030,regulation of DNA methylation,30,0,0.5,1.00000,1,1,0,BP
GO:0044247,cellular polysaccharide catabolic proces...,22,0,0.37,1.00000,1,1,0,BP
GO:0044273,sulfur compound catabolic process,21,0,0.35,1.00000,1,1,0,BP
GO:0044275,cellular carbohydrate catabolic process,36,0,0.6,1.00000,1,1,0,BP
GO:0044319,"wound healing, spreading of cells",31,0,0.52,1.00000,1,1,0,BP
GO:0044331,cell-cell adhesion mediated by cadherin,40,0,0.67,1.00000,1,1,0,BP
GO:0044342,type B pancreatic cell proliferation,28,0,0.47,1.00000,1,1,0,BP
GO:0044346,fibroblast apoptotic process,21,0,0.35,1.00000,1,1,0,BP
GO:0044364,disruption of cells of other organism,40,0,0.67,1.00000,1,1,0,BP
GO:0044458,motile cilium assembly,30,0,0.5,1.00000,1,1,0,BP
GO:0044550,secondary metabolite biosynthetic proces...,28,0,0.47,1.00000,1,1,0,BP
GO:0044764,multi-organism cellular process,41,0,0.69,1.00000,1,1,0,BP
GO:0044773,mitotic DNA damage checkpoint,57,0,0.95,1.00000,1,1,0,BP
GO:0044774,mitotic DNA integrity checkpoint,65,0,1.09,1.00000,1,1,0,BP
GO:0044783,G1 DNA damage checkpoint,20,0,0.34,1.00000,1,1,0,BP
GO:0044818,mitotic G2/M transition checkpoint,31,0,0.52,1.00000,1,1,0,BP
GO:0044819,mitotic G1/S transition checkpoint,20,0,0.34,1.00000,1,1,0,BP
GO:0044851,hair cycle phase,22,0,0.37,1.00000,1,1,0,BP
GO:0045058,T cell selection,55,0,0.92,1.00000,1,1,0,BP
GO:0045061,thymic T cell selection,28,0,0.47,1.00000,1,1,0,BP
GO:0045063,T-helper 1 cell differentiation,22,0,0.37,1.00000,1,1,0,BP
GO:0045071,negative regulation of viral genome repl...,57,0,0.95,1.00000,1,1,0,BP
GO:0045076,regulation of interleukin-2 biosynthetic...,20,0,0.34,1.00000,1,1,0,BP
GO:0045109,intermediate filament organization,26,0,0.44,1.00000,1,1,0,BP
GO:0045123,cellular extravasation,66,0,1.11,1.00000,1,1,0,BP
GO:0045143,homologous chromosome segregation,62,0,1.04,1.00000,1,1,0,BP
GO:0045187,regulation of circadian sleep/wake cycle...,28,0,0.47,1.00000,1,1,0,BP
GO:0045191,regulation of isotype switching,40,0,0.67,1.00000,1,1,0,BP
GO:0045445,myoblast differentiation,93,0,1.56,1.00000,1,1,0,BP
GO:0045494,photoreceptor cell maintenance,41,0,0.69,1.00000,1,1,0,BP
GO:0045577,regulation of B cell differentiation,33,0,0.55,1.00000,1,1,0,BP
GO:0045589,regulation of regulatory T cell differen...,30,0,0.5,1.00000,1,1,0,BP
GO:0045600,positive regulation of fat cell differen...,62,0,1.04,1.00000,1,1,0,BP
GO:0045604,regulation of epidermal cell differentia...,54,0,0.9,1.00000,1,1,0,BP
GO:0045606,positive regulation of epidermal cell di...,22,0,0.37,1.00000,1,1,0,BP
GO:0045616,regulation of keratinocyte differentiati...,32,0,0.54,1.00000,1,1,0,BP
GO:0045622,regulation of T-helper cell differentiat...,38,0,0.64,1.00000,1,1,0,BP
GO:0045623,negative regulation of T-helper cell dif...,20,0,0.34,1.00000,1,1,0,BP
GO:0045624,positive regulation of T-helper cell dif...,22,0,0.37,1.00000,1,1,0,BP
GO:0045638,negative regulation of myeloid cell diff...,97,0,1.62,1.00000,1,1,0,BP
GO:0045648,positive regulation of erythrocyte diffe...,25,0,0.42,1.00000,1,1,0,BP
GO:0045649,regulation of macrophage differentiation,20,0,0.34,1.00000,1,1,0,BP
GO:0045652,regulation of megakaryocyte differentiat...,31,0,0.52,1.00000,1,1,0,BP
GO:0045661,regulation of myoblast differentiation,63,0,1.06,1.00000,1,1,0,BP
GO:0045662,negative regulation of myoblast differen...,31,0,0.52,1.00000,1,1,0,BP
GO:0045663,positive regulation of myoblast differen...,28,0,0.47,1.00000,1,1,0,BP
GO:0045668,negative regulation of osteoblast differ...,65,0,1.09,1.00000,1,1,0,BP
GO:0045671,negative regulation of osteoclast differ...,28,0,0.47,1.00000,1,1,0,BP
GO:0045682,regulation of epidermis development,80,0,1.34,1.00000,1,1,0,BP
GO:0045683,negative regulation of epidermis develop...,22,0,0.37,1.00000,1,1,0,BP
GO:0045684,positive regulation of epidermis develop...,37,0,0.62,1.00000,1,1,0,BP
GO:0045723,positive regulation of fatty acid biosyn...,24,0,0.4,1.00000,1,1,0,BP
GO:0045737,positive regulation of cyclin-dependent ...,26,0,0.44,1.00000,1,1,0,BP
GO:0045738,negative regulation of DNA repair,27,0,0.45,1.00000,1,1,0,BP
GO:0045742,positive regulation of epidermal growth ...,26,0,0.44,1.00000,1,1,0,BP
GO:0045745,positive regulation of G protein-coupled...,36,0,0.6,1.00000,1,1,0,BP
GO:0045746,negative regulation of Notch signaling p...,38,0,0.64,1.00000,1,1,0,BP
GO:0045747,positive regulation of Notch signaling p...,40,0,0.67,1.00000,1,1,0,BP
GO:0045761,regulation of adenylate cyclase activity,26,0,0.44,1.00000,1,1,0,BP
GO:0045814,"negative regulation of gene expression, ...",90,0,1.51,1.00000,1,1,0,BP
GO:0045815,"positive regulation of gene expression, ...",36,0,0.6,1.00000,1,1,0,BP
GO:0045824,negative regulation of innate immune res...,60,0,1.01,1.00000,1,1,0,BP
GO:0045830,positive regulation of isotype switching,30,0,0.5,1.00000,1,1,0,BP
GO:0045880,positive regulation of smoothened signal...,38,0,0.64,1.00000,1,1,0,BP
GO:0045907,positive regulation of vasoconstriction,47,0,0.79,1.00000,1,1,0,BP
GO:0045910,negative regulation of DNA recombination,48,0,0.8,1.00000,1,1,0,BP
GO:0045912,negative regulation of carbohydrate meta...,52,0,0.87,1.00000,1,1,0,BP
GO:0045923,positive regulation of fatty acid metabo...,42,0,0.7,1.00000,1,1,0,BP
GO:0045933,positive regulation of muscle contractio...,53,0,0.89,1.00000,1,1,0,BP
GO:0045940,positive regulation of steroid metabolic...,35,0,0.59,1.00000,1,1,0,BP
GO:0045948,positive regulation of translational ini...,21,0,0.35,1.00000,1,1,0,BP
GO:0045980,negative regulation of nucleotide metabo...,31,0,0.52,1.00000,1,1,0,BP
GO:0045987,positive regulation of smooth muscle con...,36,0,0.6,1.00000,1,1,0,BP
GO:0045992,negative regulation of embryonic develop...,29,0,0.49,1.00000,1,1,0,BP
GO:0046039,GTP metabolic process,29,0,0.49,1.00000,1,1,0,BP
GO:0046129,purine ribonucleoside biosynthetic proce...,20,0,0.34,1.00000,1,1,0,BP
GO:0046131,pyrimidine ribonucleoside metabolic proc...,20,0,0.34,1.00000,1,1,0,BP
GO:0046189,phenol-containing compound biosynthetic ...,51,0,0.85,1.00000,1,1,0,BP
GO:0046339,diacylglycerol metabolic process,22,0,0.37,1.00000,1,1,0,BP
GO:0046425,regulation of JAK-STAT cascade,166,0,2.78,1.00000,1,1,0,BP
GO:0046426,negative regulation of JAK-STAT cascade,25,0,0.42,1.00000,1,1,0,BP
GO:0046427,positive regulation of JAK-STAT cascade,103,0,1.73,1.00000,1,1,0,BP
GO:0046488,phosphatidylinositol metabolic process,133,0,2.23,1.00000,1,1,0,BP
GO:0046513,ceramide biosynthetic process,56,0,0.94,1.00000,1,1,0,BP
GO:0046579,positive regulation of Ras protein signa...,64,0,1.07,1.00000,1,1,0,BP
GO:0046580,negative regulation of Ras protein signa...,55,0,0.92,1.00000,1,1,0,BP
GO:0046597,negative regulation of viral entry into ...,22,0,0.37,1.00000,1,1,0,BP
GO:0046636,negative regulation of alpha-beta T cell...,42,0,0.7,1.00000,1,1,0,BP
GO:0046637,regulation of alpha-beta T cell differen...,67,0,1.12,1.00000,1,1,0,BP
GO:0046638,positive regulation of alpha-beta T cell...,49,0,0.82,1.00000,1,1,0,BP
GO:0046639,negative regulation of alpha-beta T cell...,27,0,0.45,1.00000,1,1,0,BP
GO:0046653,tetrahydrofolate metabolic process,20,0,0.34,1.00000,1,1,0,BP
GO:0046685,response to arsenic-containing substance,24,0,0.4,1.00000,1,1,0,BP
GO:0046834,lipid phosphorylation,53,0,0.89,1.00000,1,1,0,BP
GO:0046839,phospholipid dephosphorylation,36,0,0.6,1.00000,1,1,0,BP
GO:0046854,phosphatidylinositol phosphorylation,41,0,0.69,1.00000,1,1,0,BP
GO:0046856,phosphatidylinositol dephosphorylation,24,0,0.4,1.00000,1,1,0,BP
GO:0046885,regulation of hormone biosynthetic proce...,39,0,0.65,1.00000,1,1,0,BP
GO:0048009,insulin-like growth factor receptor sign...,36,0,0.6,1.00000,1,1,0,BP
GO:0048010,vascular endothelial growth factor recep...,48,0,0.8,1.00000,1,1,0,BP
GO:0048011,neurotrophin TRK receptor signaling path...,32,0,0.54,1.00000,1,1,0,BP
GO:0048013,ephrin receptor signaling pathway,33,0,0.55,1.00000,1,1,0,BP
GO:0048048,embryonic eye morphogenesis,32,0,0.54,1.00000,1,1,0,BP
GO:0048103,somatic stem cell division,28,0,0.47,1.00000,1,1,0,BP
GO:0048148,behavioral response to cocaine,25,0,0.42,1.00000,1,1,0,BP
GO:0048172,regulation of short-term neuronal synapt...,20,0,0.34,1.00000,1,1,0,BP
GO:0048245,eosinophil chemotaxis,20,0,0.34,1.00000,1,1,0,BP
GO:0048265,response to pain,40,0,0.67,1.00000,1,1,0,BP
GO:0048266,behavioral response to pain,25,0,0.42,1.00000,1,1,0,BP
GO:0048286,lung alveolus development,62,0,1.04,1.00000,1,1,0,BP
GO:0048333,mesodermal cell differentiation,23,0,0.39,1.00000,1,1,0,BP
GO:0048339,paraxial mesoderm development,22,0,0.37,1.00000,1,1,0,BP
GO:0048483,autonomic nervous system development,49,0,0.82,1.00000,1,1,0,BP
GO:0048485,sympathetic nervous system development,23,0,0.39,1.00000,1,1,0,BP
GO:0048486,parasympathetic nervous system developme...,22,0,0.37,1.00000,1,1,0,BP
GO:0048490,anterograde synaptic vesicle transport,20,0,0.34,1.00000,1,1,0,BP
GO:0048520,positive regulation of behavior,40,0,0.67,1.00000,1,1,0,BP
GO:0048521,negative regulation of behavior,27,0,0.45,1.00000,1,1,0,BP
GO:0048535,lymph node development,31,0,0.52,1.00000,1,1,0,BP
GO:0048536,spleen development,45,0,0.75,1.00000,1,1,0,BP
GO:0048546,digestive tract morphogenesis,54,0,0.9,1.00000,1,1,0,BP
GO:0048557,embryonic digestive tract morphogenesis,20,0,0.34,1.00000,1,1,0,BP
GO:0048565,digestive tract development,122,0,2.04,1.00000,1,1,0,BP
GO:0048566,embryonic digestive tract development,33,0,0.55,1.00000,1,1,0,BP
GO:0048569,post-embryonic animal organ development,21,0,0.35,1.00000,1,1,0,BP
GO:0048596,embryonic camera-type eye morphogenesis,28,0,0.47,1.00000,1,1,0,BP
GO:0048643,positive regulation of skeletal muscle t...,30,0,0.5,1.00000,1,1,0,BP
GO:0048659,smooth muscle cell proliferation,171,0,2.86,1.00000,1,1,0,BP
GO:0048660,regulation of smooth muscle cell prolife...,166,0,2.78,1.00000,1,1,0,BP
GO:0048661,positive regulation of smooth muscle cel...,107,0,1.79,1.00000,1,1,0,BP
GO:0048662,negative regulation of smooth muscle cel...,55,0,0.92,1.00000,1,1,0,BP
GO:0048665,neuron fate specification,37,0,0.62,1.00000,1,1,0,BP
GO:0048730,epidermis morphogenesis,37,0,0.62,1.00000,1,1,0,BP
GO:0048745,smooth muscle tissue development,27,0,0.45,1.00000,1,1,0,BP
GO:0048799,animal organ maturation,26,0,0.44,1.00000,1,1,0,BP
GO:0048806,genitalia development,51,0,0.85,1.00000,1,1,0,BP
GO:0048820,hair follicle maturation,28,0,0.47,1.00000,1,1,0,BP
GO:0048821,erythrocyte development,39,0,0.65,1.00000,1,1,0,BP
GO:0048841,regulation of axon extension involved in...,33,0,0.55,1.00000,1,1,0,BP
GO:0048843,negative regulation of axon extension in...,27,0,0.45,1.00000,1,1,0,BP
GO:0048846,axon extension involved in axon guidance,37,0,0.62,1.00000,1,1,0,BP
GO:0048857,neural nucleus development,22,0,0.37,1.00000,1,1,0,BP
GO:0050434,positive regulation of viral transcripti...,20,0,0.34,1.00000,1,1,0,BP
GO:0050654,chondroitin sulfate proteoglycan metabol...,30,0,0.5,1.00000,1,1,0,BP
GO:0050701,interleukin-1 secretion,62,0,1.04,1.00000,1,1,0,BP
GO:0050702,interleukin-1 beta secretion,53,0,0.89,1.00000,1,1,0,BP
GO:0050704,regulation of interleukin-1 secretion,54,0,0.9,1.00000,1,1,0,BP
GO:0050706,regulation of interleukin-1 beta secreti...,46,0,0.77,1.00000,1,1,0,BP
GO:0050716,positive regulation of interleukin-1 sec...,40,0,0.67,1.00000,1,1,0,BP
GO:0050718,positive regulation of interleukin-1 bet...,37,0,0.62,1.00000,1,1,0,BP
GO:0050732,negative regulation of peptidyl-tyrosine...,55,0,0.92,1.00000,1,1,0,BP
GO:0050777,negative regulation of immune response,159,0,2.66,1.00000,1,1,0,BP
GO:0050795,regulation of behavior,95,0,1.59,1.00000,1,1,0,BP
GO:0050802,"circadian sleep/wake cycle, sleep",29,0,0.49,1.00000,1,1,0,BP
GO:0050829,defense response to Gram-negative bacter...,94,0,1.57,1.00000,1,1,0,BP
GO:0050832,defense response to fungus,25,0,0.42,1.00000,1,1,0,BP
GO:0050869,negative regulation of B cell activation,36,0,0.6,1.00000,1,1,0,BP
GO:0050873,brown fat cell differentiation,49,0,0.82,1.00000,1,1,0,BP
GO:0050879,multicellular organismal movement,57,0,0.95,1.00000,1,1,0,BP
GO:0050881,musculoskeletal movement,57,0,0.95,1.00000,1,1,0,BP
GO:0050891,multicellular organismal water homeostas...,50,0,0.84,1.00000,1,1,0,BP
GO:0050892,intestinal absorption,38,0,0.64,1.00000,1,1,0,BP
GO:0050901,leukocyte tethering or rolling,27,0,0.45,1.00000,1,1,0,BP
GO:0050907,detection of chemical stimulus involved ...,59,0,0.99,1.00000,1,1,0,BP
GO:0050908,detection of light stimulus involved in ...,21,0,0.35,1.00000,1,1,0,BP
GO:0050910,detection of mechanical stimulus involve...,20,0,0.34,1.00000,1,1,0,BP
GO:0050912,detection of chemical stimulus involved ...,52,0,0.87,1.00000,1,1,0,BP
GO:0050913,sensory perception of bitter taste,51,0,0.85,1.00000,1,1,0,BP
GO:0050919,negative chemotaxis,45,0,0.75,1.00000,1,1,0,BP
GO:0050922,negative regulation of chemotaxis,55,0,0.92,1.00000,1,1,0,BP
GO:0050926,regulation of positive chemotaxis,27,0,0.45,1.00000,1,1,0,BP
GO:0050927,positive regulation of positive chemotax...,26,0,0.44,1.00000,1,1,0,BP
GO:0050931,pigment cell differentiation,39,0,0.65,1.00000,1,1,0,BP
GO:0050951,sensory perception of temperature stimul...,26,0,0.44,1.00000,1,1,0,BP
GO:0050953,sensory perception of light stimulus,166,0,2.78,1.00000,1,1,0,BP
GO:0050962,detection of light stimulus involved in ...,21,0,0.35,1.00000,1,1,0,BP
GO:0050966,detection of mechanical stimulus involve...,20,0,0.34,1.00000,1,1,0,BP
GO:0050996,positive regulation of lipid catabolic p...,27,0,0.45,1.00000,1,1,0,BP
GO:0051057,positive regulation of small GTPase medi...,71,0,1.19,1.00000,1,1,0,BP
GO:0051058,negative regulation of small GTPase medi...,61,0,1.02,1.00000,1,1,0,BP
GO:0051123,RNA polymerase II preinitiation complex ...,26,0,0.44,1.00000,1,1,0,BP
GO:0051150,regulation of smooth muscle cell differe...,32,0,0.54,1.00000,1,1,0,BP
GO:0051180,vitamin transport,32,0,0.54,1.00000,1,1,0,BP
GO:0051181,cofactor transport,36,0,0.6,1.00000,1,1,0,BP
GO:0051195,negative regulation of cofactor metaboli...,21,0,0.35,1.00000,1,1,0,BP
GO:0051205,protein insertion into membrane,25,0,0.42,1.00000,1,1,0,BP
GO:0051290,protein heterotetramerization,54,0,0.9,1.00000,1,1,0,BP
GO:0051307,meiotic chromosome separation,28,0,0.47,1.00000,1,1,0,BP
GO:0051310,metaphase plate congression,58,0,0.97,1.00000,1,1,0,BP
GO:0051339,regulation of lyase activity,40,0,0.67,1.00000,1,1,0,BP
GO:0051349,positive regulation of lyase activity,20,0,0.34,1.00000,1,1,0,BP
GO:0051384,response to glucocorticoid,87,0,1.46,1.00000,1,1,0,BP
GO:0051447,negative regulation of meiotic cell cycl...,20,0,0.34,1.00000,1,1,0,BP
GO:0051450,myoblast proliferation,21,0,0.35,1.00000,1,1,0,BP
GO:0051482,positive regulation of cytosolic calcium...,37,0,0.62,1.00000,1,1,0,BP
GO:0051497,negative regulation of stress fiber asse...,26,0,0.44,1.00000,1,1,0,BP
GO:0051560,mitochondrial calcium ion homeostasis,27,0,0.45,1.00000,1,1,0,BP
GO:0051590,positive regulation of neurotransmitter ...,51,0,0.85,1.00000,1,1,0,BP
GO:0051673,membrane disruption in other organism,28,0,0.47,1.00000,1,1,0,BP
GO:0051703,intraspecies interaction between organis...,53,0,0.89,1.00000,1,1,0,BP
GO:0051767,nitric-oxide synthase biosynthetic proce...,27,0,0.45,1.00000,1,1,0,BP
GO:0051769,regulation of nitric-oxide synthase bios...,27,0,0.45,1.00000,1,1,0,BP
GO:0051770,positive regulation of nitric-oxide synt...,21,0,0.35,1.00000,1,1,0,BP
GO:0051788,response to misfolded protein,25,0,0.42,1.00000,1,1,0,BP
GO:0051797,regulation of hair follicle development,22,0,0.37,1.00000,1,1,0,BP
GO:0051818,disruption of cells of other organism in...,21,0,0.35,1.00000,1,1,0,BP
GO:0051875,pigment granule localization,23,0,0.39,1.00000,1,1,0,BP
GO:0051883,killing of cells in other organism invol...,21,0,0.35,1.00000,1,1,0,BP
GO:0051898,negative regulation of protein kinase B ...,44,0,0.74,1.00000,1,1,0,BP
GO:0051905,establishment of pigment granule localiz...,20,0,0.34,1.00000,1,1,0,BP
GO:0051930,regulation of sensory perception of pain,54,0,0.9,1.00000,1,1,0,BP
GO:0051931,regulation of sensory perception,55,0,0.92,1.00000,1,1,0,BP
GO:0051953,negative regulation of amine transport,36,0,0.6,1.00000,1,1,0,BP
GO:0051955,regulation of amino acid transport,50,0,0.84,1.00000,1,1,0,BP
GO:0051957,positive regulation of amino acid transp...,28,0,0.47,1.00000,1,1,0,BP
GO:0051969,regulation of transmission of nerve impu...,23,0,0.39,1.00000,1,1,0,BP
GO:0052652,cyclic purine nucleotide metabolic proce...,24,0,0.4,1.00000,1,1,0,BP
GO:0055003,cardiac myofibril assembly,26,0,0.44,1.00000,1,1,0,BP
GO:0055075,potassium ion homeostasis,31,0,0.52,1.00000,1,1,0,BP
GO:0055123,digestive system development,135,0,2.26,1.00000,1,1,0,BP
GO:0060004,reflex,25,0,0.42,1.00000,1,1,0,BP
GO:0060037,pharyngeal system development,28,0,0.47,1.00000,1,1,0,BP
GO:0060039,pericardium development,29,0,0.49,1.00000,1,1,0,BP
GO:0060045,positive regulation of cardiac muscle ce...,27,0,0.45,1.00000,1,1,0,BP
GO:0060065,uterus development,26,0,0.44,1.00000,1,1,0,BP
GO:0060080,inhibitory postsynaptic potential,23,0,0.39,1.00000,1,1,0,BP
GO:0060099,"regulation of phagocytosis, engulfment",20,0,0.34,1.00000,1,1,0,BP
GO:0060123,regulation of growth hormone secretion,20,0,0.34,1.00000,1,1,0,BP
GO:0060142,regulation of syncytium formation by pla...,37,0,0.62,1.00000,1,1,0,BP
GO:0060143,positive regulation of syncytium formati...,32,0,0.54,1.00000,1,1,0,BP
GO:0060148,positive regulation of posttranscription...,26,0,0.44,1.00000,1,1,0,BP
GO:0060218,hematopoietic stem cell differentiation,30,0,0.5,1.00000,1,1,0,BP
GO:0060252,positive regulation of glial cell prolif...,20,0,0.34,1.00000,1,1,0,BP
GO:0060259,regulation of feeding behavior,38,0,0.64,1.00000,1,1,0,BP
GO:0060260,regulation of transcription initiation f...,29,0,0.49,1.00000,1,1,0,BP
GO:0060261,positive regulation of transcription ini...,23,0,0.39,1.00000,1,1,0,BP
GO:0060285,cilium-dependent cell motility,35,0,0.59,1.00000,1,1,0,BP
GO:0060294,cilium movement involved in cell motilit...,20,0,0.34,1.00000,1,1,0,BP
GO:0060307,regulation of ventricular cardiac muscle...,20,0,0.34,1.00000,1,1,0,BP
GO:0060317,cardiac epithelial to mesenchymal transi...,30,0,0.5,1.00000,1,1,0,BP
GO:0060325,face morphogenesis,40,0,0.67,1.00000,1,1,0,BP
GO:0060333,interferon-gamma-mediated signaling path...,23,0,0.39,1.00000,1,1,0,BP
GO:0060337,type I interferon signaling pathway,39,0,0.65,1.00000,1,1,0,BP
GO:0060338,regulation of type I interferon-mediated...,25,0,0.42,1.00000,1,1,0,BP
GO:0060351,cartilage development involved in endoch...,52,0,0.87,1.00000,1,1,0,BP
GO:0060389,pathway-restricted SMAD protein phosphor...,66,0,1.11,1.00000,1,1,0,BP
GO:0060393,regulation of pathway-restricted SMAD pr...,63,0,1.06,1.00000,1,1,0,BP
GO:0060411,cardiac septum morphogenesis,86,0,1.44,1.00000,1,1,0,BP
GO:0060412,ventricular septum morphogenesis,51,0,0.85,1.00000,1,1,0,BP
GO:0060441,epithelial tube branching involved in lu...,36,0,0.6,1.00000,1,1,0,BP
GO:0060443,mammary gland morphogenesis,58,0,0.97,1.00000,1,1,0,BP
GO:0060444,branching involved in mammary gland duct...,28,0,0.47,1.00000,1,1,0,BP
GO:0060445,branching involved in salivary gland mor...,28,0,0.47,1.00000,1,1,0,BP
GO:0060456,positive regulation of digestive system ...,20,0,0.34,1.00000,1,1,0,BP
GO:0060479,lung cell differentiation,35,0,0.59,1.00000,1,1,0,BP
GO:0060487,lung epithelial cell differentiation,34,0,0.57,1.00000,1,1,0,BP
GO:0060512,prostate gland morphogenesis,34,0,0.57,1.00000,1,1,0,BP
GO:0060536,cartilage morphogenesis,27,0,0.45,1.00000,1,1,0,BP
GO:0060575,intestinal epithelial cell differentiati...,22,0,0.37,1.00000,1,1,0,BP
GO:0060602,branch elongation of an epithelium,22,0,0.37,1.00000,1,1,0,BP
GO:0060603,mammary gland duct morphogenesis,40,0,0.67,1.00000,1,1,0,BP
GO:0060612,adipose tissue development,50,0,0.84,1.00000,1,1,0,BP
GO:0060669,embryonic placenta morphogenesis,32,0,0.54,1.00000,1,1,0,BP
GO:0060674,placenta blood vessel development,37,0,0.62,1.00000,1,1,0,BP
GO:0060706,cell differentiation involved in embryon...,33,0,0.55,1.00000,1,1,0,BP
GO:0060711,labyrinthine layer development,59,0,0.99,1.00000,1,1,0,BP
GO:0060713,labyrinthine layer morphogenesis,27,0,0.45,1.00000,1,1,0,BP
GO:0060716,labyrinthine layer blood vessel developm...,26,0,0.44,1.00000,1,1,0,BP
GO:0060740,prostate gland epithelium morphogenesis,33,0,0.55,1.00000,1,1,0,BP
GO:0060749,mammary gland alveolus development,22,0,0.37,1.00000,1,1,0,BP
GO:0060761,negative regulation of response to cytok...,56,0,0.94,1.00000,1,1,0,BP
GO:0060795,cell fate commitment involved in formati...,31,0,0.52,1.00000,1,1,0,BP
GO:0060914,heart formation,31,0,0.52,1.00000,1,1,0,BP
GO:0060972,left/right pattern formation,23,0,0.39,1.00000,1,1,0,BP
GO:0060977,coronary vasculature morphogenesis,32,0,0.54,1.00000,1,1,0,BP
GO:0061005,cell differentiation involved in kidney ...,48,0,0.8,1.00000,1,1,0,BP
GO:0061035,regulation of cartilage development,69,0,1.16,1.00000,1,1,0,BP
GO:0061036,positive regulation of cartilage develop...,31,0,0.52,1.00000,1,1,0,BP
GO:0061037,negative regulation of cartilage develop...,30,0,0.5,1.00000,1,1,0,BP
GO:0061082,myeloid leukocyte cytokine production,30,0,0.5,1.00000,1,1,0,BP
GO:0061099,negative regulation of protein tyrosine ...,27,0,0.45,1.00000,1,1,0,BP
GO:0061162,establishment of monopolar cell polarity,20,0,0.34,1.00000,1,1,0,BP
GO:0061180,mammary gland epithelium development,78,0,1.31,1.00000,1,1,0,BP
GO:0061298,retina vasculature development in camera...,27,0,0.45,1.00000,1,1,0,BP
GO:0061311,cell surface receptor signaling pathway ...,28,0,0.47,1.00000,1,1,0,BP
GO:0061323,cell proliferation involved in heart mor...,21,0,0.35,1.00000,1,1,0,BP
GO:0061339,establishment or maintenance of monopola...,21,0,0.35,1.00000,1,1,0,BP
GO:0061371,determination of heart left/right asymme...,67,0,1.12,1.00000,1,1,0,BP
GO:0061377,mammary gland lobule development,22,0,0.37,1.00000,1,1,0,BP
GO:0061436,establishment of skin barrier,26,0,0.44,1.00000,1,1,0,BP
GO:0061437,renal system vasculature development,27,0,0.45,1.00000,1,1,0,BP
GO:0061440,kidney vasculature development,27,0,0.45,1.00000,1,1,0,BP
GO:0061614,pri-miRNA transcription by RNA polymeras...,52,0,0.87,1.00000,1,1,0,BP
GO:0061756,leukocyte adhesion to vascular endotheli...,37,0,0.62,1.00000,1,1,0,BP
GO:0061982,meiosis I cell cycle process,117,0,1.96,1.00000,1,1,0,BP
GO:0062009,secondary palate development,24,0,0.4,1.00000,1,1,0,BP
GO:0070050,neuron cellular homeostasis,25,0,0.42,1.00000,1,1,0,BP
GO:0070076,histone lysine demethylation,28,0,0.47,1.00000,1,1,0,BP
GO:0070129,regulation of mitochondrial translation,27,0,0.45,1.00000,1,1,0,BP
GO:0070168,negative regulation of biomineral tissue...,26,0,0.44,1.00000,1,1,0,BP
GO:0070193,synaptonemal complex organization,25,0,0.42,1.00000,1,1,0,BP
GO:0070207,protein homotrimerization,40,0,0.67,1.00000,1,1,0,BP
GO:0070227,lymphocyte apoptotic process,98,0,1.64,1.00000,1,1,0,BP
GO:0070228,regulation of lymphocyte apoptotic proce...,76,0,1.27,1.00000,1,1,0,BP
GO:0070229,negative regulation of lymphocyte apopto...,49,0,0.82,1.00000,1,1,0,BP
GO:0070230,positive regulation of lymphocyte apopto...,21,0,0.35,1.00000,1,1,0,BP
GO:0070231,T cell apoptotic process,58,0,0.97,1.00000,1,1,0,BP
GO:0070232,regulation of T cell apoptotic process,43,0,0.72,1.00000,1,1,0,BP
GO:0070233,negative regulation of T cell apoptotic ...,26,0,0.44,1.00000,1,1,0,BP
GO:0070242,thymocyte apoptotic process,22,0,0.37,1.00000,1,1,0,BP
GO:0070269,pyroptosis,23,0,0.39,1.00000,1,1,0,BP
GO:0070286,axonemal dynein complex assembly,32,0,0.54,1.00000,1,1,0,BP
GO:0070306,lens fiber cell differentiation,30,0,0.5,1.00000,1,1,0,BP
GO:0070534,protein K63-linked ubiquitination,47,0,0.79,1.00000,1,1,0,BP
GO:0070536,protein K63-linked deubiquitination,31,0,0.52,1.00000,1,1,0,BP
GO:0070734,histone H3-K27 methylation,22,0,0.37,1.00000,1,1,0,BP
GO:0070830,bicellular tight junction assembly,44,0,0.74,1.00000,1,1,0,BP
GO:0070841,inclusion body assembly,22,0,0.37,1.00000,1,1,0,BP
GO:0070897,transcription preinitiation complex asse...,33,0,0.55,1.00000,1,1,0,BP
GO:0070977,bone maturation,22,0,0.37,1.00000,1,1,0,BP
GO:0070988,demethylation,64,0,1.07,1.00000,1,1,0,BP
GO:0071108,protein K48-linked deubiquitination,28,0,0.47,1.00000,1,1,0,BP
GO:0071168,protein localization to chromatin,28,0,0.47,1.00000,1,1,0,BP
GO:0071218,cellular response to misfolded protein,23,0,0.39,1.00000,1,1,0,BP
GO:0071234,cellular response to phenylalanine,25,0,0.42,1.00000,1,1,0,BP
GO:0071312,cellular response to alkaloid,25,0,0.42,1.00000,1,1,0,BP
GO:0071357,cellular response to type I interferon,39,0,0.65,1.00000,1,1,0,BP
GO:0071361,cellular response to ethanol,27,0,0.45,1.00000,1,1,0,BP
GO:0071384,cellular response to corticosteroid stim...,48,0,0.8,1.00000,1,1,0,BP
GO:0071385,cellular response to glucocorticoid stim...,46,0,0.77,1.00000,1,1,0,BP
GO:0071391,cellular response to estrogen stimulus,38,0,0.64,1.00000,1,1,0,BP
GO:0071392,cellular response to estradiol stimulus,24,0,0.4,1.00000,1,1,0,BP
GO:0071425,hematopoietic stem cell proliferation,26,0,0.44,1.00000,1,1,0,BP
GO:0071459,"protein localization to chromosome, cent...",22,0,0.37,1.00000,1,1,0,BP
GO:0071467,cellular response to pH,23,0,0.39,1.00000,1,1,0,BP
GO:0071470,cellular response to osmotic stress,51,0,0.85,1.00000,1,1,0,BP
GO:0071472,cellular response to salt stress,29,0,0.49,1.00000,1,1,0,BP
GO:0071474,cellular hyperosmotic response,27,0,0.45,1.00000,1,1,0,BP
GO:0071475,cellular hyperosmotic salinity response,23,0,0.39,1.00000,1,1,0,BP
GO:0071548,response to dexamethasone,31,0,0.52,1.00000,1,1,0,BP
GO:0071549,cellular response to dexamethasone stimu...,28,0,0.47,1.00000,1,1,0,BP
GO:0071577,zinc ion transmembrane transport,23,0,0.39,1.00000,1,1,0,BP
GO:0071677,positive regulation of mononuclear cell ...,25,0,0.42,1.00000,1,1,0,BP
GO:0071684,organism emergence from protective struc...,40,0,0.67,1.00000,1,1,0,BP
GO:0071711,basement membrane organization,25,0,0.42,1.00000,1,1,0,BP
GO:0071887,leukocyte apoptotic process,132,0,2.21,1.00000,1,1,0,BP
GO:0071985,multivesicular body sorting pathway,32,0,0.54,1.00000,1,1,0,BP
GO:0072012,glomerulus vasculature development,26,0,0.44,1.00000,1,1,0,BP
GO:0072079,nephron tubule formation,20,0,0.34,1.00000,1,1,0,BP
GO:0072087,renal vesicle development,20,0,0.34,1.00000,1,1,0,BP
GO:0072111,cell proliferation involved in kidney de...,22,0,0.37,1.00000,1,1,0,BP
GO:0072132,mesenchyme morphogenesis,51,0,0.85,1.00000,1,1,0,BP
GO:0072170,metanephric tubule development,21,0,0.35,1.00000,1,1,0,BP
GO:0072202,cell differentiation involved in metanep...,23,0,0.39,1.00000,1,1,0,BP
GO:0072207,metanephric epithelium development,24,0,0.4,1.00000,1,1,0,BP
GO:0072210,metanephric nephron development,38,0,0.64,1.00000,1,1,0,BP
GO:0072215,regulation of metanephros development,22,0,0.37,1.00000,1,1,0,BP
GO:0072243,metanephric nephron epithelium developme...,20,0,0.34,1.00000,1,1,0,BP
GO:0072273,metanephric nephron morphogenesis,22,0,0.37,1.00000,1,1,0,BP
GO:0072337,modified amino acid transport,23,0,0.39,1.00000,1,1,0,BP
GO:0072376,protein activation cascade,64,0,1.07,1.00000,1,1,0,BP
GO:0072395,signal transduction involved in cell cyc...,29,0,0.49,1.00000,1,1,0,BP
GO:0072401,signal transduction involved in DNA inte...,29,0,0.49,1.00000,1,1,0,BP
GO:0072422,signal transduction involved in DNA dama...,29,0,0.49,1.00000,1,1,0,BP
GO:0072527,pyrimidine-containing compound metabolic...,51,0,0.85,1.00000,1,1,0,BP
GO:0072528,pyrimidine-containing compound biosynthe...,27,0,0.45,1.00000,1,1,0,BP
GO:0072538,T-helper 17 type immune response,32,0,0.54,1.00000,1,1,0,BP
GO:0072539,T-helper 17 cell differentiation,28,0,0.47,1.00000,1,1,0,BP
GO:0072577,endothelial cell apoptotic process,57,0,0.95,1.00000,1,1,0,BP
GO:0072606,interleukin-8 secretion,25,0,0.42,1.00000,1,1,0,BP
GO:0072643,interferon-gamma secretion,24,0,0.4,1.00000,1,1,0,BP
GO:0072662,protein localization to peroxisome,20,0,0.34,1.00000,1,1,0,BP
GO:0072663,establishment of protein localization to...,20,0,0.34,1.00000,1,1,0,BP
GO:0072677,eosinophil migration,24,0,0.4,1.00000,1,1,0,BP
GO:0080053,response to phenylalanine,25,0,0.42,1.00000,1,1,0,BP
GO:0080111,DNA demethylation,21,0,0.35,1.00000,1,1,0,BP
GO:0080154,regulation of fertilization,28,0,0.47,1.00000,1,1,0,BP
GO:0086005,ventricular cardiac muscle cell action p...,28,0,0.47,1.00000,1,1,0,BP
GO:0089718,amino acid import across plasma membrane,28,0,0.47,1.00000,1,1,0,BP
GO:0090025,regulation of monocyte chemotaxis,26,0,0.44,1.00000,1,1,0,BP
GO:0090049,regulation of cell migration involved in...,40,0,0.67,1.00000,1,1,0,BP
GO:0090050,positive regulation of cell migration in...,21,0,0.35,1.00000,1,1,0,BP
GO:0090114,COPII-coated vesicle budding,25,0,0.42,1.00000,1,1,0,BP
GO:0090162,establishment of epithelial cell polarit...,31,0,0.52,1.00000,1,1,0,BP
GO:0090201,negative regulation of release of cytoch...,22,0,0.37,1.00000,1,1,0,BP
GO:0090280,positive regulation of calcium ion impor...,25,0,0.42,1.00000,1,1,0,BP
GO:0090317,negative regulation of intracellular pro...,43,0,0.72,1.00000,1,1,0,BP
GO:0090344,negative regulation of cell aging,26,0,0.44,1.00000,1,1,0,BP
GO:0090504,epiboly,32,0,0.54,1.00000,1,1,0,BP
GO:0090505,epiboly involved in wound healing,31,0,0.52,1.00000,1,1,0,BP
GO:0090630,activation of GTPase activity,83,0,1.39,1.00000,1,1,0,BP
GO:0097009,energy homeostasis,39,0,0.65,1.00000,1,1,0,BP
GO:0097028,dendritic cell differentiation,38,0,0.64,1.00000,1,1,0,BP
GO:0097150,neuronal stem cell population maintenanc...,24,0,0.4,1.00000,1,1,0,BP
GO:0097186,amelogenesis,24,0,0.4,1.00000,1,1,0,BP
GO:0097205,renal filtration,23,0,0.39,1.00000,1,1,0,BP
GO:0097352,autophagosome maturation,35,0,0.59,1.00000,1,1,0,BP
GO:0097366,response to bronchodilator,34,0,0.57,1.00000,1,1,0,BP
GO:0097502,mannosylation,23,0,0.39,1.00000,1,1,0,BP
GO:0097696,STAT cascade,195,0,3.27,1.00000,1,1,0,BP
GO:0097722,sperm motility,105,0,1.76,1.00000,1,1,0,BP
GO:0098581,detection of external biotic stimulus,23,0,0.39,1.00000,1,1,0,BP
GO:0098743,cell aggregation,20,0,0.34,1.00000,1,1,0,BP
GO:0098868,bone growth,46,0,0.77,1.00000,1,1,0,BP
GO:0099500,vesicle fusion to plasma membrane,26,0,0.44,1.00000,1,1,0,BP
GO:0099514,synaptic vesicle cytoskeletal transport,20,0,0.34,1.00000,1,1,0,BP
GO:0099517,synaptic vesicle transport along microtu...,20,0,0.34,1.00000,1,1,0,BP
GO:0099622,cardiac muscle cell membrane repolarizat...,29,0,0.49,1.00000,1,1,0,BP
GO:0099623,regulation of cardiac muscle cell membra...,24,0,0.4,1.00000,1,1,0,BP
GO:0099625,ventricular cardiac muscle cell membrane...,22,0,0.37,1.00000,1,1,0,BP
GO:0101023,vascular endothelial cell proliferation,23,0,0.39,1.00000,1,1,0,BP
GO:0106030,neuron projection fasciculation,26,0,0.44,1.00000,1,1,0,BP
GO:0120192,tight junction assembly,45,0,0.75,1.00000,1,1,0,BP
GO:0120193,tight junction organization,50,0,0.84,1.00000,1,1,0,BP
GO:0140053,mitochondrial gene expression,103,0,1.73,1.00000,1,1,0,BP
GO:0140115,export across plasma membrane,34,0,0.57,1.00000,1,1,0,BP
GO:0150077,regulation of neuroinflammatory response,25,0,0.42,1.00000,1,1,0,BP
GO:1900015,regulation of cytokine production involv...,42,0,0.7,1.00000,1,1,0,BP
GO:1900017,positive regulation of cytokine producti...,21,0,0.35,1.00000,1,1,0,BP
GO:1900101,regulation of endoplasmic reticulum unfo...,21,0,0.35,1.00000,1,1,0,BP
GO:1900274,regulation of phospholipase C activity,30,0,0.5,1.00000,1,1,0,BP
GO:1900543,negative regulation of purine nucleotide...,30,0,0.5,1.00000,1,1,0,BP
GO:1900744,regulation of p38MAPK cascade,41,0,0.69,1.00000,1,1,0,BP
GO:1900745,positive regulation of p38MAPK cascade,28,0,0.47,1.00000,1,1,0,BP
GO:1901017,negative regulation of potassium ion tra...,21,0,0.35,1.00000,1,1,0,BP
GO:1901068,guanosine-containing compound metabolic ...,35,0,0.59,1.00000,1,1,0,BP
GO:1901071,glucosamine-containing compound metaboli...,26,0,0.44,1.00000,1,1,0,BP
GO:1901186,positive regulation of ERBB signaling pa...,28,0,0.47,1.00000,1,1,0,BP
GO:1901380,negative regulation of potassium ion tra...,26,0,0.44,1.00000,1,1,0,BP
GO:1901522,positive regulation of transcription fro...,21,0,0.35,1.00000,1,1,0,BP
GO:1901532,regulation of hematopoietic progenitor c...,27,0,0.45,1.00000,1,1,0,BP
GO:1901658,glycosyl compound catabolic process,25,0,0.42,1.00000,1,1,0,BP
GO:1901659,glycosyl compound biosynthetic process,31,0,0.52,1.00000,1,1,0,BP
GO:1901739,regulation of myoblast fusion,26,0,0.44,1.00000,1,1,0,BP
GO:1901741,positive regulation of myoblast fusion,23,0,0.39,1.00000,1,1,0,BP
GO:1901797,negative regulation of signal transducti...,32,0,0.54,1.00000,1,1,0,BP
GO:1901984,negative regulation of protein acetylati...,24,0,0.4,1.00000,1,1,0,BP
GO:1902186,regulation of viral release from host ce...,32,0,0.54,1.00000,1,1,0,BP
GO:1902230,negative regulation of intrinsic apoptot...,25,0,0.42,1.00000,1,1,0,BP
GO:1902254,negative regulation of intrinsic apoptot...,20,0,0.34,1.00000,1,1,0,BP
GO:1902284,neuron projection extension involved in ...,37,0,0.62,1.00000,1,1,0,BP
GO:1902475,L-alpha-amino acid transmembrane transpo...,39,0,0.65,1.00000,1,1,0,BP
GO:1902476,chloride transmembrane transport,39,0,0.65,1.00000,1,1,0,BP
GO:1902667,regulation of axon guidance,46,0,0.77,1.00000,1,1,0,BP
GO:1902668,negative regulation of axon guidance,28,0,0.47,1.00000,1,1,0,BP
GO:1902750,negative regulation of cell cycle G2/M p...,52,0,0.87,1.00000,1,1,0,BP
GO:1902893,regulation of pri-miRNA transcription by...,45,0,0.75,1.00000,1,1,0,BP
GO:1902895,positive regulation of pri-miRNA transcr...,35,0,0.59,1.00000,1,1,0,BP
GO:1902914,regulation of protein polyubiquitination,23,0,0.39,1.00000,1,1,0,BP
GO:1902932,positive regulation of alcohol biosynthe...,28,0,0.47,1.00000,1,1,0,BP
GO:1903020,positive regulation of glycoprotein meta...,23,0,0.39,1.00000,1,1,0,BP
GO:1903053,regulation of extracellular matrix organ...,41,0,0.69,1.00000,1,1,0,BP
GO:1903055,positive regulation of extracellular mat...,23,0,0.39,1.00000,1,1,0,BP
GO:1903131,mononuclear cell differentiation,29,0,0.49,1.00000,1,1,0,BP
GO:1903319,positive regulation of protein maturatio...,30,0,0.5,1.00000,1,1,0,BP
GO:1903432,regulation of TORC1 signaling,37,0,0.62,1.00000,1,1,0,BP
GO:1903487,regulation of lactation,29,0,0.49,1.00000,1,1,0,BP
GO:1903489,positive regulation of lactation,27,0,0.45,1.00000,1,1,0,BP
GO:1903510,mucopolysaccharide metabolic process,58,0,0.97,1.00000,1,1,0,BP
GO:1903579,negative regulation of ATP metabolic pro...,29,0,0.49,1.00000,1,1,0,BP
GO:1903671,negative regulation of sprouting angioge...,26,0,0.44,1.00000,1,1,0,BP
GO:1903793,positive regulation of anion transport,65,0,1.09,1.00000,1,1,0,BP
GO:1903901,negative regulation of viral life cycle,82,0,1.37,1.00000,1,1,0,BP
GO:1904036,negative regulation of epithelial cell a...,49,0,0.82,1.00000,1,1,0,BP
GO:1904292,regulation of ERAD pathway,28,0,0.47,1.00000,1,1,0,BP
GO:1904705,regulation of vascular smooth muscle cel...,53,0,0.89,1.00000,1,1,0,BP
GO:1904707,positive regulation of vascular smooth m...,35,0,0.59,1.00000,1,1,0,BP
GO:1904892,regulation of STAT cascade,171,0,2.86,1.00000,1,1,0,BP
GO:1904893,negative regulation of STAT cascade,26,0,0.44,1.00000,1,1,0,BP
GO:1904894,positive regulation of STAT cascade,107,0,1.79,1.00000,1,1,0,BP
GO:1904994,regulation of leukocyte adhesion to vasc...,20,0,0.34,1.00000,1,1,0,BP
GO:1905208,negative regulation of cardiocyte differ...,24,0,0.4,1.00000,1,1,0,BP
GO:1905268,negative regulation of chromatin organiz...,62,0,1.04,1.00000,1,1,0,BP
GO:1905314,semi-lunar valve development,31,0,0.52,1.00000,1,1,0,BP
GO:1905562,regulation of vascular endothelial cell ...,23,0,0.39,1.00000,1,1,0,BP
GO:1905939,regulation of gonad development,25,0,0.42,1.00000,1,1,0,BP
GO:1990126,"retrograde transport, endosome to plasma...",29,0,0.49,1.00000,1,1,0,BP
GO:1990403,embryonic brain development,20,0,0.34,1.00000,1,1,0,BP
GO:1990573,potassium ion import across plasma membr...,43,0,0.72,1.00000,1,1,0,BP
GO:1990874,vascular smooth muscle cell proliferatio...,53,0,0.89,1.00000,1,1,0,BP
GO:2000050,regulation of non-canonical Wnt signalin...,26,0,0.44,1.00000,1,1,0,BP
GO:2000106,regulation of leukocyte apoptotic proces...,108,0,1.81,1.00000,1,1,0,BP
GO:2000107,negative regulation of leukocyte apoptot...,69,0,1.16,1.00000,1,1,0,BP
GO:2000108,positive regulation of leukocyte apoptot...,33,0,0.55,1.00000,1,1,0,BP
GO:2000136,regulation of cell proliferation involve...,20,0,0.34,1.00000,1,1,0,BP
GO:2000142,regulation of DNA-templated transcriptio...,39,0,0.65,1.00000,1,1,0,BP
GO:2000144,positive regulation of DNA-templated tra...,31,0,0.52,1.00000,1,1,0,BP
GO:2000193,positive regulation of fatty acid transp...,21,0,0.35,1.00000,1,1,0,BP
GO:2000209,regulation of anoikis,21,0,0.35,1.00000,1,1,0,BP
GO:2000272,negative regulation of signaling recepto...,27,0,0.45,1.00000,1,1,0,BP
GO:2000279,negative regulation of DNA biosynthetic ...,44,0,0.74,1.00000,1,1,0,BP
GO:2000311,regulation of AMPA receptor activity,28,0,0.47,1.00000,1,1,0,BP
GO:2000316,regulation of T-helper 17 type immune re...,23,0,0.39,1.00000,1,1,0,BP
GO:2000351,regulation of endothelial cell apoptotic...,54,0,0.9,1.00000,1,1,0,BP
GO:2000352,negative regulation of endothelial cell ...,31,0,0.52,1.00000,1,1,0,BP
GO:2000353,positive regulation of endothelial cell ...,22,0,0.37,1.00000,1,1,0,BP
GO:2000463,positive regulation of excitatory postsy...,38,0,0.64,1.00000,1,1,0,BP
GO:2000482,regulation of interleukin-8 secretion,21,0,0.35,1.00000,1,1,0,BP
GO:2000515,"negative regulation of CD4-positive, alp...",31,0,0.52,1.00000,1,1,0,BP
GO:2000637,positive regulation of gene silencing by...,25,0,0.42,1.00000,1,1,0,BP
GO:2000648,positive regulation of stem cell prolife...,56,0,0.94,1.00000,1,1,0,BP
GO:2000677,regulation of transcription regulatory r...,52,0,0.87,1.00000,1,1,0,BP
GO:2000678,negative regulation of transcription reg...,20,0,0.34,1.00000,1,1,0,BP
GO:2000679,positive regulation of transcription reg...,25,0,0.42,1.00000,1,1,0,BP
GO:2000726,negative regulation of cardiac muscle ce...,20,0,0.34,1.00000,1,1,0,BP
GO:2000737,negative regulation of stem cell differe...,26,0,0.44,1.00000,1,1,0,BP
GO:2000757,negative regulation of peptidyl-lysine a...,22,0,0.37,1.00000,1,1,0,BP
GO:2000780,negative regulation of double-strand bre...,26,0,0.44,1.00000,1,1,0,BP
GO:2000826,regulation of heart morphogenesis,42,0,0.7,1.00000,1,1,0,BP
GO:2000831,regulation of steroid hormone secretion,23,0,0.39,1.00000,1,1,0,BP
GO:2001021,negative regulation of response to DNA d...,71,0,1.19,1.00000,1,1,0,BP
GO:2001026,regulation of endothelial cell chemotaxi...,22,0,0.37,1.00000,1,1,0,BP
GO:2001258,negative regulation of cation channel ac...,41,0,0.69,1.00000,1,1,0,BP
GO:0019899,enzyme binding,2351,110,39.38,1.2e-24,9.948e-22,9.948e-22,2.79,MF
GO:0015078,proton transmembrane transporter activit...,121,25,2.03,2.1e-20,1.7409e-17,8.7045e-18,12.32,MF
GO:0005515,protein binding,8941,226,149.75,9.9e-17,8.2071e-14,1.421142857142857e-14,1.51,MF
GO:0044769,"ATPase activity, coupled to transmembran...",34,14,0.57,1.1e-16,9.119e-14,1.421142857142857e-14,24.56,MF
GO:0019829,cation-transporting ATPase activity,61,17,1.02,1.2e-16,9.948e-14,1.421142857142857e-14,16.67,MF
GO:0022853,active ion transmembrane transporter act...,61,17,1.02,1.2e-16,9.948e-14,1.421142857142857e-14,16.67,MF
GO:0042625,ATPase coupled ion transmembrane transpo...,61,17,1.02,1.2e-16,9.948e-14,1.421142857142857e-14,16.67,MF
GO:0003735,structural constituent of ribosome,151,21,2.53,1.0e-13,8.29e-11,1.03625e-11,8.3,MF
GO:0031625,ubiquitin protein ligase binding,307,28,5.14,3.8e-13,3.1502e-10,3.5002222222222225e-11,5.45,MF
GO:0044877,protein-containing complex binding,1256,59,21.04,5.2e-13,4.3108e-10,4.1449999999999996e-11,2.8,MF
GO:0005488,binding,13259,283,222.08,5.5e-13,4.5594999999999996e-10,4.1449999999999996e-11,1.27,MF
GO:0044389,ubiquitin-like protein ligase binding,326,28,5.46,1.6e-12,1.3264e-9,1.1053333333333332e-10,5.13,MF
GO:0042626,"ATPase activity, coupled to transmembran...",113,17,1.89,6.4e-12,5.3056e-9,4.0812307692307693e-10,8.99,MF
GO:0043492,"ATPase activity, coupled to movement of ...",114,17,1.91,7.4e-12,6.1346e-9,4.381857142857143e-10,8.9,MF
GO:0009055,electron transfer activity,72,14,1.21,1.3e-11,1.0777e-8,6.339411764705882e-10,11.57,MF
GO:0015405,P-P-bond-hydrolysis-driven transmembrane...,118,17,1.98,1.3e-11,1.0777e-8,6.339411764705882e-10,8.59,MF
GO:0016491,oxidoreductase activity,796,43,13.33,1.3e-11,1.0777e-8,6.339411764705882e-10,3.23,MF
GO:0003723,RNA binding,1068,51,17.89,1.4e-11,1.1606e-8,6.447777777777778e-10,2.85,MF
GO:0015399,primary active transmembrane transporter...,119,17,1.99,1.5e-11,1.2435e-8,6.544736842105263e-10,8.54,MF
GO:0036442,proton-exporting ATPase activity,31,10,0.52,5.0e-11,4.1450000000000004e-8,2.0725e-9,19.23,MF
GO:0017111,nucleoside-triphosphatase activity,830,42,13.9,1.8e-10,1.4922e-7,7.1057142857142856e-9,3.02,MF
GO:0005198,structural molecule activity,610,35,10.22,2.5e-10,2.0725e-7,9.420454545454546e-9,3.42,MF
GO:0016462,pyrophosphatase activity,883,43,14.79,3.6e-10,2.9844e-7,1.2975652173913043e-8,2.91,MF
GO:0016817,"hydrolase activity, acting on acid anhyd...",886,43,14.84,4.0e-10,3.3160000000000003e-7,1.3263999999999999e-8,2.9,MF
GO:0016818,"hydrolase activity, acting on acid anhyd...",886,43,14.84,4.0e-10,3.3160000000000003e-7,1.3263999999999999e-8,2.9,MF
GO:0016887,ATPase activity,386,26,6.47,2.1e-09,1.7409000000000001e-6,6.69576923076923e-8,4.02,MF
GO:0015077,monovalent inorganic cation transmembran...,363,25,6.08,2.8e-09,2.3212e-6,8.597037037037036e-8,4.11,MF
GO:0042623,"ATPase activity, coupled",286,22,4.79,3.4e-09,2.8186e-6,1.0066428571428571e-7,4.59,MF
GO:0003729,mRNA binding,270,21,4.52,6.4e-09,5.3056000000000005e-6,1.8295172413793102e-7,4.65,MF
GO:0019904,protein domain specific binding,813,38,13.62,1.2e-08,9.948e-6,3.316e-7,2.79,MF
GO:0044325,ion channel binding,139,15,2.33,1.3e-08,1.0777e-5,3.476451612903226e-7,6.44,MF
GO:0097159,organic cyclic compound binding,5162,133,86.46,1.9e-08,1.5751000000000002e-5,4.922187500000001e-7,1.54,MF
GO:0019843,rRNA binding,71,11,1.19,2.6e-08,2.1554e-5,6.531515151515152e-7,9.24,MF
GO:0046961,"proton-transporting ATPase activity, rot...",21,7,0.35,3.3e-08,2.7357e-5,8.046176470588235e-7,20,MF
GO:1901363,heterocyclic compound binding,5061,130,84.77,3.7e-08,3.0673e-5,8.763714285714286e-7,1.53,MF
GO:0051082,unfolded protein binding,97,12,1.62,8.0e-08,6.632e-5,1.8422222222222223e-6,7.41,MF
GO:0004129,cytochrome-c oxidase activity,24,7,0.4,9.4e-08,7.7926e-5,1.998102564102564e-6,17.5,MF
GO:0015002,heme-copper terminal oxidase activity,24,7,0.4,9.4e-08,7.7926e-5,1.998102564102564e-6,17.5,MF
GO:0016676,"oxidoreductase activity, acting on a hem...",24,7,0.4,9.4e-08,7.7926e-5,1.998102564102564e-6,17.5,MF
GO:0016675,"oxidoreductase activity, acting on a hem...",25,7,0.42,1.3e-07,1.0776999999999999e-4,2.69425e-6,16.67,MF
GO:0003824,catalytic activity,5780,141,96.81,1.8e-07,1.4921999999999998e-4,3.639512195121951e-6,1.46,MF
GO:0003954,NADH dehydrogenase activity,29,7,0.49,4.0e-07,3.316e-4,7.895238095238095e-6,14.29,MF
GO:0019900,kinase binding,821,35,13.75,4.4e-07,3.6476e-4,8.482790697674419e-6,2.55,MF
GO:0097367,carbohydrate derivative binding,2158,67,36.14,4.6e-07,3.8134e-4,8.6668181818181808e-06,1.85,MF
GO:0000166,nucleotide binding,2075,65,34.75,5.2e-07,4.3107999999999997e-4,9.371304347826086e-6,1.87,MF
GO:1901265,nucleoside phosphate binding,2075,65,34.75,5.2e-07,4.3107999999999997e-4,9.371304347826086e-6,1.87,MF
GO:0036094,small molecule binding,2460,73,41.2,7.0e-07,5.803e-4,1.2346808510638298e-5,1.77,MF
GO:0017076,purine nucleotide binding,1843,58,30.87,2.1e-06,0.0017408999999999999,3.626875e-5,1.88,MF
GO:0043168,anion binding,2733,77,45.78,2.4e-06,0.0019896,4.060408163265306e-5,1.68,MF
GO:0022804,active transmembrane transporter activit...,355,20,5.95,2.6e-06,0.0021554,4.3107999999999995e-5,3.36,MF
GO:0019901,protein kinase binding,740,31,12.39,3.0e-06,0.002487,4.876470588235294e-5,2.5,MF
GO:0005525,GTP binding,360,20,6.03,3.2e-06,0.0026528,5.101538461538461e-5,3.32,MF
GO:0008092,cytoskeletal protein binding,976,37,16.35,3.3e-06,0.0027357,5.1616981132075474e-5,2.26,MF
GO:0032555,purine ribonucleotide binding,1831,57,30.67,3.6e-06,0.0029844,5.477321428571429e-5,1.86,MF
GO:0008137,NADH dehydrogenase (ubiquinone) activity,26,6,0.44,3.7e-06,0.0030673000000000002,5.477321428571429e-5,13.64,MF
GO:0050136,NADH dehydrogenase (quinone) activity,26,6,0.44,3.7e-06,0.0030673000000000002,5.477321428571429e-5,13.64,MF
GO:0032550,purine ribonucleoside binding,367,20,6.15,4.3e-06,0.0035647,6.253859649122808e-5,3.25,MF
GO:0032553,ribonucleotide binding,1848,57,30.95,4.8e-06,0.0039792,6.860689655172414e-5,1.84,MF
GO:0022890,inorganic cation transmembrane transport...,575,26,9.63,5.0e-06,0.004145,7.02542372881356e-5,2.7,MF
GO:0001883,purine nucleoside binding,372,20,6.23,5.3e-06,0.0043937,7.202786885245902e-5,3.21,MF
GO:0032549,ribonucleoside binding,372,20,6.23,5.3e-06,0.0043937,7.202786885245902e-5,3.21,MF
GO:0042802,identical protein binding,1906,58,31.92,5.8e-06,0.0048082,7.755161290322582e-5,1.82,MF
GO:0001882,nucleoside binding,383,20,6.41,8.1e-06,0.0067149,1.0658571428571429e-4,3.12,MF
GO:0019001,guanyl nucleotide binding,384,20,6.43,8.4e-06,0.0069635999999999995,1.0713230769230769e-4,3.11,MF
GO:0032561,guanyl ribonucleotide binding,384,20,6.43,8.4e-06,0.0069635999999999995,1.0713230769230769e-4,3.11,MF
GO:0035639,purine ribonucleoside triphosphate bindi...,1756,54,29.41,9.6e-06,0.0079584,1.2058181818181817e-4,1.84,MF
GO:0005200,structural constituent of cytoskeleton,63,8,1.06,9.9e-06,0.0082071,1.2249402985074626e-4,7.55,MF
GO:0015075,ion transmembrane transporter activity,855,32,14.32,2.0e-05,0.01658,2.4382352941176473e-4,2.23,MF
GO:0008324,cation transmembrane transporter activit...,627,26,10.5,2.3e-05,0.019067,2.763333333333333e-4,2.48,MF
GO:0016655,"oxidoreductase activity, acting on NAD(P...",37,6,0.62,3.2e-05,0.026528,3.789714285714286e-4,9.68,MF
GO:0015318,inorganic molecular entity transmembrane...,796,30,13.33,3.3e-05,0.027357000000000003,3.853098591549296e-4,2.25,MF
GO:0030234,enzyme regulator activity,973,34,16.3,4.5e-05,0.037305000000000005,5.18125e-4,2.09,MF
GO:0033218,amide binding,364,18,6.1,4.7e-05,0.038963,5.337397260273973e-4,2.95,MF
GO:0047485,protein N-terminus binding,130,10,2.18,6.9e-05,0.057200999999999995,7.729864864864865e-4,4.59,MF
GO:0001540,amyloid-beta binding,61,7,1.02,7.0e-05,0.05803,7.737333333333332e-4,6.86,MF
GO:0016787,hydrolase activity,2534,67,42.44,9.4e-05,0.077926,0.0010253421052631578,1.58,MF
GO:0043167,ion binding,5533,124,92.67,0.00012,0.09948,0.001291948051948052,1.34,MF
GO:0042277,peptide binding,298,15,4.99,0.00016,0.13264,0.0017005128205128206,3.01,MF
GO:0035254,glutamate receptor binding,70,7,1.17,0.00017,0.14093,0.0017839240506329116,5.98,MF
GO:0051117,ATPase binding,94,8,1.57,0.00018,0.14922000000000002,0.0018422222222222223,5.1,MF
GO:0048306,calcium-dependent protein binding,71,7,1.19,0.00018,0.14922000000000002,0.0018422222222222223,5.88,MF
GO:0002020,protease binding,148,10,2.48,0.00020,0.1658,0.002021951219512195,4.03,MF
GO:0015631,tubulin binding,339,16,5.68,0.00021,0.17409,0.0020725,2.82,MF
GO:0022857,transmembrane transporter activity,1013,33,16.97,0.00021,0.17409,0.0020725,1.94,MF
GO:0008553,"proton-exporting ATPase activity, phosph...",20,4,0.33,0.00030,0.24869999999999998,0.0029258823529411766,12.12,MF
GO:0019003,GDP binding,77,7,1.29,0.00031,0.25699,0.0029882558139534884,5.43,MF
GO:0005215,transporter activity,1099,34,18.41,0.00044,0.36476000000000003,0.00419264367816092,1.85,MF
GO:0050998,nitric-oxide synthase binding,22,4,0.37,0.00045,0.37305,0.004239204545454545,10.81,MF
GO:0015662,"ATPase activity, coupled to transmembran...",39,5,0.65,0.00046,0.38134,0.004284719101123596,7.69,MF
GO:0016651,"oxidoreductase activity, acting on NAD(P...",84,7,1.41,0.00052,0.43107999999999996,0.004789777777777777,4.96,MF
GO:0003924,GTPase activity,303,14,5.07,0.00063,0.52227,0.005739230769230769,2.76,MF
GO:0048487,beta-tubulin binding,43,5,0.72,0.00073,0.60517,0.0065779347826086946,6.94,MF
GO:0042393,histone binding,218,11,3.65,0.00117,0.9699300000000001,0.010429354838709678,3.01,MF
GO:0030554,adenyl nucleotide binding,1505,41,25.21,0.00144,1,0.012699574468085109,1.63,MF
GO:0042287,MHC protein binding,30,4,0.5,0.00150,1,0.013089473684210526,8,MF
GO:0008135,"translation factor activity, RNA binding",78,6,1.31,0.00197,1,0.017011770833333332,4.58,MF
GO:0004857,enzyme inhibitor activity,381,15,6.38,0.00205,1,0.017520103092783505,2.35,MF
GO:0003676,nucleic acid binding,3105,72,52.01,0.00224,1,0.01884090909090909,1.38,MF
GO:0032559,adenyl ribonucleotide binding,1494,40,25.02,0.00225,1,0.01884090909090909,1.6,MF
GO:0005102,signaling receptor binding,1644,43,27.54,0.00239,1,0.0198131,1.56,MF
GO:0031072,heat shock protein binding,140,8,2.34,0.00252,1,0.0206839603960396,3.42,MF
GO:0016209,antioxidant activity,85,6,1.42,0.00305,1,0.02478872549019608,4.23,MF
GO:1901681,sulfur compound binding,253,11,4.24,0.00375,1,0.030182038834951453,2.59,MF
GO:0051287,NAD binding,63,5,1.06,0.00407,1,0.03244259615384615,4.72,MF
GO:0043021,ribonucleoprotein complex binding,152,8,2.55,0.00416,1,0.03284419047619048,3.14,MF
GO:0042826,histone deacetylase binding,122,7,2.04,0.00451,1,0.03527160377358491,3.43,MF
GO:0043531,ADP binding,41,4,0.69,0.00481,1,0.03726626168224299,5.8,MF
GO:0005524,ATP binding,1429,37,23.93,0.00563,1,0.043215462962962956,1.55,MF
GO:0019887,protein kinase regulator activity,164,8,2.75,0.00653,1,0.049663944954128444,2.91,MF
GO:0070840,dynein complex binding,24,3,0.4,0.00726,1,0.054714,7.5,MF
GO:0015459,potassium channel regulator activity,48,4,0.8,0.00843,1,0.06295918918918919,5,MF
GO:0005509,calcium ion binding,621,19,10.4,0.00889,1,0.06580187500000001,1.83,MF
GO:0015605,organophosphate ester transmembrane tran...,27,3,0.45,0.01012,1,0.0735919298245614,6.67,MF
GO:0008144,drug binding,1685,41,28.22,0.01012,1,0.0735919298245614,1.45,MF
GO:0004601,peroxidase activity,52,4,0.87,0.01114,1,0.08030486956521739,4.6,MF
GO:0003697,single-stranded DNA binding,113,6,1.89,0.01196,1,0.08547275862068965,3.17,MF
GO:0098772,molecular function regulator,1760,42,29.48,0.01265,1,0.08963119658119657,1.42,MF
GO:0016853,isomerase activity,152,7,2.55,0.01429,1,0.09989798319327732,2.75,MF
GO:0016684,"oxidoreductase activity, acting on perox...",56,4,0.94,0.01434,1,0.09989798319327732,4.26,MF
GO:0030507,spectrin binding,32,3,0.54,0.01613,1,0.11143141666666666,5.56,MF
GO:0008201,heparin binding,156,7,2.61,0.01627,1,0.1114696694214876,2.68,MF
GO:0004620,phospholipase activity,89,5,1.49,0.01693,1,0.11504073770491803,3.36,MF
GO:0008081,phosphoric diester hydrolase activity,90,5,1.51,0.01768,1,0.11886790322580645,3.31,MF
GO:0019207,kinase regulator activity,196,8,3.28,0.01778,1,0.11886790322580645,2.44,MF
GO:0003755,peptidyl-prolyl cis-trans isomerase acti...,34,3,0.57,0.01900,1,0.12600799999999998,5.26,MF
GO:0036002,pre-mRNA binding,35,3,0.59,0.02052,1,0.1328990625,5.08,MF
GO:0097718,disordered domain specific binding,35,3,0.59,0.02052,1,0.1328990625,5.08,MF
GO:1901567,fatty acid derivative binding,35,3,0.59,0.02052,1,0.1328990625,5.08,MF
GO:0008017,microtubule binding,242,9,4.05,0.02126,1,0.13662434108527133,2.22,MF
GO:0042162,telomeric DNA binding,36,3,0.6,0.02212,1,0.14105753846153848,5,MF
GO:0043022,ribosome binding,66,4,1.11,0.02474,1,0.15656076335877864,3.6,MF
GO:0016616,"oxidoreductase activity, acting on the C...",134,6,2.24,0.02548,1,0.15837611940298507,2.68,MF
GO:0016859,cis-trans isomerase activity,38,3,0.64,0.02550,1,0.15837611940298507,4.69,MF
GO:0005539,glycosaminoglycan binding,210,8,3.52,0.02560,1,0.15837611940298507,2.27,MF
GO:0031406,carboxylic acid binding,211,8,3.53,0.02623,1,0.16107162962962962,2.27,MF
GO:0051087,chaperone binding,100,5,1.67,0.02651,1,0.16159404411764705,2.99,MF
GO:0008289,lipid binding,748,20,12.53,0.02758,1,0.16688919708029196,1.6,MF
GO:0033293,monocarboxylic acid binding,69,4,1.16,0.02855,1,0.171506884057971,3.45,MF
GO:0098631,cell adhesion mediator activity,40,3,0.67,0.02915,1,0.17385143884892088,4.48,MF
GO:0072341,modified amino acid binding,104,5,1.74,0.03071,1,0.18184707142857146,2.87,MF
GO:0002039,p53 binding,72,4,1.21,0.03269,1,0.19165552447552447,3.31,MF
GO:0051219,phosphoprotein binding,106,5,1.78,0.03295,1,0.19165552447552447,2.81,MF
GO:0015036,disulfide oxidoreductase activity,42,3,0.7,0.03306,1,0.19165552447552447,4.29,MF
GO:0016614,"oxidoreductase activity, acting on CH-OH...",143,6,2.4,0.03354,1,0.19308791666666666,2.5,MF
GO:0019212,phosphatase inhibitor activity,43,3,0.72,0.03511,1,0.19935746575342467,4.17,MF
GO:0043548,phosphatidylinositol 3-kinase binding,43,3,0.72,0.03511,1,0.19935746575342467,4.17,MF
GO:0043177,organic acid binding,224,8,3.75,0.03554,1,0.20042625850340137,2.13,MF
GO:0016247,channel regulator activity,146,6,2.45,0.03656,1,0.20478540540540544,2.45,MF
GO:0097110,scaffold protein binding,76,4,1.27,0.03874,1,0.21553999999999995,3.15,MF
GO:0005504,fatty acid binding,45,3,0.75,0.03941,1,0.2178059333333333,4,MF
GO:0016860,intramolecular oxidoreductase activity,46,3,0.77,0.04165,1,0.2286612582781457,3.9,MF
GO:0099106,ion channel regulator activity,117,5,1.96,0.04710,1,0.25688092105263155,2.55,MF
GO:0048156,tau protein binding,21,2,0.35,0.04764,1,0.25812784313725495,5.71,MF
GO:0019894,kinesin binding,49,3,0.82,0.04876,1,0.2624807792207792,3.66,MF
GO:0001091,RNA polymerase II basal transcription fa...,22,2,0.37,0.05184,1,0.2724156962025317,5.41,MF
GO:0008483,transaminase activity,22,2,0.37,0.05184,1,0.2724156962025317,5.41,MF
GO:0044183,protein binding involved in protein fold...,22,2,0.37,0.05184,1,0.2724156962025317,5.41,MF
GO:0051015,actin filament binding,200,7,3.35,0.05192,1,0.2724156962025317,2.09,MF
GO:0016298,lipase activity,122,5,2.04,0.05456,1,0.28289625,2.45,MF
GO:0046983,protein dimerization activity,1422,32,23.82,0.05460,1,0.28289625,1.34,MF
GO:0019208,phosphatase regulator activity,86,4,1.44,0.05645,1,0.2906649068322982,2.78,MF
GO:0003779,actin binding,429,12,7.19,0.05860,1,0.29987283950617283,1.67,MF
GO:0004860,protein kinase inhibitor activity,53,3,0.89,0.05908,1,0.3004743558282209,3.37,MF
GO:0031683,G-protein beta/gamma-subunit complex bin...,24,2,0.4,0.06061,1,0.3045193333333333,5,MF
GO:0051787,misfolded protein binding,24,2,0.4,0.06061,1,0.3045193333333333,5,MF
GO:0050662,coenzyme binding,295,9,4.94,0.06132,1,0.3046450898203593,1.82,MF
GO:0051020,GTPase binding,527,14,8.83,0.06137,1,0.3046450898203593,1.59,MF
GO:0008134,transcription factor binding,726,18,12.16,0.06417,1,0.31410424418604654,1.48,MF
GO:0005178,integrin binding,128,5,2.14,0.06436,1,0.31410424418604654,2.34,MF
GO:0016769,"transferase activity, transferring nitro...",25,2,0.42,0.06517,1,0.31410424418604654,4.76,MF
GO:0030515,snoRNA binding,25,2,0.42,0.06517,1,0.31410424418604654,4.76,MF
GO:0030742,GTP-dependent protein binding,25,2,0.42,0.06517,1,0.31410424418604654,4.76,MF
GO:0000062,fatty-acyl-CoA binding,26,2,0.44,0.06985,1,0.333258,4.55,MF
GO:0016667,"oxidoreductase activity, acting on a sul...",57,3,0.95,0.07035,1,0.333258,3.16,MF
GO:0045309,protein phosphorylated amino acid bindin...,57,3,0.95,0.07035,1,0.333258,3.16,MF
GO:0019210,kinase inhibitor activity,58,3,0.97,0.07330,1,0.3439179096045198,3.09,MF
GO:0019902,phosphatase binding,217,7,3.63,0.07343,1,0.3439179096045198,1.93,MF
GO:0008143,poly(A) binding,27,2,0.45,0.07462,1,0.3455864804469274,4.44,MF
GO:0031435,mitogen-activated protein kinase kinase ...,27,2,0.45,0.07462,1,0.3455864804469274,4.44,MF
GO:0003727,single-stranded RNA binding,95,4,1.59,0.07552,1,0.34588994475138124,2.52,MF
GO:0003730,mRNA 3'-UTR binding,95,4,1.59,0.07552,1,0.34588994475138124,2.52,MF
GO:0050840,extracellular matrix binding,59,3,0.99,0.07632,1,0.3476334065934066,3.03,MF
GO:0042803,protein homodimerization activity,950,22,15.91,0.07886,1,0.35624594594594594,1.38,MF
GO:0005507,copper ion binding,60,3,1,0.07938,1,0.35624594594594594,3,MF
GO:0001530,lipopolysaccharide binding,28,2,0.47,0.07950,1,0.35624594594594594,4.26,MF
GO:0015301,anion:anion antiporter activity,29,2,0.49,0.08448,1,0.3745129411764706,4.08,MF
GO:0030291,protein serine/threonine kinase inhibito...,29,2,0.49,0.08448,1,0.3745129411764706,4.08,MF
GO:0005080,protein kinase C binding,62,3,1.04,0.08567,1,0.3777682446808511,2.88,MF
GO:0001786,phosphatidylserine binding,63,3,1.06,0.08889,1,0.3898931746031746,2.83,MF
GO:0016765,"transferase activity, transferring alkyl...",64,3,1.07,0.09216,1,0.4021086315789474,2.8,MF
GO:0004623,phospholipase A2 activity,31,2,0.52,0.09470,1,0.4053126288659794,3.85,MF
GO:0043236,laminin binding,31,2,0.52,0.09470,1,0.4053126288659794,3.85,MF
GO:0098632,cell-cell adhesion mediator activity,31,2,0.52,0.09470,1,0.4053126288659794,3.85,MF
GO:1990782,protein tyrosine kinase binding,103,4,1.73,0.09485,1,0.4053126288659794,2.31,MF
GO:0005516,calmodulin binding,191,6,3.2,0.10261,1,0.43622405128205133,1.88,MF
GO:0045505,dynein intermediate chain binding,33,2,0.55,0.10525,1,0.4426776262626263,3.64,MF
GO:0005496,steroid binding,107,4,1.79,0.10531,1,0.4426776262626263,2.23,MF
GO:0048365,Rac GTPase binding,68,3,1.14,0.10573,1,0.4426776262626263,2.63,MF
GO:0008022,protein C-terminus binding,238,7,3.99,0.10628,1,0.44274432160804017,1.75,MF
GO:0046982,protein heterodimerization activity,579,14,9.7,0.10957,1,0.45410321782178215,1.44,MF
GO:0004364,glutathione transferase activity,34,2,0.57,0.11065,1,0.45410321782178215,3.51,MF
GO:0051019,mitogen-activated protein kinase binding,34,2,0.57,0.11065,1,0.45410321782178215,3.51,MF
GO:0008200,ion channel inhibitor activity,35,2,0.59,0.11611,1,0.47183916666666664,3.39,MF
GO:0070717,poly-purine tract binding,35,2,0.59,0.11611,1,0.47183916666666664,3.39,MF
GO:0050839,cell adhesion molecule binding,245,7,4.1,0.11874,1,0.4801729756097561,1.71,MF
GO:0016597,amino acid binding,72,3,1.21,0.12002,1,0.4829931067961165,2.48,MF
GO:0019888,protein phosphatase regulator activity,73,3,1.22,0.12370,1,0.4953975845410628,2.46,MF
GO:0048037,cofactor binding,542,13,9.08,0.12524,1,0.4985899521531101,1.43,MF
GO:0001664,G protein-coupled receptor binding,296,8,4.96,0.12570,1,0.4985899521531101,1.61,MF
GO:0016248,channel inhibitor activity,37,2,0.62,0.12723,1,0.5022555714285715,3.23,MF
GO:0030971,receptor tyrosine kinase binding,75,3,1.26,0.13119,1,0.5154336966824644,2.38,MF
GO:0043014,alpha-tubulin binding,38,2,0.64,0.13288,1,0.5196109433962264,3.12,MF
GO:0004864,protein phosphatase inhibitor activity,39,2,0.65,0.13859,1,0.5368743457943925,3.08,MF
GO:0051539,"4 iron, 4 sulfur cluster binding",39,2,0.65,0.13859,1,0.5368743457943925,3.08,MF
GO:0046914,transition metal ion binding,971,21,16.26,0.13980,1,0.5390427906976745,1.29,MF
GO:0060590,ATPase regulator activity,40,2,0.67,0.14435,1,0.5540099537037037,2.99,MF
GO:0030295,protein kinase activator activity,79,3,1.32,0.14660,1,0.5596890825688073,2.27,MF
GO:0008047,enzyme activator activity,457,11,7.65,0.14718,1,0.5596890825688073,1.44,MF
GO:0005547,"phosphatidylinositol-3,4,5-trisphosphate...",41,2,0.69,0.15016,1,0.567262090909091,2.9,MF
GO:0042578,phosphoric ester hydrolase activity,359,9,6.01,0.15054,1,0.567262090909091,1.5,MF
GO:0019903,protein phosphatase binding,170,5,2.85,0.15745,1,0.5906156108597286,1.75,MF
GO:0015932,nucleobase-containing compound transmemb...,44,2,0.74,0.16785,1,0.6267912162162161,2.7,MF
GO:0043169,cation binding,3631,68,60.82,0.17032,1,0.6291188888888889,1.12,MF
GO:0019209,kinase activator activity,85,3,1.42,0.17075,1,0.6291188888888889,2.11,MF
GO:0048029,monosaccharide binding,85,3,1.42,0.17075,1,0.6291188888888889,2.11,MF
GO:0005543,phospholipid binding,422,10,7.07,0.17271,1,0.6335247345132744,1.41,MF
GO:0035255,ionotropic glutamate receptor binding,45,2,0.75,0.17382,1,0.6347875770925111,2.67,MF
GO:0003725,double-stranded RNA binding,86,3,1.44,0.17488,1,0.6358575438596491,2.08,MF
GO:1901505,carbohydrate derivative transmembrane tr...,46,2,0.77,0.17983,1,0.6493833333333333,2.6,MF
GO:0046872,metal ion binding,3533,66,59.17,0.18066,1,0.6493833333333333,1.12,MF
GO:0030674,"protein binding, bridging",132,4,2.21,0.18095,1,0.6493833333333333,1.81,MF
GO:0003774,motor activity,133,4,2.23,0.18430,1,0.6584881623931624,1.79,MF
GO:0003743,translation initiation factor activity,47,2,0.79,0.18587,1,0.6584881623931624,2.53,MF
GO:0015485,cholesterol binding,47,2,0.79,0.18587,1,0.6584881623931624,2.53,MF
GO:0035258,steroid hormone receptor binding,89,3,1.49,0.18744,1,0.6612245106382978,2.01,MF
GO:0005246,calcium channel regulator activity,48,2,0.8,0.19193,1,0.6741947881355932,2.5,MF
GO:0030544,Hsp70 protein binding,49,2,0.82,0.19802,1,0.6926522362869199,2.44,MF
GO:0061630,ubiquitin protein ligase activity,235,6,3.94,0.20261,1,0.7057297899159665,1.52,MF
GO:0016830,carbon-carbon lyase activity,51,2,0.85,0.21028,1,0.7293812552301255,2.35,MF
GO:0005548,phospholipid transporter activity,52,2,0.87,0.21643,1,0.7475852916666667,2.3,MF
GO:0052689,carboxylic ester hydrolase activity,143,4,2.4,0.21873,1,0.7523948962655602,1.67,MF
GO:0030276,clathrin binding,53,2,0.89,0.22260,1,0.7594049382716049,2.25,MF
GO:0032934,sterol binding,53,2,0.89,0.22260,1,0.7594049382716049,2.25,MF
GO:0061659,ubiquitin-like protein ligase activity,244,6,4.09,0.22645,1,0.7693731557377049,1.47,MF
GO:0099516,ion antiporter activity,54,2,0.9,0.22879,1,0.7741506530612245,2.22,MF
GO:0004866,endopeptidase inhibitor activity,197,5,3.3,0.23562,1,0.7940202439024391,1.52,MF
GO:0016627,"oxidoreductase activity, acting on the C...",56,2,0.94,0.24119,1,0.8095000404858299,2.13,MF
GO:0045182,translation regulator activity,57,2,0.95,0.24740,1,0.8269943548387098,2.11,MF
GO:0000287,magnesium ion binding,202,5,3.38,0.25117,1,0.8362246184738956,1.48,MF
GO:0001098,basal transcription machinery binding,58,2,0.97,0.25362,1,0.8376533067729085,2.06,MF
GO:0001099,basal RNA polymerase II transcription ma...,58,2,0.97,0.25362,1,0.8376533067729085,2.06,MF
GO:0061135,endopeptidase regulator activity,204,5,3.42,0.25746,1,0.8469616666666667,1.46,MF
GO:0030145,manganese ion binding,59,2,0.99,0.25984,1,0.8514124901185772,2.02,MF
GO:0042562,hormone binding,107,3,1.79,0.26664,1,0.8702541732283464,1.68,MF
GO:0030414,peptidase inhibitor activity,208,5,3.48,0.27016,1,0.8782848627450981,1.44,MF
GO:0003713,transcription coactivator activity,261,6,4.37,0.27370,1,0.886317578125,1.37,MF
GO:0000049,tRNA binding,63,2,1.06,0.28472,1,0.9039882509505703,1.89,MF
GO:0051536,iron-sulfur cluster binding,63,2,1.06,0.28472,1,0.9039882509505703,1.89,MF
GO:0051540,metal cluster binding,63,2,1.06,0.28472,1,0.9039882509505703,1.89,MF
GO:0001618,virus receptor activity,20,1,0.33,0.28679,1,0.9039882509505703,3.03,MF
GO:0043274,phospholipase binding,20,1,0.33,0.28679,1,0.9039882509505703,3.03,MF
GO:0047555,"3',5'-cyclic-GMP phosphodiesterase activ...",20,1,0.33,0.28679,1,0.9039882509505703,3.03,MF
GO:0104005,hijacked molecular function,20,1,0.33,0.28679,1,0.9039882509505703,3.03,MF
GO:0043621,protein self-association,65,2,1.09,0.29714,1,0.9104980147058824,1.83,MF
GO:0004298,threonine-type endopeptidase activity,21,1,0.35,0.29874,1,0.9104980147058824,2.86,MF
GO:0031489,myosin V binding,21,1,0.35,0.29874,1,0.9104980147058824,2.86,MF
GO:0031690,adrenergic receptor binding,21,1,0.35,0.29874,1,0.9104980147058824,2.86,MF
GO:0035259,glucocorticoid receptor binding,21,1,0.35,0.29874,1,0.9104980147058824,2.86,MF
GO:0042975,peroxisome proliferator activated recept...,21,1,0.35,0.29874,1,0.9104980147058824,2.86,MF
GO:0051428,peptide hormone receptor binding,21,1,0.35,0.29874,1,0.9104980147058824,2.86,MF
GO:0051861,glycolipid binding,21,1,0.35,0.29874,1,0.9104980147058824,2.86,MF
GO:0070003,threonine-type peptidase activity,21,1,0.35,0.29874,1,0.9104980147058824,2.86,MF
GO:0005506,iron ion binding,167,4,2.8,0.30683,1,0.9206473793103448,1.43,MF
GO:0001223,transcription coactivator binding,22,1,0.37,0.31050,1,0.9206473793103448,2.7,MF
GO:0004602,glutathione peroxidase activity,22,1,0.37,0.31050,1,0.9206473793103448,2.7,MF
GO:0022829,wide pore channel activity,22,1,0.37,0.31050,1,0.9206473793103448,2.7,MF
GO:0030552,cAMP binding,22,1,0.37,0.31050,1,0.9206473793103448,2.7,MF
GO:0004842,ubiquitin-protein transferase activity,383,8,6.41,0.31329,1,0.9206473793103448,1.25,MF
GO:0004869,cysteine-type endopeptidase inhibitor ac...,68,2,1.14,0.31569,1,0.9206473793103448,1.75,MF
GO:0000149,SNARE binding,118,3,1.98,0.31684,1,0.9206473793103448,1.52,MF
GO:0004867,serine-type endopeptidase inhibitor acti...,118,3,1.98,0.31684,1,0.9206473793103448,1.52,MF
GO:0017137,Rab GTPase binding,170,4,2.85,0.31816,1,0.9206473793103448,1.4,MF
GO:0140030,modification-dependent protein binding,171,4,2.86,0.32194,1,0.9206473793103448,1.4,MF
GO:0003950,NAD+ ADP-ribosyltransferase activity,23,1,0.39,0.32206,1,0.9206473793103448,2.56,MF
GO:0016405,CoA-ligase activity,23,1,0.39,0.32206,1,0.9206473793103448,2.56,MF
GO:0017056,structural constituent of nuclear pore,23,1,0.39,0.32206,1,0.9206473793103448,2.56,MF
GO:0030506,ankyrin binding,23,1,0.39,0.32206,1,0.9206473793103448,2.56,MF
GO:0031681,G-protein beta-subunit binding,23,1,0.39,0.32206,1,0.9206473793103448,2.56,MF
GO:0046965,retinoid X receptor binding,23,1,0.39,0.32206,1,0.9206473793103448,2.56,MF
GO:0090079,"translation regulator activity, nucleic ...",23,1,0.39,0.32206,1,0.9206473793103448,2.56,MF
GO:0004722,protein serine/threonine phosphatase act...,70,2,1.17,0.32801,1,0.9305592508143323,1.71,MF
GO:0001085,RNA polymerase II transcription factor b...,173,4,2.9,0.32952,1,0.9305592508143323,1.38,MF
GO:0015026,coreceptor activity,24,1,0.4,0.33343,1,0.9305592508143323,2.5,MF
GO:0016628,"oxidoreductase activity, acting on the C...",24,1,0.4,0.33343,1,0.9305592508143323,2.5,MF
GO:0016638,"oxidoreductase activity, acting on the C...",24,1,0.4,0.33343,1,0.9305592508143323,2.5,MF
GO:0048027,mRNA 5'-UTR binding,24,1,0.4,0.33343,1,0.9305592508143323,2.5,MF
GO:0050780,dopamine receptor binding,24,1,0.4,0.33343,1,0.9305592508143323,2.5,MF
GO:0004721,phosphoprotein phosphatase activity,175,4,2.93,0.33711,1,0.9305592508143323,1.37,MF
GO:0008094,DNA-dependent ATPase activity,72,2,1.21,0.34026,1,0.9305592508143323,1.65,MF
GO:0004181,metallocarboxypeptidase activity,25,1,0.42,0.34461,1,0.9305592508143323,2.38,MF
GO:0005212,structural constituent of eye lens,25,1,0.42,0.34461,1,0.9305592508143323,2.38,MF
GO:0008106,alcohol dehydrogenase (NADP+) activity,25,1,0.42,0.34461,1,0.9305592508143323,2.38,MF
GO:0008307,structural constituent of muscle,25,1,0.42,0.34461,1,0.9305592508143323,2.38,MF
GO:0016722,"oxidoreductase activity, oxidizing metal...",25,1,0.42,0.34461,1,0.9305592508143323,2.38,MF
GO:0030371,translation repressor activity,25,1,0.42,0.34461,1,0.9305592508143323,2.38,MF
GO:0031210,phosphatidylcholine binding,25,1,0.42,0.34461,1,0.9305592508143323,2.38,MF
GO:0050997,quaternary ammonium group binding,25,1,0.42,0.34461,1,0.9305592508143323,2.38,MF
GO:0043130,ubiquitin binding,74,2,1.24,0.35244,1,0.9307801156069364,1.61,MF
GO:0005158,insulin receptor binding,26,1,0.44,0.35560,1,0.9307801156069364,2.27,MF
GO:0005537,mannose binding,26,1,0.44,0.35560,1,0.9307801156069364,2.27,MF
GO:0016878,acid-thiol ligase activity,26,1,0.44,0.35560,1,0.9307801156069364,2.27,MF
GO:0017134,fibroblast growth factor binding,26,1,0.44,0.35560,1,0.9307801156069364,2.27,MF
GO:0046625,sphingolipid binding,26,1,0.44,0.35560,1,0.9307801156069364,2.27,MF
GO:0046966,thyroid hormone receptor binding,26,1,0.44,0.35560,1,0.9307801156069364,2.27,MF
GO:0050750,low-density lipoprotein particle recepto...,26,1,0.44,0.35560,1,0.9307801156069364,2.27,MF
GO:0001158,enhancer sequence-specific DNA binding,127,3,2.13,0.35806,1,0.9307801156069364,1.41,MF
GO:0017022,myosin binding,75,2,1.26,0.35850,1,0.9307801156069364,1.59,MF
GO:0016788,"hydrolase activity, acting on ester bond...",741,14,12.41,0.36073,1,0.9307801156069364,1.13,MF
GO:0003712,transcription coregulator activity,460,9,7.7,0.36544,1,0.9307801156069364,1.17,MF
GO:0016866,intramolecular transferase activity,27,1,0.45,0.36640,1,0.9307801156069364,2.22,MF
GO:0017075,syntaxin-1 binding,27,1,0.45,0.36640,1,0.9307801156069364,2.22,MF
GO:0051427,hormone receptor binding,183,4,3.07,0.36751,1,0.9307801156069364,1.3,MF
GO:0019787,ubiquitin-like protein transferase activ...,405,8,6.78,0.36842,1,0.9307801156069364,1.18,MF
GO:0061134,peptidase regulator activity,239,5,4,0.37174,1,0.9307801156069364,1.25,MF
GO:0017124,SH3 domain binding,131,3,2.19,0.37630,1,0.9307801156069364,1.37,MF
GO:0015297,antiporter activity,78,2,1.31,0.37656,1,0.9307801156069364,1.53,MF
GO:0004033,aldo-keto reductase (NADP) activity,28,1,0.47,0.37703,1,0.9307801156069364,2.13,MF
GO:0004407,histone deacetylase activity,28,1,0.47,0.37703,1,0.9307801156069364,2.13,MF
GO:0005070,SH3/SH2 adaptor activity,28,1,0.47,0.37703,1,0.9307801156069364,2.13,MF
GO:0008574,ATP-dependent microtubule motor activity...,28,1,0.47,0.37703,1,0.9307801156069364,2.13,MF
GO:0033612,receptor serine/threonine kinase binding,28,1,0.47,0.37703,1,0.9307801156069364,2.13,MF
GO:0043027,cysteine-type endopeptidase inhibitor ac...,28,1,0.47,0.37703,1,0.9307801156069364,2.13,MF
GO:0019905,syntaxin binding,79,2,1.32,0.38253,1,0.9307801156069364,1.52,MF
GO:0000175,3'-5'-exoribonuclease activity,29,1,0.49,0.38748,1,0.9307801156069364,2.04,MF
GO:0004190,aspartic-type endopeptidase activity,29,1,0.49,0.38748,1,0.9307801156069364,2.04,MF
GO:0008266,poly(U) RNA binding,29,1,0.49,0.38748,1,0.9307801156069364,2.04,MF
GO:0019706,protein-cysteine S-palmitoyltransferase ...,29,1,0.49,0.38748,1,0.9307801156069364,2.04,MF
GO:0019707,protein-cysteine S-acyltransferase activ...,29,1,0.49,0.38748,1,0.9307801156069364,2.04,MF
GO:0033558,protein deacetylase activity,29,1,0.49,0.38748,1,0.9307801156069364,2.04,MF
GO:0035198,miRNA binding,29,1,0.49,0.38748,1,0.9307801156069364,2.04,MF
GO:0043539,protein serine/threonine kinase activato...,29,1,0.49,0.38748,1,0.9307801156069364,2.04,MF
GO:0071813,lipoprotein particle binding,29,1,0.49,0.38748,1,0.9307801156069364,2.04,MF
GO:0071814,protein-lipid complex binding,29,1,0.49,0.38748,1,0.9307801156069364,2.04,MF
GO:0071889,14-3-3 protein binding,29,1,0.49,0.38748,1,0.9307801156069364,2.04,MF
GO:0140142,nucleocytoplasmic carrier activity,29,1,0.49,0.38748,1,0.9307801156069364,2.04,MF
GO:0005253,anion channel activity,80,2,1.34,0.38848,1,0.9307801156069364,1.49,MF
GO:0004114,"3',5'-cyclic-nucleotide phosphodiesteras...",30,1,0.5,0.39775,1,0.9333138873239437,2,MF
GO:0004693,cyclin-dependent protein serine/threonin...,30,1,0.5,0.39775,1,0.9333138873239437,2,MF
GO:0045503,dynein light chain binding,30,1,0.5,0.39775,1,0.9333138873239437,2,MF
GO:0050681,androgen receptor binding,30,1,0.5,0.39775,1,0.9333138873239437,2,MF
GO:0070001,aspartic-type peptidase activity,30,1,0.5,0.39775,1,0.9333138873239437,2,MF
GO:0070325,lipoprotein particle receptor binding,30,1,0.5,0.39775,1,0.9333138873239437,2,MF
GO:0098918,structural constituent of synapse,30,1,0.5,0.39775,1,0.9333138873239437,2,MF
GO:0017016,Ras GTPase binding,417,8,6.98,0.39888,1,0.9333138873239437,1.15,MF
GO:0003682,chromatin binding,589,11,9.87,0.39967,1,0.9333138873239437,1.11,MF
GO:0004112,cyclic-nucleotide phosphodiesterase acti...,31,1,0.52,0.40785,1,0.9336193530997305,1.92,MF
GO:0016896,"exoribonuclease activity, producing 5'-p...",31,1,0.52,0.40785,1,0.9336193530997305,1.92,MF
GO:0050699,WW domain binding,31,1,0.52,0.40785,1,0.9336193530997305,1.92,MF
GO:0097472,cyclin-dependent protein kinase activity,31,1,0.52,0.40785,1,0.9336193530997305,1.92,MF
GO:0035326,enhancer binding,138,3,2.31,0.40793,1,0.9336193530997305,1.3,MF
GO:0035091,phosphatidylinositol binding,251,5,4.2,0.41151,1,0.9336193530997305,1.19,MF
GO:0003777,microtubule motor activity,84,2,1.41,0.41201,1,0.9336193530997305,1.42,MF
GO:0038024,cargo receptor activity,84,2,1.41,0.41201,1,0.9336193530997305,1.42,MF
GO:0015085,calcium ion transmembrane transporter ac...,140,3,2.34,0.41688,1,0.9336193530997305,1.28,MF
GO:0004532,exoribonuclease activity,32,1,0.54,0.41778,1,0.9336193530997305,1.85,MF
GO:0008198,ferrous iron binding,32,1,0.54,0.41778,1,0.9336193530997305,1.85,MF
GO:0016504,peptidase activator activity,32,1,0.54,0.41778,1,0.9336193530997305,1.85,MF
GO:0043425,bHLH transcription factor binding,32,1,0.54,0.41778,1,0.9336193530997305,1.85,MF
GO:0051059,NF-kappaB binding,32,1,0.54,0.41778,1,0.9336193530997305,1.85,MF
GO:0071855,neuropeptide receptor binding,32,1,0.54,0.41778,1,0.9336193530997305,1.85,MF
GO:0043178,alcohol binding,85,2,1.42,0.41782,1,0.9336193530997305,1.41,MF
GO:0008013,beta-catenin binding,86,2,1.44,0.42361,1,0.9401563660477453,1.39,MF
GO:0008509,anion transmembrane transporter activity,313,6,5.24,0.42715,1,0.9401563660477453,1.15,MF
GO:0016417,S-acyltransferase activity,33,1,0.55,0.42755,1,0.9401563660477453,1.82,MF
GO:0017080,sodium channel regulator activity,33,1,0.55,0.42755,1,0.9401563660477453,1.82,MF
GO:0035035,histone acetyltransferase binding,33,1,0.55,0.42755,1,0.9401563660477453,1.82,MF
GO:0042974,retinoic acid receptor binding,33,1,0.55,0.42755,1,0.9401563660477453,1.82,MF
GO:0060090,molecular adaptor activity,200,4,3.35,0.43164,1,0.9462071801566578,1.19,MF
GO:0035064,methylated histone binding,88,2,1.47,0.43509,1,0.9462071801566578,1.36,MF
GO:0140034,methylation-dependent protein binding,88,2,1.47,0.43509,1,0.9462071801566578,1.36,MF
GO:0031267,small GTPase binding,432,8,7.24,0.43698,1,0.9462071801566578,1.1,MF
GO:0008187,poly-pyrimidine tract binding,34,1,0.57,0.43715,1,0.9462071801566578,1.75,MF
GO:0016831,carboxy-lyase activity,34,1,0.57,0.43715,1,0.9462071801566578,1.75,MF
GO:0015238,drug transmembrane transporter activity,89,2,1.49,0.44078,1,0.9515797395833333,1.34,MF
GO:0001965,G-protein alpha-subunit binding,35,1,0.59,0.44660,1,0.9616399999999999,1.69,MF
GO:0005154,epidermal growth factor receptor binding,36,1,0.6,0.45588,1,0.9740322680412371,1.67,MF
GO:0030551,cyclic nucleotide binding,36,1,0.6,0.45588,1,0.9740322680412371,1.67,MF
GO:0061980,regulatory RNA binding,36,1,0.6,0.45588,1,0.9740322680412371,1.67,MF
GO:0033613,activating transcription factor binding,92,2,1.54,0.45767,1,0.9753430077120824,1.3,MF
GO:0016877,"ligase activity, forming carbon-sulfur b...",37,1,0.62,0.46501,1,0.98340125,1.61,MF
GO:0043394,proteoglycan binding,37,1,0.62,0.46501,1,0.98340125,1.61,MF
GO:0046915,transition metal ion transmembrane trans...,37,1,0.62,0.46501,1,0.98340125,1.61,MF
GO:0008514,organic anion transmembrane transporter ...,210,4,3.52,0.46859,1,0.9884506615776081,1.14,MF
GO:0030246,carbohydrate binding,269,5,4.51,0.47036,1,0.9896660913705584,1.11,MF
GO:0032182,ubiquitin-like protein binding,95,2,1.59,0.47426,1,0.9953456708860761,1.26,MF
GO:0035257,nuclear hormone receptor binding,154,3,2.58,0.47814,1,0.9956454975124379,1.16,MF
GO:0004197,cysteine-type endopeptidase activity,96,2,1.61,0.47972,1,0.9956454975124379,1.24,MF
GO:0004712,protein serine/threonine/tyrosine kinase...,39,1,0.65,0.48281,1,0.9956454975124379,1.54,MF
GO:0016409,palmitoyltransferase activity,39,1,0.65,0.48281,1,0.9956454975124379,1.54,MF
GO:0017069,snRNA binding,39,1,0.65,0.48281,1,0.9956454975124379,1.54,MF
GO:0043028,cysteine-type endopeptidase regulator ac...,39,1,0.65,0.48281,1,0.9956454975124379,1.54,MF
GO:0061631,ubiquitin conjugating enzyme activity,39,1,0.65,0.48281,1,0.9956454975124379,1.54,MF
GO:0004725,protein tyrosine phosphatase activity,98,2,1.64,0.49054,1,1,1.22,MF
GO:0031369,translation initiation factor binding,40,1,0.67,0.49149,1,1,1.49,MF
GO:0032266,phosphatidylinositol-3-phosphate binding,41,1,0.69,0.50003,1,1,1.45,MF
GO:0061650,ubiquitin-like protein conjugating enzym...,41,1,0.69,0.50003,1,1,1.45,MF
GO:0000980,RNA polymerase II distal enhancer sequen...,100,2,1.67,0.50121,1,1,1.2,MF
GO:0004180,carboxypeptidase activity,42,1,0.7,0.50842,1,1,1.43,MF
GO:0019213,deacetylase activity,42,1,0.7,0.50842,1,1,1.43,MF
GO:0008374,O-acyltransferase activity,43,1,0.72,0.51667,1,1,1.39,MF
GO:0017048,Rho GTPase binding,166,3,2.78,0.52817,1,1,1.08,MF
GO:1901981,phosphatidylinositol phosphate binding,166,3,2.78,0.52817,1,1,1.08,MF
GO:0001784,phosphotyrosine residue binding,45,1,0.75,0.53275,1,1,1.33,MF
GO:0016706,"oxidoreductase activity, acting on paire...",45,1,0.75,0.53275,1,1,1.33,MF
GO:0016790,thiolester hydrolase activity,46,1,0.77,0.54060,1,1,1.3,MF
GO:0051879,Hsp90 protein binding,46,1,0.77,0.54060,1,1,1.3,MF
GO:0016538,cyclin-dependent protein serine/threonin...,47,1,0.79,0.54831,1,1,1.27,MF
GO:0016879,"ligase activity, forming carbon-nitrogen...",47,1,0.79,0.54831,1,1,1.27,MF
GO:0070888,E-box binding,47,1,0.79,0.54831,1,1,1.27,MF
GO:0042805,actinin binding,48,1,0.8,0.55589,1,1,1.25,MF
GO:1902936,phosphatidylinositol bisphosphate bindin...,111,2,1.86,0.55729,1,1,1.08,MF
GO:1990939,ATP-dependent microtubule motor activity,49,1,0.82,0.56335,1,1,1.22,MF
GO:0060589,nucleoside-triphosphatase regulator acti...,299,5,5.01,0.56366,1,1,1,MF
GO:0008408,3'-5' exonuclease activity,50,1,0.84,0.57068,1,1,1.19,MF
GO:0016763,"transferase activity, transferring pento...",50,1,0.84,0.57068,1,1,1.19,MF
GO:0030331,estrogen receptor binding,50,1,0.84,0.57068,1,1,1.19,MF
GO:0140104,molecular carrier activity,50,1,0.84,0.57068,1,1,1.19,MF
GO:0001221,transcription cofactor binding,51,1,0.85,0.57789,1,1,1.18,MF
GO:0004540,ribonuclease activity,116,2,1.94,0.58126,1,1,1.03,MF
GO:0008028,monocarboxylic acid transmembrane transp...,52,1,0.87,0.58497,1,1,1.15,MF
GO:0016796,"exonuclease activity, active with either...",52,1,0.87,0.58497,1,1,1.15,MF
GO:0017046,peptide hormone binding,52,1,0.87,0.58497,1,1,1.15,MF
GO:0030165,PDZ domain binding,118,2,1.98,0.59058,1,1,1.01,MF
GO:0008235,metalloexopeptidase activity,53,1,0.89,0.59194,1,1,1.12,MF
GO:0030170,pyridoxal phosphate binding,53,1,0.89,0.59194,1,1,1.12,MF
GO:1990841,promoter-specific chromatin binding,53,1,0.89,0.59194,1,1,1.12,MF
GO:0005160,transforming growth factor beta receptor...,54,1,0.9,0.59879,1,1,1.11,MF
GO:0051018,protein kinase A binding,54,1,0.9,0.59879,1,1,1.11,MF
GO:0070279,vitamin B6 binding,54,1,0.9,0.59879,1,1,1.11,MF
GO:0016829,lyase activity,185,3,3.1,0.60159,1,1,0.97,MF
GO:0001102,RNA polymerase II activating transcripti...,55,1,0.92,0.60553,1,1,1.09,MF
GO:0016836,hydro-lyase activity,55,1,0.92,0.60553,1,1,1.09,MF
GO:0035591,signaling adaptor activity,55,1,0.92,0.60553,1,1,1.09,MF
GO:0003714,transcription corepressor activity,190,3,3.18,0.61962,1,1,0.94,MF
GO:0001047,core promoter binding,62,1,1.04,0.64964,1,1,0.96,MF
GO:0015103,inorganic anion transmembrane transporte...,132,2,2.21,0.65148,1,1,0.9,MF
GO:0016791,phosphatase activity,266,4,4.46,0.65380,1,1,0.9,MF
GO:0016705,"oxidoreductase activity, acting on paire...",203,3,3.4,0.66387,1,1,0.88,MF
GO:0004521,endoribonuclease activity,65,1,1.09,0.66700,1,1,0.92,MF
GO:0005319,lipid transporter activity,136,2,2.28,0.66750,1,1,0.88,MF
GO:0016835,carbon-oxygen lyase activity,67,1,1.12,0.67810,1,1,0.89,MF
GO:0005518,collagen binding,68,1,1.14,0.68350,1,1,0.88,MF
GO:0005254,chloride channel activity,69,1,1.16,0.68882,1,1,0.86,MF
GO:0019838,growth factor binding,146,2,2.45,0.70496,1,1,0.82,MF
GO:0008083,growth factor activity,147,2,2.46,0.70851,1,1,0.81,MF
GO:0016874,ligase activity,147,2,2.46,0.70851,1,1,0.81,MF
GO:0070851,growth factor receptor binding,148,2,2.48,0.71202,1,1,0.81,MF
GO:0016782,"transferase activity, transferring sulfu...",74,1,1.24,0.71411,1,1,0.81,MF
GO:0004527,exonuclease activity,75,1,1.26,0.71891,1,1,0.79,MF
GO:0008270,zinc ion binding,691,10,11.57,0.72467,1,1,0.86,MF
GO:0004386,helicase activity,156,2,2.61,0.73885,1,1,0.77,MF
GO:0005546,"phosphatidylinositol-4,5-bisphosphate bi...",80,1,1.34,0.74176,1,1,0.75,MF
GO:0070405,ammonium ion binding,80,1,1.34,0.74176,1,1,0.75,MF
GO:0004175,endopeptidase activity,440,6,7.37,0.74915,1,1,0.81,MF
GO:0016811,"hydrolase activity, acting on carbon-nit...",82,1,1.37,0.75037,1,1,0.73,MF
GO:0015291,secondary active transmembrane transport...,235,3,3.94,0.75649,1,1,0.76,MF
GO:0050660,flavin adenine dinucleotide binding,85,1,1.42,0.76275,1,1,0.7,MF
GO:0140096,"catalytic activity, acting on a protein",2187,33,36.63,0.76326,1,1,0.9,MF
GO:0046332,SMAD binding,86,1,1.44,0.76674,1,1,0.69,MF
GO:0005096,GTPase activator activity,241,3,4.04,0.77137,1,1,0.74,MF
GO:0008234,cysteine-type peptidase activity,172,2,2.88,0.78614,1,1,0.69,MF
GO:0051213,dioxygenase activity,94,1,1.57,0.79635,1,1,0.64,MF
GO:0008237,metallopeptidase activity,177,2,2.96,0.79930,1,1,0.68,MF
GO:0015108,chloride transmembrane transporter activ...,96,1,1.61,0.80314,1,1,0.62,MF
GO:0030695,GTPase regulator activity,259,3,4.34,0.81157,1,1,0.69,MF
GO:0004553,"hydrolase activity, hydrolyzing O-glycos...",100,1,1.67,0.81606,1,1,0.6,MF
GO:0004222,metalloendopeptidase activity,101,1,1.69,0.81916,1,1,0.59,MF
GO:0008238,exopeptidase activity,101,1,1.69,0.81916,1,1,0.59,MF
GO:0019783,ubiquitin-like protein-specific protease...,109,1,1.83,0.84212,1,1,0.55,MF
GO:0008233,peptidase activity,640,8,10.72,0.84409,1,1,0.75,MF
GO:0005085,guanyl-nucleotide exchange factor activi...,198,2,3.32,0.84704,1,1,0.6,MF
GO:0004518,nuclease activity,200,2,3.35,0.85100,1,1,0.6,MF
GO:0001228,DNA-binding transcription activator acti...,443,5,7.42,0.86691,1,1,0.67,MF
GO:0016798,"hydrolase activity, acting on glycosyl b...",125,1,2.09,0.87969,1,1,0.48,MF
GO:0005088,Ras guanyl-nucleotide exchange factor ac...,128,1,2.14,0.88567,1,1,0.47,MF
GO:0004519,endonuclease activity,129,1,2.16,0.88760,1,1,0.46,MF
GO:0070011,"peptidase activity, acting on L-amino ac...",613,7,10.27,0.89140,1,1,0.68,MF
GO:0016810,"hydrolase activity, acting on carbon-nit...",133,1,2.23,0.89499,1,1,0.45,MF
GO:0019842,vitamin binding,135,1,2.26,0.89850,1,1,0.44,MF
GO:0022834,ligand-gated channel activity,136,1,2.28,0.90021,1,1,0.44,MF
GO:0016747,"transferase activity, transferring acyl ...",236,2,3.95,0.90804,1,1,0.51,MF
GO:0005201,extracellular matrix structural constitu...,141,1,2.36,0.90834,1,1,0.42,MF
GO:0001067,regulatory region nucleic acid binding,999,12,16.73,0.91260,1,1,0.72,MF
GO:0015293,symporter activity,145,1,2.43,0.91437,1,1,0.41,MF
GO:0043565,sequence-specific DNA binding,1145,14,19.18,0.91608,1,1,0.73,MF
GO:0005342,organic acid transmembrane transporter a...,150,1,2.51,0.92136,1,1,0.4,MF
GO:0046943,carboxylic acid transmembrane transporte...,150,1,2.51,0.92136,1,1,0.4,MF
GO:0022836,gated channel activity,335,3,5.61,0.92164,1,1,0.53,MF
GO:0020037,heme binding,155,1,2.6,0.92777,1,1,0.38,MF
GO:0003677,DNA binding,2059,27,34.49,0.92981,1,1,0.78,MF
GO:0046906,tetrapyrrole binding,164,1,2.75,0.93803,1,1,0.36,MF
GO:0016746,"transferase activity, transferring acyl ...",270,2,4.52,0.94256,1,1,0.44,MF
GO:0044212,transcription regulatory region DNA bind...,995,11,16.67,0.94824,1,1,0.66,MF
GO:0016757,"transferase activity, transferring glyco...",278,2,4.66,0.94867,1,1,0.43,MF
GO:0004674,protein serine/threonine kinase activity,463,4,7.75,0.95310,1,1,0.52,MF
GO:0140097,"catalytic activity, acting on DNA",191,1,3.2,0.96088,1,1,0.31,MF
GO:0005244,voltage-gated ion channel activity,195,1,3.27,0.96346,1,1,0.31,MF
GO:0022832,voltage-gated channel activity,195,1,3.27,0.96346,1,1,0.31,MF
GO:0016758,"transferase activity, transferring hexos...",209,1,3.5,0.97122,1,1,0.29,MF
GO:0022839,ion gated channel activity,323,2,5.41,0.97303,1,1,0.37,MF
GO:0005125,cytokine activity,217,1,3.63,0.97489,1,1,0.28,MF
GO:0046873,metal ion transmembrane transporter acti...,433,3,7.25,0.97733,1,1,0.41,MF
GO:0016301,kinase activity,778,7,13.03,0.97734,1,1,0.54,MF
GO:0030545,receptor regulator activity,527,4,8.83,0.97804,1,1,0.45,MF
GO:0004672,protein kinase activity,616,5,10.32,0.97845,1,1,0.48,MF
GO:0015267,channel activity,444,3,7.44,0.98039,1,1,0.4,MF
GO:0022803,passive transmembrane transporter activi...,444,3,7.44,0.98039,1,1,0.4,MF
GO:0016773,"phosphotransferase activity, alcohol gro...",717,6,12.01,0.98199,1,1,0.5,MF
GO:0140098,"catalytic activity, acting on RNA",362,2,6.06,0.98476,1,1,0.33,MF
GO:0000978,RNA polymerase II proximal promoter sequ...,573,4,9.6,0.98757,1,1,0.42,MF
GO:0001012,RNA polymerase II regulatory region DNA ...,845,7,14.15,0.98884,1,1,0.49,MF
GO:0000987,proximal promoter sequence-specific DNA ...,585,4,9.8,0.98931,1,1,0.41,MF
GO:0048018,receptor ligand activity,492,3,8.24,0.98971,1,1,0.36,MF
GO:0140110,transcription regulator activity,1354,13,22.68,0.99150,1,1,0.57,MF
GO:0005216,ion channel activity,407,2,6.82,0.99221,1,1,0.29,MF
GO:0000976,transcription regulatory region sequence...,882,7,14.77,0.99256,1,1,0.47,MF
GO:0016740,transferase activity,2276,25,38.12,0.99340,1,1,0.66,MF
GO:0022838,substrate-specific channel activity,420,2,7.03,0.99359,1,1,0.28,MF
GO:0016772,"transferase activity, transferring phosp...",921,7,15.43,0.99520,1,1,0.45,MF
GO:1990837,sequence-specific double-stranded DNA bi...,925,7,15.49,0.99542,1,1,0.45,MF
GO:0000977,RNA polymerase II regulatory region sequ...,837,6,14.02,0.99543,1,1,0.43,MF
GO:0005126,cytokine receptor binding,330,1,5.53,0.99637,1,1,0.18,MF
GO:0000981,DNA-binding transcription factor activit...,767,5,12.85,0.99650,1,1,0.39,MF
GO:0003700,DNA-binding transcription factor activit...,999,7,16.73,0.99806,1,1,0.42,MF
GO:0003690,double-stranded DNA binding,1014,7,16.98,0.99838,1,1,0.41,MF
GO:0060089,molecular transducer activity,2344,4,39.26,1.00000,1,1,0.1,MF
GO:0038023,signaling receptor activity,2295,3,38.44,1.00000,1,1,0.08,MF
GO:0003674,molecular_function,20837,349,349,1.00000,1,1,1,MF
GO:0000030,mannosyltransferase activity,26,0,0.44,1.00000,1,1,0,MF
GO:0000217,DNA secondary structure binding,25,0,0.42,1.00000,1,1,0,MF
GO:0000979,RNA polymerase II core promoter sequence...,38,0,0.64,1.00000,1,1,0,MF
GO:0000993,RNA polymerase II complex binding,38,0,0.64,1.00000,1,1,0,MF
GO:0001046,core promoter sequence-specific DNA bind...,49,0,0.82,1.00000,1,1,0,MF
GO:0001103,RNA polymerase II repressing transcripti...,35,0,0.59,1.00000,1,1,0,MF
GO:0001222,transcription corepressor binding,20,0,0.33,1.00000,1,1,0,MF
GO:0001227,DNA-binding transcription repressor acti...,241,0,4.04,1.00000,1,1,0,MF
GO:0001614,purinergic nucleotide receptor activity,20,0,0.33,1.00000,1,1,0,MF
GO:0001637,G protein-coupled chemoattractant recept...,25,0,0.42,1.00000,1,1,0,MF
GO:0001653,peptide receptor activity,149,0,2.5,1.00000,1,1,0,MF
GO:0001671,ATPase activator activity,26,0,0.44,1.00000,1,1,0,MF
GO:0001848,complement binding,22,0,0.37,1.00000,1,1,0,MF
GO:0001871,pattern binding,21,0,0.35,1.00000,1,1,0,MF
GO:0001968,fibronectin binding,31,0,0.52,1.00000,1,1,0,MF
GO:0003678,DNA helicase activity,61,0,1.02,1.00000,1,1,0,MF
GO:0003684,damaged DNA binding,56,0,0.94,1.00000,1,1,0,MF
GO:0003688,DNA replication origin binding,23,0,0.39,1.00000,1,1,0,MF
GO:0003707,steroid hormone receptor activity,55,0,0.92,1.00000,1,1,0,MF
GO:0003724,RNA helicase activity,65,0,1.09,1.00000,1,1,0,MF
GO:0003785,actin monomer binding,27,0,0.45,1.00000,1,1,0,MF
GO:0003823,antigen binding,57,0,0.95,1.00000,1,1,0,MF
GO:0003887,DNA-directed DNA polymerase activity,27,0,0.45,1.00000,1,1,0,MF
GO:0003899,DNA-directed 5'-3' RNA polymerase activi...,37,0,0.62,1.00000,1,1,0,MF
GO:0004003,ATP-dependent DNA helicase activity,22,0,0.37,1.00000,1,1,0,MF
GO:0004177,aminopeptidase activity,44,0,0.74,1.00000,1,1,0,MF
GO:0004252,serine-type endopeptidase activity,181,0,3.03,1.00000,1,1,0,MF
GO:0004402,histone acetyltransferase activity,65,0,1.09,1.00000,1,1,0,MF
GO:0004497,monooxygenase activity,141,0,2.36,1.00000,1,1,0,MF
GO:0004520,endodeoxyribonuclease activity,40,0,0.67,1.00000,1,1,0,MF
GO:0004529,exodeoxyribonuclease activity,25,0,0.42,1.00000,1,1,0,MF
GO:0004536,deoxyribonuclease activity,59,0,0.99,1.00000,1,1,0,MF
GO:0004683,calmodulin-dependent protein kinase acti...,27,0,0.45,1.00000,1,1,0,MF
GO:0004709,MAP kinase kinase kinase activity,26,0,0.44,1.00000,1,1,0,MF
GO:0004713,protein tyrosine kinase activity,129,0,2.16,1.00000,1,1,0,MF
GO:0004714,transmembrane receptor protein tyrosine ...,59,0,0.99,1.00000,1,1,0,MF
GO:0004715,non-membrane spanning protein tyrosine k...,45,0,0.75,1.00000,1,1,0,MF
GO:0004745,retinol dehydrogenase activity,21,0,0.35,1.00000,1,1,0,MF
GO:0004806,triglyceride lipase activity,27,0,0.45,1.00000,1,1,0,MF
GO:0004812,aminoacyl-tRNA ligase activity,41,0,0.69,1.00000,1,1,0,MF
GO:0004843,thiol-dependent ubiquitin-specific prote...,90,0,1.51,1.00000,1,1,0,MF
GO:0004879,nuclear receptor activity,40,0,0.67,1.00000,1,1,0,MF
GO:0004888,transmembrane signaling receptor activit...,2107,0,35.29,1.00000,1,1,0,MF
GO:0004896,cytokine receptor activity,98,0,1.64,1.00000,1,1,0,MF
GO:0004930,G protein-coupled receptor activity,750,0,12.56,1.00000,1,1,0,MF
GO:0004950,chemokine receptor activity,25,0,0.42,1.00000,1,1,0,MF
GO:0004984,olfactory receptor activity,1110,0,18.59,1.00000,1,1,0,MF
GO:0004993,G protein-coupled serotonin receptor act...,39,0,0.65,1.00000,1,1,0,MF
GO:0005044,scavenger receptor activity,45,0,0.75,1.00000,1,1,0,MF
GO:0005048,signal sequence binding,39,0,0.65,1.00000,1,1,0,MF
GO:0005089,Rho guanyl-nucleotide exchange factor ac...,70,0,1.17,1.00000,1,1,0,MF
GO:0005104,fibroblast growth factor receptor bindin...,26,0,0.44,1.00000,1,1,0,MF
GO:0005109,frizzled binding,43,0,0.72,1.00000,1,1,0,MF
GO:0005112,Notch binding,25,0,0.42,1.00000,1,1,0,MF
GO:0005132,type I interferon receptor binding,24,0,0.4,1.00000,1,1,0,MF
GO:0005148,prolactin receptor binding,27,0,0.45,1.00000,1,1,0,MF
GO:0005164,tumor necrosis factor receptor binding,34,0,0.57,1.00000,1,1,0,MF
GO:0005179,hormone activity,129,0,2.16,1.00000,1,1,0,MF
GO:0005184,neuropeptide hormone activity,25,0,0.42,1.00000,1,1,0,MF
GO:0005217,intracellular ligand-gated ion channel a...,32,0,0.54,1.00000,1,1,0,MF
GO:0005227,calcium activated cation channel activit...,29,0,0.49,1.00000,1,1,0,MF
GO:0005230,extracellular ligand-gated ion channel a...,71,0,1.19,1.00000,1,1,0,MF
GO:0005231,excitatory extracellular ligand-gated io...,36,0,0.6,1.00000,1,1,0,MF
GO:0005242,inward rectifier potassium channel activ...,20,0,0.33,1.00000,1,1,0,MF
GO:0005245,voltage-gated calcium channel activity,52,0,0.87,1.00000,1,1,0,MF
GO:0005248,voltage-gated sodium channel activity,21,0,0.35,1.00000,1,1,0,MF
GO:0005249,voltage-gated potassium channel activity,86,0,1.44,1.00000,1,1,0,MF
GO:0005251,delayed rectifier potassium channel acti...,30,0,0.5,1.00000,1,1,0,MF
GO:0005261,cation channel activity,317,0,5.31,1.00000,1,1,0,MF
GO:0005262,calcium channel activity,123,0,2.06,1.00000,1,1,0,MF
GO:0005267,potassium channel activity,123,0,2.06,1.00000,1,1,0,MF
GO:0005272,sodium channel activity,40,0,0.67,1.00000,1,1,0,MF
GO:0005310,dicarboxylic acid transmembrane transpor...,36,0,0.6,1.00000,1,1,0,MF
GO:0005326,neurotransmitter transporter activity,50,0,0.84,1.00000,1,1,0,MF
GO:0005328,neurotransmitter:sodium symporter activi...,26,0,0.44,1.00000,1,1,0,MF
GO:0005343,organic acid:sodium symporter activity,25,0,0.42,1.00000,1,1,0,MF
GO:0005355,glucose transmembrane transporter activi...,23,0,0.39,1.00000,1,1,0,MF
GO:0005385,zinc ion transmembrane transporter activ...,22,0,0.37,1.00000,1,1,0,MF
GO:0005402,carbohydrate:cation symporter activity,20,0,0.33,1.00000,1,1,0,MF
GO:0005484,SNAP receptor activity,33,0,0.55,1.00000,1,1,0,MF
GO:0005501,retinoid binding,32,0,0.54,1.00000,1,1,0,MF
GO:0005520,insulin-like growth factor binding,28,0,0.47,1.00000,1,1,0,MF
GO:0005540,hyaluronic acid binding,21,0,0.35,1.00000,1,1,0,MF
GO:0005544,calcium-dependent phospholipid binding,54,0,0.9,1.00000,1,1,0,MF
GO:0005549,odorant binding,578,0,9.68,1.00000,1,1,0,MF
GO:0005550,pheromone binding,216,0,3.62,1.00000,1,1,0,MF
GO:0008009,chemokine activity,43,0,0.72,1.00000,1,1,0,MF
GO:0008026,ATP-dependent helicase activity,22,0,0.37,1.00000,1,1,0,MF
GO:0008066,glutamate receptor activity,27,0,0.45,1.00000,1,1,0,MF
GO:0008080,N-acetyltransferase activity,94,0,1.57,1.00000,1,1,0,MF
GO:0008138,protein tyrosine/serine/threonine phosph...,40,0,0.67,1.00000,1,1,0,MF
GO:0008146,sulfotransferase activity,56,0,0.94,1.00000,1,1,0,MF
GO:0008157,protein phosphatase 1 binding,22,0,0.37,1.00000,1,1,0,MF
GO:0008168,methyltransferase activity,201,0,3.37,1.00000,1,1,0,MF
GO:0008170,N-methyltransferase activity,88,0,1.47,1.00000,1,1,0,MF
GO:0008171,O-methyltransferase activity,25,0,0.42,1.00000,1,1,0,MF
GO:0008173,RNA methyltransferase activity,63,0,1.06,1.00000,1,1,0,MF
GO:0008175,tRNA methyltransferase activity,32,0,0.54,1.00000,1,1,0,MF
GO:0008188,neuropeptide receptor activity,45,0,0.75,1.00000,1,1,0,MF
GO:0008194,UDP-glycosyltransferase activity,151,0,2.53,1.00000,1,1,0,MF
GO:0008227,G protein-coupled amine receptor activit...,72,0,1.21,1.00000,1,1,0,MF
GO:0008236,serine-type peptidase activity,203,0,3.4,1.00000,1,1,0,MF
GO:0008276,protein methyltransferase activity,86,0,1.44,1.00000,1,1,0,MF
GO:0008327,methyl-CpG binding,21,0,0.35,1.00000,1,1,0,MF
GO:0008373,sialyltransferase activity,21,0,0.35,1.00000,1,1,0,MF
GO:0008375,acetylglucosaminyltransferase activity,56,0,0.94,1.00000,1,1,0,MF
GO:0008376,acetylgalactosaminyltransferase activity,44,0,0.74,1.00000,1,1,0,MF
GO:0008378,galactosyltransferase activity,36,0,0.6,1.00000,1,1,0,MF
GO:0008391,arachidonic acid monooxygenase activity,38,0,0.64,1.00000,1,1,0,MF
GO:0008392,arachidonic acid epoxygenase activity,34,0,0.57,1.00000,1,1,0,MF
GO:0008395,steroid hydroxylase activity,73,0,1.22,1.00000,1,1,0,MF
GO:0008519,ammonium transmembrane transporter activ...,32,0,0.54,1.00000,1,1,0,MF
GO:0008527,taste receptor activity,36,0,0.6,1.00000,1,1,0,MF
GO:0008528,G protein-coupled peptide receptor activ...,140,0,2.34,1.00000,1,1,0,MF
GO:0008536,Ran GTPase binding,38,0,0.64,1.00000,1,1,0,MF
GO:0008569,ATP-dependent microtubule motor activity...,21,0,0.35,1.00000,1,1,0,MF
GO:0008757,S-adenosylmethionine-dependent methyltra...,148,0,2.48,1.00000,1,1,0,MF
GO:0009975,cyclase activity,25,0,0.42,1.00000,1,1,0,MF
GO:0010485,H4 histone acetyltransferase activity,23,0,0.39,1.00000,1,1,0,MF
GO:0015020,glucuronosyltransferase activity,33,0,0.55,1.00000,1,1,0,MF
GO:0015079,potassium ion transmembrane transporter ...,159,0,2.66,1.00000,1,1,0,MF
GO:0015081,sodium ion transmembrane transporter act...,143,0,2.4,1.00000,1,1,0,MF
GO:0015101,organic cation transmembrane transporter...,23,0,0.39,1.00000,1,1,0,MF
GO:0015106,bicarbonate transmembrane transporter ac...,20,0,0.33,1.00000,1,1,0,MF
GO:0015125,bile acid transmembrane transporter acti...,20,0,0.33,1.00000,1,1,0,MF
GO:0015144,carbohydrate transmembrane transporter a...,38,0,0.64,1.00000,1,1,0,MF
GO:0015145,monosaccharide transmembrane transporter...,25,0,0.42,1.00000,1,1,0,MF
GO:0015149,hexose transmembrane transporter activit...,23,0,0.39,1.00000,1,1,0,MF
GO:0015171,amino acid transmembrane transporter act...,75,0,1.26,1.00000,1,1,0,MF
GO:0015175,neutral amino acid transmembrane transpo...,32,0,0.54,1.00000,1,1,0,MF
GO:0015179,L-amino acid transmembrane transporter a...,57,0,0.95,1.00000,1,1,0,MF
GO:0015248,sterol transporter activity,31,0,0.52,1.00000,1,1,0,MF
GO:0015276,ligand-gated ion channel activity,133,0,2.23,1.00000,1,1,0,MF
GO:0015278,calcium-release channel activity,20,0,0.33,1.00000,1,1,0,MF
GO:0015294,solute:cation symporter activity,99,0,1.66,1.00000,1,1,0,MF
GO:0015295,solute:proton symporter activity,22,0,0.37,1.00000,1,1,0,MF
GO:0015298,solute:cation antiporter activity,29,0,0.49,1.00000,1,1,0,MF
GO:0015370,solute:sodium symporter activity,70,0,1.17,1.00000,1,1,0,MF
GO:0015464,acetylcholine receptor activity,22,0,0.37,1.00000,1,1,0,MF
GO:0015491,cation:cation antiporter activity,24,0,0.4,1.00000,1,1,0,MF
GO:0016229,steroid dehydrogenase activity,45,0,0.75,1.00000,1,1,0,MF
GO:0016278,lysine N-methyltransferase activity,56,0,0.94,1.00000,1,1,0,MF
GO:0016279,protein-lysine N-methyltransferase activ...,56,0,0.94,1.00000,1,1,0,MF
GO:0016289,CoA hydrolase activity,27,0,0.45,1.00000,1,1,0,MF
GO:0016407,acetyltransferase activity,117,0,1.96,1.00000,1,1,0,MF
GO:0016408,C-acyltransferase activity,22,0,0.37,1.00000,1,1,0,MF
GO:0016410,N-acyltransferase activity,115,0,1.93,1.00000,1,1,0,MF
GO:0016493,C-C chemokine receptor activity,24,0,0.4,1.00000,1,1,0,MF
GO:0016502,nucleotide receptor activity,20,0,0.33,1.00000,1,1,0,MF
GO:0016503,pheromone receptor activity,99,0,1.66,1.00000,1,1,0,MF
GO:0016620,"oxidoreductase activity, acting on the a...",42,0,0.7,1.00000,1,1,0,MF
GO:0016641,"oxidoreductase activity, acting on the C...",21,0,0.35,1.00000,1,1,0,MF
GO:0016645,"oxidoreductase activity, acting on the C...",28,0,0.47,1.00000,1,1,0,MF
GO:0016701,"oxidoreductase activity, acting on singl...",31,0,0.52,1.00000,1,1,0,MF
GO:0016702,"oxidoreductase activity, acting on singl...",30,0,0.5,1.00000,1,1,0,MF
GO:0016709,"oxidoreductase activity, acting on paire...",45,0,0.75,1.00000,1,1,0,MF
GO:0016712,"oxidoreductase activity, acting on paire...",61,0,1.02,1.00000,1,1,0,MF
GO:0016725,"oxidoreductase activity, acting on CH or...",23,0,0.39,1.00000,1,1,0,MF
GO:0016741,"transferase activity, transferring one-c...",213,0,3.57,1.00000,1,1,0,MF
GO:0016776,"phosphotransferase activity, phosphate g...",34,0,0.57,1.00000,1,1,0,MF
GO:0016779,nucleotidyltransferase activity,123,0,2.06,1.00000,1,1,0,MF
GO:0016799,"hydrolase activity, hydrolyzing N-glycos...",22,0,0.37,1.00000,1,1,0,MF
GO:0016814,"hydrolase activity, acting on carbon-nit...",29,0,0.49,1.00000,1,1,0,MF
GO:0016849,phosphorus-oxygen lyase activity,25,0,0.42,1.00000,1,1,0,MF
GO:0016875,"ligase activity, forming carbon-oxygen b...",41,0,0.69,1.00000,1,1,0,MF
GO:0016891,"endoribonuclease activity, producing 5'-...",28,0,0.47,1.00000,1,1,0,MF
GO:0016893,"endonuclease activity, active with eithe...",40,0,0.67,1.00000,1,1,0,MF
GO:0016895,"exodeoxyribonuclease activity, producing...",23,0,0.39,1.00000,1,1,0,MF
GO:0016903,"oxidoreductase activity, acting on the a...",52,0,0.87,1.00000,1,1,0,MF
GO:0016917,GABA receptor activity,22,0,0.37,1.00000,1,1,0,MF
GO:0016922,nuclear receptor binding,26,0,0.44,1.00000,1,1,0,MF
GO:0017025,TBP-class protein binding,23,0,0.39,1.00000,1,1,0,MF
GO:0017049,GTP-Rho binding,20,0,0.33,1.00000,1,1,0,MF
GO:0017091,AU-rich element binding,31,0,0.52,1.00000,1,1,0,MF
GO:0017112,Rab guanyl-nucleotide exchange factor ac...,38,0,0.64,1.00000,1,1,0,MF
GO:0017116,single-stranded DNA-dependent ATP-depend...,20,0,0.33,1.00000,1,1,0,MF
GO:0017127,cholesterol transporter activity,20,0,0.33,1.00000,1,1,0,MF
GO:0017147,Wnt-protein binding,38,0,0.64,1.00000,1,1,0,MF
GO:0017171,serine hydrolase activity,208,0,3.48,1.00000,1,1,0,MF
GO:0018024,histone-lysine N-methyltransferase activ...,44,0,0.74,1.00000,1,1,0,MF
GO:0019199,transmembrane receptor protein kinase ac...,76,0,1.27,1.00000,1,1,0,MF
GO:0019200,carbohydrate kinase activity,21,0,0.35,1.00000,1,1,0,MF
GO:0019205,nucleobase-containing compound kinase ac...,38,0,0.64,1.00000,1,1,0,MF
GO:0019239,deaminase activity,27,0,0.45,1.00000,1,1,0,MF
GO:0019789,SUMO transferase activity,22,0,0.37,1.00000,1,1,0,MF
GO:0019825,oxygen binding,23,0,0.39,1.00000,1,1,0,MF
GO:0019840,isoprenoid binding,38,0,0.64,1.00000,1,1,0,MF
GO:0019865,immunoglobulin binding,22,0,0.37,1.00000,1,1,0,MF
GO:0019955,cytokine binding,131,0,2.19,1.00000,1,1,0,MF
GO:0019956,chemokine binding,33,0,0.55,1.00000,1,1,0,MF
GO:0019957,C-C chemokine binding,25,0,0.42,1.00000,1,1,0,MF
GO:0022824,transmitter-gated ion channel activity,58,0,0.97,1.00000,1,1,0,MF
GO:0022835,transmitter-gated channel activity,58,0,0.97,1.00000,1,1,0,MF
GO:0022843,voltage-gated cation channel activity,146,0,2.45,1.00000,1,1,0,MF
GO:0030020,extracellular matrix structural constitu...,39,0,0.65,1.00000,1,1,0,MF
GO:0030215,semaphorin receptor binding,22,0,0.37,1.00000,1,1,0,MF
GO:0030247,polysaccharide binding,21,0,0.35,1.00000,1,1,0,MF
GO:0030332,cyclin binding,32,0,0.54,1.00000,1,1,0,MF
GO:0030374,nuclear receptor transcription coactivat...,64,0,1.07,1.00000,1,1,0,MF
GO:0030547,receptor inhibitor activity,26,0,0.44,1.00000,1,1,0,MF
GO:0030594,neurotransmitter receptor activity,117,0,1.96,1.00000,1,1,0,MF
GO:0031420,alkali metal ion binding,22,0,0.37,1.00000,1,1,0,MF
GO:0031490,chromatin DNA binding,96,0,1.61,1.00000,1,1,0,MF
GO:0031491,nucleosome binding,53,0,0.89,1.00000,1,1,0,MF
GO:0031492,nucleosomal DNA binding,23,0,0.39,1.00000,1,1,0,MF
GO:0031593,polyubiquitin modification-dependent pro...,55,0,0.92,1.00000,1,1,0,MF
GO:0031624,ubiquitin conjugating enzyme binding,34,0,0.57,1.00000,1,1,0,MF
GO:0032451,demethylase activity,42,0,0.7,1.00000,1,1,0,MF
GO:0032452,histone demethylase activity,27,0,0.45,1.00000,1,1,0,MF
GO:0032794,GTPase activating protein binding,20,0,0.33,1.00000,1,1,0,MF
GO:0032813,tumor necrosis factor receptor superfami...,46,0,0.77,1.00000,1,1,0,MF
GO:0032947,protein-containing complex scaffold acti...,22,0,0.37,1.00000,1,1,0,MF
GO:0033038,bitter taste receptor activity,29,0,0.49,1.00000,1,1,0,MF
GO:0033764,"steroid dehydrogenase activity, acting o...",37,0,0.62,1.00000,1,1,0,MF
GO:0034061,DNA polymerase activity,33,0,0.55,1.00000,1,1,0,MF
GO:0034062,5'-3' RNA polymerase activity,39,0,0.65,1.00000,1,1,0,MF
GO:0034212,peptide N-acetyltransferase activity,76,0,1.27,1.00000,1,1,0,MF
GO:0034237,protein kinase A regulatory subunit bind...,22,0,0.37,1.00000,1,1,0,MF
GO:0034593,phosphatidylinositol bisphosphate phosph...,21,0,0.35,1.00000,1,1,0,MF
GO:0035014,phosphatidylinositol 3-kinase regulator ...,20,0,0.33,1.00000,1,1,0,MF
GO:0035250,UDP-galactosyltransferase activity,25,0,0.42,1.00000,1,1,0,MF
GO:0035586,purinergic receptor activity,25,0,0.42,1.00000,1,1,0,MF
GO:0035925,mRNA 3'-UTR AU-rich region binding,29,0,0.49,1.00000,1,1,0,MF
GO:0036459,thiol-dependent ubiquitinyl hydrolase ac...,99,0,1.66,1.00000,1,1,0,MF
GO:0042054,histone methyltransferase activity,57,0,0.95,1.00000,1,1,0,MF
GO:0042056,chemoattractant activity,40,0,0.67,1.00000,1,1,0,MF
GO:0042165,neurotransmitter binding,61,0,1.02,1.00000,1,1,0,MF
GO:0042169,SH2 domain binding,39,0,0.65,1.00000,1,1,0,MF
GO:0042379,chemokine receptor binding,66,0,1.11,1.00000,1,1,0,MF
GO:0042605,peptide antigen binding,35,0,0.59,1.00000,1,1,0,MF
GO:0042887,amide transmembrane transporter activity,43,0,0.72,1.00000,1,1,0,MF
GO:0042923,neuropeptide binding,25,0,0.42,1.00000,1,1,0,MF
GO:0043015,gamma-tubulin binding,29,0,0.49,1.00000,1,1,0,MF
GO:0043138,3'-5' DNA helicase activity,21,0,0.35,1.00000,1,1,0,MF
GO:0043142,single-stranded DNA-dependent ATPase act...,20,0,0.33,1.00000,1,1,0,MF
GO:0043175,RNA polymerase core enzyme binding,43,0,0.72,1.00000,1,1,0,MF
GO:0043325,"phosphatidylinositol-3,4-bisphosphate bi...",28,0,0.47,1.00000,1,1,0,MF
GO:0044390,ubiquitin-like protein conjugating enzym...,39,0,0.65,1.00000,1,1,0,MF
GO:0045296,cadherin binding,70,0,1.17,1.00000,1,1,0,MF
GO:0045499,chemorepellent activity,28,0,0.47,1.00000,1,1,0,MF
GO:0046875,ephrin receptor binding,31,0,0.52,1.00000,1,1,0,MF
GO:0047617,acyl-CoA hydrolase activity,25,0,0.42,1.00000,1,1,0,MF
GO:0048020,CCR chemokine receptor binding,46,0,0.77,1.00000,1,1,0,MF
GO:0050321,tau-protein kinase activity,20,0,0.33,1.00000,1,1,0,MF
GO:0050431,transforming growth factor beta binding,21,0,0.35,1.00000,1,1,0,MF
GO:0050661,NADP binding,48,0,0.8,1.00000,1,1,0,MF
GO:0051119,sugar transmembrane transporter activity,26,0,0.44,1.00000,1,1,0,MF
GO:0051371,muscle alpha-actinin binding,21,0,0.35,1.00000,1,1,0,MF
GO:0051393,alpha-actinin binding,37,0,0.62,1.00000,1,1,0,MF
GO:0051537,"2 iron, 2 sulfur cluster binding",25,0,0.42,1.00000,1,1,0,MF
GO:0051721,protein phosphatase 2A binding,38,0,0.64,1.00000,1,1,0,MF
GO:0051959,dynein light intermediate chain binding,33,0,0.55,1.00000,1,1,0,MF
GO:0052745,inositol phosphate phosphatase activity,20,0,0.33,1.00000,1,1,0,MF
GO:0052866,phosphatidylinositol phosphate phosphata...,25,0,0.42,1.00000,1,1,0,MF
GO:0061733,peptide-lysine-N-acetyltransferase activ...,67,0,1.12,1.00000,1,1,0,MF
GO:0070035,purine NTP-dependent helicase activity,22,0,0.37,1.00000,1,1,0,MF
GO:0070063,RNA polymerase binding,58,0,0.97,1.00000,1,1,0,MF
GO:0070064,proline-rich region binding,20,0,0.33,1.00000,1,1,0,MF
GO:0070273,phosphatidylinositol-4-phosphate binding,36,0,0.6,1.00000,1,1,0,MF
GO:0070300,phosphatidic acid binding,20,0,0.33,1.00000,1,1,0,MF
GO:0070330,aromatase activity,35,0,0.59,1.00000,1,1,0,MF
GO:0070412,R-SMAD binding,25,0,0.42,1.00000,1,1,0,MF
GO:0070491,repressing transcription factor binding,71,0,1.19,1.00000,1,1,0,MF
GO:0070530,K63-linked polyubiquitin modification-de...,22,0,0.37,1.00000,1,1,0,MF
GO:0070566,adenylyltransferase activity,30,0,0.5,1.00000,1,1,0,MF
GO:0070696,transmembrane receptor protein serine/th...,20,0,0.33,1.00000,1,1,0,MF
GO:0071837,HMG box domain binding,25,0,0.42,1.00000,1,1,0,MF
GO:0071949,FAD binding,37,0,0.62,1.00000,1,1,0,MF
GO:0072509,divalent inorganic cation transmembrane ...,27,0,0.45,1.00000,1,1,0,MF
GO:0080025,"phosphatidylinositol-3,5-bisphosphate bi...",27,0,0.45,1.00000,1,1,0,MF
GO:0090482,vitamin transmembrane transporter activi...,22,0,0.37,1.00000,1,1,0,MF
GO:0097747,RNA polymerase activity,39,0,0.65,1.00000,1,1,0,MF
GO:0098531,"transcription factor activity, direct li...",40,0,0.67,1.00000,1,1,0,MF
GO:0098960,postsynaptic neurotransmitter receptor a...,57,0,0.95,1.00000,1,1,0,MF
GO:0099094,ligand-gated cation channel activity,99,0,1.66,1.00000,1,1,0,MF
GO:0099095,ligand-gated anion channel activity,21,0,0.35,1.00000,1,1,0,MF
GO:0099528,G protein-coupled neurotransmitter recep...,45,0,0.75,1.00000,1,1,0,MF
GO:0099529,neurotransmitter receptor activity invol...,55,0,0.92,1.00000,1,1,0,MF
GO:0099589,serotonin receptor activity,39,0,0.65,1.00000,1,1,0,MF
GO:0099604,ligand-gated calcium channel activity,26,0,0.44,1.00000,1,1,0,MF
GO:0101005,ubiquitinyl hydrolase activity,101,0,1.69,1.00000,1,1,0,MF
GO:0120013,intermembrane lipid transfer activity,29,0,0.49,1.00000,1,1,0,MF
GO:0120015,intermembrane sterol transfer activity,21,0,0.35,1.00000,1,1,0,MF
GO:0120020,intermembrane cholesterol transfer activ...,20,0,0.33,1.00000,1,1,0,MF
GO:0140101,"catalytic activity, acting on a tRNA",113,0,1.89,1.00000,1,1,0,MF
GO:0140103,"catalytic activity, acting on a glycopro...",22,0,0.37,1.00000,1,1,0,MF
GO:1901338,catecholamine binding,21,0,0.35,1.00000,1,1,0,MF
GO:1901618,organic hydroxy compound transmembrane t...,43,0,0.72,1.00000,1,1,0,MF
GO:1901682,sulfur compound transmembrane transporte...,31,0,0.52,1.00000,1,1,0,MF
GO:1904315,transmitter-gated ion channel activity i...,52,0,0.87,1.00000,1,1,0,MF
GO:1904680,peptide transmembrane transporter activi...,27,0,0.45,1.00000,1,1,0,MF
GO:0005737,cytoplasm,10993,323,186.82, 1e-30,6.300000000000001e-28,4.2000000000000004e-29,1.73,CC
GO:0044444,cytoplasmic part,8386,285,142.51, 1e-30,6.300000000000001e-28,4.2000000000000004e-29,2,CC
GO:0044424,intracellular part,13717,344,233.11, 1e-30,6.300000000000001e-28,4.2000000000000004e-29,1.48,CC
GO:0005622,intracellular,13747,344,233.62, 1e-30,6.300000000000001e-28,4.2000000000000004e-29,1.47,CC
GO:0043209,myelin sheath,219,51,3.72, 1e-30,6.300000000000001e-28,4.2000000000000004e-29,13.71,CC
GO:0043226,organelle,12314,326,209.27, 1e-30,6.300000000000001e-28,4.2000000000000004e-29,1.56,CC
GO:0043229,intracellular organelle,11997,322,203.88, 1e-30,6.300000000000001e-28,4.2000000000000004e-29,1.58,CC
GO:0043227,membrane-bounded organelle,11062,307,187.99, 1e-30,6.300000000000001e-28,4.2000000000000004e-29,1.63,CC
GO:0043231,intracellular membrane-bounded organelle,10334,292,175.62, 1e-30,6.300000000000001e-28,4.2000000000000004e-29,1.66,CC
GO:0031090,organelle membrane,1753,106,29.79, 1e-30,6.300000000000001e-28,4.2000000000000004e-29,3.56,CC
GO:0044422,organelle part,7595,239,129.07, 1e-30,6.300000000000001e-28,4.2000000000000004e-29,1.85,CC
GO:0044446,intracellular organelle part,7228,232,122.83, 1e-30,6.300000000000001e-28,4.2000000000000004e-29,1.89,CC
GO:0005739,mitochondrion,1809,106,30.74, 1e-30,6.300000000000001e-28,4.2000000000000004e-29,3.45,CC
GO:0005740,mitochondrial envelope,663,65,11.27, 1e-30,6.300000000000001e-28,4.2000000000000004e-29,5.77,CC
GO:0044464,cell part,16127,353,274.07,1.0e-30,6.300000000000001e-28,4.2000000000000004e-29,1.29,CC
GO:0005623,cell,16132,353,274.15,1.2e-30,7.5599999999999995e-28,4.7249999999999997e-29,1.29,CC
GO:0031966,mitochondrial membrane,619,62,10.52,5.1e-30,3.2129999999999998e-27,1.89e-28,5.89,CC
GO:0045202,synapse,1417,92,24.08,6.1e-30,3.843e-27,2.135e-28,3.82,CC
GO:0098800,inner mitochondrial membrane protein com...,130,33,2.21,1.6e-29,1.0080000000000001e-26,5.305263157894737e-28,14.93,CC
GO:0031967,organelle envelope,1063,79,18.06,2.2e-29,1.386e-26,6.9e-28,4.37,CC
GO:0031975,envelope,1064,79,18.08,2.3e-29,1.449e-26,6.9e-28,4.37,CC
GO:0005743,mitochondrial inner membrane,446,53,7.58,2.6e-29,1.6380000000000002e-26,7.4454545454545465e-28,6.99,CC
GO:0044455,mitochondrial membrane part,219,39,3.72,2.1e-28,1.323e-25,5.752173913043478e-27,10.48,CC
GO:0019866,organelle inner membrane,489,53,8.31,2.4e-27,1.512e-24,6.3e-26,6.38,CC
GO:0044429,mitochondrial part,851,66,14.46,1.7e-25,1.071e-22,4.2839999999999996e-24,4.56,CC
GO:0032991,protein-containing complex,5422,183,92.14,6.2e-25,3.906e-22,1.5023076923076924e-23,1.99,CC
GO:0070469,respiratory chain,91,25,1.55,1.5e-23,9.4500000000000008e-21,3.5e-22,16.13,CC
GO:0097458,neuron part,1982,99,33.68,1.9e-23,1.1970000000000001e-20,4.275e-22,2.94,CC
GO:0005746,mitochondrial respiratory chain,79,23,1.34,2.0e-22,1.2600000000000002e-19,4.3448275862068974e-21,17.16,CC
GO:0098803,respiratory chain complex,83,23,1.41,7.2e-22,4.535999999999999e-19,1.512e-20,16.31,CC
GO:0016469,proton-transporting two-sector ATPase co...,49,19,0.83,1.8e-21,1.1339999999999999e-18,3.6580645161290325e-20,22.89,CC
GO:0098798,mitochondrial protein complex,266,35,4.52,4.6e-21,2.898e-18,9.05625e-20,7.74,CC
GO:0098796,membrane protein complex,1134,64,19.27,1.6e-17,1.0080000000000001e-14,3.054545454545455e-16,3.32,CC
GO:0012505,endomembrane system,3805,132,64.66,1.9e-17,1.197e-14,3.520588235294118e-16,2.04,CC
GO:0005753,mitochondrial proton-transporting ATP sy...,20,12,0.34,5.4e-17,3.402e-14,9.45e-16,35.29,CC
GO:0044456,synapse part,1098,62,18.66,5.4e-17,3.402e-14,9.45e-16,3.32,CC
GO:0045259,proton-transporting ATP synthase complex,21,12,0.36,1.2e-16,7.56e-14,2.0432432432432433e-15,33.33,CC
GO:0005829,cytosol,3292,116,55.95,1.6e-15,1.008e-12,2.6526315789473682e-14,2.07,CC
GO:0022626,cytosolic ribosome,109,20,1.85,2.2e-15,1.386e-12,3.5538461538461534e-14,10.81,CC
GO:0043005,neuron projection,1523,71,25.88,4.7e-15,2.961e-12,7.402499999999999e-14,2.74,CC
GO:0005840,ribosome,227,25,3.86,1.5e-13,9.45e-11,2.3048780487804876e-12,6.48,CC
GO:1990204,oxidoreductase complex,109,18,1.85,3.8e-13,2.394e-10,5.7e-12,9.73,CC
GO:0033177,proton-transporting two-sector ATPase co...,22,10,0.37,9.6e-13,6.047999999999999e-10,1.4065116279069766e-11,27.03,CC
GO:0044391,ribosomal subunit,192,22,3.26,2.0e-12,1.26e-9,2.8636363636363637e-11,6.75,CC
GO:0098805,whole membrane,1114,54,18.93,3.3e-12,2.079e-9,4.62e-11,2.85,CC
GO:0120025,plasma membrane bounded cell projection,2273,83,38.63,1.1e-11,6.930000000000001e-9,1.5065217391304348e-10,2.15,CC
GO:1990904,ribonucleoprotein complex,967,48,16.43,2.7e-11,1.701e-8,3.6191489361702126e-10,2.92,CC
GO:0005747,mitochondrial respiratory chain complex ...,50,12,0.85,3.3e-11,2.0790000000000003e-8,4.158e-10,14.12,CC
GO:0030964,NADH dehydrogenase complex,50,12,0.85,3.3e-11,2.0790000000000003e-8,4.158e-10,14.12,CC
GO:0045271,respiratory chain complex I,50,12,0.85,3.3e-11,2.0790000000000003e-8,4.158e-10,14.12,CC
GO:0005783,endoplasmic reticulum,1715,68,29.15,3.6e-11,2.268e-8,4.4470588235294116e-10,2.33,CC
GO:0048471,perinuclear region of cytoplasm,656,38,11.15,4.9e-11,3.087e-8,5.936538461538461e-10,3.41,CC
GO:0031982,vesicle,1969,74,33.46,5.0e-11,3.1500000000000004e-8,5.943396226415095e-10,2.21,CC
GO:0042995,cell projection,2473,86,42.03,5.2e-11,3.2760000000000004e-08,6.066666666666666e-10,2.05,CC
GO:0070069,cytochrome complex,32,10,0.54,8.2e-11,5.166e-8,9.392727272727274e-10,18.52,CC
GO:0044463,cell projection part,1567,63,26.63,1.2e-10,7.56e-8,1.303448275862069e-9,2.37,CC
GO:0120038,plasma membrane bounded cell projection ...,1567,63,26.63,1.2e-10,7.56e-8,1.303448275862069e-9,2.37,CC
GO:0099503,secretory vesicle,585,35,9.94,1.2e-10,7.56e-8,1.303448275862069e-9,3.52,CC
GO:0044445,cytosolic part,265,23,4.5,1.9e-10,1.197e-7,2.028813559322034e-9,5.11,CC
GO:0036477,somatodendritic compartment,1056,48,17.95,5.3e-10,3.3390000000000005e-7,5.5650000000000005e-9,2.67,CC
GO:0031410,cytoplasmic vesicle,1830,68,31.1,5.9e-10,3.717e-7,6.093442622950819e-9,2.19,CC
GO:0097708,intracellular vesicle,1835,68,31.18,6.6e-10,4.158e-7,6.706451612903227e-9,2.18,CC
GO:0098793,presynapse,564,33,9.58,7.6e-10,4.788e-7,7.6e-9,3.44,CC
GO:0043232,intracellular non-membrane-bounded organ...,4141,118,70.37,1.6e-09,1.0080000000000001e-6,1.5750000000000002e-8,1.68,CC
GO:0030424,axon,717,37,12.18,2.2e-09,1.386e-6,2.0686567164179102e-8,3.04,CC
GO:0043228,non-membrane-bounded organelle,4161,118,70.71,2.2e-09,1.386e-6,2.0686567164179102e-8,1.67,CC
GO:0008021,synaptic vesicle,227,20,3.86,2.2e-09,1.386e-6,2.0686567164179102e-8,5.18,CC
GO:0030425,dendrite,728,37,12.37,3.3e-09,2.079e-6,3.057352941176471e-8,2.99,CC
GO:0097447,dendritic tree,731,37,12.42,3.6e-09,2.268e-6,3.28695652173913e-8,2.98,CC
GO:0016020,membrane,9366,214,159.17,4.2e-09,2.646e-6,3.78e-8,1.34,CC
GO:0098794,postsynapse,740,37,12.58,5.1e-09,3.213e-6,4.5253521126760564e-8,2.94,CC
GO:0098588,bounding membrane of organelle,1060,46,18.01,5.4e-09,3.402e-6,4.725e-8,2.55,CC
GO:0022625,cytosolic large ribosomal subunit,61,11,1.04,5.7e-09,3.591e-6,4.91917808219178e-8,10.58,CC
GO:0070382,exocytic vesicle,247,20,4.2,9.6e-09,6.048e-6,8.172972972972974e-8,4.76,CC
GO:0033267,axon part,454,27,7.72,2.0e-08,1.26e-5,1.6800000000000002e-7,3.5,CC
GO:0014069,postsynaptic density,397,25,6.75,2.3e-08,1.449e-5,1.9065789473684209e-7,3.7,CC
GO:0032279,asymmetric synapse,400,25,6.8,2.6e-08,1.6380000000000002e-5,2.1272727272727274e-7,3.68,CC
GO:0150034,distal axon,374,24,6.36,3.0e-08,1.89e-5,2.423076923076923e-7,3.77,CC
GO:0030133,transport vesicle,324,22,5.51,4.3e-08,2.709e-5,3.429113924050633e-7,3.99,CC
GO:0022627,cytosolic small ribosomal subunit,44,9,0.75,4.5e-08,2.8349999999999998e-5,3.54375e-7,12,CC
GO:0043197,dendritic spine,197,17,3.35,4.9e-08,3.087e-5,3.8111111111111114e-7,5.07,CC
GO:0030672,synaptic vesicle membrane,112,13,1.9,5.9e-08,3.717e-5,4.478313253012048e-7,6.84,CC
GO:0099501,exocytic vesicle membrane,112,13,1.9,5.9e-08,3.717e-5,4.478313253012048e-7,6.84,CC
GO:0098978,glutamatergic synapse,514,28,8.74,7.0e-08,4.41e-5,5.250000000000001e-7,3.2,CC
GO:0044309,neuron spine,202,17,3.43,7.1e-08,4.473e-5,5.262352941176471e-7,4.96,CC
GO:0098984,neuron to neuron synapse,425,25,7.22,8.5e-08,5.3549999999999994e-5,6.226744186046511e-7,3.46,CC
GO:0005634,nucleus,6846,164,116.34,9.6e-08,6.048e-5,6.951724137931034e-7,1.41,CC
GO:0099572,postsynaptic specialization,436,25,7.41,1.4e-07,8.82e-5,1.0022727272727274e-6,3.37,CC
GO:0044297,cell body,811,36,13.78,1.6e-07,1.008e-4,1.12e-6,2.61,CC
GO:0015934,large ribosomal subunit,122,13,2.07,1.6e-07,1.008e-4,1.12e-6,6.28,CC
GO:0033176,proton-transporting V-type ATPase comple...,26,7,0.44,1.9e-07,1.1970000000000001e-4,1.3153846153846156e-6,15.91,CC
GO:0098589,membrane region,383,23,6.51,2.0e-07,1.26e-4,1.3695652173913041e-6,3.53,CC
GO:0044425,membrane part,7301,170,124.08,3.5e-07,2.205e-4,2.370967741935484e-6,1.37,CC
GO:0045121,membrane raft,370,22,6.29,4.3e-07,2.709e-4,2.881914893617021e-6,3.5,CC
GO:0098857,membrane microdomain,371,22,6.3,4.5e-07,2.835e-4,2.9842105263157896e-6,3.49,CC
GO:0005773,vacuole,536,27,9.11,5.7e-07,0.00035910000000000006,3.7406250000000003e-6,2.96,CC
GO:0015935,small ribosomal subunit,76,10,1.29,6.3e-07,3.969e-4,4.091752577319588e-6,7.75,CC
GO:0042788,polysomal ribosome,31,7,0.53,7.2e-07,4.5359999999999997e-4,4.628571428571429e-6,13.21,CC
GO:0045277,respiratory chain complex IV,20,6,0.34,7.3e-07,4.599e-4,4.645454545454545e-6,17.65,CC
GO:0030658,transport vesicle membrane,144,13,2.45,1.1e-06,6.93e-4,6.9300000000000006e-6,5.31,CC
GO:0012506,vesicle membrane,336,20,5.71,1.4e-06,8.82e-4,8.732673267326732e-6,3.5,CC
GO:0098563,intrinsic component of synaptic vesicle ...,65,9,1.1,1.5e-06,9.45e-4,9.264705882352942e-6,8.18,CC
GO:0030659,cytoplasmic vesicle membrane,309,19,5.25,1.6e-06,0.001008,9.786407766990291e-6,3.62,CC
GO:0043292,contractile fiber,229,16,3.89,2.1e-06,0.001323,1.2721153846153845e-5,4.11,CC
GO:0030426,growth cone,206,15,3.5,2.6e-06,0.0016380000000000001,1.56e-5,4.29,CC
GO:0005768,endosome,840,34,14.28,2.9e-06,0.001827,1.7235849056603776e-5,2.38,CC
GO:1902494,catalytic complex,1365,47,23.2,3.2e-06,0.002016,1.8841121495327103e-5,2.03,CC
GO:0030427,site of polarized growth,211,15,3.59,3.5e-06,0.002205,2.0416666666666664e-5,4.18,CC
GO:0031672,A band,40,7,0.68,4.4e-06,0.002772,2.543119266055046e-5,10.29,CC
GO:0005844,polysome,75,9,1.27,5.0e-06,0.0031500000000000005,2.863636363636364e-5,7.09,CC
GO:0043025,neuronal cell body,722,30,12.27,6.9e-06,0.004347,3.916216216216216e-5,2.44,CC
GO:0030141,secretory granule,385,20,6.54,1.1e-05,0.0069299999999999995,6.1875e-5,3.06,CC
GO:0031252,cell leading edge,387,20,6.58,1.2e-05,0.00756,6.690265486725664e-5,3.04,CC
GO:0005794,Golgi apparatus,1398,46,23.76,1.3e-05,0.00819,7.184210526315788e-5,1.94,CC
GO:0031984,organelle subcompartment,913,34,15.52,1.7e-05,0.01071,9.31304347826087e-5,2.19,CC
GO:0030017,sarcomere,192,13,3.26,2.6e-05,0.01638,1.4120689655172414e-4,3.99,CC
GO:0098590,plasma membrane region,1226,41,20.83,2.8e-05,0.01764,1.5076923076923077e-4,1.97,CC
GO:0005790,smooth endoplasmic reticulum,36,6,0.61,2.9e-05,0.01827,1.5483050847457628e-4,9.84,CC
GO:0042175,nuclear outer membrane-endoplasmic retic...,554,24,9.41,3.0e-05,0.0189,1.588235294117647e-4,2.55,CC
GO:0005774,vacuolar membrane,169,12,2.87,3.4e-05,0.02142,1.785e-4,4.18,CC
GO:0031300,intrinsic component of organelle membran...,256,15,4.35,3.5e-05,0.022049999999999997,1.8223140495867766e-4,3.45,CC
GO:0044433,cytoplasmic vesicle part,527,23,8.96,3.9e-05,0.024569999999999998,2.013934426229508e-4,2.57,CC
GO:0044432,endoplasmic reticulum part,641,26,10.89,4.3e-05,0.02709,2.202439024390244e-4,2.39,CC
GO:0044449,contractile fiber part,206,13,3.5,5.5e-05,0.03465,2.794354838709678e-4,3.71,CC
GO:0098827,endoplasmic reticulum subcompartment,543,23,9.23,6.2e-05,0.039060000000000004,3.1e-4,2.49,CC
GO:0044437,vacuolar part,180,12,3.06,6.2e-05,0.039060000000000004,3.1e-4,3.92,CC
GO:0005764,lysosome,440,20,7.48,7.2e-05,0.045360000000000004,3.5716535433070865e-4,2.67,CC
GO:0000323,lytic vacuole,441,20,7.49,7.4e-05,0.046619999999999995,3.6421874999999996e-4,2.67,CC
GO:0030016,myofibril,215,13,3.65,8.5e-05,0.05355,4.1511627906976745e-4,3.56,CC
GO:0030285,integral component of synaptic vesicle m...,45,6,0.76,0.00011,0.0693,5.290076335877863e-4,7.89,CC
GO:0044295,axonal growth cone,45,6,0.76,0.00011,0.0693,5.290076335877863e-4,7.89,CC
GO:0005789,endoplasmic reticulum membrane,529,22,8.99,0.00012,0.0756,5.727272727272727e-4,2.45,CC
GO:0099512,supramolecular fiber,899,31,15.28,0.00016,0.10080000000000001,7.578947368421053e-4,2.03,CC
GO:0099081,supramolecular polymer,905,31,15.38,0.00018,0.1134,8.46268656716418e-4,2.02,CC
GO:0099080,supramolecular complex,906,31,15.4,0.00019,0.1197,8.801470588235296e-4,2.01,CC
GO:0045335,phagocytic vesicle,93,8,1.58,0.00019,0.1197,8.801470588235296e-4,5.06,CC
GO:0044306,neuron projection terminus,207,12,3.52,0.00023,0.1449,0.0010576642335766424,3.41,CC
GO:0090723,growth cone part,20,4,0.34,0.00032,0.20160000000000003,0.0014608695652173914,11.76,CC
GO:0005856,cytoskeleton,2118,57,35.99,0.00033,0.2079,0.00149568345323741,1.58,CC
GO:0008180,COP9 signalosome,36,5,0.61,0.00034,0.2142,0.0015300000000000001,8.2,CC
GO:0044428,nuclear part,3985,94,67.72,0.00037,0.2331,0.001653191489361702,1.39,CC
GO:0070013,intracellular organelle lumen,3883,92,65.99,0.00038,0.2394,0.0016625000000000001,1.39,CC
GO:0031974,membrane-enclosed lumen,3884,92,66.01,0.00038,0.2394,0.0016625000000000001,1.39,CC
GO:0043233,organelle lumen,3884,92,66.01,0.00038,0.2394,0.0016625000000000001,1.39,CC
GO:0001772,immunological synapse,38,5,0.65,0.00044,0.2772,0.0019117241379310347,7.69,CC
GO:0031430,M band,22,4,0.37,0.00047,0.2961,0.0020280821917808218,10.81,CC
GO:0031301,integral component of organelle membrane,228,12,3.87,0.00056,0.35279999999999995,0.0024,3.1,CC
GO:0005765,lysosomal membrane,110,8,1.87,0.00059,0.37170000000000003,0.002511486486486487,4.28,CC
GO:0098852,lytic vacuole membrane,111,8,1.89,0.00062,0.3906,0.002621476510067114,4.23,CC
GO:0099568,cytoplasmic region,481,19,8.17,0.00063,0.39690000000000003,0.0026460000000000003,2.33,CC
GO:0044430,cytoskeletal part,1561,44,26.53,0.00066,0.4158,0.0027536423841059607,1.66,CC
GO:0005770,late endosome,203,11,3.45,0.00074,0.4662,0.0030470588235294114,3.19,CC
GO:0036464,cytoplasmic ribonucleoprotein granule,203,11,3.45,0.00074,0.4662,0.0030470588235294114,3.19,CC
GO:0042588,zymogen granule,25,4,0.42,0.00078,0.4914,0.0031909090909090906,9.52,CC
GO:0005791,rough endoplasmic reticulum,92,7,1.56,0.00098,0.6174,0.003983225806451613,4.49,CC
GO:0097223,sperm part,244,12,4.15,0.00101,0.6363,0.004078846153846154,2.89,CC
GO:0071944,cell periphery,5388,118,91.57,0.00102,0.6426000000000001,0.0040929936305732495,1.29,CC
GO:0002102,podosome,27,4,0.46,0.00106,0.6678,0.004226582278481012,8.7,CC
GO:0005938,cell cortex,316,14,5.37,0.00110,0.6930000000000001,0.00433125,2.61,CC
GO:0030135,coated vesicle,181,10,3.08,0.00110,0.6930000000000001,0.00433125,3.25,CC
GO:0035770,ribonucleoprotein granule,214,11,3.64,0.00114,0.7182,0.004460869565217391,3.02,CC
GO:0097386,glial cell projection,28,4,0.48,0.00122,0.7686,0.004744444444444444,8.33,CC
GO:0043679,axon terminus,185,10,3.14,0.00130,0.819,0.005024539877300613,3.18,CC
GO:0005681,spliceosomal complex,194,10,3.3,0.00185,1,0.007106707317073171,3.03,CC
GO:0015630,microtubule cytoskeleton,1156,33,19.65,0.00258,1,0.00985090909090909,1.68,CC
GO:0043204,perikaryon,139,8,2.36,0.00264,1,0.010019277108433736,3.39,CC
GO:0030667,secretory granule membrane,84,6,1.43,0.00309,1,0.01165688622754491,4.2,CC
GO:0005886,plasma membrane,5243,112,89.1,0.00351,1,0.013159171597633136,1.26,CC
GO:0034399,nuclear periphery,115,7,1.95,0.00353,1,0.013159171597633136,3.59,CC
GO:0098685,Schaffer collateral - CA1 synapse,116,7,1.97,0.00370,1,0.013705263157894738,3.55,CC
GO:0001726,ruffle,147,8,2.5,0.00372,1,0.013705263157894738,3.2,CC
GO:0030054,cell junction,1144,32,19.44,0.00405,1,0.014834302325581394,1.65,CC
GO:0016363,nuclear matrix,90,6,1.53,0.00435,1,0.01575,3.92,CC
GO:0031970,organelle envelope lumen,90,6,1.53,0.00435,1,0.01575,3.92,CC
GO:0044292,dendrite terminus,20,3,0.34,0.00448,1,0.016036363636363637,8.82,CC
GO:0098993,anchored component of synaptic vesicle m...,20,3,0.34,0.00448,1,0.016036363636363637,8.82,CC
GO:0031256,leading edge membrane,152,8,2.58,0.00454,1,0.016159322033898305,3.1,CC
GO:0015629,actin cytoskeleton,494,17,8.4,0.00494,1,0.01742178770949721,2.02,CC
GO:0010494,cytoplasmic stress granule,65,5,1.1,0.00495,1,0.01742178770949721,4.55,CC
GO:0005635,nuclear envelope,414,15,7.04,0.00509,1,0.017815,2.13,CC
GO:0101031,chaperone complex,21,3,0.36,0.00516,1,0.017960220994475137,8.33,CC
GO:0120111,neuron projection cytoplasm,42,4,0.71,0.00552,1,0.019107692307692308,5.63,CC
GO:0045177,apical part of cell,422,15,7.17,0.00604,1,0.020793442622950818,2.09,CC
GO:0031253,cell projection membrane,305,12,5.18,0.00625,1,0.021399456521739132,2.32,CC
GO:0044459,plasma membrane part,2879,66,48.93,0.00656,1,0.02233945945945946,1.35,CC
GO:0098687,chromosomal region,308,12,5.23,0.00673,1,0.02279516129032258,2.29,CC
GO:0032587,ruffle membrane,71,5,1.21,0.00718,1,0.024189304812834225,4.13,CC
GO:0030018,Z disc,133,7,2.26,0.00775,1,0.025970744680851063,3.1,CC
GO:0030027,lamellipodium,168,8,2.86,0.00818,1,0.027266666666666668,2.8,CC
GO:0005798,Golgi-associated vesicle,135,7,2.29,0.00838,1,0.027786315789473687,3.06,CC
GO:0099059,integral component of presynaptic active...,26,3,0.44,0.00947,1,0.03123612565445026,6.82,CC
GO:0016529,sarcoplasmic reticulum,76,5,1.29,0.00952,1,0.0312375,3.88,CC
GO:0016607,nuclear speck,323,12,5.49,0.00962,1,0.031402072538860105,2.19,CC
GO:0005758,mitochondrial intermembrane space,77,5,1.31,0.01004,1,0.03260412371134021,3.82,CC
GO:0032839,dendrite cytoplasm,27,3,0.46,0.01052,1,0.03398769230769231,6.52,CC
GO:0030176,integral component of endoplasmic reticu...,143,7,2.43,0.01129,1,0.03628928571428571,2.88,CC
GO:0030137,COPI-coated vesicle,28,3,0.48,0.01164,1,0.0372243654822335,6.25,CC
GO:0030139,endocytic vesicle,179,8,3.04,0.01171,1,0.03725909090909091,2.63,CC
GO:0031674,I band,145,7,2.46,0.01212,1,0.038178000000000004,2.85,CC
GO:0055037,recycling endosome,145,7,2.46,0.01212,1,0.038178000000000004,2.85,CC
GO:0005777,peroxisome,146,7,2.48,0.01255,1,0.03914108910891089,2.82,CC
GO:0042579,microbody,146,7,2.48,0.01255,1,0.03914108910891089,2.82,CC
GO:0009986,cell surface,955,26,16.23,0.01266,1,0.03928965517241379,1.6,CC
GO:0005875,microtubule associated complex,150,7,2.55,0.01439,1,0.044222926829268296,2.75,CC
GO:0099056,integral component of presynaptic membra...,116,6,1.97,0.01439,1,0.044222926829268296,3.05,CC
GO:0031227,intrinsic component of endoplasmic retic...,151,7,2.57,0.01487,1,0.045281249999999995,2.72,CC
GO:0019897,extrinsic component of plasma membrane,187,8,3.18,0.01491,1,0.045281249999999995,2.52,CC
GO:0016528,sarcoplasm,85,5,1.44,0.01495,1,0.045281249999999995,3.47,CC
GO:0005802,trans-Golgi network,225,9,3.82,0.01517,1,0.04572775119617225,2.36,CC
GO:0098945,intrinsic component of presynaptic activ...,31,3,0.53,0.01539,1,0.046169999999999996,5.66,CC
GO:0097060,synaptic membrane,516,16,8.77,0.01581,1,0.04720521327014218,1.82,CC
GO:0005871,kinesin complex,57,4,0.97,0.01598,1,0.047487735849056606,4.12,CC
GO:0000775,"chromosome, centromeric region",195,8,3.31,0.01871,1,0.05533943661971832,2.42,CC
GO:0005788,endoplasmic reticulum lumen,60,4,1.02,0.01897,1,0.055846261682243,3.92,CC
GO:0070062,extracellular exosome,91,5,1.55,0.01953,1,0.05722744186046511,3.23,CC
GO:0044438,microbody part,61,4,1.04,0.02004,1,0.05818064516129032,3.85,CC
GO:0044439,peroxisomal part,61,4,1.04,0.02004,1,0.05818064516129032,3.85,CC
GO:0051233,spindle midzone,35,3,0.59,0.02132,1,0.06161284403669725,5.08,CC
GO:0016324,apical plasma membrane,320,11,5.44,0.02159,1,0.062108219178082194,2.02,CC
GO:0098889,intrinsic component of presynaptic membr...,128,6,2.18,0.02227,1,0.06351312217194571,2.75,CC
GO:0014704,intercalated disc,63,4,1.07,0.02228,1,0.06351312217194571,3.74,CC
GO:0044431,Golgi apparatus part,497,15,8.45,0.02361,1,0.06700135135135135,1.78,CC
GO:0032432,actin filament bundle,96,5,1.63,0.02399,1,0.06777443946188341,3.07,CC
GO:0031981,nuclear lumen,3506,74,59.58,0.02571,1,0.072309375,1.24,CC
GO:0031594,neuromuscular junction,98,5,1.67,0.02595,1,0.07266,2.99,CC
GO:1903561,extracellular vesicle,99,5,1.68,0.02696,1,0.07515398230088496,2.98,CC
GO:0030863,cortical cytoskeleton,134,6,2.28,0.02712,1,0.0752407894736842,2.63,CC
GO:0005741,mitochondrial outer membrane,171,7,2.91,0.02723,1,0.0752407894736842,2.41,CC
GO:0044448,cell cortex part,212,8,3.6,0.02897,1,0.07969912663755459,2.22,CC
GO:0000776,kinetochore,137,6,2.33,0.02979,1,0.08154545454545453,2.58,CC
GO:0005793,endoplasmic reticulum-Golgi intermediate...,69,4,1.17,0.02990,1,0.08154545454545453,3.42,CC
GO:0044427,chromosomal part,991,25,16.84,0.03243,1,0.08806422413793104,1.48,CC
GO:0005874,microtubule,429,13,7.29,0.03270,1,0.08841630901287553,1.78,CC
GO:0005776,autophagosome,73,4,1.24,0.03574,1,0.09622307692307694,3.23,CC
GO:0005720,nuclear heterochromatin,43,3,0.73,0.03642,1,0.09763659574468085,4.11,CC
GO:0030496,midbody,144,6,2.45,0.03667,1,0.09789025423728814,2.45,CC
GO:0016604,nuclear body,670,18,11.39,0.03846,1,0.10223544303797469,1.58,CC
GO:0005694,chromosome,1111,27,18.88,0.03997,1,0.10580294117647059,1.43,CC
GO:0016234,inclusion body,76,4,1.29,0.04052,1,0.10681004184100418,3.1,CC
GO:0098791,Golgi subcompartment,444,13,7.55,0.04121,1,0.10817624999999999,1.72,CC
GO:0019867,outer membrane,189,7,3.21,0.04314,1,0.11103428571428572,2.18,CC
GO:0031968,organelle outer membrane,189,7,3.21,0.04314,1,0.11103428571428572,2.18,CC
GO:0008287,protein serine/threonine phosphatase com...,46,3,0.78,0.04318,1,0.11103428571428572,3.85,CC
GO:0048787,presynaptic active zone membrane,46,3,0.78,0.04318,1,0.11103428571428572,3.85,CC
GO:1903293,phosphatase complex,46,3,0.78,0.04318,1,0.11103428571428572,3.85,CC
GO:0005881,cytoplasmic microtubule,78,4,1.33,0.04390,1,0.11197165991902834,3.01,CC
GO:0008076,voltage-gated potassium channel complex,78,4,1.33,0.04390,1,0.11197165991902834,3.01,CC
GO:0031091,platelet alpha granule,20,2,0.34,0.04474,1,0.11365403225806453,5.88,CC
GO:0000781,"chromosome, telomeric region",114,5,1.94,0.04522,1,0.113925,2.58,CC
GO:0043230,extracellular organelle,114,5,1.94,0.04522,1,0.113925,2.58,CC
GO:0009295,nucleoid,47,3,0.8,0.04557,1,0.113925,3.75,CC
GO:0042645,mitochondrial nucleoid,47,3,0.8,0.04557,1,0.113925,3.75,CC
GO:0098797,plasma membrane protein complex,545,15,9.26,0.04684,1,0.11635157480314962,1.62,CC
GO:0005925,focal adhesion,153,6,2.6,0.04691,1,0.11635157480314962,2.31,CC
GO:0019898,extrinsic component of membrane,320,10,5.44,0.04780,1,0.11809411764705884,1.84,CC
GO:0098862,cluster of actin-based cell projections,194,7,3.3,0.04843,1,0.119183203125,2.12,CC
GO:0000242,pericentriolar material,21,2,0.36,0.04890,1,0.11987159533073931,5.56,CC
GO:0005801,cis-Golgi network,49,3,0.83,0.05052,1,0.12336279069767442,3.61,CC
GO:0005819,spindle,280,9,4.76,0.05073,1,0.12339729729729729,1.89,CC
GO:0005811,lipid droplet,83,4,1.41,0.05301,1,0.1279236641221374,2.84,CC
GO:0071013,catalytic step 2 spliceosome,83,4,1.41,0.05301,1,0.1279236641221374,2.84,CC
GO:0001891,phagocytic cup,22,2,0.37,0.05320,1,0.1279236641221374,5.41,CC
GO:0005924,cell-substrate adherens junction,159,6,2.7,0.05463,1,0.13086273764258555,2.22,CC
GO:0044291,cell-cell contact zone,84,4,1.43,0.05495,1,0.1311306818181818,2.8,CC
GO:0042734,presynaptic membrane,200,7,3.4,0.05531,1,0.1314,2.06,CC
GO:0000139,Golgi membrane,242,8,4.11,0.05548,1,0.1314,1.95,CC
GO:0036126,sperm flagellum,121,5,2.06,0.05577,1,0.13159213483146068,2.43,CC
GO:0035371,microtubule plus-end,23,2,0.39,0.05763,1,0.13496988847583644,5.13,CC
GO:0097470,ribbon synapse,23,2,0.39,0.05763,1,0.13496988847583644,5.13,CC
GO:0044304,main axon,86,4,1.46,0.05894,1,0.13752666666666669,2.74,CC
GO:0005813,centrosome,517,14,8.79,0.05962,1,0.1386,1.59,CC
GO:0031514,motile cilium,204,7,3.47,0.06022,1,0.13948014705882356,2.02,CC
GO:0030134,COPII-coated ER to Golgi transport vesic...,53,3,0.9,0.06118,1,0.14118461538461538,3.33,CC
GO:0033017,sarcoplasmic reticulum membrane,24,2,0.41,0.06218,1,0.14296861313868614,4.88,CC
GO:0009898,cytoplasmic side of plasma membrane,165,6,2.8,0.06308,1,0.14451054545454545,2.14,CC
GO:0031902,late endosome membrane,54,3,0.92,0.06400,1,0.14608695652173914,3.26,CC
GO:0030055,cell-substrate junction,166,6,2.82,0.06456,1,0.1468332129963899,2.13,CC
GO:0034705,potassium channel complex,89,4,1.51,0.06520,1,0.14775539568345322,2.65,CC
GO:0097729,9+2 motile cilium,128,5,2.18,0.06761,1,0.15266774193548388,2.29,CC
GO:0001669,acrosomal vesicle,129,5,2.19,0.06941,1,0.15568398576512457,2.28,CC
GO:0098858,actin-based cell projection,211,7,3.59,0.06944,1,0.15568398576512457,1.95,CC
GO:0005911,cell-cell junction,484,13,8.23,0.07123,1,0.1583621052631579,1.58,CC
GO:0005654,nucleoplasm,2607,54,44.3,0.07135,1,0.1583621052631579,1.22,CC
GO:0005689,U12-type spliceosomal complex,26,2,0.44,0.07164,1,0.1583621052631579,4.55,CC
GO:0005868,cytoplasmic dynein complex,26,2,0.44,0.07164,1,0.1583621052631579,4.55,CC
GO:0005912,adherens junction,301,9,5.12,0.07274,1,0.16023146853146855,1.76,CC
GO:0048786,presynaptic active zone,94,4,1.6,0.07638,1,0.16680830449826992,2.5,CC
GO:0097440,apical dendrite,27,2,0.46,0.07652,1,0.16680830449826992,4.35,CC
GO:0099524,postsynaptic cytosol,27,2,0.46,0.07652,1,0.16680830449826992,4.35,CC
GO:0032838,plasma membrane bounded cell projection ...,174,6,2.96,0.07711,1,0.1675148275862069,2.03,CC
GO:0031045,dense core granule,28,2,0.48,0.08152,1,0.1764865979381443,4.17,CC
GO:0031234,extrinsic component of cytoplasmic side ...,98,4,1.67,0.08597,1,0.1854832191780822,2.4,CC
GO:0030136,clathrin-coated vesicle,99,4,1.68,0.08845,1,0.18989694915254238,2.38,CC
GO:0034703,cation channel complex,224,7,3.81,0.08867,1,0.18989694915254238,1.84,CC
GO:1902495,transmembrane transporter complex,314,9,5.34,0.08892,1,0.18989694915254238,1.69,CC
GO:0098562,cytoplasmic side of membrane,182,6,3.09,0.09095,1,0.19357601351351353,1.94,CC
GO:0070161,anchoring junction,316,9,5.37,0.09159,1,0.1942818181818182,1.68,CC
GO:0099699,integral component of synaptic membrane,228,7,3.87,0.09514,1,0.200046,1.81,CC
GO:0005905,clathrin-coated pit,64,3,1.09,0.09526,1,0.200046,2.75,CC
GO:0032421,stereocilium bundle,64,3,1.09,0.09526,1,0.200046,2.75,CC
GO:0000407,phagophore assembly site,31,2,0.53,0.09705,1,0.20245529801324505,3.77,CC
GO:1990752,microtubule end,31,2,0.53,0.09705,1,0.20245529801324505,3.77,CC
GO:0044441,ciliary part,464,12,7.89,0.09962,1,0.20713069306930693,1.52,CC
GO:0032281,AMPA glutamate receptor complex,32,2,0.54,0.10241,1,0.21223124999999998,3.7,CC
GO:1990351,transporter complex,325,9,5.52,0.10416,1,0.21515016393442624,1.63,CC
GO:0005834,heterotrimeric G-protein complex,33,2,0.56,0.10784,1,0.22130032573289904,3.57,CC
GO:1905360,GTPase complex,33,2,0.56,0.10784,1,0.22130032573289904,3.57,CC
GO:0031965,nuclear membrane,237,7,4.03,0.11062,1,0.2262681818181818,1.74,CC
GO:0005604,basement membrane,108,4,1.84,0.11232,1,0.22900194174757282,2.17,CC
GO:0032588,trans-Golgi network membrane,34,2,0.58,0.11334,1,0.23033612903225806,3.45,CC
GO:0097730,non-motile cilium,152,5,2.58,0.11778,1,0.23858971061093248,1.94,CC
GO:0099513,polymeric cytoskeletal fiber,679,16,11.54,0.11872,1,0.23972307692307693,1.39,CC
GO:0005929,cilium,632,15,10.74,0.12254,1,0.24664600638977638,1.4,CC
GO:0005643,nuclear pore,72,3,1.22,0.12389,1,0.24778,2.46,CC
GO:0032592,integral component of mitochondrial memb...,72,3,1.22,0.12389,1,0.24778,2.46,CC
GO:0099240,intrinsic component of synaptic membrane,246,7,4.18,0.12735,1,0.25389398734177215,1.67,CC
GO:0000785,chromatin,588,14,9.99,0.13005,1,0.25845899053627763,1.4,CC
GO:0098573,intrinsic component of mitochondrial mem...,74,3,1.26,0.13149,1,0.2604990566037736,2.38,CC
GO:0005913,cell-cell adherens junction,115,4,1.95,0.13264,1,0.261953605015674,2.05,CC
GO:0034702,ion channel complex,299,8,5.08,0.13875,1,0.2731640625,1.57,CC
GO:0030684,preribosome,78,3,1.33,0.14715,1,0.28870434782608695,2.26,CC
GO:0044451,nucleoplasm part,1017,22,17.28,0.14756,1,0.28870434782608695,1.27,CC
GO:0010008,endosome membrane,210,6,3.57,0.14896,1,0.29054117647058825,1.68,CC
GO:0044450,microtubule organizing center part,165,5,2.8,0.15061,1,0.29285277777777774,1.79,CC
GO:0000784,"nuclear chromosome, telomeric region",79,3,1.34,0.15116,1,0.29301784615384613,2.24,CC
GO:0099522,region of cytosol,41,2,0.7,0.15366,1,0.29695030674846623,2.86,CC
GO:0000790,nuclear chromatin,406,10,6.9,0.15570,1,0.2999724770642202,1.45,CC
GO:0044853,plasma membrane raft,123,4,2.09,0.15754,1,0.3025920731707317,1.91,CC
GO:0005771,multivesicular body,42,2,0.71,0.15962,1,0.30565531914893623,2.82,CC
GO:0005730,nucleolus,821,18,13.95,0.16331,1,0.3117736363636364,1.29,CC
GO:0031305,integral component of mitochondrial inne...,43,2,0.73,0.16563,1,0.31524743202416916,2.74,CC
GO:0005759,mitochondrial matrix,266,7,4.52,0.16872,1,0.31920000000000004,1.55,CC
GO:0005769,early endosome,266,7,4.52,0.16872,1,0.31920000000000004,1.55,CC
GO:0031304,intrinsic component of mitochondrial inn...,44,2,0.75,0.17168,1,0.3238275449101797,2.67,CC
GO:0005778,peroxisomal membrane,45,2,0.76,0.17777,1,0.33232967359050447,2.63,CC
GO:0031903,microbody membrane,45,2,0.76,0.17777,1,0.33232967359050447,2.63,CC
GO:0055038,recycling endosome membrane,45,2,0.76,0.17777,1,0.33232967359050447,2.63,CC
GO:0032391,photoreceptor connecting cilium,46,2,0.78,0.18388,1,0.340624926686217,2.56,CC
GO:0005815,microtubule organizing center,680,15,11.56,0.18430,1,0.340624926686217,1.3,CC
GO:0001725,stress fiber,87,3,1.48,0.18437,1,0.340624926686217,2.03,CC
GO:0097517,contractile actin filament bundle,87,3,1.48,0.18437,1,0.340624926686217,2.03,CC
GO:0005903,brush border,137,4,2.33,0.20477,1,0.37720789473684213,1.72,CC
GO:0005902,microvillus,92,3,1.56,0.20602,1,0.3784040816326531,1.92,CC
GO:0098686,hippocampal mossy fiber to CA3 synapse,50,2,0.85,0.20863,1,0.3815791304347826,2.35,CC
GO:0044440,endosomal part,234,6,3.98,0.20896,1,0.3815791304347826,1.51,CC
GO:0030175,filopodium,93,3,1.58,0.21042,1,0.3831346820809248,1.9,CC
GO:0016323,basolateral plasma membrane,236,6,4.01,0.21432,1,0.3891112391930836,1.5,CC
GO:0000792,heterochromatin,95,3,1.61,0.21928,1,0.39697241379310344,1.86,CC
GO:1904949,ATPase complex,96,3,1.63,0.22374,1,0.4038859598853868,1.84,CC
GO:0060170,ciliary membrane,53,2,0.9,0.22740,1,0.40932,2.22,CC
GO:0042641,actomyosin,98,3,1.67,0.23271,1,0.4176846153846154,1.8,CC
GO:0032420,stereocilium,54,2,0.92,0.23368,1,0.4182340909090909,2.17,CC
GO:0030864,cortical actin cytoskeleton,101,3,1.72,0.24627,1,0.43951869688385264,1.74,CC
GO:1902911,protein kinase complex,102,3,1.73,0.25082,1,0.4463745762711864,1.73,CC
GO:0008328,ionotropic glutamate receptor complex,57,2,0.97,0.25259,1,0.44825830985915494,2.06,CC
GO:0001917,photoreceptor inner segment,58,2,0.99,0.25890,1,0.4556061452513967,2.02,CC
GO:0030286,dynein complex,58,2,0.99,0.25890,1,0.4556061452513967,2.02,CC
GO:0045171,intercellular bridge,58,2,0.99,0.25890,1,0.4556061452513967,2.02,CC
GO:0000118,histone deacetylase complex,59,2,1,0.26521,1,0.46283185595567866,2,CC
GO:0097525,spliceosomal snRNP complex,59,2,1,0.26521,1,0.46283185595567866,2,CC
GO:0098878,neurotransmitter receptor complex,59,2,1,0.26521,1,0.46283185595567866,2,CC
GO:0062023,collagen-containing extracellular matrix,360,8,6.12,0.27026,1,0.4703419889502763,1.31,CC
GO:0072686,mitotic spindle,110,3,1.87,0.28760,1,0.49703233695652166,1.6,CC
GO:0000159,protein phosphatase type 2A complex,20,1,0.34,0.29033,1,0.49703233695652166,2.94,CC
GO:0005686,U2 snRNP,20,1,0.34,0.29033,1,0.49703233695652166,2.94,CC
GO:0030904,retromer complex,20,1,0.34,0.29033,1,0.49703233695652166,2.94,CC
GO:0031616,spindle pole centrosome,20,1,0.34,0.29033,1,0.49703233695652166,2.94,CC
GO:0044232,organelle membrane contact site,20,1,0.34,0.29033,1,0.49703233695652166,2.94,CC
GO:0030532,small nuclear ribonucleoprotein complex,64,2,1.09,0.29675,1,0.5066463414634147,1.83,CC
GO:0030673,axolemma,21,1,0.36,0.30240,1,0.5093903743315509,2.78,CC
GO:0030992,intraciliary transport particle B,21,1,0.36,0.30240,1,0.5093903743315509,2.78,CC
GO:0035267,NuA4 histone acetyltransferase complex,21,1,0.36,0.30240,1,0.5093903743315509,2.78,CC
GO:0042611,MHC protein complex,21,1,0.36,0.30240,1,0.5093903743315509,2.78,CC
GO:0043189,H4/H2A histone acetyltransferase complex,21,1,0.36,0.30240,1,0.5093903743315509,2.78,CC
GO:0097733,photoreceptor cell cilium,114,3,1.94,0.30616,1,0.5143487999999999,1.55,CC
GO:0045211,postsynaptic membrane,376,8,6.39,0.30962,1,0.5187781914893617,1.25,CC
GO:0005814,centriole,115,3,1.95,0.31081,1,0.5193907161803714,1.54,CC
GO:0031307,integral component of mitochondrial oute...,22,1,0.37,0.31427,1,0.5237833333333334,2.7,CC
GO:0097731,9+0 non-motile cilium,116,3,1.97,0.31546,1,0.5239942105263158,1.52,CC
GO:0042383,sarcolemma,167,4,2.84,0.31606,1,0.5239942105263158,1.41,CC
GO:0019005,SCF ubiquitin ligase complex,68,2,1.16,0.32183,1,0.5278719794344473,1.72,CC
GO:0043198,dendritic shaft,68,2,1.16,0.32183,1,0.5278719794344473,1.72,CC
GO:0000421,autophagosome membrane,23,1,0.39,0.32594,1,0.5278719794344473,2.56,CC
GO:0002080,acrosomal membrane,23,1,0.39,0.32594,1,0.5278719794344473,2.56,CC
GO:0005797,Golgi medial cisterna,23,1,0.39,0.32594,1,0.5278719794344473,2.56,CC
GO:0031306,intrinsic component of mitochondrial out...,23,1,0.39,0.32594,1,0.5278719794344473,2.56,CC
GO:0046930,pore complex,23,1,0.39,0.32594,1,0.5278719794344473,2.56,CC
GO:0071782,endoplasmic reticulum tubular network,23,1,0.39,0.32594,1,0.5278719794344473,2.56,CC
GO:0099243,extrinsic component of synaptic membrane,23,1,0.39,0.32594,1,0.5278719794344473,2.56,CC
GO:0032589,neuron projection membrane,69,2,1.17,0.32807,1,0.5299592307692307,1.71,CC
GO:0099055,integral component of postsynaptic membr...,171,4,2.91,0.33143,1,0.5340176470588235,1.37,CC
GO:0005721,pericentric heterochromatin,24,1,0.41,0.33740,1,0.54225,2.44,CC
GO:0005615,extracellular space,1621,30,27.55,0.33972,1,0.5445893129770992,1.09,CC
GO:0000151,ubiquitin ligase complex,282,6,4.79,0.34708,1,0.5505473684210527,1.25,CC
GO:0044421,extracellular region part,1855,34,31.52,0.34724,1,0.5505473684210527,1.08,CC
GO:0030687,"preribosome, large subunit precursor",25,1,0.42,0.34868,1,0.5505473684210527,2.38,CC
GO:0035327,transcriptionally active chromatin,25,1,0.42,0.34868,1,0.5505473684210527,2.38,CC
GO:0060077,inhibitory synapse,25,1,0.42,0.34868,1,0.5505473684210527,2.38,CC
GO:0099523,presynaptic cytosol,25,1,0.42,0.34868,1,0.5505473684210527,2.38,CC
GO:0035869,ciliary transition zone,73,2,1.24,0.35286,1,0.5557545,1.61,CC
GO:0098552,side of membrane,615,12,10.45,0.35400,1,0.5561596009975063,1.15,CC
GO:0005884,actin filament,125,3,2.12,0.35729,1,0.5591327586206897,1.42,CC
GO:0099061,integral component of postsynaptic densi...,74,2,1.26,0.35901,1,0.5591327586206897,1.59,CC
GO:0005732,small nucleolar ribonucleoprotein comple...,26,1,0.44,0.35976,1,0.5591327586206897,2.27,CC
GO:0097038,perinuclear endoplasmic reticulum,26,1,0.44,0.35976,1,0.5591327586206897,2.27,CC
GO:0043235,receptor complex,396,8,6.73,0.36033,1,0.5591327586206897,1.19,CC
GO:0120114,Sm-like protein family complex,75,2,1.27,0.36514,1,0.5642273838630807,1.57,CC
GO:0098936,intrinsic component of postsynaptic memb...,180,4,3.06,0.36612,1,0.5642273838630807,1.31,CC
GO:0044454,nuclear chromosome part,621,12,10.55,0.36630,1,0.5642273838630807,1.14,CC
GO:0070971,endoplasmic reticulum exit site,27,1,0.46,0.37065,1,0.5695353658536585,2.17,CC
GO:0098802,plasma membrane receptor complex,182,4,3.09,0.37383,1,0.5730240875912408,1.29,CC
GO:0031526,brush border membrane,77,2,1.31,0.37733,1,0.5769851941747572,1.53,CC
GO:0070603,SWI/SNF superfamily-type complex,78,2,1.33,0.38338,1,0.5848169491525423,1.5,CC
GO:0000780,"condensed nuclear chromosome, centromeri...",29,1,0.49,0.39189,1,0.5920640287769784,2.04,CC
GO:0016342,catenin complex,29,1,0.49,0.39189,1,0.5920640287769784,2.04,CC
GO:0030140,trans-Golgi network transport vesicle,29,1,0.49,0.39189,1,0.5920640287769784,2.04,CC
GO:0030990,intraciliary transport particle,29,1,0.49,0.39189,1,0.5920640287769784,2.04,CC
GO:0001750,photoreceptor outer segment,80,2,1.36,0.39542,1,0.594545584725537,1.47,CC
GO:0099146,intrinsic component of postsynaptic dens...,80,2,1.36,0.39542,1,0.594545584725537,1.47,CC
GO:0005865,striated muscle thin filament,30,1,0.51,0.40224,1,0.601926840855107,1.96,CC
GO:0044305,calyx of Held,30,1,0.51,0.40224,1,0.601926840855107,1.96,CC
GO:0031225,anchored component of membrane,192,4,3.26,0.41220,1,0.6111739436619719,1.23,CC
GO:0042470,melanosome,31,1,0.53,0.41241,1,0.6111739436619719,1.89,CC
GO:0048770,pigment granule,31,1,0.53,0.41241,1,0.6111739436619719,1.89,CC
GO:0099634,postsynaptic specialization membrane,137,3,2.33,0.41244,1,0.6111739436619719,1.29,CC
GO:0017053,transcriptional repressor complex,83,2,1.41,0.41327,1,0.6111739436619719,1.42,CC
GO:0030666,endocytic vesicle membrane,32,1,0.54,0.42241,1,0.6217717289719626,1.85,CC
GO:0036379,myofilament,32,1,0.54,0.42241,1,0.6217717289719626,1.85,CC
GO:0005795,Golgi stack,86,2,1.46,0.43085,1,0.6318125290023202,1.37,CC
GO:0046540,U4/U6 x U5 tri-snRNP complex,33,1,0.56,0.43224,1,0.6318125290023202,1.79,CC
GO:0097526,spliceosomal tri-snRNP complex,33,1,0.56,0.43224,1,0.6318125290023202,1.79,CC
GO:0043195,terminal bouton,87,2,1.48,0.43665,1,0.6354270207852194,1.35,CC
GO:0000228,nuclear chromosome,655,12,11.13,0.43673,1,0.6354270207852194,1.08,CC
GO:0005684,U2-type spliceosomal complex,89,2,1.51,0.44816,1,0.6505548387096775,1.32,CC
GO:0005719,nuclear euchromatin,35,1,0.59,0.45140,1,0.6507597254004577,1.69,CC
GO:0015030,Cajal body,35,1,0.59,0.45140,1,0.6507597254004577,1.69,CC
GO:0097546,ciliary base,35,1,0.59,0.45140,1,0.6507597254004577,1.69,CC
GO:0032809,neuronal cell body membrane,36,1,0.61,0.46074,1,0.6627082191780822,1.64,CC
GO:0031463,Cul3-RING ubiquitin ligase complex,37,1,0.63,0.46992,1,0.6713142857142858,1.59,CC
GO:0031941,filamentous actin,37,1,0.63,0.46992,1,0.6713142857142858,1.59,CC
GO:0032040,small-subunit processome,37,1,0.63,0.46992,1,0.6713142857142858,1.59,CC
GO:0005901,caveola,94,2,1.6,0.47632,1,0.6789176470588236,1.25,CC
GO:0044298,cell body membrane,38,1,0.65,0.47895,1,0.6796905405405406,1.54,CC
GO:0031224,intrinsic component of membrane,6068,104,103.12,0.47902,1,0.6796905405405406,1.01,CC
GO:0016235,aggresome,40,1,0.68,0.49654,1,0.7029667415730336,1.47,CC
GO:0098839,postsynaptic density membrane,98,2,1.67,0.49821,1,0.7037495515695067,1.2,CC
GO:0031461,cullin-RING ubiquitin ligase complex,160,3,2.72,0.51319,1,0.7221515625,1.1,CC
GO:0032154,cleavage furrow,42,1,0.71,0.51353,1,0.7221515625,1.41,CC
GO:0000307,cyclin-dependent protein kinase holoenzy...,43,1,0.73,0.52182,1,0.7305479999999999,1.37,CC
GO:1902562,H4 histone acetyltransferase complex,43,1,0.73,0.52182,1,0.7305479999999999,1.37,CC
GO:0098982,GABA-ergic synapse,104,2,1.77,0.52994,1,0.740270953436807,1.13,CC
GO:0000791,euchromatin,45,1,0.76,0.53796,1,0.7498115044247787,1.32,CC
GO:0099060,integral component of postsynaptic speci...,107,2,1.82,0.54528,1,0.757429295154185,1.1,CC
GO:0034707,chloride channel complex,46,1,0.78,0.54583,1,0.757429295154185,1.28,CC
GO:0031519,PcG protein complex,47,1,0.8,0.55357,1,0.7664815384615384,1.25,CC
GO:0032590,dendrite membrane,48,1,0.82,0.56117,1,0.7753006578947368,1.22,CC
GO:0031012,extracellular matrix,477,8,8.11,0.56478,1,0.7785807439824944,0.99,CC
GO:0031201,SNARE complex,49,1,0.83,0.56865,1,0.7822041484716157,1.2,CC
GO:0098948,intrinsic component of postsynaptic spec...,113,2,1.92,0.57491,1,0.787704989154013,1.04,CC
GO:0035861,site of double-strand break,50,1,0.85,0.57599,1,0.787704989154013,1.18,CC
GO:0016021,integral component of membrane,5896,99,100.2,0.57640,1,0.787704989154013,0.99,CC
GO:0000779,"condensed chromosome, centromeric region",51,1,0.87,0.58322,1,0.7935822894168466,1.15,CC
GO:0031901,early endosome membrane,51,1,0.87,0.58322,1,0.7935822894168466,1.15,CC
GO:0008023,transcription elongation factor complex,53,1,0.9,0.59729,1,0.8074950643776824,1.11,CC
GO:0030173,integral component of Golgi membrane,53,1,0.9,0.59729,1,0.8074950643776824,1.11,CC
GO:0032155,cell division site part,53,1,0.9,0.59729,1,0.8074950643776824,1.11,CC
GO:0044452,nucleolar part,184,3,3.13,0.60775,1,0.8198768736616703,0.96,CC
GO:0031228,intrinsic component of Golgi membrane,55,1,0.93,0.61090,1,0.8206119402985075,1.08,CC
GO:0099738,cell cortex region,55,1,0.93,0.61090,1,0.8206119402985075,1.08,CC
GO:0031312,extrinsic component of organelle membran...,56,1,0.95,0.61753,1,0.8277529787234044,1.05,CC
GO:0005876,spindle microtubule,57,1,0.97,0.62405,1,0.8347165605095541,1.03,CC
GO:0016328,lateral plasma membrane,58,1,0.99,0.63045,1,0.8397114164904862,1.01,CC
GO:0032153,cell division site,58,1,0.99,0.63045,1,0.8397114164904862,1.01,CC
GO:0000315,organellar large ribosomal subunit,60,1,1.02,0.64294,1,0.8509499999999999,0.98,CC
GO:0005762,mitochondrial large ribosomal subunit,60,1,1.02,0.64294,1,0.8509499999999999,0.98,CC
GO:0016459,myosin complex,60,1,1.02,0.64294,1,0.8509499999999999,0.98,CC
GO:0005930,axoneme,130,2,2.21,0.65108,1,0.8599169811320754,0.9,CC
GO:0031985,Golgi cisterna,62,1,1.05,0.65501,1,0.85995,0.95,CC
GO:0001650,fibrillar center,131,2,2.23,0.65520,1,0.85995,0.9,CC
GO:0097014,ciliary plasm,131,2,2.23,0.65520,1,0.85995,0.9,CC
GO:1990234,transferase complex,770,12,13.09,0.66109,1,0.865876715176715,0.92,CC
GO:0030660,Golgi-associated vesicle membrane,64,1,1.09,0.66667,1,0.8713736514522822,0.92,CC
GO:0090734,site of DNA damage,65,1,1.1,0.67235,1,0.8769782608695652,0.91,CC
GO:0000502,proteasome complex,66,1,1.12,0.67793,1,0.8824295454545454,0.89,CC
GO:1905369,endopeptidase complex,67,1,1.14,0.68342,1,0.8877414432989691,0.88,CC
GO:0005576,extracellular region,2399,38,40.77,0.70303,1,0.9113351851851852,0.93,CC
GO:0000932,P-body,73,1,1.24,0.71446,1,0.9223561475409835,0.81,CC
GO:0016605,PML body,73,1,1.24,0.71446,1,0.9223561475409835,0.81,CC
GO:0030315,T-tubule,74,1,1.26,0.71933,1,0.9250714285714287,0.79,CC
GO:0036064,ciliary basal body,148,2,2.52,0.71950,1,0.9250714285714287,0.79,CC
GO:0060076,excitatory synapse,76,1,1.29,0.72882,1,0.9351458248472505,0.78,CC
GO:0005667,transcription factor complex,426,6,7.24,0.73379,1,0.9396091463414635,0.83,CC
GO:0009897,external side of plasma membrane,434,6,7.38,0.74975,1,0.9580983772819472,0.81,CC
GO:0000123,histone acetyltransferase complex,83,1,1.41,0.75959,1,0.9667509090909091,0.71,CC
GO:1902554,serine/threonine protein kinase complex,83,1,1.41,0.75959,1,0.9667509090909091,0.71,CC
GO:0045111,intermediate filament cytoskeleton,166,2,2.82,0.77628,1,0.9860008064516129,0.71,CC
GO:0000313,organellar ribosome,93,1,1.58,0.79760,1,1,0.63,CC
GO:0005761,mitochondrial ribosome,93,1,1.58,0.79760,1,1,0.63,CC
GO:0031248,protein acetyltransferase complex,93,1,1.58,0.79760,1,1,0.63,CC
GO:1902493,acetyltransferase complex,93,1,1.58,0.79760,1,1,0.63,CC
GO:1905368,peptidase complex,93,1,1.58,0.79760,1,1,0.63,CC
GO:0061695,"transferase complex, transferring phosph...",249,3,4.23,0.79807,1,1,0.71,CC
GO:0005887,integral component of plasma membrane,1526,22,25.93,0.81778,1,1,0.85,CC
GO:0032993,protein-DNA complex,191,2,3.25,0.83838,1,1,0.62,CC
GO:0005923,bicellular tight junction,122,1,2.07,0.87719,1,1,0.48,CC
GO:0031226,intrinsic component of plasma membrane,1604,22,27.26,0.87865,1,1,0.81,CC
GO:0005882,intermediate filament,125,1,2.12,0.88338,1,1,0.47,CC
GO:0070160,tight junction,129,1,2.19,0.89115,1,1,0.46,CC
GO:0000922,spindle pole,134,1,2.28,0.90014,1,1,0.44,CC
GO:0043296,apical junction complex,142,1,2.41,0.91302,1,1,0.41,CC
GO:0000794,condensed nuclear chromosome,144,1,2.45,0.91597,1,1,0.41,CC
GO:0090575,RNA polymerase II transcription factor c...,166,1,2.82,0.94252,1,1,0.35,CC
GO:0000793,condensed chromosome,197,1,3.35,0.96637,1,1,0.3,CC
GO:0044798,nuclear transcription factor complex,207,1,3.52,0.97171,1,1,0.28,CC
GO:0005575,cellular_component,21419,364,364,1.00000,1,1,1,CC
GO:0000152,nuclear ubiquitin ligase complex,41,0,0.7,1.00000,1,1,0,CC
GO:0000178,exosome (RNase complex),23,0,0.39,1.00000,1,1,0,CC
GO:0000314,organellar small ribosomal subunit,31,0,0.53,1.00000,1,1,0,CC
GO:0000428,DNA-directed RNA polymerase complex,101,0,1.72,1.00000,1,1,0,CC
GO:0000777,condensed chromosome kinetochore,35,0,0.59,1.00000,1,1,0,CC
GO:0000786,nucleosome,88,0,1.5,1.00000,1,1,0,CC
GO:0000788,nuclear nucleosome,38,0,0.65,1.00000,1,1,0,CC
GO:0000795,synaptonemal complex,81,0,1.38,1.00000,1,1,0,CC
GO:0000803,sex chromosome,41,0,0.7,1.00000,1,1,0,CC
GO:0000930,gamma-tubulin complex,20,0,0.34,1.00000,1,1,0,CC
GO:0001533,cornified envelope,56,0,0.95,1.00000,1,1,0,CC
GO:0001673,male germ cell nucleus,23,0,0.39,1.00000,1,1,0,CC
GO:0001741,XY body,22,0,0.37,1.00000,1,1,0,CC
GO:0005581,collagen trimer,83,0,1.41,1.00000,1,1,0,CC
GO:0005637,nuclear inner membrane,42,0,0.71,1.00000,1,1,0,CC
GO:0005657,replication fork,72,0,1.22,1.00000,1,1,0,CC
GO:0005669,transcription factor TFIID complex,38,0,0.65,1.00000,1,1,0,CC
GO:0005680,anaphase-promoting complex,20,0,0.34,1.00000,1,1,0,CC
GO:0005763,mitochondrial small ribosomal subunit,31,0,0.53,1.00000,1,1,0,CC
GO:0005838,proteasome regulatory particle,23,0,0.39,1.00000,1,1,0,CC
GO:0005849,mRNA cleavage factor complex,20,0,0.34,1.00000,1,1,0,CC
GO:0005858,axonemal dynein complex,24,0,0.41,1.00000,1,1,0,CC
GO:0005891,voltage-gated calcium channel complex,45,0,0.76,1.00000,1,1,0,CC
GO:0005921,gap junction,33,0,0.56,1.00000,1,1,0,CC
GO:0005922,connexin complex,20,0,0.34,1.00000,1,1,0,CC
GO:0005942,phosphatidylinositol 3-kinase complex,30,0,0.51,1.00000,1,1,0,CC
GO:0008305,integrin complex,32,0,0.54,1.00000,1,1,0,CC
GO:0009925,basal plasma membrane,43,0,0.73,1.00000,1,1,0,CC
GO:0012507,ER to Golgi transport vesicle membrane,21,0,0.36,1.00000,1,1,0,CC
GO:0016010,dystrophin-associated glycoprotein compl...,20,0,0.34,1.00000,1,1,0,CC
GO:0016327,apicolateral plasma membrane,22,0,0.37,1.00000,1,1,0,CC
GO:0016442,RISC complex,123,0,2.09,1.00000,1,1,0,CC
GO:0016591,"RNA polymerase II, holoenzyme",77,0,1.31,1.00000,1,1,0,CC
GO:0016592,mediator complex,36,0,0.61,1.00000,1,1,0,CC
GO:0018995,host,24,0,0.41,1.00000,1,1,0,CC
GO:0022624,proteasome accessory complex,25,0,0.42,1.00000,1,1,0,CC
GO:0030057,desmosome,25,0,0.42,1.00000,1,1,0,CC
GO:0030117,membrane coat,100,0,1.7,1.00000,1,1,0,CC
GO:0030118,clathrin coat,49,0,0.83,1.00000,1,1,0,CC
GO:0030119,AP-type membrane coat adaptor complex,48,0,0.82,1.00000,1,1,0,CC
GO:0030120,vesicle coat,58,0,0.99,1.00000,1,1,0,CC
GO:0030125,clathrin vesicle coat,29,0,0.49,1.00000,1,1,0,CC
GO:0030131,clathrin adaptor complex,30,0,0.51,1.00000,1,1,0,CC
GO:0030132,clathrin coat of coated pit,22,0,0.37,1.00000,1,1,0,CC
GO:0030662,coated vesicle membrane,79,0,1.34,1.00000,1,1,0,CC
GO:0030665,clathrin-coated vesicle membrane,37,0,0.63,1.00000,1,1,0,CC
GO:0030686,90S preribosome,30,0,0.51,1.00000,1,1,0,CC
GO:0030880,RNA polymerase complex,104,0,1.77,1.00000,1,1,0,CC
GO:0030894,replisome,25,0,0.42,1.00000,1,1,0,CC
GO:0031082,BLOC complex,20,0,0.34,1.00000,1,1,0,CC
GO:0031231,intrinsic component of peroxisomal membr...,20,0,0.34,1.00000,1,1,0,CC
GO:0031233,intrinsic component of external side of ...,25,0,0.42,1.00000,1,1,0,CC
GO:0031332,RNAi effector complex,123,0,2.09,1.00000,1,1,0,CC
GO:0031362,anchored component of external side of p...,22,0,0.37,1.00000,1,1,0,CC
GO:0032426,stereocilium tip,20,0,0.34,1.00000,1,1,0,CC
GO:0032806,carboxy-terminal domain protein kinase c...,21,0,0.36,1.00000,1,1,0,CC
GO:0032994,protein-lipid complex,36,0,0.61,1.00000,1,1,0,CC
GO:0033643,host cell part,22,0,0.37,1.00000,1,1,0,CC
GO:0033646,host intracellular part,20,0,0.34,1.00000,1,1,0,CC
GO:0034358,plasma lipoprotein particle,34,0,0.58,1.00000,1,1,0,CC
GO:0034364,high-density lipoprotein particle,23,0,0.39,1.00000,1,1,0,CC
GO:0034451,centriolar satellite,32,0,0.54,1.00000,1,1,0,CC
GO:0034704,calcium channel complex,64,0,1.09,1.00000,1,1,0,CC
GO:0034706,sodium channel complex,24,0,0.41,1.00000,1,1,0,CC
GO:0034708,methyltransferase complex,118,0,2.01,1.00000,1,1,0,CC
GO:0035097,histone methyltransferase complex,94,0,1.6,1.00000,1,1,0,CC
GO:0035145,exon-exon junction complex,21,0,0.36,1.00000,1,1,0,CC
GO:0036452,ESCRT complex,24,0,0.41,1.00000,1,1,0,CC
GO:0043073,germ cell nucleus,30,0,0.51,1.00000,1,1,0,CC
GO:0043083,synaptic cleft,20,0,0.34,1.00000,1,1,0,CC
GO:0043194,axon initial segment,22,0,0.37,1.00000,1,1,0,CC
GO:0043596,nuclear replication fork,41,0,0.7,1.00000,1,1,0,CC
GO:0043601,nuclear replisome,24,0,0.41,1.00000,1,1,0,CC
GO:0043656,intracellular region of host,20,0,0.34,1.00000,1,1,0,CC
GO:0043657,host cell,24,0,0.41,1.00000,1,1,0,CC
GO:0044215,other organism,30,0,0.51,1.00000,1,1,0,CC
GO:0044216,other organism cell,30,0,0.51,1.00000,1,1,0,CC
GO:0044217,other organism part,30,0,0.51,1.00000,1,1,0,CC
GO:0044420,extracellular matrix component,52,0,0.88,1.00000,1,1,0,CC
GO:0044447,axoneme part,40,0,0.68,1.00000,1,1,0,CC
GO:0044665,MLL1/2 complex,30,0,0.51,1.00000,1,1,0,CC
GO:0044815,DNA packaging complex,96,0,1.63,1.00000,1,1,0,CC
GO:0045095,keratin filament,40,0,0.68,1.00000,1,1,0,CC
GO:0045120,pronucleus,23,0,0.39,1.00000,1,1,0,CC
GO:0045178,basal part of cell,66,0,1.12,1.00000,1,1,0,CC
GO:0045334,clathrin-coated endocytic vesicle,31,0,0.53,1.00000,1,1,0,CC
GO:0046658,anchored component of plasma membrane,73,0,1.24,1.00000,1,1,0,CC
GO:0048475,coated membrane,100,0,1.7,1.00000,1,1,0,CC
GO:0055029,nuclear DNA-directed RNA polymerase comp...,100,0,1.7,1.00000,1,1,0,CC
GO:0061702,inflammasome complex,21,0,0.36,1.00000,1,1,0,CC
GO:0070461,SAGA-type complex,26,0,0.44,1.00000,1,1,0,CC
GO:0071005,U2-type precatalytic spliceosome,49,0,0.83,1.00000,1,1,0,CC
GO:0071007,U2-type catalytic step 2 spliceosome,28,0,0.48,1.00000,1,1,0,CC
GO:0071011,precatalytic spliceosome,50,0,0.85,1.00000,1,1,0,CC
GO:0071339,MLL1 complex,30,0,0.51,1.00000,1,1,0,CC
GO:0080008,Cul4-RING E3 ubiquitin ligase complex,32,0,0.54,1.00000,1,1,0,CC
GO:0090568,nuclear transcriptional repressor comple...,29,0,0.49,1.00000,1,1,0,CC
GO:0090665,glycoprotein complex,20,0,0.34,1.00000,1,1,0,CC
GO:0097225,sperm midpiece,28,0,0.48,1.00000,1,1,0,CC
GO:0097228,sperm principal piece,32,0,0.54,1.00000,1,1,0,CC
GO:0097346,INO80-type complex,24,0,0.41,1.00000,1,1,0,CC
GO:0097431,mitotic spindle pole,30,0,0.51,1.00000,1,1,0,CC
GO:0098636,protein complex involved in cell adhesio...,37,0,0.63,1.00000,1,1,0,CC
GO:0098688,parallel fiber to Purkinje cell synapse,33,0,0.56,1.00000,1,1,0,CC
GO:0098831,presynaptic active zone cytoplasmic comp...,23,0,0.39,1.00000,1,1,0,CC
GO:0099023,tethering complex,63,0,1.07,1.00000,1,1,0,CC
GO:0099086,synaptonemal structure,81,0,1.38,1.00000,1,1,0,CC
GO:0099091,"postsynaptic specialization, intracellul...",38,0,0.65,1.00000,1,1,0,CC
GO:0099092,"postsynaptic density, intracellular comp...",32,0,0.54,1.00000,1,1,0,CC
GO:1902555,endoribonuclease complex,31,0,0.53,1.00000,1,1,0,CC
GO:1902710,GABA receptor complex,21,0,0.36,1.00000,1,1,0,CC
GO:1905348,endonuclease complex,32,0,0.54,1.00000,1,1,0,CC
GO:1905354,exoribonuclease complex,23,0,0.39,1.00000,1,1,0,CC
GO:1990391,DNA repair complex,38,0,0.65,1.00000,1,1,0,CC
GO:1990777,lipoprotein particle,34,0,0.58,1.00000,1,1,0,CC
